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 General Introduction & Outline of the  Thesis 
2
Outline General Introduction
Supraventricular tachycardias (SVTs) are amongst the most commonly 
encountered cardiac arrhythmias in clinical practice in both children and 
adults.1, 2 The causative mechanisms underlying the appearance of most of 
these SVTs have however still remained as intriguing as they are unexplained. 
In this thesis, cardiac development is analyzed in relation to the etiology of 
clinical supraventricular arrhythmias with a special focus on structure-function 
relations. 
 Firstly, in PART I of this thesis, both the (patho) physiological 
development of the annulus fibrosus cordis and the etiological origin of clinical 
accessory AV pathway (AP) mediated AVRT in children and adults is analyzed in 
experimental animal models and human sections. Secondly, in PART II of this 
thesis a review of the different ontogenic theories on the embryonic development 
of the AV Node (AVN) in literature is followed by an experimental study 
postulating a new concept on the developmental origin of the AVN in relation to 
the etiology of AV Nodal Reentrant Tachycardia (AVNRT).
 As a general introduction to both these ‘basic research’ (I & II) and the 
‘clinical’ (III) parts of this thesis, structural cardiac development in avians (with 
references to equivalent mouse and human developmental timelines) (Figure 
1) will first be described since the development of the cardiac conduction 
system (CCS) and structural cardiogenesis are intimately related. Next, the 
developmental transitions in impulse propagation and the construction of the 
individual components of the specialized CCS and the AVN in particular will be 
shortly outlined. Following a description of the changes in electrocardiograms 
(ECGs) during cardiogenesis, current concepts on the transitions in ventricular 
activation sequences during embryogenesis will be discussed. Thereafter, 
contemporary knowledge on the development of the isolating annulus fibrosis, 
the key structure involved in AP persistence, in relation to general CCS 
development will be reviewed. Subsequently, relevant general characteristics 
of the different animal models and the immunohistochemical markers used 
in this thesis are briefly discussed. Following the description of the structural 
basics of cardiogenesis, attention will be focused on current knowledge of clinical 
SVTs in neonates and children and the treatment of these arrhythmias. These 
therapeutic clinical issues will be further outlined in PART III of this thesis. 
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Figure 1. Schematic overview of the major staging systems of embryonic 
development in the avian, mouse and human embryonic developmental timeline. 
Sources: Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. 
J Morphol. 1951;88:49-92, Fishman MC, et al. Development.1997;124:2099-2117, O’Rahilly R. Early 
human development and the chief sources of information on staged human embryos. Eur J Obstet 
Gynecol Reprod Biol. 1979;9:273-80, Edinburgh Human Developmental Anatomy (EHDA) Human 
versus Mouse Developmental Stage Comparison, University of New South Wales (UNSW) Carnegie 
Stage Comparison, University of New South Wales (UNSW) Chicken Developmental Stages.
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STRUCTURAL CARDIOGENESIS AND TRANSITIONS IN 
ELECTRICAL WIRING OF THE DEVELOPING HEART
..  Structural Heart Development
During cardiogenesis intriguing processes of cell recruitment, fusion, looping and 
septation, ultimately facilitate the formation of the four-chambered heart. The 
first cardiac progenitor cells can already be identified even before gastrulation in 
the epiblast layer as it is separating from the hypoblast.3, 4 These heart precursor 
cells will invaginate through the rostral half of the primitive streak and are 
amongst the first embryonic cells to gastrulate.5-9 In avians, the gastrulation 
process sets off at Hamburger-Hamilton (HH) stage 4 to 5 (human embryonic 
day (E) ~16-18, mouse ~E 7-7.5), with the recruitment of the cardiac progenitor 
cells from the primitive streak.10-13 These cells will subsequently migrate to the 
bilateral splanchic mesodermal crescent-like primary heart fields, that express 
cardiac-specific genes like Nkx2.5 and GATA 4-6,11, 14, 15 already indicating their 
potential to terminally differentiate into myocardial cells.16 
 At about HH stage 8 to 9 (human ~E 20-21, mouse ~E 8-9), the bilateral 
heart fields will fuse in the ventral midline in cephalocaudal direction to 
ultimately give rise to the primitive linear heart tube.12, 17 The process of fusion of 
the bilateral heart fields is a sequential process, since fusion of these endocardial 
primordia spatiotemporally highly depends on definitive closure of the floor of the 
developing foregut. As a consequence, the heart tube is formed in a cephalocaudal 
sequence, first forming the truncoventricular portion, then the atrium and last 
of all the sinus venosus.18-20 The ultimate straight heart tube contains an outer 
myocardium and an inner endocardium (derived from the remaining endothelial 
cells of the embryo that are recruited for vascular development) separated by an 
extracellular matrix (ECM) known as the cardiac jelly. The dorsal mesocardium, 
which will later on be separated to form the arterial and venous pole connections, 
links the primary heart tube to the dorsal body wall. Cranially the heart tube 
is connected to the pharyngeal arches and caudally to the omphalomesenteric 
veins.12, 13
 The myocardium of the tubular and later looped heart forms a single or 
double cell layer at the circular periphery and is not yet covered by epicardium. 
However already at these early stages, anisotropic arrangement of the 
cardiomyocytes is clearly evident; the inner cell layer is more differentiated21 
and along the length of the heart tube preferential circular alignment of the 
myofibrils is seen in the AV canal and outflow tract region.22
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The primitive heart tube will begin it’s rightward folding process at about HH 
stage 10 (human ~E 22, mouse ~E 8.5-9.5), first transforming in a C-shaped 
and than in a more S-shaped structure in order to facilitate adequate mature 
positioning of the cardiac chambers (e.g. positioning of the future right atrium 
above the future right ventricle).17, 23 This looping program is regulated by a 
cascade of genes of which the exact interactions are still largely unclear, but that 
are also critical for the left and right programming of the embryo itself.14, 24 
 Whilst the heart tube undergoes its dextral looping phase (HH stage 9-
34), the cardiac jelly lining the inside of the myocardium is unevenly remodeled 
over the full length of the heart tube into endocardial cushions in the AV canal 
and the outflow tract, which are subsequently invaded by mesenchymal cells 
derived from the endocardium by Epithelial-Mesenchymal-Transformation 
(EMT).25 
 During looping, the heart tube consists of several cardiac segments: 
the left and right sinus venosus horns, the primitive atrium, the ventricular 
inlet segment and the ventricular outlet segment. These segments are divided 
by so-called transitional zones, brought together in the inner curvature of the 
heart by the looping process.25 With continued looping, the cardiac chambers 
will further differentiate, a process controlled by a different subset of genes 
and transcription factors,26, 27 which subsequently results in positioning of the 
ventricles and outflow tract of the heart in an anterior/ventral position and of 
the atria in a dorsal/posterior position. Figure 2 schematically demonstrates 
the location of the transitional zones during the major developmental stages in 
cardiogenesis.
 
6
Figure 2. Schematic representation of the spatiotemporal relation of the 
transitional zones in cardiogenesis. The bilateral cardiogenic plates are derived from 
the splanchic mesoderm (a). These bilateral plates fuse in the ventral midline in cephalo-
caudal direction to form the primitive linear heart tube (b). Subsequently, the linear 
heart tube undergoes dextral looping, that transforms the heart in a C-shape and later in 
a S-shape (c). After looping, the transitional zones or rings dividing the different putative 
chambers of the heart can be recognized, being the sinu-atrial transition (SAR), the 
atrioventricular ring (AVR), the primary ring (PR) and the ventriculo-arterial transition 
(VAR) (e-f). AP=arterial pole, VP=venous pole, PA=primitive atrium, AS=arterial 
segment, VOS= ventricular outflow segment, VIS= ventricular inflow segment. Adapted 
from: Gittenberger-de Groot AC, et al. Pediatr Res. 2005;57:169-176.
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The next stage in ventricular morphogenesis involves the development of 
trabeculation, needed to increase the surface area to increase diffusion potential 
for nourishing the still avascular myocardium, allow the myocardial mass to 
increase, coordinate intraventricular conduction, enhance contractility and 
effectively route blood flow.28-30 The bulk of compact myocardium is subsequently 
formed by trabecular compaction, which coincides with the onset of ventricular 
septation and the now compulsory development of coronary circulation.29, 31
 At this time, in order to construct a mature four-chambered heart, 
septation is initiated at the level of the atrium, the ventricle and the arterial 
pole. Moreover, at the venous pole the sinus venosus becomes incorporated in 
the dorsal wall of the right and left atrium and receives the venous inflow of the 
left and right superior cardinal veins as well as the pulmonary veins.23, 32 In the 
human heart, as development proceeds, the left cardinal vein regresses becoming 
the ligament of Marshall and oblique vein, while the remaining proximal portion 
(with part of the left sinus horn) becomes the coronary sinus (CS), which will 
open via the sinoatrial foramen into the right atrium.10, 32-36 
 As a result of subsequent endocardial cushion remodeling, the AV 
cushions take part in formation of the AV septal structures and AV valves (mitral 
and tricuspid valve), while the cushion tissues in the outflow tract are essential 
for the formation of the semilunar valves of the aorta and pulmonary artery and 
contribute to outflow tract septation.35, 37 Due to the resultant formation of the 
cardiac septa and of the mitral and tricuspid valve and aortic and pulmonary 
valve, a functional four-chambered heart can now direct the future separate 
systemic and pulmonary circulation. Figure 3 summarizes the transitions in 
alignment of the cardiac segments during cardiogenesis.
8
Figure 3. Transitions in  alignment of the cardiac segments during cardiogenesis. 
A. At HH 10 the primitive heart tube begins it’s rightward folding process. B. Around HH 
17 the C-shaped heart tube is still in the midst of its looping phase. C. At HH 24, the right 
atrium becomes positioned above the right ventricle, whilst the left atrium is positioned 
above the left ventricle. D. Around HH 34 a four-chambered heart has been formed, which 
can now separate the future systemic and pulmonary circulation.
Figure 4. (right) Schematic representation of the primary linear heart tube (in brown) 
and the secondary added myocardium derived from the second heart field (in yellow).The 
second heart field is subdivided in the anterior heart field (arterial pole), the secondary 
heart field (arterial pole) and the posterior heart field (venous pole).The pro-epicardial 
organ (PEO), the source of Epicardium-Derived-Cells (EPDCs) is also derived from the 
posterior heart field at the venous pole of the heart. Cardiac neural crest cells (blue) enter 
the heart at both the arterial and venous pole. AVC=atrioventricular canal, CV=cardinal 
veins, CCS=cardiac conduction system, DOT=distal outflow tract, LV=left ventricle, 
OFT=outflow tract, PAA=pharyngeal arch arteries, ggl=ganglions, POT=proximal outflow 
tract, PV=pulmonary veins, RV=right ventricle, SAN=sinoatrial node, SV=sinus venosus. 
Adapted from: Jongbloed MRM, et al. Development of the cardiac conduction system and the possible 
relation to predilection sites of arrhythmogenesis. The Scientific World Journal. 2008;8:239-269.
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.2. Secondary & Extracardiac Contributions to the Heart
.2.. Secondary Contributions to the Heart
The major cardiac segments of the linear primitive heart tube - the left ventricle 
(LV), the AV canal (AVC) and part of the atria - are derived from the bilateral 
splanchic mesodermal primary heart fields (first heart field), as described above 
(Figure 4). The pharyngeal mesoderm provides the heart with a second cardiac 
progenitor pool (second heart field) that enters the heart at both the venous 
and arterial pole (Figure 5).38-40 The second heart field can be subdivided in the 
anterior heart field (AHF) and the secondary heart field (SHF) at the arterial 
pole41-43 and the posterior heart field (PHF) at the venous pole (Figure 4).20, 32, 
44-51
 
20
The cardiac outflow tract (OFT) myocardium and a large part of the right 
ventricle (RV) are one of the last segments of the heart to form and will be added 
to the arterial pole of the primitive heart tube. These cardiac structures arise 
from a cellular population of the pharyngeal mesoderm, which initially starts 
migrating to the conotruncal area between HH stage 7 (human ~E 20, mouse ~E 
8.0) and HH stage 13-14 (human ~E 26, mouse ~E 9.5), prior to neural crest cell 
invasion.38-40, 52 
 Cardiac progenitor cells derived from the posterior heart field added to 
the heart at the venous pole, have been shown to contribute to the formation of 
the atria, interatrial septum (IAS), pulmonary veins (PV), cardinal veins (CV), 
sinus venosus (SV) and the components of the CCS (Figure 4,5).20, 32, 40-53
Figure 5. Schematic figure depicting the contribution of the primary (pink & 
blue) and secondary (yellow) heart-forming fields. The second heart field (SHF) 
can be divided into the anterior heart field (AHF) at the arterial pole of the heart and 
the posterior heart field (PHF) at the venous pole of the heart. The Pro-Epicardial-
Organ (PEO) develops as part of the PHF (yellow). AP=arterial pole, VP=venous pole, 
PHT=primary heart tube, PAA=pharyngeal arch arteries, DAo=dorsal aorta, C=coelomic 
cavity, EC=endocardial cushions, G=gut.  Adapted from: Gittenberger-de Groot AC, et al. 
Cardiac morphogenesis. In Fetal Cardiology. 2nd ed. Yagel S, Silverman NH and Gembruch U, Eds. 
Taylor and Francis. London, 2008, in press.
2
C
hapter 
G
eneral Introduction
.2.2. Epicardium-Derived-Cells (EPDCs) 
Classically, Epicardium-Derived-Cells (EPDCs), derived from the Pro-Epicardial-
Organ (PEO), have been considered as one of the extracardiac contributors to 
the developing heart.54 In view of recent new concepts on the spatiotemporal 
addition of cells from the different heart forming fields, the true extracardiac 
origin of EPDCs can be debated.47, 54 The posterior heart field (derived from the 
splanchic mesoderm) is located at the site where the sinus venosus enters the 
pericardial cavity, which is also the site where de PEO originates.47, 55  In Figure 
6 the spatial relation of the primary and secondary (anterior and posterior) heart 
fields, the neural crest cells and the PEO is depicted.
 
Figure 6.  Spatial relation of the primary and secondary heart fields, the neural 
crest and PEO. Extracardiac contribution of the cardiac neural crest cells to the arterial 
and venous pole of the heart (blue cells). The secondary heart field is depicted in yellow. 
Adapted from: Gittenberger-de Groot AC, et al. Cardiac morphogenesis. In. Fetal Cardiology. 2nd ed. 
Yagel S, Silverman NH and Gembruch U, Eds. Taylor and Francis. London; in press.
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During embryonic development, the epicardium is formed from the 
splanchnopleural mesoderm of the PHF by formation of a cauliflower like villous 
structure known as the pericardial serosa, proepicardium or Pro-Epicardial-
Organ (or PEO) on the pericardial wall covering the SV and venous pole of the 
heart. The PEO protrudes from the pericardial mesothelium into the pericardial 
cavity in the direction of the looped heart.56-61
 Both in mammalian and avian embryos, the PEO is initially formed as 
paired bilateral symmetrical structures on the transverse septum (mouse) and 
sinus venosus (avian). In chicken, the left PEO Anlage does however not persist, 
whereas the right PEO will develop into the cauliflower like protrusion (PEO).62, 
63In avians, around HH stage 16, EPDCs will migrate to the naked heart tube 
by means of a tissue bridge which is formed between the SV and the dorsal wall 
of the AV canal of the looped heart and initially forms a mesothelial outside 
covering of the myocardium. After attachment to the myocardial surface, the 
cells start to migrate radially and start to circumvent the AV region, the inner 
curvature and the dorsal side of the outflow tract.61, 64, 65 After covering the last 
parts of the heart – the left atrium and parts of the distal outflow tract - the 
heart will be completely covered by mesothelium by HH stage 26.61 Figure 7 
schematically demonstrates the temporal relations in cardiogenesis and EPDC 
formation. 
 From HH stage 19 onwards, immediately after the onset of spreading 
of EPDCs over the myocardial surface, the epicardial mesothelial sheet will 
undergo Epithelium-to-Mesenchymal Transformation (EMT).64, 66, 67 Initially, the 
resultant mesenchymal EPDCs reside in the subepicardial matrix. In chicken 
embryos, the subepicardum is relatively thin (one to three cell layers) at the 
atrial and ventricular myocardium, while it is very thick in the AV sulcus where 
abundant EMT is needed to provide EPDCs for coronary formation.66 
 Mesenchymal EPDCs will subsequently invade the myocardium in a 
spatiotemporally regulated fashion.64, 66, 67 While the precise temporal regulation 
of EPDC migration has remained unknown, two distinct influxes into the 
myocardium of the chicken heart have been described. The first influx directly 
follows the process of EMT and formation of the subepicardium and takes 
place between HH stage 19 and HH stage 31, while the second influx takes 
place between HH stage 31 and HH stage 43. First influx EPDCs will take 
up subendocardial positions in the atrium and ventricle and will migrate into 
the myocardial interstitial spaces, whereas EPDCs from the second influx will 
mainly migrate into the AV cushions (Figure 7).64, 68
23
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From previous studies in epicardial quail-chicken chimeras, we know that at 
HH stage 35, most EPDCs will have taken up their final position: around the 
coronary arteries as smooth muscle cells (SMCs) and fibroblasts,66, 69-71 in the 
ventricular myocardium as interstitial fibroblasts,64, 68, 70 in the AV cushions68, 70 
and in the subendocardium of the ventricular trabeculae and atria.68
 Numerous studies in experimental models in which epicardial 
development has been disturbed mechanically or genetically, have proven the 
functional significance of EPDCs in cardiac development.67, 72-83 In this respect, 
EPDCs have been inferred to play crucial roles in the development of the 
coronary vasculature, the AV valves, the myocardial architecture, the peripheral 
conduction system (Purkinje fibers) and in the formation of the isolating AV 
annulus fibrosis (Figure 8)(see also Chapter 3, this thesis).
Figure 7. Temporal timeline in avian cardiogenesis and formation of 
Epicardium-Derived-Cells (EPDCs). The different stages of cardiogenesis are 
indicated by red blocks (primary heart fields, tubular heart, looped heart and septated 
heart) and schematic figures outlining the overall structure of the heart. At the bottom of 
the timeline, major events in cardiogenesis are indicated (red). Additionally, ingrowth of 
the second heart field population of cells and the extracardiac NCCs is indicated in yellow 
and blue, respectively. Contemporary processes of PEO-formation, EPDCs migration and 
myocardial invasion are indicated at the top of the timeline (green).
24
Figure 8. Schematic figure depicting EPDC fate and function.  A. In avians, around 
HH stage 16, EPDCs will migrate to the naked heart tube from the sinus venosus region 
to the dorsal wall of the AV canal of the looped heart. After attachment to the myocardial 
surface, the cells start to migrate radially and start to circumvent the atrioventricular 
region, the inner curvature and the dorsal side of the outflow tract. After covering of the 
left atrium and parts of the distal outflow tract, the heart will be completely covered by 
HH stage 26. B. The proepicardial cells migrate from the Pro-Epicardial-Organ (PEO) 
to the heart tube. After migration, epithelium-mesenchymal-transformation (EMT) and 
formation of the subepicardium, the EPDCs start migrating into the myocardium and 
differentiate into smooth muscle cells (SMCs) in the media and adventitia of the coronary 
vessels and fibroblasts in the interstitium and the fibrous heart skeleton. C. From HH32 
onwards, subepicardial EPDCs in the AV sulcus (S) migrate through the continuous AV 
junctional myocardium to ultimately populate the endocardial AV cushions (Cu). In the 
normal 4-chambered heart, EPDCs continue populating the AV cushions and favour 2 
positions: 1) the myocardial/endocardial cushion interface and 2) the subendocardially at 
the luminal face of the AV cushions. Figure A,B Adapted from: Winter EM, et al. Epicardium-
derived cells in cardiogenesis and cardiac regeneration. Cell Mol Life Sci. 2007;64:692-703. Figure C 
adapted from Kolditz DP, et al. Epicardium-Derived-Cells (EPDCs) in Annulus Fibrosis Development 
and Persistence of Accessory Pathways. Circulation 2008;117:1508-1517.
25
C
hapter 
G
eneral Introduction
.2.3. Extracardiac Contributions to the Heart – Neural Crest  
Cells (NCCs)
After looping of the single linear heart tube, the true extracardiac contributors to 
heart development, the pluripotent neural crest cells (NCCs), migrate from the 
neural crest into the arterial and venous pole of the developing heart (Figure 
6).84-86 Neural crest cells or ectomesenchymal cells have been traced to various 
parts of the embryo, including the face, thymus and the thoracic great vessels.25 
It is well established that NCCs originating from the posterior rhombencephalic 
segments of the neural tube (from the otic placode to the third somite) contribute to 
multiple aspects of cardiac development and function. However, the contribution 
of these cardiac NCCs has been suggested to be mostly instructive rather 
than constructive since the majority of NCCs are destined for apoptosis.87 The 
contribution of NCCs to the vessels of the arterial pole however is substantiated, 
since the major part of the smooth muscle cells have a NCC origin.88
 The mesenchymal NCCs first arrive at the outflow tract (arterial pole) 
and thereafter populate the inflow tract of the heart (venous pole).25 Seminal 
work using NCC extirpation and analysis of quail-chick chimeras, demonstrated 
that NCCs entering the heart through the pharyngeal arches at the arterial 
pole, contribute to the neurons of the cardiac autonomic nervous system, 
aortopulmonary septum, the tunica media of the great arteries, the outflow tract 
septum and the semilunar valves.88-97 The cardiac NCCs entering the heart at 
the venous pole, migrate to the dorsal mesenchymal protrusion forming the 
vestibular spine, from where they contribute to the base of the atrial septum 
and the condensed mesenchyme that is forming the membranous part of the 
ventricular septum.98-100 Furthermore, NCCs entering the heart at the venous 
pole have been observed in vicinity of putative elements of the CCS before they 
undergo their fate of apoptosis. 99, 101, 102 Interestingly, neural crest ablation in 
the chick was recently shown to result in a lack of differentiation of the compact 
lamellar organization of the His bundle, which separates this essential structure 
from the surrounding working myocardium.103 
26
.3. Impulse Propagation During Cardiogenesis 
.3.. Tubular Heart 
In the avian embryo, when only 7 to 10 somites have yet developed (HH stage 
9, equivalent age in human ~E 21-22 and mouse ~E 8.5), a small dominant 
pacemaking area already becomes established at the posterior inflow side of 
the heart (the presumptive atrium and SV region), well before formation of the 
tubular heart is completed and contraction is initiated.104-106 The posterior inflow 
tract myocardium thus becomes electrically active, long before the primitive 
myocardium of the heart tube acquires the ability to contract.107 
 The very first faint and slow but rhythmic contractions (approximately 
24 beats/min. in avians) will subsequently appear in the cephalic ventricular 
myocardium (first fused cardiac segment) around HH stage 10 (equivalent to 
9-10 somites, human ~E 22, mouse ~E 8.5-9.5) even before cephalocaudal 
fusion of the paired primordia is complete in the atrial region.18, 108-110 At this 
developmental stage, the atria and SV do not yet exist as a differentiated part of 
the heart, but are merely represented by endocardial primordia which are still 
widely separated from each other in the bilateral heart fields.18
 These early pulsations are however still inefficient to set the blood 
in motion through the developing blood vessels and merely consist of non-
propagating local twitchings that initially appear as fibrillar contractions along 
the right margin of the bulboventricular region and then coalesce to produce 
a concerted movement of the entire right side of the ventricle.18, 111 Next, the 
left side of the ventricle becomes involved in these twitchings and subsequently 
the entire primitive ventricle displays synchronous contractions. These early 
contractions are however not yet regularly occurring, but are interrupted by rest 
periods, which will become progressively shortened as a slow regular rhythm 
gradually becomes established.111 
 The continuing Anlage of the fusing caudal cardiac segments is 
spatiotemporally correlated to the onset of myocardial contractions with 
progressively higher intrinsic pulsation rates along the anteroposterior axis, 
reaching its peak after final fusion of the sinus primordia at the venous pole.105, 
107, 111-113 Pacemaker dominance thus spatiotemporally spreads to the different 
cardiac regions in the same sequence in which they are formed by continued 
caudal fusion of the bilateral heart fields.18
 In the completely fused primitive heart tube (HH stage 10), equivalent to 
~23 days post conception (dpc) in humans (mouse ~E 8.5), stronger and regular 
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peristaltic caudal to cranial contractions, finally facilitating the first efficient 
propulsion of blood from the venous to the arterial pole of the heart, will be seen. 
At this developmental stage, when the atrial primordia have fused, spontaneous 
action potentials are generated in a dominant area of pacemaker cells in the left 
posterior inflow-site of the heart (atria and SV region).13, 105, 111, 114-117 
 Only some time after the beginning of circulation, the SV is formed (> 
HH stage 10) and ultimately starts to dominate the pacemaking rate. At this 
stage, the cardiac impulse is efficiently conducted through the heart with a 
constant conduction velocity from the most caudal SV inflow site of the heart (or 
most posterior site), through the future atrial segment, the direct myocardial AV 
connection between the future atria and ventricles, through the ventricles and 
finally to the outflow site of the heart (or most anterior site).111
 In short, in the primary myocardium of the embryonic tubular heart, 
each myocardial cell inherently possesses intrinsic pacemaker activity, which on 
the cellular level is reflected by action potentials displaying slow depolarizations 
typical of slow voltage-gated calcium ion channels (reminiscent of pacemaker 
action potentials). The regional differences in intrinsic beat rates, reflected in 
their characteristic action potential shapes and underlying action currents, most 
likely result from the differential expression of largely unknown gene products in 
different regions of the heart that cause the individual segments to have diverse 
types and numbers of channels and pumps.118-120 In general, impulse propagation 
through the primary myocardium of the tubular heart is relatively slow, due to 
poor intercellular coupling in the embryonic myocardium at this developmental 
stage.121-123 
.3.2. Looped Heart
As the developing heart transforms from a tubular to a looped morphology, the 
pattern and speed of ventricular activation also undergo their first changes. The 
pattern of universally slow propagation along the primitive tubular heart develops 
heterogeneities in conduction properties in the different cardiac segments.124-126 
In avians, by 42 hours of development (equivalent to HH stage 11, human ~E 
23, mouse ~E 8.5) as looping proceeds, a slowly conducting AV canal is forming 
separating the synchronous activation of the atrial and ventricular segments.127-
129 Concordantly emerging are action potentials in the atrial and ventricular 
working myocardium with a fast rising phase and high amplitude, characteristic 
of fast voltage-gated sodium channels.122, 130
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As a consequence, the emerging atrium and ventricle in the looped heart 
start displaying fast conduction, while the myocardium of the AV junction is 
characterized by slow conduction, which is thought to result from a lack of fast 
sodium channels and a relative lack of the gap junctional protein connexin-43.18, 
111, 131  In the looped heart, the cardiac impulse is thus propagated with alternating 
conduction velocities form base-to-apex through the different segments of the 
looped heart resulting in a sequential contraction pattern still following the 
direction of the blood flow (from inflow to outflow tract).124
 Interestingly, the cellular electrophysiology of the embryonic AV 
junctional tissue is already quite similar to adult nodal tissues,132 e.g. it responds 
to adenosine with a reduction in action potential amplitude and dV/dtmax.
133 
Histologically, like the Sino Atrial Node (SAN) and AVN and unlike the working 
myocardium, the AV junctional myocardium is relatively devoid of connexin-
43.134 Myocytes at the AV junction preferentially however express connexin 45,135 
a low conductance gap junction channel that is also expressed in the SAN as well 
as in the AVN of the mature heart.136 
 Coincident with the emergence of ventricular trabeculation and the 
formation of the primordia of the interventricular septum (IVS),28, 137 preferential 
temporal anterior and posterior myocardial AV activation pathways can be 
identified between HH stages 16 and 24 of avian embryogenesis (human ~E 30-
42, mouse ~E 11-13).138 As development proceeds, these pathways are masked by 
the appearance of more trabeculae and will finally be superseded by functioning of 
the mature His-Purkinje system.138 The anterior activation pathway (or anterior 
septal branch), is not unique to the chick heart but has also been functionally 
demonstrated in the embryonic rat E 11.5 heart and the embryonic mouse 
heart.138, 139
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Functionally, in the looped heart the dominant pacemaking area remains 
localized in the left sinus primordium up to 5-6 days of incubation (HH stage 27-
29, human ~E 44-48, mouse ~E 13-14), with resultant left atrial depolarization 
preceding right atrial depolarization.105, 106, 140-142 Morphologically, nodal cells 
are also found in the right sinushorn around the 4th day of incubation (HH 
stage 24, human ~E 41, mouse ~E12.5) temporarily remaining functionally 
quiescent.142, 143 With the outgrowth of the right atrium, between 6 and 7 days 
of avian development (HH stage 29-31, human ~E 48-52, mouse ~E 14-15), the 
SV completes its shift to the right and becomes submerged in the right atrium. 
Around this developmental stage, the myocardium in the dorsal mesocardium 
has completely developed excluding the large veins from the atria only leaving 
contact with the non-cardiac dorsal mesoderm at the arterial and venous pole 
and impulse generation switches to the adult right position.140
 The AVN and His bundle, of mainly unestablished origin, also start to 
develop around this developmental stage.144 Additionally, the atria and ventricles 
become subjected to chamber differentiation and trabeculation and start 
expressing the inward-rectifier potassium current (IK1) stabilizing a strongly 
negative resting potential suppressing excitability, which ultimately renders 
the atria and ventricles electrically quiescent while the rate and rhythm will 
exclusively be controlled by the compact nodes.145 Concomitantly (HH 28-29), the 
IVS and AV cushions have started to fuse,146, 147 completing ventricular septation 
around HH stage 34.127
.3.3.  Septated Heart 
By the stage at which the ventricles have septated (> HH stage 34), the AVN 
and His bundle will have formed and attained their definitive positions close 
to the inferior edge of the atrial septum, while the annulus fibrosis still has to 
undergo extensive developmental changes (see also Chapters 2-5, this thesis). 
To facilitate propulsion of blood into the arterial trunks of the four-chambered 
heart, the initial base-to-apex direction of impulse propagation is reversed to 
a more mature apex-to-base oriented conduction and myocardial contraction 
(which will be further outlined in paragraph 1.6. “Transitions in Ventricular 
Activation During Cardiogenesis”).
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.4. Development of the Specialized Cardiac Conduction 
System (CCS)
The specialized Cardiac Conduction System (CCS) is comprised of separate 
subcomponents with distinct functions and has mainly been studied in avian 
embryos.141, 142 Firstly, the SAN generates the cardiac impulse and sets the 
leading pacemaker rate. The electrical impulse will subsequently be conducted 
via the internodal pathways to the AVN. After a short AV delay, the cardiac 
impulse is then rapidly transmitted to the His bundle, bundle branches and 
Purkinje fiber network.
 
.4.. The Origin of the CCS
The origin of the CCS has been a subject of debate for many years now. In 
the debate of the 19th century, both “myogenic” and “neurogenic” origins of 
the CCS were suggested. Temporarily, with the discovery of the existence of 
intraventricular neurons in the early 19th century, the balance was tipped in 
the neurogenic direction.148, 149 Again, a quite similar debate arose at the end of 
the 20th century with the demonstration of neural cell-type gene expression in 
the cells of the CCS, now proposing the neural crest cell (NCC) as a candidate 
parental population for the developing CCS.99, 150-153
 An elegant series of 20th century retroviral lineage studies has however 
unambiguously demonstrated that cardiomyocytes are the true and sole 
progenitors of the CCS cells.99, 154 Indeed, cardiomyocytes of the CCS share 
with the cardiomyocytes of the ordinary working myocardium four basic 
elements: 1) contraction, 2) autorhythmicity, 3) intercellular conduction and 4) 
electromechanical coupling.120 The still unresolved question however remains, 
if the CCS cardiomyocytes are derived from the division of differentiated (pre-
specified) conduction cells (the“specification”-model) or are recruited from a pool of 
multipotent undifferentiated cardiomyogenic cells (the “recruitment”-model).155
.4.2.  CCS Development and The 4-Ring Theory
In an attempt to distinguish the working myocardium from the myocardium of the 
specialized CCS, the observation was made that after looping of the heart tube, 
4 rings of ‘special’ tissue could be distinguished from the working myocardium, 
as was described by Wenink and others.156-158 These rings or transitional zones 
consist of: 1) the sinoatrial ring in between the SV segment and the primitive 
atrium, 2) the AV ring in between the primitive atrium and primitive left 
ventricle, 3) the primary ring or fold separating the primitive left ventricle from 
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the primitive right ventricle and 4) the ventriculo-arterial ring positioned at the 
junction of the primitive right ventricle with the truncus or putative outflow 
tract of the heart (Figure 2).
 This ‘ring-theory’, hypothesized that these 4 rings of ‘special’ tissue are 
the precursors of the CCS. During development these rings will come together 
in the inner curvature of the heart and partly loose their specialized character, 
while the remaining parts are identified as putative parts of the mature CCS.158 
Classically, in this theory, the SA ring was thought to contribute to formation of 
the SAN, the SA ring and the AV ring to contribute to the AVN and the primary 
ring to give rise to the His bundle and bundle branches.23, 25, 37, 48, 52, 158 This theory 
has however been the subject of discussion and controversy for many years. Later 
on, contemporary marker studies could again confirm the important contribution 
of the SA ring to the developing SAN and AVN by HNK-1 expression patterns 
in the developing human embryo and analysis of CCS-LacZ and MinK-LacZ 
expression in the mouse embryo identified the SA ring, AV ring and primary 
ring as important contributors to CCS development.23,25,37,48,52
.4.3. Molecular Markers for CCS Development
In the early embryonic heart, the individual cells of the CCS can hardly be 
distinguished from the surrounding myocardium by unique histological features, 
while their separate arrangement and topography can in some cases be helpful.159-
162 Histologically, in the adult heart nodal cardiomyocytes of the CCS display some 
characteristics comparable to embryonic working cardiomyocytes: they are small 
compared to the cardiomyocytes of the surrounding adult working myocardium 
and have poorly organized actin and myosin filaments and a scantily developed 
sarcoplasmatic reticulum.159
 By applying the criteria established by Monckeberg and Aschoff in 1910, 
using the AV conduction axis as the paradigm, discrete specialized conduction 
tracts in the postnatal heart: 1) are histologically distinct, 2) can be followed from 
section to section and 3) are insulated from the adjacent working myocardium 
by fibrous tissue.163 While these criteria permit adequate recognition of the 
specialized components of the CCS in the postnatal human heart, identification 
of the embryologic conduction tissues in the developing heart has remained fairly 
challenging. A multitude of transgenes, such as minK-LacZ,49 Engrailed2-lacZ/
CCS-LacZ48, 164 has however been consistently proposed to reflect the arrangement 
of the developing CCS. 
Moreover, each subcomponent of the CCS expresses a distinct set of 
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discriminating ion channels,165, 166 channel-associated proteins,167 connexins,136, 
168-172 cytoskeletal components173, 174 and transcriptional regulators,175, 176 useful for 
immunohistological recognition. Additionally, important known signaling and 
transcription factors implicated in the induction, maturation and patterning of 
the CCS including endothelin (ET),177-182 neuregulin,139, 183 Notch,183 Wnt,184 Msx,185 
Nkx,44, 186-188 Hop,189 Id-2,50 podoplanin47 and Tbx and GATA gene families190-193 
can also be of help. State-of-the-art studies focusing on the transcription factors 
involved in cardiogenesis have made evident that myocardial differentiation to 
CCS cells cannot be dependent on a single gene, but should be considered as 
a multifactorial process in which a multitude of different gene families must 
contribute.
.4.4.  The Individual Components of the CCS
.4.4.. The Sino Atrial Node (SAN)
In humans and other mammals, the first morphological signs of the developing 
SAN are present at Carnegie stage 15 (~5 weeks of human development, avians 
~HH stage 18, mouse ~E 11.5)120 in the anteromedial wall of the right common 
cardinal vein, which will ultimately give rise to the superior caval vein.160, 194
 In the adult heart, the SAN is located in the crista terminalis (representing 
the internal fusion-line of the SV and the primitive atrium) near the superior caval 
entrance into the right atrium.119, 195 During formation of the SAN, a considerable 
portion of the right horn of the SV becomes incorporated in the dorsal wall of 
the right atrium. The SAN myocardium, thus represents myocardium which 
was originally associated with the right sinus horn. Interestingly, as described 
above, in the early stages of development the sinus horns belong to the most 
caudal regions of the cardiac primordia harboring the highest cephalocaudal 
pacemaking rate.111
 While all adult heart muscle cells retain the capacity to rhythmically 
beat without an external stimulus, the cells of the SAN are those with the 
most rapid intrinsic rate of excitation (the dominant pacemaking rate).196 In 
generating the pacemaker action potential of the SAN, the hyperpolarization 
activated If  (pacemaker or “funny”) current plays a major role. Furthermore, the 
pacemaking action potential is regulated by several genes, including those for 
the T- and L-type calcium currents and the sustained inward current, producing 
a slow and diastolic depolarization.166, 197 From genetic studies in human and 
mouse we know that Hyperpolarization-activated Cyclic Nucleotide gated (HCN) 
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channels are required to generate the If current or normal pacemaking current, 
but it is however still unclear how the complex expression of HCN channels is 
induced and regulated at specific regions of the developing heart.198, 199 
.4.4.2. The Internodal Tracts
Considerable controversy and debate, lasting for almost a century, has 
surrounded the mostly semantic discussion on the existence of specialized, 
insulated internodal tracts in the atrium between the SAN and AVN. Within the 
right atrium three internodal tracts for preferential interatrial conduction have 
been demonstrated between the SAN and AVN: 1) the anterior bundle running 
through the septum spurium (SS),23,46,48 which connects to Bachmann’s bundle200-
202 running in a retroaortic position connecting the right atrium to the left atrium, 
2) the posterior bundle running through the right venous valve (RVV)23,46,48 
partly corresponding to the posterior bundle or Thorel’s bundle localized along 
the crista terminalis and 3) the posterior bundle running through the left venous 
valve (LVV)26 partly corresponding to the middle bundle or Wenckebach’s bundle. 
23, 46, 48, 158, 200-202
  Currently, it is well established that preferential conduction 
between the cardiac nodes (SAN and AVN), through the ultrastructural and 
electrophysiological heterogenic atrial myocardium, highly depends on the 
nonuniform anisotropic arrangement of the normal working myocardial fibers,203 
instead of on the existence of truly specialized insulated atrial internodal tracts. 
These non-specialized internodal atrial tracts are made up in part of transitional 
cells, which interpose between the working atrial myocardium and the 
unequivocally histologically specialized compact AV Node.204 While structurally 
these tracts have been extensively demonstrated,23, 46, 48, 49 their functionality has 
still not been shown.
.4.4.3. The Atrioventricular Node (AVN)
In the human embryo, the developing AVN becomes gradually identifiable from 
Carnegie stage 16/17 (~5/6 weeks of human development) onwards.161, 162, 205 
Early in the sixth week of human development (~HH stage 25, mouse ~E 13) 
a compact cluster of cells makes its appearance in the posterior wall of the AV 
canal, towards its right side.206 This cluster of cells is thought to represent the 
primitive AVN, which is in cellular continuity with the atrial muscle and AV 
bundle.
The architecture of the adult AV conduction axis was first described by Sunao 
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Tawara in 1906.149 In the mature heart, the compact AVN is positioned in the 
apex of the triangle of Koch at the base of the interatrial septum, where it lies 
only a few millimeters anterior to the coronary sinus (CS) ostium and directly 
beneath the right atrial septal endocardium and the septal attachment of the 
tricuspid valve where it rests on the central fibrous body, which forms the anchor 
for the septal portion of the mural leaflet of the mitral valve. The atrial margin 
of the AVN is apposed to the myocardialized vestibular spine, containing the 
tendon of Todaro, while the ventricular margin of the AVN is continuous with 
the bundle of His.207, 208
  The triangle of Koch occupies the atrial component of the muscular AV 
septum and is limited by three anatomical landmarks: 1) superiorly by the tendon 
of Todaro (the fibrous commissure of the flap guarding the openings of the inferior 
caval vein and the CS), 2) inferiorly by the attachment of the septal leaflet of the 
tricuspid valve and 3) at the base by the mouth of the CS. The apex of the triangle 
of Koch overlies the membranous component of the AV septum and lies at the 
center of the short axis of the heart.209 The triangle of Koch not only harbors the 
AV nodal tissues but also the remnants of the embryologic primordium of the 
specialized myocardium that surrounds the primary interventricular foramen 
(primary ring), extending rightward and inferiorly from the compact node.204 
 The main functions of the adult AVN are: 1) gathering the incoming 
signals from the SAN, 2) directing the signals through the AVN to the His bundle, 
3) maintaining an AV delay, 4) generating an escape rhythm when needed and 5) 
responding to the autonomic nervous system and humoral signals.210, 211
 The ontogenic development of the AV specialized tissues has, since 
the first detailed report on the AVN by Tawara in 1906, been studied for over 
100 years now. In the debate of the 20th century, competing theories based on 
observations in different species complicated by the use of variable terminology 
for identification and non-specific staining, however failed to provide a resolution 
on this subject. The developmental origin of the AVN will more extensively be 
reviewed and analyzed in Chapter 6 & 7 of this thesis.
.4.4.4. The His Bundle and Bundle Branches (His & BBs)
From the AVN, propagation of the electrical impulse is subsequently accelerated 
along the AV bundle (His bundle) and bundle branches. Around 6 weeks of 
human development (avians ~HH stage 25, mouse ~E 13), the AV bundle can 
first be found to run across the top of the thick IVS, behind and under the dorsal 
endocardial cushion. Subsequently, after 8 weeks of human development (avians 
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~HH stage 35, mouse ~E 15.5), the bundle branches arise from the terminal end 
of the His bundle.212
 The His bundle in the adult heart, as first described in the mammalian 
heart by His in 1893, originates at the posterior right atrial wall near the atrial 
septum above the AV groove and than passes over the upper margin of the 
ventricular septal muscle, where its fibers intermingle with the cardiomyocytes. 
Near the aorta it subsequently bifurcates in the right and left bundle branch, the 
later terminating at the base of the aortic leaflet of the mitral valve.149, 176, 213
 Controversy concerning the development of the His bundle has led 
to various proposals on the origin of the His bundle: 1) Viragh and Challice 
demonstrated in 1976 that the AVN and His bundle develop simultaneously,205, 
214 while 2) others found that the AVN develops first and the AV bundle arises 
later as an outgrowth of the AVN,206, 215-217 3) others have suggested that the AV 
bundle develops first and than the AVN develops as an outgrowth of its proximal 
portion218-220 and 4) in the classical ‘ring theory’, the AVN and AV bundle have 
been shown to originate independently from the AV and bulboventricular ring 
respectively and join secondarily.158, 221, 222
 
.4.4.5. The Purkinje Fibers
In the human embryo, Purkinje fibers do not appear until rather late, between 
the 10th and 15th week of development.206 The original description of the Purkinje 
fiber in 1845 by Purkinje stated that these special cells can ultrastructurally 
be identified as cardiac fibers without transverse tubules.223 Since the Purkinje 
fibers have been found to co-express both myogenic and neurogenic gene products, 
the origin of the Purkinje fiber system has also been a subject of longstanding 
controversies.
 Individual Purkinje fibers are scattered throughout the myocardium 
but can be distinguished from the working myocardium by their distinct 
electrophysiological and molecular characteristics. Functionally, these cells of 
the fast conduction system are electrically coupled to neighboring muscle cells via 
gap junctions and exhibit a faster action potential upstroke, a prolonged action 
potential duration, a higher membrane diastolic potential and greater electrical 
restitution properties in comparison to the slow conducting components of the 
CCS.178, 182, 224
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While the proximal components of the Purkinje system run subendocardially 
regardless of species, the presence and distribution of the more distal 
intramyocardial branches of the fast conduction network is highly variable among 
species.120, 174 Furthermore, in avian hearts in addition to the subendocardial 
Purkinje fibers, intramyocardial Purkinje fibers penetrate along the coronary 
artery branches (periarterial Purkinje fibers).154, 176, 182, 225, 226 
 Cell tracing studies have demonstrated that Purkinje fiber recruitment 
from the myocardium takes place at two restricted sites: periarterially and 
subendocardially.71 In this respect, recent studies have shown that Purkinje 
fiber differentiation is tightly regulated by hemodynamic alterations, while 
endothelin-1 (ET-1) and ET-converting enzyme 1 (ECE1) were identified as 
inductive molecules.179, 182, 227 Concomitant retroviral expression of mature ET-1 
and ECE1 was even shown to be sufficient for the ectopic conversion of adjacent 
cardiomyocytes into Purkinje fibers.182 Prompted by the periarterial and 
interstitial arrangement of EPDCs in the developing heart, an instrumental role 
of EPDCs in Purkinje fiber differentiation could recently also be demonstrated.68, 
77
 
Figure 9. (right) Scanning electron microscopic photographs of the developing 
chicken heart with matching electrocardiograms (adapted from Seidl W, et al. A 
few remarks on the physiology of the chick embryo heart (Gallus gallus). Folia Morphol. 
1981;29:237–242). At Hamburger Hamilton (HH) stage 11, a linear peristaltic contracting 
heart tube has developed, from which a matching sinusoidal electrocardiogram can be 
derived. At HH stage 14, a sharp downward deflection approximately 80 ms ahead of the 
QRS-complex can be recorded (presumptive inverted P-wave). When the ventricular loop 
is subsequently looped backward, around HH 18, and becomes to be positioned caudal 
to the outflow tract, the P-wave appears above the iso-electric line and an adult type 
electrocardiogram can be recorded. ap = arterial pole; A = atrium; avc = atrioventricular 
canal; oft = outflow tract; V = ventricle; vp = venous pole. Adapted and modified from Moorman 
AFM, et al. Anatomic substrates for cardiac conduction. Heart Rhythm 2005;2:875– 886.
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.5.  The Electrocardiogram (ECG) in Cardiogenesis
The youngest embryo of which a primitive ECG has been recorded, is a chick 
embryo of only 15 somites (33-36 hours of development, HH stage 9-10), a 
developmental stage at which the heart tube almost solely consists of the common 
ventricle. The ECG recorded at this developmental stage, shows a sinusoidal 
curve dropping below and above the isoelectric line, reflecting the vector of 
myocardial contractions in caudocephalic direction.111, 128, 228, 229 In Figure 9, an 
example of such a sinusoidal ECG recorded in the developing tubular chick heart 
is shown, reflecting linear and isotropic impulse conduction with constant low 
velocity resulting in the typical primitive peristaltic unidirectional contraction 
pattern.230, 231 
 With progression in caudal fusion of the cardiac primordia, the SV is 
formed and becomes positioned posterior to the atrium and a sharp downward 
deflection approximately 80 ms ahead of the QRS-complex can be recorded 
(presumptive inverted P-wave). When the ventricular loop is subsequently looped 
backward and becomes positioned caudal to the outflow tract (day 4 or HH stage 
23-24), the P-wave starts to appear above the isoelectric line (Figure 9).128 
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As described above, in the looped embryonic heart, the different cardiac 
segments will contract sequentially and conduct the electrical impulse 
with distinct conduction velocities - slow conduction in the AV canal and 
outflow myocardium and fast conduction in the future atrial and ventricular 
myocardium - from the ventricular base to the ventricular apex of the developing 
heart.124 As a consequence, the electrocardiogram of a 3 to 4 day old chick (~HH 
stage 18-22) already reveals the presence of a PR interval (AV delay) in the 
absence of a structural AVN.230, 232 In the looped embryonic heart, an adult type 
electrocardiogram including a P-wave reflecting atrial activation, an AV delay 
caused by slow conduction in the AV junctional myocardium and a QRS complex 
reflecting fast ventricular activation, can thus be recorded.107, 230 
 The first electrocardiographic tracings in the human fetal heart have 
been recorded in the 1930-ies with direct chest leads from fetuses removed by 
hysterectomy. An adult type tracing could be obtained from an embryo of between 
6 and 7 weeks of gestation (avians ~HH stage 25-30, mouse ~E 13-14) and of 
about 16 mm Crown-Romb-Length (CRL) (Figure 10). At this developmental 
stage, the AVN and His bundle are morphologically recognizable but their 
differentiation is still far from complete yet. 233, 234
 
Figure 10. The first electrocardiographic tracings in the human fetal heart, recorded 
in the 1930-ies with direct chest leads form a foetus of 6-7 weeks of gestation (avians 
~HH stage 25-29, mouse ~E 13-14) removed by hysterectomy. Adapted from: Marcel MP, 
Exchaquet JP. L’electrocardiogramme du foetus human. Arch Ml Coeur. 1938;1:52.
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.6. Transitions in Ventricular Activation During 
Cardiogenesis 
During cardiogenesis, the ventricular activation sequence changes concomitantly 
with changes in ventricular geometry and microarchitecture, from a slow 
peristaltoid base-to-apex pattern in the tubular heart, through a sequential base-
to-apex pattern in the looped trabeculated heart and ultimately to the mature 
apex-to-base sequention in the septated heart.138, 235 Generally, myocardial 
activation proceeds from the venous inflow towards the arterial outflow end of 
the heart and thus consistently follows the direction of the blood flow (Figure 
11).
 
Figure 11.  Transitions in ventricular activation sequences during cardiogenesis.
The ventricular activation sequence changes from a slow peristaltoid caudocephalic base-
to-apex pattern in the tubular heart (A), to a sequential base-to-apex pattern in the looped 
trabeculated heart due to the development of an AV delay (B&C) and ultimately to the 
mature apex-to-base sequention in the septated heart (D).
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As described above, at the earlier stages of development the heart resembles a 
tube rather than an ellipsoid with a widely separated inflow and outflow tract. 
In the tubular heart, the primitive slow caudocephalic peristaltic contractions 
are sufficient to facilitate efficient slow propulsion of blood from the venous to 
the arterial pole. 
 Subsequent configuration of the alternating slow- and fast conducting 
segments in the looped heart, inherently subjected to progressive spatiotemporal 
changes in chamber arrangement, guarantees that the downstream ventricular 
segment does not start contracting before contraction of the upstream atrial 
segment is terminated. This electrical configuration also ensures that relaxation 
of the atrial or ventricular segment does not occur before contraction of a 
downstream flanking segment. This sphincter-like prolonged peristaltic 
contraction of the slow conducting flanking segments in a way substitutes for 
the adult type of one-way valves.124
 In the septated heart, the inflow and outflow tract ultimately become 
more closely aligned at the top of the ventricles and a morphogenetic division 
between the atrial and ventricular chambers (annulus fibrosis) dissociating 
direct morphological coupling between the atrial and ventricular chambers is 
laid down, necessitating the start of ventricular activation from the apex to the 
base of the ventricle to efficiently propulse the blood towards the aortic and 
pulmonary arterial outlet. This apex-to-base sequence of ventricular activation 
is not only thought to increase ventricular pumping efficiency but is also used as 
a marker for the anatomical presence of a mature and functional His-Purkinje-
System (HPS). More precisely, apex-to-base conduction functionally marks the 
emergence of mature “apex-first” epicardial breakthrough, near the termini of 
first the right (at HH stage 29) and secondly the left bundle branch.227, 236 
 The ventricles of the mammalian looped heart are however already 
capable to contract from apex-to-base even before ventricular septation is 
completed.164, 237 In a developmental timeline, apex-to-base conduction might 
thus already be facilitated before completion of formation of the four-chambered 
heart and complete structural maturation of the His-Purkinje-System (HPS).
 Furthermore, functional activation of the working muscle of the ventricle 
and its ensuing contraction, also proceed from the right or left ventricular apex 
in the primitive heart of lower vertebrates (e.g. the African lungfish, bullfrog 
and crocodilian) in whom the existence of an anatomically distinct organized 
specialized ventricular conduction system has never been demonstrated.238-240 
Coordinated contraction of the ventricular myocardium from apex-to-base or 
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from inflow to outflow tract, the common functional principle in the ventricular 
conduction system of all species, thus already seems to be realized early in 
vertebrate evolution, suggesting the presence of non-specialized preferential 
pathways of conduction.241
 Moreover, the physiological transition in ventricular activation sequence 
is highly influenced by epigenetic factors affecting general hemodynamics. For 
instance, maturation of HPS functioning has been shown to be accelerated in the 
setting of increased pressure load at distinct developmental stages, an effect that 
is probably mediated by endothelin signaling.178, 179, 227 Conversely, bundle branch 
maturation can be delayed by a decreased workload in experimental left heart 
hypoplasia and inhibition of stretch-sensitive cation channels by gadolinium.193
 Despite the onset of preferential conduction through the central AV-
conduction axis, the occurrence of immature base-to-apex conduction in the 
developing postseptated heart is not an exceptional phenomenon (this thesis).
.7. Annulus Fibrosis Development: State-of-the-Art 
Coincidently with maturation of the His-Purkinje system, completion of 
ventricular septation and the transition to an apex-to-base ventricular activation 
sequence, the AV myocardial continuity, which is present around the entire 
circumference of the slow conducting AV junction disappears as a result of 
annulus fibrosis formation.237, 242 It is well established that this AV junctional 
myocardium is incorporated in the atrial myocardium forming the smooth 
walled lower atrial rim leading toward the valvular orifices.243 A small part of 
the AV canal myocardium however remains in situ and contributes to the AVN 
and normally this structure constitutes the only site of myocardial continuity 
with the ventricular conduction system.243
 The exact signaling processes that underlie atrial and ventricular 
myocardium dissociation are still incompletely understood and the tissues 
responsible for the formation of the annulus fibrosis have largely remained 
unknown. It is however well established that the development of this isolating 
structure involves several processes in which fusion of the endocardial AV 
cushions lining the luminal side of the primitive AV canal and the epicardially 
located AV sulcus tissue at the ventricular site of the AV junction play an 
important role.243-245 State-of-the-art in literature postulates critical roles for 
bone-morphogenetic-protein (BMP) signaling and periostin (an osteoblast 
specific factor) expression in formation of the isolating annulus fibrosis (see also 
Chapters 2-5, this thesis).246-251 Moreover, recently the important role of the 
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multipotent EPDCs, migrating through the developing AV dissociated border, in 
structural formation and electrical isolation of the annulus fibrosis was further 
established by electrophysiological studies in the EPDC-inhibited quail embryo 
(see also Chapter 3, this thesis).68, 251
 
Around the 7th week of human development, the process of AV dissociation at the 
primitive AV canal has started. From the 12th week of development onwards, the 
atrial and ventricular myocardium will be completely separated by the annulus 
fibrosis, through which the AV conduction axis should be the only remaining AV 
myocardial continuity in postnatal life (see also Chapter 5, this thesis).245, 248  
 The isolating annulus fibrosis is part of the fibrous skeleton of the heart, 
which additionally consists of the AV valve annuli, the arterial orifices and the 
central fibrous body (CFB) or trigonum fibrosum (a triangular mass of fibrous 
tissue), which connects the AV and aortic valve annuli. Ingrowth of tissue 
from the dorsal mesocardium contributes to the atrial part of the CFB and is 
continuous with the tendon of Todaro - a strip of connective tissue originating in 
the anterior CFB - directly above the junction of the AVN and bundle of His, and 
passing posteriorly through the atrial septum.252
 The ventricular part of the CFB is formed by invagination of AV sulcus 
tissue from the posterior AV sulcus towards the dorsocaudal extension of the 
bulbar ridge. In this process, a small part of endocardial AV cushion tissue 
on top of the ventricular septum is trapped and incorporated in the CFB. The 
AVN passes through the CFB beneath the endocardial cushions and becomes 
separated from the atrial tissues and directly contacts the bundle of His.252  
.8. Accessory Pathway (AP) Persistence
It is certainly not uncommon for annulus fibrosis formation to be incomplete 
at birth, resulting in postnatal AP persistence providing a possible substrate 
for clinical AVRTs. During physiological embryonic development, remnants 
of the primitive AV connections bypassing the insulating AV groove, have 
morphologically been described in the post-septated embryonic and adult quail 
(see also Chapters 2 & 3, this thesis),125, 225, 249, 251 mouse (see also Chapter 4, this 
thesis)253 and human heart (see also Chapter 5, this thesis).248, 254-260 Interestingly, 
a conducting right-sided AV myocardial continuity was demonstrated in 
postseptated CCS-LacZ transgenic mice, providing a possible explanation for 
the occurrence of functional atriofascicular bypass tracts via the moderator 
band, as a possible substrate for Mahaim tachycardias.23 Additionally, another 
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electrophyiological study in wildtype mice has demonstrated the onset of AP 
mediated AVRT at early stages of mouse development261
 The structural characteristics and electrophysiological properties of 
persistent myocardial APs have however not been studied systematically and 
will be further described in Chapters 2-5 of this thesis. 
.9. Animal Models (Used in This Thesis)
Genetic pathways that dictate cardiac development are highly conserved 
across vastly diverse species from flies to humans.27 Despite diversities of body 
structures in different species, a common genetic program for the early formation 
of a circulatory system seems to exist. The cardiovascular system seems to have 
adapted increasing complexity in order to adapt to specific environments.262, 263
Figure 12. External shape of the embryonic avian, mouse and human heart. A. 
Externally, the overall shape of the avian heart closely resembles that of the human heart 
(B), while the elipsoidal mouse heart (C) is externally differently shaped in comparison to 
the more pyramidal human and avian developing heart.
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.9..  Avians (Aves, Amniota, Diapsida)
Since the days of antiquity, the chick embryo has been a very popular model for 
studying morphology and (patho)physiology of the developing heart.28, 264 Birds 
belong to the only class of vertebrates (Aves) that consists exclusively of oviparous 
forms, which makes the avian embryo a vertebrate model always ready at hand. 
Aristotle, whose work was written toward the end of the fourth century B.C., 
described many observations on the development of birds and was probably the 
first to compare the embryology of avians with that of other vertebrates. 
 The Gallus domesticus (chick) and Coturnix coturnix japonica (Japanese 
quail) are among the most frequently used avian strains in experimental 
research. Externally, the overall shape of the avian heart closely resembles 
that of the human heart (Figure 12). While birds do not have a diaphragm, the 
relatively large size of the liver leaves little free space in the pericardial and 
peritoneal cavity, which explains the similar pyramidal shape of the avian heart 
in comparison to the human heart, which rests on the diaphragm.  
 Despite the obvious differences in size, the morphological plan of the 
avian (nonmammlian vertebrate heart) and the mammalian vertebrate heart 
is quite similar.35 In comparison to the mammalian heart, the avian heart has 
valuable advantages as a research model: 1) experimental work with avian 
embryos (eggs) is much more practical than with mammalian embryos, 2) 
avians have a very rapid reproduction cycle (5 generations/year) and a very high 
offspring production (80-90 per 100 days) and 3) the avian embryonic heart has 
a relatively large size compared to hearts of mammalian embryos at equivalent 
developmental stages.
  Furthermore, the anatomy of the avian CCS is well characterized,142, 
226, 265-268 since the components of the conduction system of the birds heart can 
be more easily recognized histologically in contrast to the conducting cells in 
the mammalian heart.269 Additionally, the electrophysiology of the avian CCS 
has also been extensively characterized using microelectrodes as well as optical 
mapping with voltage sensitive dyes.124, 131, 179, 227, 237, 266, 270, 271 Functionally, the 
ventricular activation patterns in the avian and mammalian model show 
remarkable spatiotemporal homology.227, 253, 272, 273 
 As is the case with all animal models, there are however also some 
differences in anatomy between the avian and mammalian heart: 1) the 
interventricular septum (IVS) of the bird is an entirely muscular bulky structure, 
while the upper part of the IVS in the human heart is a thin fibrous structure, 
2) the right AV valve (tricuspid valve) of avians is not a fibrous, cusped valve as 
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in mammals, but consists of a large, single, sickle shaped muscular flap and 3) 
the bird heart has a very generous subendocardial and intramural distribution 
of diffuse Purkinje cells throughout the walls and septa of both the atria and 
ventricles, which is not seen in the mammalian heart.226
 
.9.2. Mouse (Mus, Amniota, Synapsida)
Due to the increasing availability of tools for genetic manipulation, the 
mouse has become one of the most popular and most used animal models for 
studying normal and abnormal cardiac development. Enormous advances in 
mouse genetics have led to the production of numerous mutants with cardiac 
abnormalities resembling those seen in human congenital heart disease.35 Apart 
from differences in heart rate (adult mouse 300-800 bpm vs. adult human 80-
100 bpm) and size (adult mouse heart 0.5 grams vs. adult human heart 250-400 
grams), the most pronounced difference between the mouse and human heart is 
found in their overall shape (Figure 12). 
 As described above, in humans, the heart rests on the diaphragm, which 
is reflected by a more pyramidal shape and a flat dorsal (or inferior) shape. The 
heart of the four-legged mouse, in comparison, does not rest on the diaphragm 
and has more room in the pericardial cavity to more freely move around which 
is reflected in a more ellipsoidal shape. Moreover, the atria in the human heart 
are very prominent, whilst in the mouse heart the atrial chambers and atrial 
appendages are very small.35
 While the cardiac anatomy of the mouse and human heart is considered 
remarkably similar, there are however small variations: 1) the AV septum (AVS) 
of the mouse is a relatively thick and mostly muscular structure, while in the 
human heart the AVS is a thin fibrous structure known as the membranous 
septum, 2) the muscular part of the IVS in the human heart is a massive and 
compact muscular structure, while this structure in the mouse is not quite as 
compact or massive, 3) in the human but not in the mouse, there is a pronounced 
difference in the morphology of the trabeculae in the right (coarse) versus 
left (relatively thin) ventricle, 4) whereas the left atrium of the human heart 
receives four pulmonary veins, in the mouse heart the pulmonary veins join in a 
pulmonary confluence behind the left atrium and 5) in the mouse heart the left 
superior cardinal vein (LSCV) persists into postnatal life, while this structure 
regresses in the human heart and becomes the ligament of Marshall and oblique 
vein.35
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.0.  Immunohistochemical Markers (Used in This Thesis)
.0.. Atrial Myosin Light Chain 2 (MLC2a)
Atrial Myosin Light Chain 2 (MLC2a) is a protein, which is predominantly 
expressed in atrial myocardium and to a lesser extent in the ventricular 
myocardium and outflow tract of the heart.274 Embryonic and adult cardiac muscle 
express two major isoforms of myosin light chain 2, MLC2v (MYL2 – Mouse 
Genome Informatics) and MLC2a (MYLC2A – Mouse Genome Informatics). 
 During cardiogenesis, MLC2v is expressed exclusively in ventricular 
and AV junctional myocardium. Ablation of MLC2v results in disruption of 
ventricular function at embryonic day 11.5 and embryonic lethality at E 12.5.275 
MLC2a is initially expressed throughout the heart at E 7.5 (human ~E 18) and 
becomes restricted to the atria after E 12.5 (human ~E 40).274 In the embryonic 
and adult avian heart however, MLC2a expression does not become restricted 
to the atria but demonstrates an expression gradient in which the atria express 
more MLC2a in comparison to the ventricular myocardium.
.0.2. Nk2 transcription factor related locus 5 (Nkx 2.5)
Nk2 transcription factor related locus 5 (Nkx2.5), also known as Cardiac specific 
homeobox protein (Csx), is a homeodomain-containing transcription factor of the 
Nkx-2 gene family. Nxk2.5 is expressed early during embryogenesis, and although 
not exclusively found in embryonic regions destined to be heart tissue, it helps to 
define the cardiogenic field.276 In many organisms, its expression persists in the 
heart throughout development. The function of Nkx2.5 and its relatives has been 
examined in a variety of ways. For instance, the loss of the fly homologe tinman 
gene prevented the development of the dorsal vessel in flies.277 Mice without 
functional Nkx2.5 formed small hearts that failed to loop, failed to septated, had 
underdeveloped ventricles and malformed AV canals.278 These null studies are 
complemented by overexpression studies carried out in Xenopus that showed 
that increased Nkx2.5 levels lead to enlarged hearts in early embryos.279
 Mutations in the Nkx2.5 gene have also been reported in humans with 
congenital heart disease. Human individuals were found to be heterozygous for 
the mutations, indicating that the mutations are either dominant or the result 
of haploinsufficiency. The phenotypes of patients are varied. Two specific Nkx2.5 
mutations (Nkx2-5 Gln170ter and Gln198ter) have been found to lead to problems 
that included atrial septal defects, AV heart block (conduction system defects), 
and less commonly, tetralogy of Fallot, mitral valve defects, left ventricular 
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hypertrophy, pulmonary atresia, and ventricular septal defects.188 Interestingly, 
recent studies have identified the contribution of a Nkx2.5 negative myocardial 
population to the developing sinus venosus and SAN.47, 192
.0.3. Periostin
Periostin was originally isolated as an osteoblast-specific factor that functions 
as a cell adhesion molecule involved in osteoblast recruitment, attachment 
and spreading. Expression of periostin mRNA was later also found in the 
embryonic mouse and chicken heart in the endocardial cushions that ultimately 
divide the primitive heart tube in a four-chambered heart.246, 250 Additionally, 
periostin expression was found to be maintained within the valves of the adult 
mouse heart.250 Periostin is secreted during cushion mesenchym formation.280 
Expression of periostin is significantly increased in response to BMP and TGF-
b signaling in mesenchymal cells undergoing differentiation.281, 282 Induction 
of periostin expression has also been shown following myocardial infarction 
in the adult heart.283 In a recent study, a 40-fold increase in periostin mRNA 
expression in mouse hearts subjected to cardiovascular overload was described.284 
Moreover, in a rat cardiac dilatation model, a decrease in periostin expression 
was correlated with an increased survival rate and left ventricular function.285 In 
literature, periostin has been suggested to induce myocardium to transform into 
mesenchym of a mixed phenotype, which can subsequently transdifferentiate 
into cells with a fibrous identity, possibly in response to shear stress during 
cardiac development,246, 280 while at late stages of development, periostin may 
also serve to maintain the integrity of the fibrous tissues of the heart.280 At the 
boundary where myocardial cells directly interface endocardial cushion tissue 
at the AV junction, periostin expression is enhanced and myocardial cells are 
replaced over time by dense fibrous periostin-positive tissue.286  
.0.4. Connexin 43 (Cx43)
Connexin 43 (Cx43) is one of the 4 major connexins in the mammalian heart: 
connexin 40 is expressed in fast conducting cardiac tissues and in the atria,287 
connexin 45 is expressed in slow conducting pathways and in the myocardium 
of the primary heart tube,135, 136, 168 connexin 30.2 is expressed in the AVN and 
contributes to slowing of propagation of excitation in the AVN288 and connexin 
43 is expressed in the slower conducting working myocardium of the atria and 
ventricles and in the distal part of the CCS.289 The expression of connexins is highly 
variable between species and varies during different stages of development.287
48
Connexin 43 expression in the avian heart is subject to considerable controversy 
in literature. Expression of connexin 43 in the developing avian embryo has been 
demonstrated in the smooth muscle cells in the media of the vessel walls of the 
arterial outflow tract of the heart (aorta, pulmonary arteries, brachiocephalic 
arteries) and the smooth muscle cells of the coronary arteries.290, 291 Additionally, 
persistent Cx43 expression throughout development and in the mature avian 
heart has been reported in a Northern blotting study of the developing chick 
heart and persisted at significant levels.292 
 In contrast, complete absence of Cx43 expression in the myocardial tissues 
of the developing and adult chick heart has also been described in literature290, 
291 and can possibly be explained by the use of mammalian antibodies and slight 
differences in the Cx43-isoform between avians and mammals.292 Freeze-fracture 
studies of avian embryonic myocardium have indicated that its gap-junctions are 
very tiny and infrequent,293 which might have a restrictive effect on the ability 
to properly detect Cx43 in the developing avian heart. Moreover, gap-junctional 
expression seems to follow an ontogenic sequence since a developmental increase 
in the density of gap junctions in prenatal rat hearts has been observed294 and 
electrophysiological studies of isolated cell pairs from developing avian hearts 
have noted a change in the regulation of gap junctions between embryonic days 
4 (~HH 24) and 18 (~HH 44).295 
.0.5. Sodium Channel, voltage-gated, type V, alpha subunit 
(SCN5a)
The Sodium Channel, voltage-gated, type V, alpha subunit (SCN5a) gene encodes 
for the Nav1.5 sodium ion channel protein and is responsible for the rapid influx 
of sodium ions (inward sodium current, INa) that initiates and propagates the 
cardiac action potential in the heart.296, 297 The SCN5A gene is located on the 
short (p) arm of chromosome 3 at position 21. The encoded protein provides 
instructions for making a sodium channel that is abundant in heart muscle and 
is responsible for the initial upstroke of the action potential. These channels 
open and close at specific times to control the flow of sodium ions into cardiac 
muscle cells.298-300 
 SCN5a mRNA can first be detected at stage E 9.5 of mouse heart 
development, peaks at E11.5, than decreases and steadily increases from 
E17.5 onwards. Mutations in the SCN5a gene are associated with diverse 
channelopathies, such as long QT syndrome type 3 (LQT3), Brugada syndrome, 
and idiopathic ventricular fibrillation.301 
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.0.6. Periodic-Acid-Schiff (PAS)-Staining
Periodic Acid Schiff (PAS) is a staining method used for histology in Pathology. 
This method is primarily used to identify glycogen in tissues. Glycogen is a high-
molecular-weight polysaccharide that serves as a repository of glucose units for 
utilization in times of metabolic need. In PAS staining, the reaction of periodic 
acid selectively oxidizes the glucose residues and creates aldehydes that react 
with the Schiff reagent and than creates a purple-magenta color. 
 The first glycogen in the muscular tissue of chick embryos becomes 
recognizable at about the time that cardiac contraction begins (9 somite stage).302 
Unlike in mammals, little or no glycogen is found in the specialized CCS tissues 
of the avian heart, while the atrial and ventricular myocardium have a high 
glycogen content.303-306
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CLINICAL ASPECTS OF SUPRAVENTRICULAR 
TACHYCARDIAS IN CHILDREN AND ADULTS
.. Clinical SVTs in Children and Adults
Supraventricular tachycardia is the most common cardiac arrhythmia in both 
children and adults, with an estimated prevalence of 2.25 per 1000 in the normal 
population.1, 2 The prevalence of SVTs in children is estimated at one in 500 
children worldwide.307 In adults, AV Nodal Reentrant Tachycardia (AVNRT) 
accounts for approximately 80% of all SVTs,308 yet it accounts for only 5% of SVT 
cases in infants and toddlers and comprises only 13–16% of SVTs in children 
and adolescents.309  Conversely, macroreentry through an accessory AV pathway 
(Atrioventricular Reentrant Tachycardia, AVRT) accounts for  ~30 % of SVT 
cases in adults, but is by far the most common (80%) mechanism of SVT in 
children.2, 310 Much less prevalent forms of SVTs include Permanent-Junctional-
Ectopic-Tachycardia (PJET), Ectopic-Atrial-Tachycardia (EAT) and Intra-Atrial-
Reentrant-Tachycardia (IART) or Atrial Flutter. 
.2.  Symptoms of SVTs in Children and Adults
Symptoms of SVT in infancy differ from those in childhood or adolescence. 
Newborns may present with a history of fetal tachycardia, signs of left ventricular 
dysfunction or even with hydrops foetalis representing severe heart failure from 
persistent rapid fetal tachycardia (see also Chapter 9, this thesis).311, 312 Neonates 
can also present with new onset incessant and difficult to treat tachycardia at 
birth with no history of any fetal tachycardias.307 Moreover, neonates with SVTs 
are at high risk for sudden cardiac arrest, since cardiac reserve in neonates is 
very small and typical SVTs with heart rates exceeding 200/min. can lead to life 
threatening myocardial dysfunction within several days. 313  
 In infants, symptoms of SVTs are inconspicuous and masquerade those of 
many other common illnesses in infancy and include irritatebility, poor feeding, 
tachypnea, diaphoresis and poor color. Most infants with SVT have structurally 
normal hearts, while in 15% of patients tachycardia is associated with heart 
disease, drug administration or febrile illness.307 Older children and adolescents 
complain of palpitations (in excess of 150/min.), general malaise, indistinct 
pressure or discomfort in the throat, isolated headaches, fatigue, chest discomfort, 
shortness of breath or lightheadedness. Syncope is unusual and may indicate 
life-threatening arrhythmia. In adolescence, typical SVTs are characterized by a 
sudden onset (often in rest) and sudden termination of tachycardia.
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.3. Treatment of SVTs in Children and Adults
Regardless of SVT type, maneuvers that increase parasympathetic (vagal) tone, 
slow down conduction through the AVN and break the reentry circuit responsible 
for SVT, apply to all patients.  Different measures may be successful in different 
children and include placing an ice-bag around the nose and mouth or abdomen, 
immersion in ice-cold water, applying the Valsalva maneuver (take a deep breath 
and bear down), pressure on the abdomen, carotid sinus massage or blowing on 
a thumb.307
 Acute treatment with intravenous administration of adenosine as a rapid 
bolus is safe in children of all ages and usually breaks the SVT. When symptoms 
however resume, beta-blockers (e.g. propranolol), procainamide, a calcium 
blocker (e.g.verapamil) or amiodarone should additionally be administrated.314
 Chronic management of SVTs should be individualized, but in general 
prophylactic treatment with antiarrhythmic medication is prescribed to infants 
younger than 1 year of age. At the age of 1 year, this prophylactic treatment is 
temporarily discontinued in order to see if tachycardia recurs.315 Elimination of 
the arrhythmogenic substrate and permanent cure from almost all forms of SVT 
can be achieved by percutaneous radiofrequency catheter ablation (RFCA) or 
surgery.307, 316, 317
 During a RFCA procedure, the cardiac tissue is locally heated to 50-60 
˚C by alternating current (350 kHz to 1 MHz) delivered by the small metal tip 
of a RF catheter, producing a permanent small scar measuring approximately 4 
mm in diameter and 4 mm in depth.318 The initial success rates of RFCA exceed 
90%.312 In Chapter 8 of this thesis the therapeutic issues in pediatric SVT are 
further outlined.
 
.4. AV Reentrant Tachycardias  in Children and Adults
AV Reentrant Tachycardia (AVRT) is by far the most common (80%) mechanism 
of SVT in children,1, 2 and accounts for ~30% of SVTs in adults.310 
.4.. Arrhythmogenic Substrate in AVRT
AV Reentrant Tachycardia (AVRT) involves the presence of an accessory 
myocardial AV pathway (AP) that bypasses the annulus fibrosis. The overall 
incidence of APs in the general population is 0.1-0.3% and 3.4% in first degree 
relatives of patients with ventricular preexcitation on ECG.319 
 Commonly, the APs are “concealed” bypass tracts, which are capable of 
conducting solely in the retrograde direction (from the ventricles to the atria). 
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The ECG of a patient with a concealed AP during sinus rhythm is normal (no 
signs of ventricular preexcitation). Accessory pathways in patients with the 
Wolff-Parkinson-White (WPW) syndrome are however usually capable of both 
antegrade and retrograde conduction and give rise to ventricular preexcitation 
on ECG recordings during sinus rhythm.307 
 Other, less frequently encountered APs include substrates with 
decremental (nodal) properties mostly located in the septal or inferior half of the 
tricuspid valve, Mahaim fibers producing ventricular preexcitation resembling 
left bundle branch block and slow conducting APs giving rise to Permanent 
Junctional Reciprocating Tachycardia (PJRT).307
.4.2. Natural Course of AVRTs
In approximately 60% of pediatric patients, the first episode of AVRT occurs 
before birth or in infancy and appears to spontaneously resolve completely in 
two thirds of cases before the age of 1 year, while more than 80-90% of patients 
become asymptomatic after the first year of life.1, 2 Relapse during follow-up is 
however observed in 20-30% of these cases.320 A second new onset AVRT incidence 
peak is seen around the age of 8-12 years, in which case spontaneous regression 
of symptoms is only observed in approximately 20% of cases.321 
 
.4.3. Arrhythmia Mechanism in AVRT 
Orthodromic AVRT is the most common tachycardia mechanism in AVRT in 
both children and adults. In orthodromic AVRT, antegrade conduction occurs 
through the normal AV conduction system, while retrograde conduction to 
the atria occurs via the AP. Antidromic AVRT is far less common and utilizes 
the AP as the antegrade pathway of circus movement conduction. Reentrant 
tachycardia may also involve multiple APs, providing both antegrade and 
retrograde conduction.322 
 Besides an anatomical substrate two additional conditions are required 
for functional preexcitation during sinus rhythm to occur: 1) electrical coupling 
between adjacent ventricular and atrial myocytes, and 2) a higher conduction 
velocity through the AP than in the normal ventricular conduction system. Reentry 
tachycardia can occur when: 1) at least two functionally distinct conduction 
pathways are present, 2) unidirectional block is induced in one pathway and 3) 
conduction time is slow enough over the nonblocked pathway to allow recovery 
of excitability in the blocked pathway, thereby permitting retrograde conduction 
over the blocked pathway and completing the reentry circuit.322, 323 
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.4. The Wolff-Parkinson-White (WPW) Syndrome
.4.4.. Epidemiology of WPW Syndrome
The estimated prevalence of typical WPW syndrome is 0.1 to 3.1 per 1000 
persons.324, 325 Because of its intermittent pattern, the precise incidence of 
WPW is unknown.326 The incidence of WPW in males is more than twice that in 
females.324, 326-328 Additionally, in female patients, an incidence peak around the 
age of 7 years has been reported, while men are significantly younger at first 
presentation than women.326 
  The AP in WPW, known as the bundle of Kent, is usually located in the 
lateral rings of the annulus fibrosis and consists of a thin muscular segment 
that does not posses decremental properties.254, 329-331 Approximately 10% of 
patients may have two or more AV bypass tracts. Most patients with typical 
WPW syndrome demonstrate isolated ventricular preexcitation in a structurally 
normal heart.332 In a small percentage of patients with WPW, APs however occur 
in association with other cardiac abnormalities or congenital heart disease.333 
WPW is more prevalent in children with Epstein anomaly of the tricuspid valve, 
AV septal defects and ventricular septal defects, while occasionally the WPW 
syndrome may be inherited.328, 334 Moreover, coronary artery disease was found 
to be associated with WPW in 6% of patients.326
.4.4.2. Genetics in WPW Syndrome
The inherited form of WPW syndrome is an autosomal dominant trait of which the 
gene has been identified on chromosome 7q34-q36.335, 336 A point mutation in the 
PRKAG2 gene, which encodes the regulatory g-subunit of AMP-activated protein 
kinase (AMPK), results in the substitution of glutamine for arginine (R302Q).335 
These mutations cause glycogen-storage hypertrophic cardiomyopathy (HCM) 
associated with Wolff-Parkinson-White ventricular preexcitation syndrome 
and progressive cardiac conduction system disease.337 In other hereditary forms 
of ventricular preexcitation associated with glycogen storage hypertrophic 
cardiomyopathy, mutations in the Lysosome associated protein 2 (LAMP2) and 
a-galactosidase A (GLA) have been identified.338-340 
4.4.4.3. Arrhythmia Mechanism in WPW Syndrome
The macroreentry circuit in WPW syndrome is produced in the atrial muscle, 
AVN, ventricular muscle and the AP itself. This circuit facilitates continuous 
alternate depolarization of the atrial and ventricular myocardium.
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In typical orthodromic reciprocating AV tachycardia, the electrical impulse 
proceeds from the atria to the ventricles through the AVN and retrograde 
back up to the atria from the ventricle via the AP. In this type of AVRT, the 
effective refractory period of the AP exceeds that of the normal AV Nodal His-
Purkinje pathway.341 In orthodromic AVRT, the QRS complexes are narrow and 
a retrograde P wave can be seen embedded in the early portion of the T wave 
(best seen in leads II and V2).307
 Infrequently, the reentry circuit in WPW can proceed in the opposite 
direction and produce antidromic AVRT. In this type of AVRT the effective 
refractory period of the AP is shorter than that of the normal HPS pathway.341 
The ECG demonstrates very abnormally wide QRS complexes resembling those 
seen in ventricular tachycardia.307 
 
4.4.4. The WPW Syndrome ECG
The typical ECG recorded during sinus rhythm in a patients with WPW syndrome 
shows ventricular preexcitation manifested by: 1) a short PR interval, 2) a wide 
QRS complex, and 3) initial slurring (delta wave) of the QRS complex. Ventricular 
preexcitation during sinus rhythm is produced by a fast wave of depolarization, 
which prematurely enters one of the ventricles through the AP. In most patients, 
ventricular preexcitation is present at all times and all heart rates, while in 
some cases preexcitation is intermittent. In the later, preexcitation is usually 
only present at lower heart rates.322
  
4.4.5. Atrial Fibrillation in WPW Syndrome
Episodes of atrial fibrillation are reported in 20% to 30% of adult patients with 
WPW syndrome, while atrial fibrillation is uncommon in children.342, 343 These 
episodes are clinically important, since extreme rapid rates may occur over the 
bypass tract, leading to hemodynamic deterioration or ventricular fibrillation. In 
case of atrial fibrillation, the AP conducts the atrial rate to the ventricles, which 
in this case can exhibit extremely rapid rates, possibly resulting in ventricular 
fibrillation and cardiac arrest. Patients are considered to be at high risk for 
ventricular fibrillation when the shortest interval between two subsequent 
preexcited ventricular beats during atrial fibrillation is less than 220 ms .344, 345
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4.4.6. Treatment Options in WPW Syndrome
Currently, conservative treatment with class I anti-arrhythmic drugs, beta-
blockers (class II) and/or amidarone (class III) achieves a 70-80% efficacy in 
prevention of arrhythmia relapse.346 Patients with WPW syndrome should not 
be treated with medications which shorten refractoriness along the bypass tract, 
such as calcium channel blockers and digoxin.326
 After thorough evaluation of the risk/benefit ratio, radiofrequency (RF) 
ablation has been shown to also be a highly effective definitive treatment in the 
pediatric age group.346 Since the risk of fatal complications is estimated to be 
up to 0.3% in children less than 4-5 years of age, the Pediatric Radiofrequency 
Catheter Ablation Registry advises to restrict the indication for RF ablation 
to children older than 10-12 years.346 Currently, main concerns in pediatric 
RF ablation focus on X-ray exposure and possible damage to the CCS,346 in 
which respect new systems of 3D mapping or the ‘non-contact’ system and the 
introduction of cryoablation are promising.347-349 
 
.4.4.7. Sudden Infant Death in WPW Syndrome
Sudden death (SD) in ventricular preexcitation syndrome is rare with an overall 
risk rate of 0.006 per patient-year, and mostly occurs in young and otherwise 
healthy individuals and can be the first manifestation of the WPW syndrome in 
previously asymptomatic patients.256, 324, 328, 350-354 In a clinicopathological series 
on 273 SDs in children and young adults (aged < 35 years), a 3.6% prevalence 
of ventricular preexcitation syndrome was reported.355 The fatal event was not 
preceded by warning symptoms in 40% of patients and death almost invariably 
occurred at rest and often during sleep. In 50% of these SD patients additional 
isolated acute atrial myocarditis was found on histological examination.355
 Pathophysiologically, in most cases SD results from a rapid ventricular 
response to atrial fibrillation over an AP with a short refractory period.354 In 
these cases, atrial fibrillation might be triggered by a primary atrial pathology 
or be secondary to AV reentrant tachycardia (AVRT).354 Additionally, strenuous 
physical activities shorten the refractory period of the bypass tract and may 
precipitate atrial fibrillation or flutter.326
 Syncope in patients with WPW might indicate high risk of sudden death. 
Successful ablation of the AP eliminates the risk of sudden death from WPW.
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.4.4.8. Animal WPW-Models 
Most electrophysiological characteristics of APs and their role in causing AVRT 
have been obtained from clinical studies in humans. Extensive electrophysiological 
experiments in dogs have provided additional detailed insights in types A and 
B ventricular preexcitation.341 Moreover, since the mutation for familial WPW 
syndrome was identified transgenic technology has been used to generate 
transgenic models for WPW. 335, 336
 Transgenic mice overexpressing the mutated PRKAG2 gene, were 
recently found to nicely recapitulate the human phenotype of familial WPW 
syndrome and glycogen storage cardiac hypertrophy.335, 338 In this model, the 
mutated PRKAG2 gene, which encodes for the g-2 subunit of AMP-activated-
protein-kinase (AMPK), was cloned along side a powerful alpha-myosin heavy 
chain promoter. Histopathology demonstrated glycogen filled cardiomyocytes 
disrupting the annulus fibrosis and functionally giving rise to ventricular 
preexcitation. Additionally, in a similar transgenic mouse model overexpressing 
the PRKGA2 mutation, the preexcitation phenotype was reproduced and SVTs 
could be induced.356 
 Furthermore, deletion of the ALK3 gene (BMP receptor type IA), which 
encodes for the type 1a receptor for bone morphogenetic proteins (BMPs), in the 
AV canal cardiomyocytes during development causes ventricular preexcitation, 
possibly indicating an important role for the ALK3 gene in the etiology of the 
WPW syndrome.247, 357
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.5. AV Nodal Reentrant Tachycardias in Children and 
Adults
.5.. Epidemiology in AVNRT
AV Nodal Reentrant Tachycardia (AVNRT) is the most common form of SVT in 
adolescence and adulthood, while its very unusual in infants and toddlers (<5 %) 
and only school-aged children may present with AVNRT.2, 308 
.5.2. Arrhythmogenic Substrate in AVNRT
AV Nodal Reentrant Tachycardia (AVNRT) is based on the concept of AV Nodal 
conduction dichotomy, which implies that AV Nodal conduction is longitudinally 
dissociated in a slow and fast pathway. Functionally, the slow (a) and fast (b) 
pathways have distinct conduction velocities and refractory periods, while their 
precise anatomic boundaries are unknown. The fast pathway conducts rapidly 
and has a relatively long refractory period in the antegrade direction, while the 
slow pathway conducts relatively slowly and has a shorter refractory period than 
the fast pathway.358 The polemic in dual AV nodal pathways concentrates on 
confinement of the slow and fast pathway to the AVN itself or the presence of 
an upper common pathway in the adjacent atrial tissues to complete the reentry 
circuit.
 The dual input to the AVN seems to be a normal, physiological finding. 
Large studies on the inducebility of echoes or repetitive reentry in normal 
hearts do not exist. It is said that dual pathways existing in response to atrial 
extrastimulation may be found in up to 25% of patients without SVT.325 In 
arrhythmia free children with congenital heart disease, the prevalence of dual 
antegrade AV Nodal pathways was 35%.359 Moreover, dual AV Nodal physiology 
was found to be present in 62% of pediatric patients with AVNRT.349Interestingly, 
dual AV Nodal conduction pathways have been identified in up to 12% of patients 
with WPW-syndrome.360  
 The slow pathway is predominantly posteroinferiory located between 
the ostium of the CS and the septal leaflet of the tricuspid valve, while the fast 
pathway allegedly starts anterosuperiorly in the interatrial septum. These 
pathways converge onto the AVN at sites known as the posterior and anterior 
nodal inputs.361 In addition, left-sided atrial inputs were implicated and proved 
in the structurally normal human heart.362
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.5.3. Arrhythmia Mechanism in AVNRT
In patients with AVNRT, the physiological conduction properties of the slow and 
fast pathway are such that they allow for a microreentry circuit at the entrance 
of the AVN.307 
 Subforms of AVNRT based on the location of earliest atrial activation 
include: 1) the most common subform, slow-fast conduction (antegrade conduction 
over the slow pathway and retrograde conduction over the fast pathway, 81,4%), 
2) the slow-slow form (both antegrade and retrograde conduction over a slow 
pathway, 13,7%) and 3) the fast-slow form (antegrade conduction over the fast 
pathway and retrograde conduction over the slow pathway, 4,9%).363 
.5.4. The ECG in AVNRT
In patients with AVNRT, the ECG recorded during sinus rhythm is normal. An 
ECG recorded during an episode of AVNRT however shows normal but usually 
narrow QRS complexes. In these ECGs, the P waves are not clearly seen since 
activation of the atria and ventricles occurs at the same time and P waves are 
thus embedded in the QRS complexes.307 
 On electrophysiological study, the classic clinical finding of AV Nodal 
dual pathway electrophysiology – the 50 ms jump in the AH (atrium-His) interval 
for a 10 ms decrement in AA (atrium-atrium) interval during atrial stimulation- 
is applicable to 60-85% of cases with AVNRT.364, 365 A second but far less specific 
parameter to show the presence of a slow AV Nodal pathway is a PR greater 
than or equal to RR during atrial overdrive pacing. In adults with AVNRT, this 
finding is present in 93% of cases.366 
.5.5. Treatment Options in AVNRT
In the initial attempts of RF ablation for AVNRT, the fast pathway was targeted 
by application of RF energy superior and anterior to the His bundle region, 
with success rates of 80-90% but with AV block induction in as many as 21% of 
patients. Currently slow pathway ablation, first introduced by Jackman et al., 
is targeted to cure AVNRT. With this technique the slow pathway is targeted by 
placing the catheter over the posteroinferior septum in the region of the CS and 
has reached success rates of 99% in experienced centers.365, 367-371 In Chapter 8 
RF ablation in pediatric AVNRT is further outlined.
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Aim and Outline of the Thesis
This thesis focuses on structure-function relations in cardiogenesis in relation 
to clinical arrhythmia etiology. The aim of the first two parts of this thesis is 
to correlate the results of basic experimental studies in the developing avian, 
mouse and human heart to the etiology of clinical AV Reentrant Tachycardias 
(AVRT) and AV Nodal Reentrant Tachycardias (AVNRT) in both children and 
adults. In the third part of this thesis, therapeutic clinical issues in pediatric 
supraventricular tachycardia (SVT) will be outlined.
 In PART I, Chapter 2 describes the physiological development of the 
isolating annulus fibrosis and the persistence of functional APs in the postseptated 
embryonic avian heart in relation to the etiology of AVRTs in neonates and  children. 
In Chapter 3, the pathological development of the isolating annulus fibrosis was 
studied in an experimental avian model in which the outgrowth of Epicardium-
Derived-Cells (EPDCs) was delayed by an in-ovo microsurgical technique. In this 
model the persistence of APs was analyzed in relation to the etiology of AVRTs in 
adolescents and adults. Chapter 4 subsequently extrapolates the acquired avian 
data to mammalian heart development and describes the persistence of APs in 
mouse heart development as a possible anatomical substrate for perinatal SVTs. 
In Chapter 5, the postulated etiological considerations described in the previous 
‘basic experimental’ chapters are extrapolated to humans by a systematical 
immunohistochemical analysis of the physiological development of the annulus 
fibrosis in serial sections of the developing human heart at consequent stages of 
embryonic development. 
 In PART II, Chapter 6 provides a historical review of the different 
theories on the ontogenic development of the AVN in relation to AVNRT etiology. 
In Chapter 7, the developmental origin of the AVN was subsequently analyzed 
in an experimental study in the avian embryo, providing a new concept on the 
origin of the adult AV nodal region. 
 Chapter 8 in PART III, describes the treatment options, success-, 
complication- and recurrence rates for pediatric SVTs. Finally, in Chapter 9 an 
illustrative case report of incessant AP mediated SVT in a premature neonate 
with hydrops foetalis, is presented. 
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Abstract
Background. During heart development, the ventricular 
activation sequence changes from a base-to-apex to an apex-to-base 
pattern. We investigated the possibility of impulse propagation 
through remnants of atrioventricular (AV) connections in quail 
hearts. 
Methods and Results. In 86 hearts (group A, HH30-34, n=15; 
group B, HH35-44, n=65; group C, 5-6 months, n=6) electrodes were 
positioned on the left atrium (LA), right ventricular base (RVB), left 
ventricular base (LVB) and left ventricular apex (LVA). In group 
A, LVB activation preceded LVA activation in the majority of cases 
(60%; 9/15), while hearts in group B primarily demonstrated a LV 
apex-to-base activation pattern (72%; 47/65). Interestingly, in group 
B the RVB (17%; 11/65) or LVB (8%; 5/65) exhibited premature 
activation in 25% (16/65) of cases, while in 26% (17/65) the RVB 
or LVB was activated simultaneously with the LVA. Morphological 
analysis confirmed functional data by showing persistent muscular 
AV connections in embryonic hearts. Interestingly, all myocardial 
AV connections stained positive for periostin, a non-myocardial 
marker. Longitudinal analysis (HH35-44) demonstrated a decrease 
in both the number of hearts exhibiting premature base activation 
(p=0.015) as the number (p=0.004) and width (p=0.179) of accessory 
AV pathways with developmental stage in a similar time course. 
In the adult quail hearts, accessory myocardial AV-pathways were 
functionally and morphologically absent.
Conclusion. Thus, impulse propagation through persistent 
accessory AV connections remains possible at near-hatching stages 
(HH44) of development, which may provide a substrate for AV 
reentrant arrhythmias in perinatal life. Periostin positivity and 
absence of AV pathways in the adult heart, suggest that these 
connections eventually loose their myocardial phenotype, implicating 
ongoing AV-ring isolation peri- and postnatally.
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Introduction
Atrioventricular (AV) reentrant tachycardias involve the presence of an accessory 
myocardial AV pathway bypassing the insulating annulus fibrosis and are one of 
the most common arrhythmias in humans.1-3 In children, the first episode of this 
arrhythmia occurs prenatally or in the first months of life in approximately 60% 
of cases and appears to resolve spontaneously in two-thirds of cases before the 
age of one year.4, 5 The natural course in foetuses or neonates is usually benign,4 
but a radiofrequency catheter ablation procedure may be necessary to control the 
arrhythmia.6 Although a causal relationship between abnormal cardiogenesis 
and arrhythmogenesis has been hypothesized,7 the underlying mechanisms 
responsible for the development of these accessory pathways (APs) are still not 
completely understood.
 In the early tubular heart, the atrial myocardium is continuous with the 
ventricular myocardium and the blood is driven in a caudal to cranial direction 
by virtue of a slow peristaltic contraction pattern, originating from the primitive 
pacemaker in the caudal sinus venosus region8, 9 and with the endocardial 
cushions serving as primitive valves.10 Shortly thereafter, the emerging atrium 
and ventricle in the looped heart start to contract sequentially as a result of 
the development of alternating slow (sinoatrial region, atrioventricular junction 
and outflow tract) and fast (atrial and ventricular regions) conducting regions, 
while propagation of the depolarization wave keeps following the direction of 
the bloodstream.11 Ultimately however, ventricular activation shifts from this 
immature base-to-apex sequence to a mature apex-to-base pattern.12-19 
This transition in ventricular activation pattern reflects maturation of 
the His-Purkinje system (HPS) and coincides with completion of ventricular 
septation.12, 17 Importantly, and almost simultaneously, the existing AV myocardial 
continuity, which is present all around the circumference of the AV junction in 
the looped embryonic heart, disappears due to formation of the fibrous annulus.14 
Although morphologically, remnants of these AV connections, bypassing the 
insulating AV groove, have been found in post-septated embryonic and/or adult 
chick,20, 21 mouse,22 and human23-27 hearts, the electrophysiological properties 
have not been studied systematically. Recently, a conducting right-sided AV 
myocardial continuity was demonstrated in post-septated CCS-lacZ transgenic 
mice, providing a possible explanation for the occurrence of functional atrio-
fascicular bypass tracts via the moderator band causing Mahaim tachycardias.28 
The developmental mechanisms underlying the occurrence, and in many cases 
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early and spontaneous disappearance of APs in foetuses and neonates,4, 5 are 
however incompletely understood.
We hypothesized that accessory AV connections bypassing the insulating 
annulus fibrosis are embryonic remnants of myocardium that retain their 
conducting properties in post-natal life. By analyzing the ventricular activation 
sequence in embryonic and adult quail hearts with extracellular electrode 
recordings and by correlating these electrophysiological data with morphology, 
we could demonstrate that functional remnants of AV connections indeed remain 
present at late post-septational stages of embryonic heart development.
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Materials and Methods
Experimental Preparations
Fertilized eggs of the Japanese quail (Coturnix coturnix japonica) were incubated 
at 37.5°C and 80% humidity. All animal experiments were in accordance with 
the institutional guidelines of the Leiden University Medical Center. After 
termination of incubation at the desired developmental stages (HH30-34, n=15; 
HH35-44, n=65) and staging according to Hamburger-Hamilton criteria,29 the 
embryonic hearts were carefully isolated from the embryo after euthanization 
by decapitation. Additionally, 6 hearts were harvested from adult quails (5-6 
months) after cervical dislocation.
The hearts were placed into a custom-built fluid-heated temperature-
controlled tissue bath. Subsequently, the embryonic hearts were superfused 
(30±0.1°C) and the adult hearts Langendorff-perfused (65 mmHg, 37±0.1°C) with 
carboxygenated (95% O2, 5% CO2) Tyrode’s solution: NaCl 130, KCl 4, KH2PO4 
1.2, MgSO4 0.6, NaHCO3 20, CaCl2 1.5, glucose 10 (mmol/l) (pH 7.35). 
Electrophysiological Recordings – Technical Features
Unipolar extracellular recordings were performed by consistently positioning 
4 tungsten electrodes (tip: 1-2µm; impedance 0.5-1.0MΩ, WPI Inc., Berlin, 
Germany) on the left atrium (LA), right ventricular base (RVB), left ventricular 
base (LVB) and left ventricular apex (LVA)(Figure 1). Electrograms were 
recorded using a high-gain low-noise DC bio-amplifier system (Iso-DAM8A; 
WPI Inc., Berlin, Germany). The signals were band-pass- (300Hz-1kHz) and 
notch-filtered (50Hz) before being digitized at a sampling rate of  ≥ 1kHz using 
a computerized recording system (Prucka Engineering Inc., Houston TX., USA). 
Pacing was performed with a stimulator (EP-3, EP MedSystems Inc., West-
Berlin NJ, USA), providing monophasic stimuli (strength 5-10mA, width 1.0ms). 
The embryonic hearts were stimulated at the high right atrium (RA). 
00
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Figure 1. A representative HH43 embryonic heart showing recording electrode placement 
on the LA, RVB, LVB and LVA. A bipolar pacing electrode for pacing of the hearts was 
placed on the high RA. Ao=aorta, PT=pulmonary trunk, Bc=brachiocephalic artery, 
LA=left atrium, RA=right atrium, LVB=left ventricular base, RVB=right ventricular 
base, LVA=left ventricular apex
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Electrophysiological Recording Protocol
The experimental preparations were allowed to equilibrate for 10 minutes before 
starting the recording protocol. Hearts were categorized in three groups: group 
A (HH30-34, n=15), group B (HH35-44, n=65) and group C (5-6 months, n=6). 
Embryonic hearts in group A, hearts in group B with a stable spontaneous 
HR of at least 60 bpm (group B1) and hearts in group C were allowed to beat 
spontaneously, whereas hearts with a HR of <60 bpm (group B2) were stimulated 
at a fixed CL of 500 ms. 
In 15 hearts (HH38-41), after baseline recordings, 1 ml adenosine (0.3mg/
ml) was superfused on the heart to a final concentration of 0.03mg/ml(0.11�M) 
in the tissue bath, to analyze transitions in ventricular activation sequence after 
slowing conducting through the AV node.
Statistical analysis
Heart rate and AV interval were compared between groups with a 2-tailed 
Student’s t-test for normally distributed values; otherwise, the Mann-Whitney 
U test was used (AV interval group B1). The symmetry of the distribution was 
determined by measuring the Skewness value. For comparison of categorical 
variables (ventricular activation patterns, AP-number, AP-width), the c2-test 
was performed.  Results are presented as mean ± SD (range). A probability value 
of < 0.05 (2-tailed) was considered statistically significant. All analyses were 
performed with the Statistical Package for Social Studies version 11.0 (SPSS 
Inc, Chicago, Ill).
The online-only Data Supplement contains more information about methods 
(Definitions and Immunohistochemistry) used in this study. 
The authors had full access to the data and take responsibility for its integrity. 
All authors have read and agree to the manuscript as written.
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Results
Experimental Preparations
In 15 group A hearts (HH30-34), electrograms were recorded during stable heart 
rhythm of 143±30 bpm (AV interval 100±20ms). In 15 group B1 hearts (HH35-
44), the heart rate (HR) (91±36 bpm) and the AV interval (80±15ms) were not 
significantly different compared to group A (p=0.414 and p=0.415 respectively). 
During RA-pacing (120 bpm) in the remaining 50 hearts in group B2 (HH35-
44), the mean AV interval was 78±28ms (p=0.758, compared to group B1). The 6 
adult quail hearts showed a HR of 199±52 bpm and an AV interval of 80±7ms. 
Table 1 summarizes the general (electrophysiological) characteristics of the 
quail hearts. 
Left Ventricular Activation Sequence: Base-to-Apex or Apex-to-
Base ?
Since initial studies mainly reported on LV-activation patterns,12 we initially 
analyzed the relationship between LVA and LVB electrograms. Hearts in group 
A primarily showed base-to-apex LV-activation patterns (9/15; 60%), with LVB 
activation preceding LVA activation by 5±4 ms (Table 2).
In contrast, hearts in group B mainly demonstrated apex-to-base LV-
activation patterns, with LVA activation preceding LVB activation by 4±3 ms 
in 47/65 hearts (72%)(Table 2). In group B, no differences in LV-activation 
patterns were observed between hearts beating spontaneously and hearts driven 
by RA-pacing (p=0.843). Representative examples of electrode recordings in an 
embryonic heart from group A (panel a) and an embryonic heart from group B2 
(panel b) are shown in Figure 2.
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Group
Age
(HH/mnths)
SR/paced N
HR(bpm)
mean±SD (range)
AV(ms)
mean±SD (range)
A(n=15) 30 SR 5 140±33(100-184) 100±15(87-125)
31 SR 5 142±41(94-180) 93±10(82-107)
32 SR 1 175 115
33 SR 2 140±11(132-147) 137±12(129-146)
34 SR 2 141±6(137-145) 76±2(74-78)
subtotal 15 143±30(94-184)
†
100±20(74-146)
‡
B1(n=15) 35 SR 1 76 87
36 SR 2 170±5(167-174) 91±19(78-105)
37 SR 2 76±21(61-90) 74±20(60-89)
38 SR 4 76±12( 63-92) 71±9(62-81)
39 SR 3 94±17(77-112) 72±9(61-78)
40 SR 3 77±13(63-90) 94±18(78-114)
subtotal 15 91±36(41-174)
†
80±15(60-114)
*‡
B2 (n=50) 35 paced 1 120 48
36 paced 4 120 96±40(62-132)
37 paced 2 120 88±4(85-91)
38 paced 3 120 93±46(42-132)
39 paced 16 120 71±24(47-140)
40 paced 6 120 67±21(41-89)
41 paced 5 120 96±33(57-140)
42 paced 7 120 77±28(47-127)
43 paced 4 120 87±24(67-120)
44 paced 2 120 58±10(51-65)
subtotal 50 120 78±28(41-140)
*
C(n=6) 5.5 months SR 6 199±52(134-251) 80±7(71-89)
Table 1. Developmental stages of the quail hearts from both group A, B and 
C, with corresponding HRs and AV-intervals. SR=sinus rhythm, HR=heart rate, 
AV=atrioventricular interval. * p=0.758 (Student’s t-test), †p=0.414 (Student’s t-test), 
‡p=0.415 (Student’s t-test).
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LV-activation
sequence
N (%)
LVB
first
RVB
first
LVA
first
LVB or RVB = LVA
group A base-to-apex 9(60%) 6 3 - -
concurrent 5(33%) - - - 5
apex-to-base 1(7%) - - - 1
subtotal 15 6(40%) 3(20%) - 6(40%)
group B base-to-apex 7(11%) 5 2 - -
concurrent 11(17%) - 2 - 9
apex-to-base 47(72%) - 7 32 8
subtotal 65 5(8%) 11(17%) 32(49%) 17(26%)
group B1 base-to-apex 1(7%) 1 - - -
concurrent 3(20%) - - - 3
apex-to-base 11(73%) - - 9 2
subtotal 15 1(7%) - 9(60%) 5(33%)
group B2 base-to-apex 6(12%) 4 1 - 1
concurrent 8(16%) - - - 8
apex-to-base 36(72%) - 7 23 6
subtotal 50 4(8%) 8(16%) 23(46%) 15(30%)
Group C base-to-apex - - - - -
concurrent - - - - -
apex-to-base 6(100%) - - 6(100%)
-
Table 2. LV-activation sequences in both group A, B and C, with correspond-
ing locations of earliest ventricular activation. LVB=left ventricular base, 
RVB=right ventricular base, LVA=left ventricular apex
05
C
hapter 2
A
ccessory AV
 Pathw
ays in the Em
bryonic Q
uail H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
B
Figure 2. A. A representative example of electrograms recorded in a pre-septated quail 
heart at HH31 (HR 85 bpm, AV-interval 91ms), demonstrating a typical base-to-apex 
LV-activation pattern. As can be seen in the magnification, the LVB was activated 2ms 
earlier than the LVA. B. Electrograms recorded in a post-septated HH39 quail heart 
(HRpaced 120 bpm, AV-interval 113ms), representing a typical apex-to-base LV-activa-
tion pattern. The magnification shows that the LVA was activated 9ms prior to LVB acti-
vation. LA=left atrium, LVB=left ventricular base, LVA=left ventricular apex
A
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Global (LV and RV) Activation Patterns
Analysis of the more global ventricular activation patterns, including RVB 
activation, revealed that quail hearts in group A demonstrated earliest 
ventricular activation at the LVB in 40% (n=6) of cases, while the RVB was the 
site of earliest ventricular activation in 20% (n=3) of cases (Table 2).
Interestingly, even at late developmental stages of embryonic 
development (HH35-44)(group B), the LVA was the true site of earliest activation 
in only 32/65(49%) hearts, while the RVB or LVB exhibited earliest ventricular 
activation in 11(17%) and 5(8%) cases respectively. In the remaining 17/65(26%) 
hearts concurrent activation of the LVA and RVB or LVB was observed (Table 
2). Representative examples of electrogram recordings in embryonic hearts from 
group B, displaying early RVB and early LVB activation are shown in Figure 3a 
and Figure 3b, respectively.
 In post-septated hearts (group B) with earliest ventricular activation of 
the LVB (n=5) or RVB (n=11), the AV intervals were 62±15ms and 74±31ms, 
respectively (p=0.540). Activation of the ventricular base occurred significantly 
faster in quails with a global base-to-apex pattern (69±26ms) of ventricular 
activation compared to quails with an apex-to-base pattern (83±22ms)(p=0.005), 
which suggests that slow conduction through the AV node was indeed bypassed 
in these hearts.
 Additional longitudinal analysis demonstrated early activation of 
the ventricular base in 93%(14/15) of pre-septated HH30-34 hearts, while in 
60%(23/38) of post-septated HH35-39 and in only 37%(10/27) of post-septated 
HH40-44 hearts the ventricular base was prematurely activated (p=0.015).
Ventricular Activation Patterns in the Adult Heart
In all adult quail hearts (n=6) in group C (HR 199±52, AV interval 80±7ms), 
the LVA was the location of earliest ventricular activation and was activated 
5±4ms prior to the LVB or RVB. Surface ECG-recordings (n=4) did not reveal 
ventricular preexcitation: PR-intervals were not shortened (69±2ms, range 66-
71ms) and showed an isoelectric segment and QRS-complexes did not show a 
delta-wave (31±2ms, 29-33ms). A representative example of extracellular- and 
surface ECG-recordings in an adult quail heart from group C is shown in Figure 
4.
07
C
hapter 2
A
ccessory AV
 Pathw
ays in the Em
bryonic Q
uail H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Figure 3. A. A representative example of electrograms recorded in a post-septated 
HH39 quail heart (HRpaced120 bpm, AV-interval 96ms), demonstrating an apex-to-base 
LV-activation pattern (LVA activation 1ms earlier than LVB activation), with premature 
RVB activation. The RVB was activated 7ms earlier than the LVA. B. Electrograms 
recorded in a post-septated HH42 quail heart (HRpaced120 bpm, AV-interval 78ms), 
representing a base-to-apex LV-activation pattern at this late developmental stage. The 
magnification shows that the LVB was activated 6 ms prior to LVA activation. The RVB 
was also activated prior (1 ms) to the LVA. LA=left atrium, RVB=right ventricular base, 
LVB=left ventricular base, LVA=left ventricular apex.
A
B
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Effect of Adenosine on Ventricular Activation
Adenosine was administrated in 15 (HH38-41) hearts from group B, which 
resulted in a rapid (1-2 minutes) and marked increase in AV interval from 
67±18ms to 149±9ms (p<0.001) and concurrent changes in ventricular activation 
pattern (p=0.022). For instance, in 44% (4/9) of hearts with an apex-to-base global 
ventricular activation pattern (9/15,60%; AV interval 72±18ms) at baseline, the 
ventricular activation pattern switched to base-to-apex (RVB, n=2; LVB, n=1; 
AV interval 149±12 ms), while in 11% (1/9) of the cases a concurrent ventricular 
activation pattern was observed (AV interval 140ms). The ventricular activation 
sequence in hearts with a global base-to-apex pattern at baseline (5/15,33%; 
AV interval 61±15ms), remained unaltered, while the AV interval increased 
to 154±7ms. In the remaining heart (7%, AV interval 47ms) with a concurrent 
ventricular activation pattern (LVB and LVA activation simultaneously) at 
baseline, adenosine increased the AV interval to 149ms and the RVB was shown 
to be the location of earliest ventricular activation. Interestingly, in hearts 
with base-first activation, conduction through the AP also decreased markedly 
indicating intrinsic AV nodal conduction properties.
Figure 4. Extracellular and surface electrogram recordings in an adult quail heart (HR 
160 bpm, AV interval 76ms, QRS 30ms, PR 70ms). The left ventricular apex (LVA) was 
the location of earliest ventricular activation. 
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Immunohistochemical Correlations with Electrophysiological 
Data
In all 16 sectioned post-septated embryonic quail hearts (HH35-44), a MLC2a 
positive myocardial AV continuity was found at the right posteroseptal region. 
In all hearts, one or more, mostly right-sided additional AV continuities could 
be identified up until stage HH44. Left-sided continuities were frequently 
found in HH35-39 hearts (9/10,90%), while only 1/6 (17%) of HH40-44 hearts 
showed a left-sided continuity (Table 3). All APs could be followed easily from 
section to section. Interestingly, all MLC2a positive myocardial APs found in 
these embryonic post-septated hearts also stained positive for periostin, a non-
myocardial marker. In Figure 5A-H representative examples of MLC2a and 
periostin staining in a HH36 and HH39 embryonic heart are given.
Embryo
#
HH-
stage
Location of AP Cumulative (and 
individual) AP width
in µm (AP-widths)
Global Activation Pattern
1 36 RAS+RMS+ RPS+LAS+LAL 120 (30,15,30,20,25) RVB-first
2 37 RAS+RMS+RPS+RML+LPS 100 (25,15,30,15,15) LVA-first
3 37 RMS+RPS+RPM+RML 135 (25,40,30,40) RVB-first
4 38 RMS+RPS+RMP+LMS+LPL 140 (40,45,15,15,25) LVA-first
5 38 RAS+RMS+RPS+RMP+LML 120 (20,25,30,20,25) LVA-first
6 38 RMS+RPS+RPL+RMP+LPS 140 (35,30,40,20,15) RVB+LVA concurrent
7 39 RAS+RMS+RPS+RMP+LML 115 (20,35,25,20,15) LVA-first
8 39 RMS+RPS+RMP+LAS+LML 80 (15,30,15,10,10) RVB+LVA concurrent
9 39 RAS+RPS+LMS+LML+LPS 115 (30,40,15,15,15) LVB-first
10 39 RMS+RPS+RPM+LML 85 (25,35,15,10) LVB-first
11 40 RAS+RPS 45 (15,30) LVA-first
12 40 RMS+RPS+RMP 80 (25,35,20) LVA-first
13 41 RMS+RPS 40 (15,25) LVA-first
14 41 RMS+RPS 40 (20,20) LVA-first
15 42 RMS+RPS+LPS 75 (20,45,10) LVB-first
16 44 RMS+RPS 30 (10,20) RVB-first
Table 3. Location of APs, cumulative and individual width and correspond-
ing global activation patterns in the 16 morphologically analyzed embryonic 
quail hearts. AP=accessory pathway, RAS=right anteroseptal, RMS=right midseptal, 
RPS=right posteroseptal, RMP=right midposterior, RPL=right posterolateral, LAL=left 
anterolateral, LAS=left anteroseptal, LAL=left anterolateral, LMS = left midseptal, 
LPS=left posteroseptal, LPL=left posterolateral.
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Longitudinal analysis showed that with increasing developmental stage both 
the number (p=0.004) and width (p=0.179) of APs decreased. Whereas hearts at 
HH35-39 showed multiple broad APs in various locations, hearts at HH40-44 
primarily harbored small AV continuities in the right posteroseptal and right 
midseptal region, while the adult heart demonstrated complete fibrous annular 
isolation.
Morphological findings could not be directly correlated with 
electrophysiological data: right- or left-sided APs were found both in embryonic 
hearts displaying earliest ventricular activation at the RVB or LVB as in hearts 
with a concurrent or apex-to-base global ventricular activation pattern (Table 
3). Morphologically, the APs showed no discriminating features which could 
explain these different ventricular activation sequences.
Figure 5. A. Morphological findings in a representative example of a post-septated 
HH36 quail heart, which demonstrated earliest ventricular activation at the RVB. Histo-
logically, a broad region of AV-myocardial continuity was found in the RPS region of the 
MLC2a stained slides. Bar = 1000µm. B. Magnification of boxed area, in which these AV-
myocardial continuities (arrows), are shown. Bar = 100µm. C. Periostin staining (blue) 
from adjacent section, superimposed on the MLC2a stained section, showing periostin 
expression in the AV-myocardial bridges. Bar = 1000µm. D. Magnification of boxed area. 
Bar = 100µm. E. Morphological findings in a representative example of a post-septated 
HH39 quail heart, which demonstrated concurrent activation of the RVB and LVA. Histo-
logically, a small RPS AV-myocardial continuity was found in the MLC2a stained slides. 
Bar = 1000µm. F. Magnification of boxed area, in which this AP (arrow), is shown to co-
urse through the insulating annulus fibrosis. Bar = 100µm. G. Periostin staining (blue), 
showing marked periostin expression in the AP. Bar = 1000µm. H. Magnification of boxed 
area. Bar = 100µm. 
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Discussion
We analyzed ventricular activation patterns in embryonic and adult quail hearts 
using extracellular electrode recording techniques and correlated these activation 
patterns with the morphology of the insulating AV annulus. Key finding of this 
study is that although the LV-activation pattern in septated hearts changed 
from an immature base-to-apex to a mature apex-to-base pattern, premature 
activation of the RVB and LVB remained present in 51%(33/65) of post-septated 
hearts up to HH44 (hatching at HH45-46). This premature ventricular base 
activation can morphologically be explained, as shown in this study, by persisting 
accessory myocardial continuities between atrium and ventricle.
Transition of the Ventricular Activation Sequence Versus 
Persistent Early Activation of the Ventricular Base
While hearts at pre-septational stages of development (group A) primarily 
exhibited an immature base-to-apex pattern of LV-activation (9/15; 60%), hearts 
at post-septational stages of development (group B1,2) demonstrated a mature 
apex-to-base LV-activation pattern in the vast majority of cases (47/65; 72%). 
This transition from an immature base-to-apex to a mature apex-to-base LV-
activation pattern has been studied previously and is associated with maturation 
of the HPS.12, 13, 15-19 Optical mapping studies indeed showed that this transition 
marks the emergence of mature ‘apex-first’ epicardial breakthrough near the 
termini of the bundle branches and demonstrated that right and left bundle 
branch apical breakthrough sites appear at HH29 and HH35 respectively,15 
which is consistent with the transition of the LV-activation sequence occurring 
at HH35 in this study. Different from previous studies, we observed that in post-
septated hearts (HH35-44), the ventricular base could still be “prematurely” 
activated in a significant number of cases (33/65,51%). For instance, the RVB 
was activated prior to the LVA in 11(17%) cases and the LVB prior to the LVA in 
5(8%) cases, while in another 17(26%) hearts the ventricular base and LVA were 
activated simultaneously. This simultaneous activation can, given the position 
of our recording electrodes (Figure 1), most likely be explained by simultaneous 
conduction over two different pathways, being the AVN/HPS on one hand and 
an AP on the other hand. Furthermore, in 44% (4/9) of hearts with an apex-to-
base global ventricular activation pattern at baseline, the ventricular activation 
pattern switched to base-to-apex after administration of adenosine, indicating 
conduction through an AP.
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Thus, in contrast to previous studies, our data show that despite maturation 
of the HPS and transition of the LV-activation sequence from base-to-apex to 
apex-to-base, premature and direct activation of the ventricular base remained 
present in 51% of post-septated hearts at baseline.
Early Activation of The Ventricular Base in Post-Septated 
Embryonic Hearts can be Explained by Persisting AV 
Continuities
In the present study, continuities between atrial and ventricular myocardium 
were found in the posteroseptal region of the tricuspid annulus in all 16 analyzed 
post-septated quail hearts. In addition, in several hearts one or more connections 
were found mostly at the right anteroseptal and midseptal regions, while left-
sided pathways were less frequently encountered (Table 3).
The fact that left-sided APs were structurally uncommonly found 
in late post-septated embryonic hearts (HH40-44)(1/6,17%), might reflect a 
developmental time-difference in completion of left and right AV ring isolation, 
which agrees with a previous description that the left annulus fibrosis in the 
human adult heart is anatomically usually well formed and nearly always 
complete, in contrast to the poorly formed and at many sites deficient right 
annulus fibrosis.23 Further supported by the demonstrated difference in AV 
interval between hearts with earliest ventricular activation at the RVB (74±31 
ms) versus the LVB (62±15 ms)(p=0.540), it may be speculated that different 
developmental mechanisms can be anticipated to cause the appearance of right- 
and left-sided APs.
Normal Development of the Isolating AV ring: Possible Fate of 
Persisting AV Connections and Periostin Expression
In the looped embryonic heart, the AV junction constitutes one of the slow 
conducting regions of the heart responsible for the sequential contraction 
pattern at this developmental stage.11, 30 The subsequent separation of the atria 
and ventricles is thought to be caused by the fusion of the epicardially located 
AV sulcus with the endocardially situated AV cushions at the ventricular site 
of the junction.31 The processes underlying atrial and ventricular myocardium 
dissociation are however still incompletely understood and the tissues responsible 
for the formation of the annulus fibrosis have yet remained mainly unknown. 
Epicardium Derived Cells (EPDCs) migrating through the developing AV 
dissociated borderline have been followed in their differentiation and shown to 
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become fibroblasts of the fibrous heart skeleton.32 During formation of the annulus 
fibrosis, the embryonic slow conducting AV junctional myocardium becomes 
incorporated in the definitive atrium.31, 33, 34 With completion of this AV isolation, 
the primitive AV myocardial connections make way for conduction through the 
AVN/HPS, which eventually constitutes the only remaining conduction pathway 
of the adult heart.35 Since the sulcus and cushion tissue fuse at the ventricular 
side of the AV junctional myocardium,31, 33, 34 we postulate that the myocardium 
of the APs found in the post-septated quail hearts consists of primitive remnants 
of the slow conducting AV junctional myocardium in the looped heart. This is in 
ample agreement with the relatively slow conduction through these pathways as 
found in our current study compared to the higher conduction velocity through 
the AVN/HPS and the decrease in conduction velocity through the AP after 
administrating adenosine.
Interestingly, in the present study anatomical AV myocardial continuities 
were found both in embryonic hearts exhibiting base-first activation as in those 
with a concurrent or apex-first activation pattern. Based on morphological data, 
we were unable to find any discriminating factors that can explain why some 
of the morphologically demonstrated APs in retrospect gave rise to premature 
ventricular activation and others did not. We propose that inter-embryonic 
variance in conduction properties of the AV connections on one hand and of 
the AVN/HPS on the other hand can be held responsible for this observation. 
Poor cellular coupling, a slow upstroke of the action potential and perhaps “zig-
zag conduction” or an unfavorable source-sink relationship at the ventricular 
insertion side may all contribute to the very slow conduction or even conduction 
block at the AP causing preferential activation via the AVN/HPS.36-38 In précis, 
the presence of an AP is required to give rise to ventricular preexcitation, but 
their mere presence does however not assure the existence of a faster route for 
anterograde AV conduction. The high prevalence of functional APs in hearts 
at late post-septational stages however strengthens the hypothesis that APs 
causing AV reentrant tachycardias in neonates are remnants of primitive AV 
myocardium.
Periostin was originally isolated as an osteoblast-specific factor that 
functions as a cell adhesion molecule involved in osteoblast recruitment, 
attachment and spreading. Expression of periostin mRNA was later also found 
in the embryonic mouse and chicken heart in the endocardial cushions that 
ultimately divide the primitive heart tube in a four-chambered heart.39, 40 Periostin 
is secreted during cushion mesenchym formation41 and has been suggested to 
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induce myocardium to transform into mesenchym of a mixed phenotype, which 
can subsequently transdifferentiate into cells with a fibrous identity, while at 
late stages of development periostin may also serve to maintain the integrity 
of the fibrous tissues of the heart.41, 42 At the boundary where myocardial cells 
directly face endocardial cushion tissue at the AV junction, periostin expression 
is enhanced and myocardial cells are replaced over time by dense fibrous 
periostin-positive tissue.43 Periostin is also abundantly present in epicardium 
and EPDCs.
 Based on our observations that 1) the functionality, number and width 
of persisting APs decreased with developmental stage, 2) the persistent APs 
all stained positive for periostin and 3) APs were functionally and structurally 
absent in the adult quail heart, we assume that periostin expression in persistent 
myocardial APs perinatally results in inhibition of the myocardial phenotype by 
transdifferentiation of these myocytes into fibrous tissue. This implicates that 
these AV connections will thus disappear within the first weeks to months after 
birth. 
This postulated ongoing process of isolation of the AV ring postnatally 
provides a good etiological explanation for the clinical observation that AV 
reentrant tachycardias in human neonates spontaneously disappear before the 
age of 1 year in the majority of cases,4, 5 which is further strengthened by the 
previously reported remarkable morphological transformations of the sinus 
node, AVN and bundle of His, which similarly commences about 1-2 weeks after 
birth.44-46 Furthermore, local failure or a delay in this remodeling process until 
adolescence or adulthood, may explain the occurrence of reentrant tachycardias 
later in life.46
Limitations of the Study
It was the aim of this study to investigate whether AV conduction remains 
possible via remnants of AV connections in post-septated hearts despite the well 
known maturation of the HPS. Although we indeed showed that early activation 
of the ventricular base is present in a large number of post-septated hearts, 
which can be explained by the demonstrated persisting connections between 
atrial and ventricular myocardium, we did not demonstrate that the strands 
of tissue found by immunohistochemical staining were indeed the structures 
responsible for the recorded premature ventricular activation. For this, detailed 
mapping of impulse propagation via these connections and 1:1 correlation with 
morphology in all hearts will be necessary.
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Furthermore, in order to meet the metabolic demands of the older embryonic 
hearts we performed our experiments, similar to others,11 at subphysiological 
temperatures (30°C). Although this might have had an effect on our measurements 
(e.g. slower heart rates or longer conduction times), the recorded AV intervals, 
time-differences between apex and base activation and the developmental stage 
at which the transition in LV-activation sequence occurred, were comparable to 
previous studies.12, 13, 15, 17, 18
Conclusions
AV myocardial pathways bypassing the AVN remain present and functional 
in hearts at late post-septational stages of embryonic development and may 
provide a physiological substrate for AV reentrant tachycardias in peri- and 
postnatal life. However, since 1) the number of embryonic hearts with premature 
ventricular base activation decreased significantly with developmental stage, 2) 
a decrease in both AP-number and AP-width was observed in a similar time-
course, 3) persistent APs stained positive for periostin and 4) APs were proven 
to be structurally and functionally absent in the adult heart, it is likely that 
these AV connections will disappear within the first weeks to months after birth. 
Further research should clarify the processes causing the disappearance or 
persistence of these APs more precisely.
Funding Sources
None
Disclosures
None
7
C
hapter 2
A
ccessory AV
 Pathw
ays in the Em
bryonic Q
uail H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
References
1. Ko JK, Deal BJ, Strasburger JF, Benson DW. Supraventricular tachycardia 
mechanisms and their age distribution in pediatric patients. Am J Cardiol. 
1992;69(12):1028-1032.
2. Kolditz DP, Blom NA, Bökenkamp R, Bootsma M, Zeppenfeld K, Schalij 
MJ. Radiofrequency catheter ablation for treating children with cardiac 
arrhythmias: favourable results after a mean of 4 years. Ned Tijdschr Geneeskd. 
2005;149(24):1339-1346.
3. Morady F. Catheter ablation of supraventricular arrhythmias: state of the art. J 
Cardiovasc Electrophysiol. 2004;15(1):124-139.
4. Bauersfeld U, Pfammatter JP, Jaeggi E. Treatment of supraventricular 
tachycardias in the new millennium--drugs or radiofrequency catheter ablation? 
Eur J Pediatr. 2001;160(1):1-9.
5. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for 
supraventricular tachycardia in neonates and infants. Am Heart J. 1996;131(1):66-
72.
6. Kolditz DP, Blom NA, Bökenkamp R, Schalij MJ. Low-energy radiofrequency 
catheter ablation as therapy for supraventricular tachycardia in a premature 
neonate. Eur J Pediatr. 2005;164(9):559-562.
7. Janse  MK, Anderson RH, van Capelle FJ, Durrer D. A combined 
electrophysiological and anatomical study of the human fetal heart. Am Heart J. 
1976;91(5):556-562.
8. Kamino K. Optical approaches to ontogeny of electrical activity and related 
functional organization during early heart development. Physiol Rev. 
1991;71(1):53-91.
9. Patten BM. The initiation of contraction in th embryonic chick heart. Am J Anat. 
1933;53(349-375).
10. Patten BM. Initiation and early changes in the character of the heart beat in 
vertebrate embryos. Physiol Rev. 1949;29(1):31-47.
11. de Jong F, Opthof T, Wilde AA, Janse MJ, Charles R, Lamers WH, Moorman AF. 
Persisting zones of slow impulse conduction in developing chicken hearts. Circ 
Res. 1992;71(2):240-250.
12. Chuck ET, Freeman DM, Watanabe M, Rosenbaum DS. Changing activation 
sequence in the embryonic chick heart. Implications for the development of the 
His-Purkinje system. Circ Res. 1997;81(4):470-476.
8
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
13. Chuck ET, Meyers K, France D, Creazzo TL, Morley GE. Transitions in 
ventricular activation revealed by two-dimensional optical mapping. Anat Rec. 
2004;280(2):990-1000.
14. Moorman AF, Lamers WH. Molecular anatomy of the developing heart. Trends 
Cardiovasc Med. 1994;4:257-264.
15. Reckova M, Rosengarten C, deAlmeida A, Stanley CP, Wessels A, Gourdie 
RG, Thompson RP, Sedmera D. Hemodynamics is a key epigenetic factor in 
development of the cardiac conduction system. Circ Res. 2003;93(1):77-85.
16. Rothenberg F, Nikolski VP, Watanabe M, Efimov IR. Electrophysiology and 
anatomy of embryonic rabbit hearts before and after septation. Am J Physiol 
Heart Circ Physiol. 2005;288(1):H344-351.
17. Rothenberg F, Watanabe M, Eloff B, Rosenbaum D. Emerging patterns of cardiac 
conduction in the chick embryo: waveform analysis with photodiode array-based 
optical imaging. Dev Dyn. 2005;233(2):456-465.
18. Sedmera D, Reckova M, Bigelow MR, deAlmeida A, Stanley CP, Mikawa T, 
Gourdie RG, Thompson RP. Developmental transitions in electrical activation 
patterns in chick embryonic heart. Anat Rec. 2004;280(2):1001-1009.
19. Sedmera D, Reckova M, Rosengarten C, Torres MI, Gourdie RG, Thompson 
RP. Optical mapping of electrical activation in the developing heart. Microsc 
Microanal. 2005;11(3):209-215.
20. Davies F. The conducting system of the bird’s heart. J Anat. 1930;64:129-146.
21. Lieberman M, P. The electrophysioloical Organization of the Embryonic Chick 
Heart. J Gen Physiol. 1965.
22. Rentschler S, Vaidya DM, Tamaddon H, Degenhardt K, Sassoon D, Morley 
GE, Jalife J, Fishman GI. Visualization and functional characterization of the 
developing murine cardiac conduction system. Development. 2001;128(10):1785-
1792.
23. Becker AE, Anderson RH, Durrer D, Wellens HJ. The anatomical substrates 
of wolff-parkinson-white syndrome. A clinicopathologic correlation in seven 
patients. Circulation. 1978;57(5):870-879.
24. Klein GJ, Hackel DB, Gallagher JJ. Anatomic substrate of impaired antegrade 
conduction over an accessory atrioventricular pathway in the Wolff-Parkinson-
White syndrome. Circulation. 1980;61(6):1249-1256.
25. Ohnell RF. Preexcitation, a cardiac abnormality. Acta Med Scand. 1944;152:1-
167.
9
C
hapter 2
A
ccessory AV
 Pathw
ays in the Em
bryonic Q
uail H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
26. Peters NS, Rowland E, Bennett JG, Green CR, Anderson RH, Severs NJ. The 
Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the 
accessory atrioventricular pathway. Eur Heart J. 1994;15(7):981-987.
27. Wood FC. Histologic demonstration of ccessory muscular connections between 
auricle and ventricle in a case of short P-R interval and prolonged QRS complex. 
Am Heart J. 1943;25:454-462.
28. Jongbloed MR, Wijffels MC, Schalij MJ, Blom NA, Poelmann RE, van der Laarse 
A, Mentink MM, Wang Z, Fishman GI, Gittenberger-de Groot AC. Development 
of the right ventricular inflow tract and moderator band: a possible morphological 
and functional explanation for Mahaim tachycardia. Circ Res. 2005;96(7):776-
783.
29. Hamburger V, Hamilton HL. A series of normal stages in the development of the 
chick embryo. 1951. Dev Dyn. 1992;195(4):231-272.
30. Argüello C, Alanís J, Pantoja O, Valenzuela B. Electrophysiological and 
ultrastructural study of the atrioventricular canal during the development of the 
chick embryo. J Mol Cell Cardiol. 1986;18(5):499-510.
31. Wessels A, Markman MW, Vermeulen JL, Anderson RH, Moorman AF, Lamers 
WH. The development of the atrioventriclar junction in the human heart. Circ 
Res. 1996;78:110-117.
32. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG, 
Poelmann RE. Epicardium-derived cells contribute a novel population to the 
myocardial wall and the atrioventricular cushions. Circ Res. 1998;82(10):1043-
1052.
33. Di Lisi R, Sandri C, Franco D, Ausoni S, Moorman AF, Schiaffino S. An 
atrioventricular canal domain defined by cardiac troponin I transgene expression 
in the embryonic myocardium. Anat Embryol. 2000;202(2):95-101.
34. Kim JS, Virágh S, Moorman AF, Anderson RH, Lamers WH. Development of the 
myocardium of the atrioventricular canal and the vestibular spine in the human 
heart. Circ Res. 2001;88(4):395-402.
35. Lev M, Lerner R. The theory of Kent; a histologic study of the normal 
atrioventricular communications of the human heart. Circulation. 1955;12(2):176-
184.
36. Cranefield PF, Wit AL, Hoffman BF. Conduction of the cardiac impulse. 3. 
Characteristics of very slow conduction. J Gen Physiol. 1972;59(2):227-246.
37. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge 
N, Lahpor JR. Slow conduction in the infarcted human heart. ‘Zigzag’ course of 
activation. Circulation. 1993;88(3):915-926.
20
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
38. Jalife J, Sicouri S, Delmar M, Michaels DC. Electrical uncoupling and impulse 
propagation in isolated sheep Purkinje fibers. Am J Physiol. 1989;257(1 Pt 2):
H179-189.
39. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. 
Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse 
heart during valve formation. Mech Dev. 2001;103(1-2):183-188.
40. Norris RA, Kern CB, Wessels A, Moralez EI, Markwald RR, Mjaatvedt CH. 
Identification and detection of the periostin gene in cardiac development. Anat 
Rec. 2004;281(2):1227-1233.
41. Kern CB, Hoffman S, Moreno R, Damon BJ, Norris RA, Krug EL, Markwald RR, 
Mjaatvedt CH. Immunolocalization of chick periostin protein in the developing 
heart. Anat Rec. 2005;284(1):415-423.
42. Ji X, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T. Patterns of gene expression 
associated with BMP-2-induced osteoblast and adipocyte differentiation of 
mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab. 2000;18(3):132-
139.
43. Litvin J, Zhu S, Norris R, Markwald R. Periostin family of proteins: therapeutic 
targets for heart disease. Anat Rec. 2005;287(2):1205-1212.
44. James TN. Sudden death in babies: new observations in the heart. Am J Cardiol. 
1968;22(4):479-506.
45. James TN. Cardiac conduction system: fetal and postnatal development. Am J 
Cardiol. 1970;25(2):213-226.
46. James TN. Normal and abnormal consequences of apoptosis in the human 
heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 
1994;90(1):556-573.
2
C
hapter 2
A
ccessory AV
 Pathw
ays in the Em
bryonic Q
uail H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Clinical Perspective
The embryogenesis of the structures involved in AV conduction is as intriguing 
as it is unexplained. Nonetheless, knowledge of the anatomical substrates 
resulting in accessory pathway mediated tachycardia has progressed from being 
of purely scientific interest to being integral to the management of patients who 
suffer from them. Within a short time, the primary heart tube transforms into 
a four chambered heart. Whereas initially sequential activation is caused by 
slow conduction over the circumferential AV continuity, the AV ring becomes 
isolated in later stages and conduction runs through the AVN/His-Purkinje 
system (HPS). As a result, ventricular activation changes from an immature 
base-to-apex pattern in pre-septated hearts to a mature apex-to-base sequence 
in post-septated hearts. Abnormal development of the annulus fibrosis resulting 
in accessory pathways may cause AV reentrant arrhythmias. Because these 
arrhythmias frequently occur in fetuses and neonates, we hypothesized that during 
normal development, primitive AV connections bypassing the annulus fibrosis 
remain present even after development of the HPS. We indeed demonstrated 
that the annulus fibrosis in post-septated prenatal quail hearts is still far from 
complete, resulting in functional AV myocardial pathways. We speculate that 
AV ring isolation continues postnatally implicating disappearance of accessory 
AV connections within the first weeks after birth, which provides an etiological 
explanation for the clinical observation that AV reentrant tachycardias in human 
neonates spontaneously obliterate before the age of 1 year in the majority of 
cases. Local failure or a delay in this remodeling process of the isolating AV 
ring until adulthood may explain the occurrence of AV reentrant tachycardia, a 
prevalent adult arrhythmia, later in life.
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Online Data Supplement
Materials and Methods
Experimental Preparations
Fertilized eggs of the Japanese quail (Coturnix coturnix japonica) were 
incubated blunt end up at 37.5°C and 80% humidity. All animal experiments 
were in accordance with the institutional guidelines of the Leiden University 
Medical Center. After termination of incubation at the desired developmental 
stages (HH 30-34, n = 15, group A; HH 35-44, n = 65, group B) and staging 
according to Hamburger-Hamilton criteria,1 the embryonic hearts were carefully 
isolated from the embryo under a dissecting microscope (Wild Heerbrugg, M3, 
Switzerland) after euthanization by decapitation. Additionally, 6 hearts were 
harvested from adult quails (5-6 months) after cervical dislocation.
The hearts were placed into a custom-built fluid-heated temperature-
controlled superfused tissue bath (epoxy). The bottom of the tissue bath was 
covered with agarose (InvitrogenTM Life Technologies) to allow fixation of the 
hearts with fine wires through non-cardiac tissue at the inflow and outflow sides 
of the heart. The embryonic hearts (30±0.1°C) were superfused and the adult 
hearts Langendorff-perfused (65mmHg, 37±0.1°C) with carboxygenated (95% O2 
and 5% CO2) Tyrode’s solution with the following composition (mmol/l): NaCl 130, 
KCl 4, KH2PO4 1.2, MgSO4 0.6, NaHCO3 20, CaCl2 1.5, glucose 10 (pH 7.35). 
Electrophysiological Recordings – Technical Features
Unipolar extracellular recordings were performed by positioning 4 tungsten 
electrodes (tip diameter; 1-2 µm; impedance 0.5-1.0 MΩ, World Precision 
Instruments Inc., Berlin, Germany) on the surface of the hearts, using 
microscopic guided micromanipulators (Wild Heerbrugg, M7A, Switzerland). In 
all experiments, the electrodes were consistently positioned on the left atrium 
(LA), the right ventricular base (RVB), left ventricular base (LVB) and left 
ventricular apex (LVA), as shown in Figure 1. An Ag/AgCl electrode in the 
tissue bath served as reference electrode.
Electrograms were recorded using a high-gain low-noise DC bio-amplifier 
system (Iso-DAM8A; World Precision Instruments Inc., Berlin, Germany) with 
4 isolated preamplifier modules with an input impedance of >1012 �. The signals   
were band-pass- (300 Hz-1 kHz) and notch-filtered (50Hz) before being digitized 
at a sampling rate of  ≥1 kHz using a computerized recording system (Prucka 
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Engineering Inc., Houston TX., USA) and stored on optical disks for offline 
analysis. 
Pacing was performed with a stimulator (EP-3 clinical stimulator, 
EP MedSystems Inc., West-Berlin NJ, U.S.A.), providing monophasic stimuli 
(stimulus strength 5-10 mA, stimulus width 1.0 ms). The embryonic hearts were 
stimulated through a bipolar tungsten electrode (interelectrode distance 125 
microns (World Precision Instruments Inc., Berlin, Germany)) mounted on a 
small custom-built carbon-fiber manipulator at the high right atrium (RA) with 
a cycle length (CL) of 500 ms (slightly shorter than the observed spontaneous 
sinus CL). Stable capture of the RA was judged by 1:1 left atrial electrical 
activity. Similarly, 1:1 atrioventricular conduction was objectified by a sequential 
and stable relationship between atrial and ventricular electrical activity. In all 
experiments, electrical activity was confirmed visually by mechanical activity 
(contraction) of the atria and ventricles.
 Surface ECGs in adult quail hearts were recorded by placing 3 silver wire 
electrodes (0.5 mm) in a triangle in the petri-dish. The electrodes were glued in 
position and connected to one of the isolated preamplifier modules with an input 
impedance of >1012 � of a high-gain low-noise DC bio-amplifier system (Iso-        
DAM8A; World Precision Instruments Inc., Berlin, Germany). The ECGs were 
digitally recorded as bipolar between two electrodes (Prucka Engineering Inc., 
Houston TX., USA) continuously during and simultaneously with extracellular 
electrogram recordings. 
Electrophysiological Recording Protocol
As described above, recording electrodes were positioned on the LA, RVB, LVB 
and LVA in all experiments. The preparations were allowed to equilibrate for 10 
minutes before start of the recording protocol. 
Hearts were categorized in three groups: group A (HH30-34, n=15), group 
B (HH35-44, n=65) and group C (5-6 months, n=6). Embryonic hearts in group 
A, hearts in group B with a stable spontaneous HR of at least 60 bpm (group B1) 
and hearts in group C were allowed to beat spontaneously, whereas hearts with 
a HR of <60 bpm (group B2) were stimulated at a fixed CL of 500 ms. 
Because of its negative dromotropic effects on the atrioventricular (AV) 
node,2, 3 adenosine was used to analyze transitions in ventricular activation 
sequence after slowing atrioventricular conduction through the AVN. Since the 
onset of pharmacological sensitivity of embryonic chick hearts for the negative 
chronotropic effect of adenosine is reported to occur on embryonic day 7 (HH 
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stage 31) and does not exert its full effect until day 12 (HH stage 38),3 we 
postulated that sensitivity for the full dromotropic effect would occur around the 
same developmental stage of embryonic development as the chronotropic effect 
does and therefore conducted these experiments in embryonic hearts of at least 
HH stage 38. Furthermore, we analyzed the effect of adenosine on ventricular 
activation sequence only in post-septated embryonic quail hearts driven by 
external pacing to exclude possible bias in our results as a result of the negative 
chronotropic effect of adenosine on the sinoatrial (SA) node.2
Adenosine was administered in 15 hearts (HH 38-41) by slowly adding 1 
ml adenosine (0.3 mg/ml) on the embryonic quail heart in a petri-dish containing 
10 ml Tyrode’s solution to a final concentration of 0.03 mg/ml (0.11 �M). 
The steepest negative deflection of the unipolar electrogram was taken as 
the local activation time. Local depolarization time was consequently calculated 
from each of the four digitized recorded electrograms using the sample-point 
average of 10 consecutive beats.
Definitions
The variability in measuring local depolarization time for 10 consecutive beats 
was associated with a mean standard deviation of 0.4 ms (range 0.2-0.9 ms). 
Therefore, a mean difference in local depolarization time between two recording 
electrodes of ≥ 1 ms was considered to be significant. As a consequence, the left 
ventricular activation sequence was denominated as 1) base-to-apex if the LVB 
depolarized ≥ 1 ms earlier than the LVA, 2) apex-to-base if the LVA depolarized 
≥ 1 ms earlier than the LVB and 3) concurrent if the time difference between 
LVB and LVA activation was < 1 ms.
 In all experiments, a stable 1:1 relation between atrial activation and 
ventricular activation was assured to be present. The time difference between LA 
activation and the location of earliest ventricular activation was denominated as 
the AV interval both in embryonic hearts beating in sinus rhythm as in hearts 
driven by RA-pacing. The number of different APs in each heart was denominated 
as the AP-number, while the cumulative width (in �m) of all the APs in each 
heart was denominated as the AP-width.
Immunohistochemistry
After completion of the electrophysiological recordings, the hearts were removed 
from the Tyrode’s solution and fixated in a 4% paraformaldehyde solution for 
24 hours, dehydrated and embedded in paraffin. Subsequently, 16 preparations 
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of post-septated quail hearts which displayed variable ventricular activation 
sequences (Table 3) and one adult quail heart were serially sectioned in the 
frontal plane at 5 µm and 7 µm respectively, and transferred to albumin/glycerin-
coated objective slides. 
After deparaffinization and rehydration, the adult sections were prepared 
for standard Haematoxylin-Eosin (HE) staining and the embryonic sections were 
treated with 0.3% H2O2 in phosphate buffered saline (PBS) for 20 minutes to 
smother endogenous peroxidase activity. Routine immunohistochemical staining 
was performed by overnight incubation with the primary antibody; rabbit primary 
antibodies against Myosin-Light-Chain 2 atrium (MLC2a)4 diluted 1:5000 and 
against periostin5, 6 diluted 1:200 in PBS with 0.05% Tween-20 and 1% Bovine 
Serum Albumin (BSA) (Sigma Aldrich, USA) in a humified chamber. 
After rinsing in PBS and PBS-Tween, the sections were incubated 
with Goat-anti-Rabbit IgG labeled with biotin (GAR-Biotin) diluted 1:200 and 
Goat-serum diluted 1:66 in PSB-Tween for 40 minutes. Goat-serum was used 
to block aspecific binding of the secondary antibody. After rinsing in PBS and 
PBS-Tween, the sections were incubated with ABC-reagent, which consisted 
of reagent A diluted 1:100 and reagent B diluted 1:100 in PBS for the MLC2a 
sections and reagent A diluted 1:50 and reagent B diluted 1:50 in PBS for the 
periostin sections, in a humified chamber for 40 minutes. After rinsing with 
PBS, PBS-Tween and tris/maleate pH 7.6, the sections were incubated with 3,3’-
diaminobenzidin (DAB) in a concentration of 400 mg/l with 4 droplets of H2O2 
acting as a catalyzer, for 5 minutes. After incubation with DAB, the sections 
were rinsed with H2O-demi and counterstained with 0.1% Heamatoxylin (Merck, 
Darmstadt, Germany) for 10 seconds. Finally, the sections were rinsed with tap 
water for 10 minutes, dehydrated and mounted in Entellan.
MLC2a is a protein, which is predominantly expressed in atrial 
myocardium and to a lesser extent in the ventricular myocardium and outflow 
tract of the heart. Anti-MLC2a is a polyclonal antibody raised in rabbit against 
mouse MLC2a.4 This antibody was a gift from Dr. S.W. Kubalak (Charleston SC, 
USA). Probably due to a large homology of MLC2a in mice and avians, preliminary 
studies showed that this antibody could also be used in quails. Periostin is a 
member of the fasciclin gene family and acts as a cell adhesion protein that is 
expressed during cushion mesenchyme formation and throughout valvulogenesis 
and is thought to function in the organization of extracellular matrix molecules, 
providing cues necessary for attachment and spreading during the epithelial-
to-mesenchymal transitions (EMT) of the endocardial epithelium.5, 6 At post-
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septational stages of avian heart development, periostin is predominantly found 
in the fibrous regions of the heart.5 Anti-periostin is a polyclonal antibody raised 
in rabbit. This antibody was a gift from Prof. Dr. R.R. Markwald (Charleston, 
SC, USA).
Morphometric analysis of the AP-width (in �m) was performed by 
determining the number of frontally sectioned slides in which the AP could be 
followed multiplied by 5�m (slide thickness).
Statistical Analysis
Results are presented as means ± SD (range). c2-test, Student’s t-test and Mann-
Whitney’s test were used to compare variables. P-values of < 0.05 were considered 
statistically significant.
The authors had full access to the data and take responsibility for its integrity. 
All authors have read and agree to the manuscript as written.
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Abstract
Background. The developmental mechanisms underlying the 
persistence of myocardial accessory atrioventricular pathways (APs) 
bypassing the annulus fibrosis are mainly unknown. In this study, 
the role of Epicardium-Derived-Cells (EPDCs) in annulus fibrosis 
formation and the occurrence of APs were investigated.
Methods and Results. EPDC-migration was mechanically 
inhibited by in-ovo microsurgery in quail embryos. In-ovo 
electrocardiograms (ECGs) were recorded in wildtype (n=12) and 
EPDC-inhibited (n=12) hearts at Hamburger-Hamilton (HH) stages 
38-42. Subsequently, in these EPDC-inhibited hearts (n=12) and in 
additional wildtype hearts (n=45) (HH38-42) ex-ovo extracellular 
electrograms were recorded. Electrophysiological data were 
correlated with differentiation markers for cardiomyocytes (MLC2a) 
and fibroblasts (periostin). In-ovo ECGs showed significantly 
shorter PR-intervals in EPDC-inhibited (45±10ms) compared to 
wildtype hearts (55±8ms, 95% C.I. 50-60 ms, p=0.030), while the 
QRS-durations were significantly longer in EPDC-inhibited hearts 
(29±14ms vs.19±2ms, 95% C.I 18-21 ms, p=0.011). Furthermore, 
ex-ovo extracellular electrograms (HH38-42) displayed base-first 
ventricular activation in 44%(20/45) of wildtype hearts, whereas in 
all EPDC-inhibited hearts (100%, 12/12) the ventricular base was 
activated first (p<0.001). Small, periostin and MLC2a-positive APs 
were found mainly in the posteroseptal region of both wildtype and 
EPDC-inhibited hearts. Interestingly, in all (n=10) EPDC-inhibited 
hearts, additional large periostin-negative and MLC2a-positive APs 
were found in the right and left lateral free wall coursing through 
marked isolation defects in the annulus fibrosis until the last stages 
of embryonic development. 
Conclusions. EPDCs play an important role in annulus fibrosis 
formation. EPDC-outgrowth inhibition may result in marked defects 
in the fibrous annulus with persistence of large APs, resulting 
in ventricular preexcitation on ECG. These APs may provide a 
substrate for postnatally persistent reentrant arrhythmias.
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Introduction
Accessory atrioventricular (AV) pathway mediated reentrant tachycardia 
(AVRT) is a common arrhythmia in humans.1 It is well established that these 
accessory pathways (APs) consist of threads of abnormal cardiac musculature, 
crossing the fibrofatty AV grooves.2 The AP in itself is however an enigma, since 
the etiological mechanisms underlying the appearance of these AV continuities 
remain as intriguing as they are unexplained. 
 It has long been thought that tissues of the endocardial AV cushions 
and epicardial AV grooves play a key role in the development of the electrically 
inert annulus fibrosis, thereby creating the isolating barrier between the atrial 
and ventricular tissues necessary for normal sequential activation of the heart.3, 
4 Recently, it was suggested that bone morphogenetic protein (BMP) signaling5 
and periostin induced AV junctional myocardial remodelling6-8 play a critical role 
in configuration of the isolating annulus as well. 
 It is not uncommon that at birth annulus fibrosis formation is not 
completed and consequently APs can be found in embryonic wildtype quail 
hearts at near-hatching stages of embryonic development despite proper His-
Purkinje-System (HPS) conduction and concurrent annulus fibrosis maturation.6 
These APs can persist for some time and provide the anatomical substrate for 
neonatal AVRTs, usually resolving spontaneously during the first year of life.6, 
9 The etiology of persistent AVRTs into childhood or adult life is however not 
fully understood, nor have the cell types and/or instructive signaling routes 
responsible for normal annulus fibrosis formation been fully elucidated.
 Epicardium-Derived-Cells (EPDCs) migrating through the developing 
AV dissociated border may be crucial for proper annulus fibrosis formation, since 
the spatiotemporal expression of pro-collagen-I, a marker for collagen type-I 
synthesis, closely resembles the migratory patterns of EPDCs,10-12 while abundant 
expression of periostin at the AV junction appears to be spatiotemporally co-
localized with these cells.8, 10 Moreover, periostin was recently found to co-localize 
and directly interact with collagen type-I in murine skin and heart valves.13
 EPDCs originate from the proepicardium, which in avians initially develops 
as an outgrowth of the ventral wall of the intraembryonic splanchnopleural 
coelomic epithelium covering the sinus venosus.14 After approximately 3 days 
of incubation (Hamburger-Hamilton (HH)15 stage 16-18), the proepicardium 
transforms into a cauliflower-like cluster of vesicles - in avians generally referred 
to as the proepicardial organ (PEO)16 - enabling proepicardial cells to migrate 
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over the myocardium to form the pericardium and epicardial monolayer.14 A 
population of EPDCs is subsequently generated in the subepicardium resulting 
from epicardium-to-mesenchymal-transformation (EMT).16, 17 Most EPDCs are 
generated in the intersegmented grooves,10, 17-20 subsequently migrating through 
the continuous AV junctional myocardium to populate the endocardium-derived 
AV cushions.10-12 
 We hypothesize that EPDCs have an inductive role in annulus fibrosis 
formation, suggesting that postnatal APs may persist when EPDC-migration is 
inhibited.  In wildtype and in in-ovo PEO-outgrowth inhibited quail embryos at 
postseptated stages of embryonic development, AV conduction was studied and 
correlated with annulus fibrosis morphology.  
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Methods
Experimental Preparations 
Animal experiments were approved by the Committee on Animal Welfare of the 
Leiden University and conducted in compliance with the Guide for the Care and 
Use of Laboratory Animals (NIH Publication No.85-23, revised 1996). Fertilized 
eggs of the Japanese quail (Coturnix coturnix japonica, Leiden University) were 
incubated blunt end up at 37.5°C(80% humidity). Embryos were staged according 
to the Hamburger-Hamilton (HH) criteria.15
Outgrowth of the proepicardium was inhibited by performing in-ovo 
microsurgery, as described by Männer.21 In short, on the third day of incubation 
(HH15-18), a small piece of eggshell membrane is inserted between the dorsal 
wall of the heart and the pericardial villi, cranially anchored in the sinu-atrial-
sulcus and caudally constrained by the coelomic wall (Figure 1).
In-Ovo Electrocardiogram (ECG) Recordings 
After termination of incubation at the desired developmental stages (HH38-42), 
a subset of quail eggs (EPDC-inhibition, n=12; wildtype, n=12) was prepared 
for in-ovo electrocardiogram (ECG) recording. The ECGs were digitally recorded 
(Prucka Engineering Inc., Houston TX., USA) continuously for 10-15 minutes in 
a small custom-built shielded incubator (37±0.1ºC). In-ovo ECGs were evaluated 
by two independent observers.
 After completion of ECG-recordings, euthanization by decapitation and 
subsequent staging, the embryonic hearts were isolated and prepared for ex-ovo 
extracellular electrogram recordings.
Ex-Ovo Extracellular Electrogram Recordings 
Extracellular electrograms were recorded at HH38-42 in 45 wildtype and 12 
EPDC-inhibited hearts during superfusion with oxygenated Tyrode solution, as 
previously described.6  Definitions, immunohistochemistry, morphometry and 
statistical analysis are described in detail in the online-only Data Supplement. 
The authors had full access to the data and take responsibility for its integrity. 
All authors have read and agree to the manuscript as written. 
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Figure 1. Representative example of the mechanical EPDC-inhibition technique in a 
HH16 quail embryo. A piece of eggshell membrane (EM) is placed between the right ven-
tricle (RV) and the Pro-Epicardial-Organ (PEO). Nile blue staining was used to visualize 
transparent structures. SAS=Sinu-Atrial-Sulcus, CW=coelomic wall, DAo=dorsal aorta, 
A=atria. 
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Results
In-Ovo Electrocardiogram (ECG) Recordings
The heart rate (RR-interval) was similar in wildtype (n=12) and EPDC-inhibited 
(n=12) hearts (RR 246±29bpm vs. 252±39bpm,p=0.648). In 3/12 (25%) EPDC-
inhibited hearts (group B2) ECGs showed overt ventricular preexcitation 
reflected by: 1) short non-isoelectric PR-intervals, 2) initial slurring (delta-wave) 
and 3) resultant lengthening of the QRS-complexes. In these EPDC-inhibited 
hearts, the PR-interval during sinus rhythm was significantly shorter (33±12ms 
vs. 55±8ms,p=0.004), while the QRS-intervals were significantly longer (50±9ms 
vs.19±2ms,p=0.004) compared to wildtype hearts. EPDC-inhibited hearts 
in group B1 (n=9) demonstrated slightly shortened PR-intervals (50±6ms vs. 
55±8ms,p=0.165) and lengthened QRS-intervals (22±3ms vs. 19±2ms,p=0.064) 
compared to wildtype hearts. In EPDC-inhibited hearts the PR- and QRS-
intervals were negatively correlated (Spearman’s =r -0.314, p=0.320).
 
Figure 2. A. In-ovo ECG-recordings in a wildtype HH40 heart (group A). B. Recordings 
in an EPDC-inhibited HH40 heart (group B1) with a shortened PR-interval. C. Recor-
dings in a HH41 EPDC-inhibited heart with overt preexcitation (group B2). 
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The ECG-evaluations of two independent observers were in agreement: P-values 
of 0.830 (PR), 0.344 (RR) and 0.187 (QRS) indicated no significant difference 
between the observers. Representative examples of in-ovo ECG-recordings in 
a wildtype HH40 heart (group A), an EPDC-inhibited HH40 heart (group B1) 
and a HH41 EPDC-inhibited heart with overt preexcitation (group B2) are 
shown in Figures 2A, B and C, respectively. Table 1 summarizes the general 
electrophysiological (in-ovo and ex-ovo) characteristics of all analyzed quail 
hearts.
In-Ovo Electrocardiograms (ECGs)
Group, HH-stage n RR(bpm) PR(ms) QRS(ms)
Group A (wildtype) 12 246±29(210-287)* 55±8(46-74)
†§#*** 19±2(17-26)
‡§** ****
        HH38 3 214±4(210-217) 50±2(48-52) 18
        HH40 1 271 46 19
        HH41 4 255±27(222-287) 55±5(51-62) 18±1(17-19)
        HH42 4 254±30(212-280) 61±10(50-74) 22±3(20-26)
Group B (EPDC-inhibition) 12 252±39(212-333)* 45±10(20-57)
† || 29±14(15-60)
‡ ||
   Group B1 9 257±43(213-333) 50±6(41-57)
#
22±3(15-25)
**
        HH38 2 213 52±1(51-52) 21±4(18-23)
        HH39 2 231±1(230-232) 51±9(44-57) 20±7(15-25)
        HH40 2 308±35(283-333) 44±4(41-46) 23±3(21-25)
        HH41 2 263±46(231-296) 50±6(46-54) 22
        HH42 1 282 55 25
   Group B2 (overt preexcitation) 3 238±23(212-257) 33±12(20-40)
***
50±9(42-60)
****
        HH40 1 256 39 42
        HH41 2 229±24(212-246) 30±14(20-40) 54±9(47-60)
Ex-Ovo Electrograms
Group, HH-stage n HR(bpm) AV-interval(ms) Premature V-base activation
Group C  (wildtype) 45 111±17(63-120)
*****
79±26(41-140)
******
20/45(44%)    RVB(10),LVB(7), =(3)
Group C1 (sinus-rhythm) 10 82±15(63-112) 78±15(63-111)
*******
3/10(33%)      RVB(1), =(2)
        HH38 4 76±12(63-92) 71±9(62-81) 0/4(0%)
        HH39 3 94±17(77-112) 72±9(61-78) 2/3(67%)        =(2)
        HH40 3 77±13(63-90) 94±18(78-114) 1/3(33%)        RVB(1)
Group C2 (Ω-rhythm) 35 120 79±28(61-114)
*******
17/35(49%)    RVB(9),LVB(7), =(1)
        HH38 3 120 93±46(42-132) 3/3(100%)      RVB(2),LVB(1)
        HH39 16 120 72±24(47-140) 11/16(69%)    RVB(6),LVB(4), =(1)
        HH40 6 120 67±21(41-89) 1/6(17%)    LVB(1)
        HH41 5 120 96±33(57-140) 0/5
        HH42 5 120 92±25(65-127) 2/5(40%)        RVB(1),LVB(1)
Table 1. Electrophysiological (In-Ovo and Ex-Ovo) Characteristics of Wild-
type and EPDC-Inhibited Hearts. *p=0.648(Student t test);†p=0.030(Mann-Whitney 
U test);‡p= 0.011(Mann-Whitney U test);§Pearson’s r=0.790,p=0.002;||Spearman’s r=-
0.314,p=0.320;#p=0.165(Mann, Whitney U test),**p=0.064(Mann-Whitney U test),*** 
p=0.004(Mann-Whitney U test),****p=0.004(Mann-Whitney U test),*****p=0.693(Mann-
Whitney U test),******p=0.033(Student t test);*******p=0.938(Student t test);******** 
p=0.097(Student t test).
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Ex-Ovo Extracellular Electrogram Recordings 
The AV interval in EPDC-inhibited hearts was significantly shorter than the 
AV interval in wildtype hearts (62±12ms vs. 79±26ms,p=0.033), while the RR-
interval did not differ (125±35bpm vs. 111±17bpm,p=0.693).
 In line with previous data,6 at these late stages of embryonic heart 
development, the ventricular base was activated prematurely in a considerable 
number of embryonic wildtype hearts (20/45,44%). In contrast, all EPDC-
inhibited hearts (12/12,100%) showed earliest ventricular activation at the 
ventricular base. In the majority of hearts with premature ventricular base 
activation, the RVB was the location of first ventricular activation in both 
wildtype (RVB=10/20,50% vs. LVB=7/20,35%) and EPDC-inhibited hearts 
(RVB=9/12,75% vs. LVB=3/12,25%). 
 Interestingly, the interval between ventricular base and ventricular 
apex activation was significantly longer in EPDC-inhibited hearts (12±11ms) 
compared to wildtype hearts showing premature ventricular base activation 
(2±2ms,p<0.001). Representative examples of ex-ovo extracellular recordings in a 
wildtype HH40 heart (group C) are shown in Figures 3A and 3B and recordings 
obtained in an EPDC-inhibited HH40 heart (group D) in Figures 3C and 3D.
Morphology of the Annulus Fibrosis 
Macroscopically, EPDC-inhibited embryos and their hearts were consistently 
smaller as compared to wildtype hearts. Furthermore, various known 
characteristics of the loss-of-PEO-function phenotype were observed to occur 
coincidently in these hearts: double-outlet-right-ventricle with ventricular-
septal-defects (2/10), AV valve abnormalities (2/10), great artery abnormalities 
(1/10), coronary pathology (2/10) and myocardial hypoplasia (2/10) (Table 2).10, 12, 
19, 21-26  The central conduction axis of the EPDC-inhibited hearts did not show any 
histological abnormalities. In both wildtype (n=10) and EPDC-inhibited hearts       
(n=10), small MLC2a-positive APs with comparable volumes (1.30∙106±0.40∙106 
μm3 vs.1.26∙106±0.52∙106 μm3,p=0.864) were found in mostly the postero- and 
midseptal region of all hearts. 
 In wildtype hearts, additional smaller (0.38∙106±0.13∙106 μm3) APs were 
found in the right or left lateral wall of 6/10 hearts (Table 2). Interestingly 
however, in all EPDC-inhibited hearts multiple MLC2a-positive APs in both 
the right and left lateral free wall regions with larger volumes as compared to 
the small lateral APs in wildtype hearts were found (3,14∙106±2,25∙106 μm3 vs. 
0.38∙106±0.13∙106 μm3,p=0.001)(Table 2, Figure 4A-T, Figure 5). 
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Figure 3. A. Ex-ovo extracellular electrograms recorded in a wildtype HH40 heart 
(group C) with premature LVB activation (AV-interval 78 ms). LA-interval (pacing arte-
fact to LA activation) is 20 ms. B. Magnification showing LVB activation 6 ms before LVA 
activation. C. Recordings in an EPDC-inhibited HH40 heart (group D) demonstrating 
premature LVB activation (AV-interval 67 ms). D. Magnification showing LVB activation 
15 ms before LVA activation. 
39
C
hapter 3
Epicardium
-D
erived-C
ells (EPD
C
s) in AV
 Isolation
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Embryo #
HH-
stage
Structural
Abnormalities
 AP-
Location
Cumulative (and 
individual) AP-volumes in 
·106 µm3
Ventricular
Activation
Pattern
Wildtype
(Group
A,n=10)
† 1.67±0.69*
1 38 S+LL+RL 2.44 (1.46+0.56+0.43) LVA-first
2 38 S+LL+RL 2.15 (1.29+0.47+0.39) LVA-first
3 39 S+LL+RL 2.79 (2.10+0.43+0.26) LVA-first
4 39 S+LL 1.76 (1.33+0.43) LVB-first
5 39 S+LL+RL 1.84 (1.50+0.17+0.17) LVB-first
6 40 S 1.50 LVA-first
7 40 S+RL 1.72 (1.24+0.47) LVA-first
8 41 S 0.77 LVA-first
9 41 S 0.69 LVA-first
10 42 S 1.07 RVB-first
EPDC-
inhibited
(Group
B,n=10)
†
6.90±3.26*
Group B1
11 38 DORV+VSD+CA S+LL+RL 10.85 (1.29+4.12+5.45) RVB-first
12 38 S+LL+RL 3.22 (0.77+1.29+1.16) RVB-first
13 38 S+LL 4.33 (1.97+2.36) LVB-first
14 39 AVVA+GAA S+LL+RL 8.19 (1.89+2.49+3.82) LVB-first
15 39 DORV+VSD S+LL+RL 7.20 (1.29+0.3+5.62) RVB-first
16 40 MH+CA S+LL+RL 6.13 (0.82+0.56+4.76) RVB-first
17 41 MH S+LL 2.36 (0.82+1.54) LVB-first
Group B2
18 40 S+LL+RL 6.43 (0.52+1.12+4.80) RVB-first
19 41 AVVA S+LL+RL 12.95 (1.42+2.32+9.22) RVB-first
20 41 S+LL+RL 7.33 (1.80+2.57+2.96) RVB-first
Table 2. Structural Abnormalities, Locations of APs, Cumulative/Individual 
AP-Volumes, and Ventricular Activation Sequences in Wildtype and EPDC-
Inhibited Hearts. *volume measurements according to the Cavalieri-method; 
†p<0.001 (Student t test); Bold=largest AP, RL=right lateral, LL=left lateral, S=septal, 
DORV=Double-Outlet-Right-Ventricle, VSD=Ventricular-Septal-Defect, CA=Coronary 
Abnormalities, AVVA=Atrio-Ventricular-Valve-Abnormalities, GAA=Great Artery 
Abnormalities, MH=myocardial hypoplasia.
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As expected,6 temporal analysis showed a decrease in AP-volume with increasing 
developmental stage in wildtype hearts (Pearson’s r=-0.908,p=0.033). Maturation 
of the periostin-positive annulus fibrosis in EPDC-inhibited hearts however 
remained impeded as compared to wildtype hearts until near hatching stages of 
development. 
Periostin Expression at the Isolating AV Ring 
Periostin staining was found at the regions where EPDCs are known to be 
present, for example in the endocardial AV cushions, the atrial and ventricular 
subendocardium and at variable expression levels all around the circumference of 
the AV ring region in both wildtype and EPDC-inhibited hearts. In both wildtype 
and EPDC-inhibited hearts, periostin expression was slightly lower in the right 
AV ring region as compared to the left AV ring region. 
 The small, septal and MLC2a-positive APs in both wildtype and EPDC-
inhibited hearts and the small lateral MLC2a-positive APs in wildtype hearts, 
stained positive for periostin. Periostin staining on the annulus fibrosis was 
however locally interrupted at locations where broad lateral APs crossed the 
annulus in EPDC-inhibited hearts. In Figure 4A-T, representative examples 
of MLC2a- and periostin-staining in the annulus fibrosis region of wildtype and 
EPDC-inhibited hearts at HH39 and HH41 are given.
Figure 4. A-T. A. A small MLC2a-positive right posteroseptal AP in a HH39 wild-
type heart. Bar=300�m. B. Magnification of boxed area. Bar=50�m. C. Periostin staining. 
Bar=50�m. D. Periostin staining (blue) from adjacent section, superimposed on the MLC2a-
stained section, showing marked periostin expression in the myocardial AP. Bar=50�m. 
E. Right annulus fibrosis region of a HH39 wildtype heart. Bar=300�m. F. Magnification 
showing complete AV-isolation. Bar=2�m. G. Periostin-positivity of the fibrous annulus. 
Bar=2�m. H. Periostin-staining superimposed on MLC2a-staining. Bar=2�m. I. Right 
annulus fibrosis region of a HH39 EPDC-inhibited heart. Bar=300�m.J. Magnification 
showing a broad persistent MLC2a-positive AP in the right anterolateral AV-ring re-
gion. Bar=1�m. K. Periostin-staining. Bar=1�m. L. Periostin-staining superimposed on 
MLC2a-staining, showing periostin-negativity of the myocardial AP. Bar=1�m. M. Left 
annulus fibrosis region of a HH41 wildtype heart. Bar=300�m. N. Magnification showing 
complete AV-isolation. Bar=1�m. O. Periostin-positivity of the fibrous annulus. Bar=1�m. 
P. Periostin-staining superimposed on MLC2a-staining. Bar=1�m. Q. Left annulus fi-
brosis region of a HH41 EPDC-inhibited heart. Bar=300�m. R. Magnification showing 
a broad persistent MLC2a-positive AP in the left lateral AV-ring region. Bar=1�m. S. 
Periostin-staining. Bar=1�m. T. Periostin-staining superimposed on MLC2a-staining, 
showing periostin-negativity of the broad lateral AP. Bar=1�m. RA=right atrium, LA=left 
atrium, RV=right ventricle, LV=left ventricle, S=sulcus, Cu=cushion, TV=tricuspid valve, 
MV=mitral valve, IVS=interventricular septum, Ao=aorta. 
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Figure 5. Schematic figure of mitral (MV) and tricuspid (TV) valve annuli in wildtype 
(A) and EPDC-inhibited (B) quail hearts with AP-locations and corresponding AP-volu-
mes. CS=coronary sinus.
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Comparison of Immunohistochemical and Electrophysiological 
Data
In line with our previous report,6 AP-location in wildtype postseptated hearts 
could not be correlated directly with ex-ovo electrophysiological data: right- or 
left-sided APs were found both in hearts that displayed earliest ventricular 
activation at the RVB or LVB and in hearts with a concurrent or apex-to-base 
ventricular activation pattern. 
 In EPDC-inhibited hearts (n=10) however, right-sided APs corresponded 
with premature activation of the RVB and left-sided APs corresponded with 
premature activation of the LVB in 8/10 cases. In case of multiple APs, the location 
of earliest ventricular activation was found to correlate with the morphologically 
broadest AP present (Table 2). Moreover, conduction velocity along the AP (PR-
interval) showed negative correlation with the AP-volume in EPDC-inhibited 
hearts (Pearson’s r=-0.696,p=0.037). The observed additional structural defects 
in the EPDC-inhibited hearts did not correlate with the degree of ventricular 
preexcitation (in-ovo PR-interval) (Spearman’s r=0.000). Interestingly, hearts 
in group B2 demonstrated none to only mild additional structural abnormalities 
(Table 2).
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Discussion
Key finding of this study is that EPDCs are essential for normal annulus fibrosis 
formation. Consequently, inhibition of EPDC-migration during cardiogenesis may 
result in marked defects in the isolating annulus fibrosis with persistence of broad 
accessory myocardial AV connections, resulting in ventricular preexcitation. 
Embryonic Development of the Isolating Annulus Fibrosis: The 
Role of EPDCs at the AV Junction
During development of the electrically inert annulus fibrosis, the primitive 
slow conducting continuous AV junctional myocardium of the looped embryonic 
heart makes way for conduction through the AV node/HPS, which eventually 
constitutes the sole AV conducting pathway of the adult heart.4, 27 It is well 
established that AV junctional myocardium is incorporated within the atrial 
myocardium by fusion of the endocardial AV cushions and the epicardial AV 
sulcus,3, 4 while state of the art in literature postulates additional roles for 
bone-morphogenetic-protein (BMP) signaling and periostin in annulus fibrosis 
formation.5-8 Interestingly, expression of periostin mRNA increases significantly 
in response to mechanically regulated BMP-signaling in mesenchymal cells in 
culture.28
 Although the contribution of the multipotent EPDCs to the heart as 1) 
interstitial fibroblasts, as smooth muscle cells and fibroblasts of the coronary 
arteries and as mesenchymal cells in the developing AV cushions and 2) their 
role in formation of the compact and trabecular myocardium and in Purkinje 
fiber differentiation, has previously been shown to be indispensable,10, 22-24, 29-31 the 
role of EPDCs in annulus fibrosis development has until now not been studied in 
detail.
 Our present data show that in EPDC-inhibited hearts at late postseptated 
stages of development (HH38-42), large APs coursing through defects in the 
annulus fibrosis can be found in the right- and left-lateral free wall region, while 
as previously also described in wildtype postseptated quail hearts,6 additional 
small APs can be found in mainly the posteroseptal regions. 
 After mechanical EPDC-inhibition (this study), epicardial outgrowth 
is delayed by inserting a piece of eggshell membrane to block the normal cell 
transfer.11, 19, 21 Ultimately, regenerating PEO-cells growing around the eggshell 
membrane together with pericardial mesothelial cells originating from the 
pharyngeal arch area of the heart, form a compensatory epicardium and partially 
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rescue the normal phenotype, thereby yielding embryos with a delayed formation 
of PEO-derived tissues.12, 16, 23, 26, 32 Normally, migration of subepicardial EPDCs 
through the continuous AV junctional myocardium to the endocardial cushions 
of the four chambered heart, starts from HH32 onwards.10-12, 17, 18, 20 The impeded 
development of the AV sulcus in EPDC-inhibited hearts with consequent 
persistence of functional large APs at late postseptated developmental stages 
(HH38-42) thus strongly underlines the importance of EPDCs for the normal 
development of the annulus fibrosis. A schematic overview of the proposed role 
of EPDCs in normal annulus fibrosis formation is depicted in Figure 6.
Figure 6. Annulus fibrosis formation and the role of EPDCs. A. Continuous AV-
junctional myocardium in the looped embryonic heart. B. From HH32 onwards, sub-
epicardial EPDCs in the AV-sulcus (S) migrate through the continuous AV-junctional 
myocardium to ultimately populate the endocardial AV-cushions (Cu). C. In the normal 4-
chambered heart, EPDCs continue populating the AV-cushions and favour 2 positions: 1) 
myocardial/endocardial cushion interface, 2) subendocardially at the luminal face of the 
AV-cushions. D. Impeded development of the annulus fibrosis in EPDC-inhibited hearts 
results in subsequent persistence of large APs in the postseptated heart. A=atrium, 
V=ventricle, S=sulcus, Cu=cushion, AP=accessory pathway. 
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Periostin Expression in the Developing Annulus Fibrosis of Wildtype 
versus EPDC-Inhibited Postseptated Hearts: Relevance for EPDC-
Functioning at the AV Junction 
Periostin is a profibrogenic extracellular matrix protein secreted during cushion 
mesenchym formation and is strongly expressed in collagen-rich fibrous connective 
tissues subject to constant mechanical stress in-vivo.7, 8, 33-39 It is thought that this 
fasciclin-I related protein is an inhibitor of the myocardial phenotype under both 
physiological as well as pathological conditions.6, 30, 33, 35, 36, 40, 41 Moreover, periostin 
is likely also essential in maintaining the integrity of the fibrous heart skeleton 
of the mature heart.36 Multiple cellular mechanisms regulated by periostin 
might support destabilization of the cardiomyocyte phenotype and the formation 
and maintainability of the fibrous scaffold, since periostin is known to bind to 
fibronectin, tenascin-C, collagen-V and periostin itself.42
 The spatiotemporal colocalization of periostin and EPDCs at the 
AV junction of the developing heart substantiates its importance for EPDC-
functioning.8, 10 Interestingly, periostin was recently found to directly interact with 
collagen type-I,13 while the migratory patterns of EPDCs in the AV sulcus were 
previously established to resemble the spatiotemporal expression of procollagen-
I, a marker for collagen type-I synthesis.10-12 The presence of periostin mRNA 
in the completely epicardium-derived subepicardial mesenchym further denotes 
the EPDC as an important player in the dynamic interplay between molecular 
cues and biomechanical determinants in the AV junctional myocardium.7, 8, 10, 11 
 We recently postulated that periostin expression in persistent small, 
and mostly posteroseptal located myocardial APs in wildtype postseptated quail 
hearts indicates their ultimate perinatal fate as fibrous tissue of the annulus 
fibrosis.6 In the present study, periostin expression in the annulus fibrosis region 
of EPDC-inhibited postseptated quail hearts was found to be locally interrupted 
at sites where large myocardial APs in the lateral free wall region crossed the 
isolating annulus, further substantiating the importance of periostin in EPDC-
functioning and annulus fibrosis formation. Interestingly, similar annulus 
fibrosis malformations occur in the periostin knockout mouse and in mice with a 
conditional deletion of the Alk3-gene and consequent downregulation of periostin 
in the AV region.5, 30, 43, 44 
 As shown in Figure 4, in both wildtype and EPDC-inhibited hearts, 
periostin expression was found in the endocardial AV cushions, one of the 
regions where EPDCs are normally known to be present.10-12  Expression of 
periostin in the EPDC-deprived endocardial AV cushions of the EPDC-inhibited 
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heart, however indicates that periostin expression is not only dependent on the 
physical presence of EPDCs. Periostin expression can therefore be speculated to 
underlie the renowned,3, 4 but still largely unknown role of the endocardial AV 
cushions in annulus fibrosis development, while the constant mechanical stress 
at the developing AV junction can also be postulated to induce expression of this 
profibrogenic protein.34
Annulus Fibrosis Development and Functional AP-Persistence 
Normal formation of the epicardium is described to proceed from the point of 
attachment of the sinu-ventricular mesocardium - the dorsal atrial wall facing 
the sinus venosus - firstly to the dorsal parts of the atrial and the ventricular 
wall and subsequently to the ventral wall of the heart.14, 17, 21 By the end of 
HH26, the myocardium of the looped embryonic heart is completely covered by 
epicardium,14, 16 whereas cardiac septation and chamber formation have not been 
completed yet.45, 46 Outgrowth of the right ventricular dorsal wall myocardium 
is one of the last processes in cardiogenesis and expands the right ventricular 
inflow tract and ultimately results in an inevitable shift of the right side of the 
AV canal, to become positioned above the right ventricle.45, 46 Spatiotemporally, 
EPDC-population of the right posterior annulus fibrosis region can thus only be 
achieved after EPDC-migration through the expanding dorsal right ventricular 
wall, denoting temporal postnatal AP-persistence in the right posteroseptal 
region of embryonic wildtype quail hearts6 as physiological perinatal remodeling 
of the AV junction. 
 Dyssynchrony in the delicate interplay between EPDCs and AV junctional 
cells, as shown in the EPDC-inhibited quail model, results in persistence of large 
lateral APs. While EPDCs derived from the compensatory epicardium ultimately 
do arrive at the epicardial AV sulcus of EPDC-inhibited hearts,12, 32 these cells 
possibly encounter AV junctional cardiomyocytes already impermissive for 
EPDC-interaction and thus miss the appropriate time-window for their intended 
rescue of the normal cardiac phenotype. Persistent APs in wildtype versus EPDC-
inhibited postseptated quail hearts also displayed divergent electrophysiological 
characteristics. In line with our previous report,6 morphologically persistent APs 
in the wildtype heart, giving rise to premature ventricular activation can be 
found in a considerable number of cases. Inhibition of EPDC-migration however 
results in persistence of large APs with a relatively high conduction velocity 
(short in-ovo PR- and ex-ovo AV intervals), both not observed in any of the 
wildtype hearts, and premature ventricular base activation in all cases. 
48
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Moreover, overt ventricular preexcitation was observed in a subgroup of in-ovo 
ECGs in EPDC-inhibited hearts. Interestingly, these EPDC-inhibited hearts all 
demonstrated the 3 main clinical electrocardiographic features of ventricular 
preexcitation syndromes;47, 48 1) a short PR-interval, 2) initial slurring of the QRS-
complex, known as the delta wave and 3) a resultant prolonged QRS-complex 
(Figure 2). 
Clinical Significance
In children, the first episodes of AP-mediated AVRT occur before birth or in the 
first months of life in ~60% of cases and resolve spontaneously in most cases 
before the age of 1 year, while recurrence of tachycardia at the age of 8-10 years 
occurs in the remaining ~ 30%.1, 9 Bolstered by the normal postnatal evolutionary 
process of anatomical moulding and shaping of the heart to facilitate adjustment 
to the increasing body mass and changes in vascular pressures, we previously 
postulated that under physiological circumstances persistent functional APs at 
near-hatching stages of avian development provide the anatomical substrate for 
spontaneously resolving neonatal AVRTs.6
 However, any delay in EPDC-migration in the developing heart may 
result in imperfect annulus fibrosis development and consequently in AP-
persistence. Clinically, most patients with persistent APs are not affected by 
additional cardiac pathology, although in some cases of ventricular preexcitation 
syndromes (e.g. Wolff-Parkinson-White syndrome) AP-persistence coincides with 
congenital cor vitia, for example Ebstein’s anomaly.9, 49 When EPDC-migration 
is blocked directly after PEO-formation, as in this study, multiple mild to severe 
congenital heart defects will occur.10, 12, 22-24, 26 In humans, genetic alterations 
affecting EPDC-functioning during development and occurring after completing 
structural configuration of the heart, may result in postnatal AP-persistence in 
a structurally normal heart.1, 48 
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Limitations of the Study
Although we showed both functionally and morphologically that EPDCs 
are indispensable for proper annulus fibrosis formation, we were unable to 
demonstrate subsequent AP-persistence in hatched or adult EPDC-inhibited 
quail hearts. 
 Unfortunately, mechanical EPDC-inhibition yields embryos in which the 
degree of epicardial outgrowth inhibition is directly related to the severity of 
the cardiac abnormalities and thus to embryonic lethality.10, 22, 23, 26 While the 
operated embryos surviving beyond HH38 were typically those only mildly 
affected by comorbidity, EPDC-inhibited quail embryos are relatively small 
and seem to lack sufficient reserve to survive postnatally. Interestingly, severe 
growth retardation, postnatal lethality and dwarfism in adult life have recently 
also been described in the periostin null mouse.43, 44 
 
Conclusions
EPDCs appear to be essential for proper formation of the isolating annulus fibrosis. 
Inhibition of EPDC-migration during cardiogenesis may result in marked defects 
in the annulus fibrosis with persistence of broad APs, functionally resulting in 
ventricular preexcitation. While, under physiological conditions small septal 
APs in the wildtype heart remain temporarily functionally active,6 broad lateral 
APs in the EPDC-inhibited heart might provide a pathological substrate for 
postnatally persistent APs and AVRTs into childhood or adult life.
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Clinical Perspective
Atrio Ventricular Reentrant Tachycardia (AVRT) is a common arrhythmia in 
both children and adults. Although currently the vast majority of patients with 
AVRT are cured by standard ablative procedures, the etiological mechanisms 
underlying the appearance of accessory pathways still remain a subject of 
debate. During cardiogenesis, initial slow conduction over the circumferential 
myocardial AV continuity resulting in sequential activation of the pre-septated 
heart, is replaced by apex-to-base conduction through the specialized AV node/
His-Purkinje System (HPS) in the septated heart. Concurrently, incorporation 
of the AV junctional myocardium in the lower atrial rim by fusion of the 
endocardial AV cushions and epicardial AV sulcus results in formation of the 
isolating annulus fibrosis. Migration of the multipotent Epicardium-Derived-
Cells (EPDCs), through the continuous AV junctional myocardium to ultimately 
reach the endocardium-derived AV cushions, spatiotemporally correlates with 
annulus fibrosis formation. The AV junction has been postulated to be subjected 
to physiological perinatal remodeling, temporarily leaving functional small 
accessory pathways as anatomical substrates for spontaneously resolving 
neonatal AVRTs. Dyssynchrony in the delicate interplay between EPDCs and 
AV junctional cells, as shown in the EPDC-inhibited quail model in the present 
study, may result in marked defects in the isolating annulus fibrosis with the 
persistence of large accessory pathways functionally resulting in ventricular 
preexcitation. We speculate that absence of EPDCs or a delay in EPDC-migration 
results in the persistence of pathological substrates for postnatally persistent 
accessory pathways and AVRTs into childhood or adult life.
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Online Data Supplement 
Methods
Experimental Preparations 
All animal experiments were approved by the Committee on Animal Welfare 
of the Leiden University Medical Center (LUMC), the Netherlands. Animal 
experiments were conducted in compliance with the Guide for the Care and Use 
of Laboratory Animals (NIH Publication No.85-23, revised 1996). Fertilized eggs 
of the Japanese quail (Coturnix coturnix japonica, Leiden University Medical 
Center, The Netherlands) were incubated blunt end up at 37.5°C and 80% 
humidity. Embryos were staged according to the Hamburger-Hamilton (HH) 
criteria.1 
Complete-to-partial inhibition of outgrowth of the proepicardium was 
obtained by performing in-ovo microsurgery under stereomicroscopic control, as 
first described by Männer.2 Nile-blue staining was used to visualize transparent 
structures. In short, on the 3rd day of incubation (HH15-18), a portion of the 
eggshell was removed to expose the embryo. Subsequently, the vitelline membrane 
was locally removed from the embryo by means of watchmaker forceps. Through 
the naturally existing body wall hiatus at HH15 or through a slit in the amniotic 
and pericardial membranes at HH16-18, the pericardial cavity of the embryo 
was reached. To prevent the attachment of the pericardial villi to the heart, a 
small rectangular piece of shell membrane was cut with iridectomy scissors and 
inserted between the dorsal wall of the heart and the pericardial villi, cranially 
anchored in the sinu-atrial sulcus and caudally constrained by the coelomic wall 
(Figure 1). After implantation of the shell membrane, the eggs were closed with 
Scotch Magic-tape (3M®, Maplewood, Minnesota, USA) and re-incubated.
In-Ovo Electrocardiogram (ECG) Recordings 
After termination of incubation at the desired developmental stages (HH 38-42), 
a subset of the quail eggs (EPDC-inhibition, n=12; wildtype, n=12) was prepared 
for in-ovo electrocardiogram (ECG) recordings. The eggs were removed from 
the incubator, candled to determine the location of the embryo and marked for 
correct placement of the electrodes. Consequently, 3 AgCl wire electrodes (0.5 
mm in diameter) were inserted into small holes in the eggshell: the first in front 
of the embryo, the second behind the embryo (both on the ‘equator’) and the 
third on the ‘South Pole’(pointed bottom of the egg) (ground). The electrodes were 
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connected to an isolated preamplifier module with an input impedance of >1012 � 
of a high-gain low-noise DC bio-amplifier system (Iso-DAM8A; World Precision 
Instruments Inc., Berlin, Germany). 
 Subsequently, the ECGs were digitally recorded as bipolar between 
the two ‘equator’ electrodes (Prucka Engineering Inc., Houston TX., USA) 
continuously for 10-15 minutes in a small custom-built shielded incubator 
(37±0.1ºC) to obtain steady state ECGs under near-physiological conditions. In-
ovo ECGs were evaluated by two independent observers.
After completion of ECG recordings, euthanization by decapitation 
and staging, the embryonic hearts were carefully isolated and prepared for 
extracellular electrode recordings. 
Ex-Ovo Extracellular Electrode Recordings – Technical Features 
& Recording Protocol
In total, extracellular electrode recordings were performed at HH38-42 in 45 
wildtype (group A) and 12 EPDC-inhibited hearts (group B). The experimental 
preparations were placed in a custom-built, fluid-heated, temperature-controlled 
tissue bath and superfused with carbogenated (95% O2 and 5% CO2) Tyrode’s 
solution (30±0.1°C) with the following composition (mmol/l): NaCl 130, KCl 4, 
KH2PO4 1.2, MgSO4 0.6, NaHCO3 20, CaCl2 1.5, glucose 10 (pH 7.35). 
 Unipolar extracellular electrogram recording and bipolar atrial pacing 
was subsequently performed, as previously described,3 by consistently positioning 
4 tungsten recording electrodes (tip:1-2µm; impedance 0.5-1.0MΩ, WPI Inc., 
Berlin, Germany) on the left atrium (LA), right ventricular base (RVB), left 
ventricular base (LVB) and left ventricular apex (LVA) and a bipolar pacing 
electrode on the high right atrium. A silver reference electrode was placed in the 
tissue bath.
 In short, the experimental preparations were allowed to equilibrate 
for 10 minutes before starting the recording protocol. Embryonic hearts with a 
stable spontaneous HR of at least 60 bpm were allowed to beat spontaneously, 
whereas hearts with a HR of <60 bpm were stimulated at a fixed cycle length of 
500 ms (120 bpm). 
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Definitions
In extracellular electrogram recording, a mean difference in local depolarization 
time between two recording electrodes of ≥1 ms was considered significant.3 The 
left ventricular activation sequence was thus denominated as 1) base-to-apex if 
the ventricular base depolarized ≥1 ms earlier than LVA, 2) apex-to-base if the 
LVA depolarized ≥1 ms earlier than ventricular base and 3) concurrent if the 
time difference between ventricular base and LVA activation was <1 ms.
In all experiments, a stable 1:1 relation between atrial and ventricular 
activation was assured to be present. The time difference between LA activation 
and the location of earliest ventricular activation was denominated as the AV 
interval both in embryonic hearts beating in sinus rhythm as in hearts driven 
by RA-pacing.
Immunohistochemistry
After completion of the extracellular electrogram recordings, the hearts were 
removed from the Tyrode’s solution and fixated in a 4% paraformaldehyde solution 
for 24 hours, dehydrated and embedded in paraffin. Subsequently, 10 EPDC-
inhibited and 10 wildtype post-septated quail hearts were serially sectioned 
in the frontal plane at 5 µm, transferred to albumin/glycerin-coated objective 
slides and stained with anti-MLC2a and anti-periostin, as previously described.3 
Morphometry was performed by measurements of the total and individual AP 
volumes in each analyzed heart, according to the Cavalieri method.4 
Statistical Analysis
The symmetry of the distribution was determined by determining the Skewness 
value. RR (in-ovo) and AV intervals (ex-ovo), heart rates (ex-ovo) and AP-volume 
were compared between groups using the 2-tailed Student t test for normally 
distributed values: otherwise, the Mann-Whitney U test was used (ex-ovo RR-
intervals, in-ovo PR- and QRS-intervals). For comparison of categorical variables 
(ventricular activation sequence), the c2-test was applied. The Pearson correlation 
(r) coefficient was calculated, as a measure for the association between the AP-
volume and the developmental stage and between the AP-volume and the AP-
conduction velocity, while Spearman’s correlation coefficient (r) was used as a 
measure for the association between the PR- and QRS-intervals in in-ovo ECGs 
and between the degree of ventricular preexcitation and additional structural 
heart defects. 
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The Paired-Samples t test was used to measure inter-observer agreement in 
evaluation of the in-ovo ECGs. Results are presented as means ± SD (range). A 
P value <0.05(2-tailed) was considered statistically significant. All analysis were 
performed using the Statistical Package for Social Studies version 12.0 (SPSS 
Inc, Chicago, Ill).  
The authors had full access to the data and take responsibility for its integrity. 
All authors have read and agree to the manuscript as written. 
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By definition, accessory atrioventricular pathways are aberrant muscle bundles 
that connect the atrium to a ventricle outside of the regular atrioventricular 
conduction system. Clinically, they may manifest as substrates for ventricular 
preexcitation. The first accessory pathway in a patient who suffered from Wolff-
Parkinson-White syndrome was described in 1943 by Wood, Wolferth, and 
Geckler.1 Shortly after, Öhnell created a reconstruction of an accessory pathway 
that very elegantly showed the close proximity of the pathway to the fibrous 
attachment of the mitral valve and its relationship with the sulcus coronarius 
(Figure A).2 Subsequent histological studies have demonstrated unequivocally 
that these pathways are the anatomic substrates for the classical Wolff-Parkinson-
White variety of preexcitation. 
Figure. A,.Öhnell’s depiction of an accessory bundle in the left atrioventricular groove.
Reprinted with permission from Blackwell Publishing. B. Histological section stained 
with Masson’s trichrome (fibrous tissue in green and myocardium in red) to show an ac-
cessory left-sided pathway (arrow) skirting the mitral annulus. C. Histological section 
showing a broad right-sided accessory pathway (arrow) that is formed by a myocardial 
pouch extending from the right atrial appendage to the ventricle and ultimately traced to 
a small right ventricular vein. This pathway is some distance from the fibrous annulus of 
the tricuspid valve. *Valvar annulus.
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Accessory atrioventricular pathways are found most often in the parietal 
atrioventricular junctional areas, including the paraseptal areas. They breach the 
insulation provided by the fibrofatty tissues of the atrioventricular groove (sulcus 
tissue) and the hinge lines (fibrous annulus) of the valves. They are rarely found in 
the area of fibrous continuity between the aortic and mitral valves because in this 
area, there is usually a wide gap between the atrial myocardium and ventricular 
myocardium to accommodate the aortic outflow tract. On the left parietal side, 
the accessory pathways tend to pass close to the hinge line of the mitral valve 
(Figure B). In the right atrioventricular junction, the atrioventricular groove is 
much deeper than on the left side, and the accessory muscle bundles can cross 
at any depth. Cardiac surgeons have suggested that the deep groove may itself 
allow the atrial wall to fold over the ventricular wall, thereby producing atrial-
ventricular myocardial continuity.3 Most of the pathways identified through the 
use of microscopy have been working myocardium, with only a few reported to 
contain histologically specialized cells.4 Whether comprising working myocardium 
or abnormal myocytes, these pathways have normal gap junctions with a pattern 
suggestive of working ventricular myocardium.5 Morphologically, these threads 
of musculature are thicker at their atrial origins and they branch into finer 
strands at the ventricular insertions. They are up to 3 mm in width but may be 
10 mm or more long.2, 4, 6 
Other types of accessory atrioventricular pathways found in certain circumstances 
are well recognized. One of the 7 pathways in the study conducted by Becker 
and colleagues4 was a specialized bundle that had its atrial insertion in a node 
of specialized tissues in the parietal margin of the tricuspid annulus, forming 
an atriofascicular tract.7 Multiple pathways can occur in the setting of so-called 
Purkinje cell tumors, often with additional tumors within the ventricles. Another 
type of pathway related to coronary veins is usually manifested in the form of 
extensive myocardial cuffs around the veins crossing the atrioventricular junction 
or expanded as diverticulums into the ventricular mass. Others are related to 
the atrial appendages overlying ventricular masses (Figure C). 
For several decades, accessory pathways have been avulsed successfully through 
surgery using conventional dissection or by cryothermy or radiofrequency 
ablation. In the past 2 decades, advancements in precision mapping and ablation 
of accessory pathways via the transcatheter route have made it possible for many 
patients to be cured. Although rare, sudden death may be the first presenting 
sign in patients with undiagnosed and/or asymptomatic preexcitation syndrome. 
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This is particularly worrisome for families with an affected child. The majority 
of cases have no clear familial involvement, but a small number of patients have 
affected relatives. Recently, the transcatheter procedure has been deemed safe 
and effective in experienced hands, but whether it should be used as a prophylactic 
measure against life-threatening events remains controversial.8, 9 Clearly, there 
is a need to know more about how these pathways develop so as to guide further 
therapeutic strategies. 
In the embryonic human heart, a ring of musculature at the atrioventricular 
canal provides myocardial continuity between developing atrial and ventricular 
myocardium in the early stages. This canal myocardium was shown initially 
to have slow conduction properties in the chick.10 The canal myocardium is 
sandwiched by sulcus tissue on the outside and endocardial cushions on the 
inside. Kim and colleagues11 showed that the bulk of the canal myocardium was 
incorporated into the vestibules making up the atrial walls leading toward the 
valvar orifices, but it did not contribute to ventricular myocardium. A small part 
of the canal myocardium becomes the atrioventricular node, and normally this is 
the only site of myocardial continuity, with the developing ventricular conduction 
bundles at completion of cardiac septation. In their earlier study, however, 
Wessels and colleagues12 noted strands of myocardial continuity between atrial 
and ventricular tissues in all human fetal hearts and many normal neonatal 
hearts. 
Pivotal to the understanding of accessory atrioventricular pathways is knowledge 
of how the insulating tissue plane at the sulcus and annulus came into being. 
Wessels and colleagues,13 among others, offered the explanation that sulcus 
tissue joins with endocardial cushion tissues at the ventricular margin of the 
canal. According to this study,13 the valvar leaflets were formed by cushion 
tissue, without contribution or real inward growth of sulcus tissue. Instead, the 
ventricular walls distal to the atrioventricular canal bulged like shoulders toward 
the atria. They suggested that accessory pathways resulted from incomplete fusion 
between sulcus and cushion tissues. It is not clear from their study, however, 
how myocardial discontinuity was effected so as to allow sulcus tissue to meet 
cushion tissue. In contrast, a simpler explanation was put forward by others who 
suggested that invagination of sulcus tissue like a wedge through the muscular 
canal wall was part of the process for development of valvar leaflets, with little 
contribution from the cushions.14, 15 Be that as it may, there is consensus that the 
insulating tissues came from the epicardial side. 
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It was while studying the embryologic origins of the coronary vessels in chicken-
quail chimeras that Gittenberger-de Groot and coworkers identified and traced 
the migration of a novel population of cells termed epicardial-derived cells 
(EPDCs) into the myocardial interstitium and endocardial cushions.16 Observing 
a close relationship between EPDCs and cardiac fibroblasts, they suggested 
a potential role of migrating EPDCs in the formation of the insulating tissue 
plane between atrial and ventricular myocardium. This concept, based on 
exquisite experimental techniques, differs from their earlier work describing 
infolding of the epicardial tissues to form the core of the developing leaflets.15 The 
latest article from this group17 examines the role of EPDCs in formation of the 
insulating plane (annulus fibrosis) by comparing wild-type quail embryos with 
EPDC-inhibited embryos. In normal development, EPDCs migrate through the 
atrioventricular canal myocardium to populate the endocardial cushions.16 By 
impeding EPDC migration, Gittenberger-de Groot et al observed persistence of 
broad bundles of accessory atrioventricular myocardial connections that resulted 
in ventricular preexcitation. In agreement with the previous findings of this 
group, the accessory bundles in wild-type embryos were smaller, and there was 
no correlation with ECG recordings.17, 18 In the previous study,18 the accessory 
bundles identified as myocardial on myosin light chain 2a positivity were noted 
to be broad and multiple and in various locations in young hearts (Hamburger-
Hamilton stages 35–39), whereas in older embryos (Hamburger-Hamilton stages 
40–44), the bundles were small and mainly located on the right side. By way of 
comparison, fibrous insulation was complete in the adult quail. Coincidentally, 
they observed that MLC2a-positive pathways were also stained with periostin, a 
fibroblast marker that has a role in regulating fibroblast-myocyte interaction.19 
In the present report,17 the small pathways in both wild-type and EPDC-
inhibited hearts stained positive for both MLC2a and periostin. Broad pathways 
were only found in EPDC-inhibited hearts, but these were associated with local 
interruption of periostin staining. An important observation of the present 
study17 is the interplay between EPDCs, periostin, and accessory pathways. The 
investigators proposed the concept that impeded migration of EPDCs through 
the myocardium to the endocardial cushions delayed the development of the 
fibrous annulus. Although the study has given us a glimpse of pathways that are 
candidates for premature ventricular activation in the quail, the question of why 
some accessory pathways produce a functional effect, occasionally devastatingly 
so, whereas others do not, remains to be clarified. 
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In his monograph, Öhnell2 considered that some may have been acquired, for 
instance after myocarditis, a view also put forward more recently by Basso and 
her colleagues.6 
Developmentally, the work of Kolditz and colleagues would appear to support 
the notion that accessory pathways resulted from incomplete interruption of 
canal myocardium resulting from late arrival of EPDCs.17 Although incomplete 
interruption due to sulcus tissue stopping short of the annulus can account for 
accessory atrioventricular pathways that pass close to the annulus, it is difficult 
to picture the same process being involved in pathways that are in peripheral 
locations or in other morphologies as described above. The conundrum of whether 
those develop later by growing through holes in the tissue plane remains. For 
those related to coronary veins, what causes the walls to become muscularized 
(or remain muscularized)? Do the multipotent EPDCs and periostin have a role 
in those, too? We await further insights into this intriguing area of study. 
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Abstract
Background. Atrioventricular reentry tachycardia (AVRT) 
requiring an accessory atrioventricular pathway (AP) is the most 
common type of arrhythmia in the perinatal period of development. 
The etiology of these arrhythmias is not fully understood as well as 
their capability to resolve spontaneously in the first year of life. The 
temporary presence of APs during annulus fibrosis development 
might be the cause of this specific type of arrhythmias. 
Methods and Results. Electrophysiological recordings of 
ventricular activation patterns were studied in pre- and post-
septated embryonic mouse hearts by placing unipolar electrodes on 
the right atrium, left ventricular apex and left and right ventricular 
base. The recordings revealed the presence of functional APs in       
early (13.5-15.5 dpc) and late (16.5-18.5 dpc) post-septated stages 
of mouse heart development. Immunohistochemical analysis with 
antibodies against MLC2a, Periostin, Nkx2.5 and Cx43 confirmed 
the presence of APs, which stained positive for MLC2a and Nkx2.5 
and negative for Periostin and Cx43. Longitudinal analyses showed 
that the APs gradually decreased in number (P=0.003) and size 
(P=0.035) at subsequent stages of development (13.5-18.5 dpc). 
Expression of periostin was observed in the developing annulus 
fibrosis, adjacent to APs and other locations where formation of 
fibrous tissue is essential. 
Conclusion. Functional APs are present during normal mouse 
heart development. These functional APs especially in late stages of 
cardiac development, can serve as a transient substrate for AVRTs 
in the perinatal period of development. 
73
C
hapter 4
A
ccessory AV
 Pathw
ays in the Em
bryonic M
ouse H
eart
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Introduction
In the fetus and newborn atrioventricular (AV) reentrant tachycardia (AVRT) is 
a relatively common tachyarrhythmia. Initial management of these tachycardias 
can be difficult but the natural course is benign and most children remain 
symptom free without medication after the age of one year.1-3 AVRT requires the 
presence of an accessory atrioventricular myocardial pathway (AP) that crosses 
the annulus fibrosis. The factors contributing to the formation of APs are largely          
unknown. It has been hypothesized that the transient presence of APs during 
the normal formation of the isolating annulus fibrosis could serve as substrate 
for AVRT in the perinatal period, explaining its self-limiting character. In hearts 
of normal human fetuses and newborns the presence of APs clearly have been 
identified, but there are no data on conducting properties of these physiological 
APs in humans.4, 5 
Proper development of the annulus fibrosis plays a key role in the 
separation of atrial and ventricular myocardium in the AV canal.6 Formation 
of this isolating structure encompasses interactions between several molecular 
pathways, which have not yet been identified completely. Periostin, primarily 
described as osteoblast-specific factor 2  7 is highly expressed in collagen rich-
fibrous connective tissue in the developing heart, which is subjected to high 
mechanical stress.8, 9 Recently it has been shown that periostin directly regulates 
collagen I fibrillogenesis9 and that it is also capable to induce proliferation of 
already differentiated cardiomyocytes in injured hearts.10 The inductive role 
of periostin on both cardiomyocytes and fibrous tissue seems to be of special 
interest in the formation of the annulus fibrosis, where atrial and ventricular 
myocardium need to be separated by the formation of fibrous tissue.11, 12 
The annulus fibrosis separates the atrial and ventricular myocardium 
in two separate myocardial compartments, which are connected via the AV 
conduction axis comprising the AVN and the bundle of His.13 At early embryonic 
stages before ventricular septation has been completed and the development 
of the annulus fibrosis has started, atrial and ventricular myocardium are 
continuous in the primitive AV canal, which establishes a ventricular base-to-
apex activation pattern. At later stages, ventricular conduction transforms into 
the mature apex-to-base activation. The switch from base-to-apex in apex-to-  
base activation is suggested to be closely related to the completion of ventricular            
septation and the separation of atrial and ventricular myocardium by the 
developing annulus fibrosis.14, 15 Nevertheless, contemporary electrophysiological 
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studies in embryonic mouse hearts have shown that before completion of 
ventricular septation a mature apex-to-base activation is already present, 
suggesting that the AV conduction axis is functional far before ventricular 
septation has finished.16, 17 
Studies in avian demonstrated that antegrade conducting APs are 
present at late post-septated stages of heart development, which gradually       
diminished during fetal development.15 In mammalian hearts APs have also 
been described,17, 18 however the description of these APs mainly focused on the 
electrophysiological properties of the primitive AV canal myocardium in pre-
septated hearts17 and neither late stages of fetal heart development nor the exact 
course of APs at the developing annulus fibrosis were studied.
The current study for the first time describes the presence of “functional” APs in 
early and late post-septated stages of mouse heart development. Furthermore 
we show that periostin is highly expressed in the developing annulus fibrosis at 
locations where separation of atrial and ventricular myocardium is mandatory.
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Methods
Animals and Preparation of Hearts
All animal experiments were approved by the local medical ethical committee. 
To obtain the embryonic hearts two separate wildtype mouse strains were used, 
C57Bl6/Jico and CD1. If a vaginal plug was observed one day after breeding this 
embryonic stage was considered to be 0.5 day past conception (dpc). Embryos of 
subsequent stages were used, ranging from 11.5 dpc to 18.5 dpc (n=48). After 
cervical dislocation of the pregnant mouse, an incision was made in the mid-
abdominal region followed by the extraction of the two laterally located uterus 
horns. The complete uterus was placed in Petri dish filled with Tyrode’s solution 
containing (mmol/L) 130 NaCl, 4 KCL, 1,2 KH2PO4, 0,6 MgSO4
.7H2O, 20 NaHCO3, 
1,5 CaCL2
.2H2O and 10 glucose at 37
0 Celsius. Subsequently in Tyrode’s solution 
of 00 Celsius one-by-one the embryonic hearts were dissected. After isolation 
of the heart, excessive lung tissue was carefully removed and the hearts were 
further processed for electrophysiological recordings.
Electrophysiologic Recordings - Experimental Setup
Embryonic hearts were attached with fine wires through extra-cardiac tissue in 
a fluid heated, temperature controlled (Physitemp instruments Inc, Clifton NJ, 
USA) Petri dish of 35.5-370 Celsius onto a layer of agarose gel (Roche Diagnostics 
GmbH, Mannheim, Germany). During the equilibration period of 3 minutes 
and the subsequent electrophysiological recordings the hearts were constantly 
super-perfused with Carbogenated (95% O2 and 5% CO2) Tyrode’s solution of 37
0 
Celsius. 
For electrophysiological extracellular recordings 4 unipolar tungsten 
electrodes (tip: 1 to 2 µm; impedance 0.9 to 1.0 MΩ; WPI Inc, Sarasota FL, 
USA) were placed on the right atrium (RA), right ventricular base (RVB), 
left ventricular base (LVB) and left ventricular apex (LVA) using microscopic 
guided micromanipulators (Wild Heerbrugg, M7A, Switzerland) (Figure 1).  
Furthermore, an Ag/AgCl electrode in the Petri dish served as reference electrode. 
The complete experimental setting was located in a Faraday cage to prevent the 
recordings from exterior electrophysiological disturbances.
All electrograms were recorded with a high-gain, low-noise, direct current 
bioamplifier system (Iso-DAM8A; WPI Inc) with 4 isolated preamplifier modules 
with an output impedance of >1012 Ω. The signals were band-pass (300 Hz to 1 
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kHz) and notch filtered (50 Hz) before being digitized at a sample rate of 1≥ kHz 
with a computerized recording system (Prucka Engineering Inc, Houston, Tex) 
and stored on optical disks for offline analysis. 
Electrophysiological recordings of all cardiac developmental stages 
(12.5-18.5 dpc) were performed under stable sinus rhythm after a 3-minute 
calibration period. On the unipolar electrograms the steepest negative deflection 
was considered to be the local activation time. The local depolarization time of 
each electrode (RA, RVB, LVB and LVA) was calculated by the average of 10 
consecutive beats. Subsequently, the global ventricular activation of each heart 
could be determined: base-to-apex if the RVB or LVB depolarized 1≥ms prior to 
the LVA; apex-to-base if the LVA depolarized 1≥ms prior to the RVB or LVB; 
concurrent if the depolarization time between the LVA and LVB or RVB was 
<1ms. Furthermore, the basal cycle length/HR of each heart was calculated by 
the average of 10 consecutive beats.  
 After EP recording the hearts were fixed in 4% paraformaldehyde (PFA) 
for immunohistochemical processing. 
Figure 1. Positioning of the unipolar electrodes for electrophysiological recordings in 
a postseptated mouse heart. Electrophysiological measurements were performed under 
constant perfusion with carbogenated Tyrode’s solution at 37 degrees C. Four Tungsten 
electrodes were placed on the epicardial surface of the embryonic hearts, at the right 
atrium (RA), right ventricular base (RVB), left ventricular base (LVB) and the left 
ventricular apex (LVA). All electrophysiological recordings were performed under stable 
heart rates after a 3 minute calibration period of the hearts. AO indicates Aorta.
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Immunohistochemistry and Immunofluoresence
Standard immunohistochemistry was performed with antibodies specifically 
against atrial myosin light chain 2 (MLC2a, gift from S.W. Kubalak), Periostin 
(gift from R.R. Markwald) and Connexin 43 (Cx43, Sigma, C6219). In addition, 
immunofluorescent double staining procedures were performed with a 
combination of periostin and the NK2 transcription factor related locus 5 (Nkx2.5, 
Santa Cruz Biotechnology, sc-8697) specific antibodies. For details concerning 
the exact staining procedures, we refer to the online data supplement.
Morphology and Statistical Analysis
All hearts were carefully studied for the presence of accessory myocardial 
AV connections using an Olympus BH-2 lighting microscope. Accessory AV 
myocardial connections were classified based on their specific location at the 
developing annulus fibrosis. Furthermore the AP-width was calculated by 
counting the number of subsequent MLC2a stained sections through which a 
single accessory connection could be followed and multiplied by 25 µm (distance 
between subsequent MLC2a stained sections). 
Statistical analysis of the HR and AV conduction time was performed 
with a students-t-test if values were equally distributed (Skewness is |-1|) 
otherwise a Mann-Whitney U test was performed. Analyses of AP-number and 
AP-width were performed with a univariate analyses of variance (unianova). 
A P value of < 0.05 (2-tailed) was considered to be significant. The SPSS 15.0 
software package (SPSS Inc, Chicago, Ill) was used for all analyses.  
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Results
Electrophysiological Recordings
Pre-Septated Hearts (11.5-13.5 dpc; n=6)
After a 3-minute calibration period of the hearts in the experimental chamber, 
electrophysiological recordings were performed under stable HRs. The mean 
recorded HR in pre-septated hearts was 94±24 bpm with a mean AV interval 
of 84±13ms. Comparable to previous studies,16,17 most pre-septated hearts (n=4; 
67%) at these stages already showed a LVA activation prior to RVB or LVB 
activation, indicating that the AV conduction axis is functional before ventricular 
septation has been completed. In 33% (n=2) of hearts concurrent ventricular 
apex and base activation patterns were observed (Table 1).
Table 1. Summary of ventricular activation patterns in pre-, early post- and 
late post-septated hearts.  
Group,age,(n) HR,BPM,mean±SD (range) AV-interval,ms,mean±SD (range)   Ventricular Activation pattern n (%)
Pre-septated 94±24 (66-135)                 83±13 (64-105) LVA>LVB/RVB 4 (67)
11,5-13,5dpc (n=6) LVB>LVA -
RVB>LVA -
Concurrent 2 (33)
LVA=LVB -
LVA=RVB 2 (33)
LVA=LVB=RVB -
Early Post-septated 115±41 (67-246) 80±17 (44-112) LVA>LVB/RVB 11 (38)
13,5-15,5dpc (n=29) LVB>LVA 2 (7)
RVB>LVA 2 (7)
Concurrent 14 (48)
LVA=LVB 12 (41)
LVA=RVB 2 (7)
LVA=LVB=RVB -
Late Post-septated 95±27 (63-146)                   81±18 (56-110) LVA>LVB/RVB 6 (46)
16,5-18,5dpc (n=13) LVB>LVA 4 (31)
RVB>LVA 1 (8)
Concurrent 2 (15)
LVA=LVB 2 (15)
LVA=RVB -
LVA=LVB=RVB -
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Early Post-Septated Hearts (13.5-15.5 dpc; n=29)
In early post-septated hearts (n=29) a mean HR of 115±41 bpm was recorded 
with a mean AV interval of 80±17ms. Interestingly, only 38% (n=11) of early 
post-septated hearts showed an apex-to-base ventricular activation pattern, 
the largest group showed base-to-apex and concurrent ventricular activation 
patterns (n=18; 62%). A concurrent apex and base activation was recorded in 
the majority of early post-septated hearts (n=14; 48%). More detailed analyses of 
the concurrent activated hearts showed that in most of these hearts (n=12; 41%) 
concurrent activation occurred between the LVB and LVA. In two hearts (7 %) 
the RVB was activated prior to the LVA and also in two hearts (7%) the LVB was 
activated prior to LVA (Table 1). Statistical analyses of the AV conduction time 
showed no significant differences (P=ns) between the mean AV conduction time 
in apex-to-base (78±12ms; n=11) and the base-to-apex and concurrent (81±20ms; 
n=14) activated hearts. 
Late Post-Septated Hearts (16.5-18.5 dpc; n=13)
The mean HR recorded in these hearts was 95±27 bpm with a mean AV interval 
of 81±18ms. Even at late post-septated developmental stages a mature apex-
to-base activation pattern was observed in only 46% (n=6) of the hearts. In a 
relatively large group of hearts activation of the LVB prior to the LVA was 
recorded (31%; n=4). Concurrent apex and base activation was observed in 15% 
(n=2), by which concurrent activation only occurred between the LVB and LVA. 
Furthermore, activation of the RVB prior to the LVA was observed in one heart 
(8%) (Table 1). Analysis of the mean AV conduction time showed no significant 
difference (P=ns) in apex-to-base (80±22ms; n=6) and base-to-apex and concurrent 
(82±16ms; n=7) activated hearts. Examples of the unipolar-electrophysiological 
recordings of apex-to-base, base-to-apex and concurrent activated hearts are 
shown in Figures 2-4. 
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Figure 2. Representative electrophysiological recording of an Apex-to-Base activated 
heart. (A) shows a recording of an early post-septated embryonic heart of 13.5dpc with a 
cycle length of 703ms (85bpm). First activation of the left ventriclar apex (LVA) occurs 
89ms after activation of the right atrium (RA) followed by the activation of the left and 
right ventricular base, (LVB; 90ms) and (RVB; 92ms) respectively. (B) magnification of 
the ventricular activation patterns, clearly showing that the point of the steepest nega-
tive deflection at the LVA precedes 1ms prior to LVB and 3ms prior to RVB activation, 
thereby creating an apex-to-base activation of the ventricles. 
Figure 3. Representative electrophysiological recording of a concurrent Apex and Base 
activated heart. (A) Shows a recording of an early post-septated heart of 15.5dpc with a 
cycle length of 446ms (134bpm). 76ms after activation of the right atrium (RA), the first 
ventricular activation was observed both at the left ventricular apex (LVA) and left ven-
tricular base (LVB). Subsequently the right ventricular base (RVB) was activated after 
81ms. (B) Magnification of the ventricular activation patterns, showing that the steepest 
negative deflection of the RVB is 5ms next to that of the LVA and LVB, which are acti-
vated at the same time point. Therefore this heart showed a concurrent LVA and LVB 
activation.
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Morphological Substrates for Arrhythmias
In all pre-septated hearts (n=6) the MLC2a stained sections showed a myocardial 
continuity between the atria and ventricles in the region of the primitive AV 
canal. At several locations in the left and right AV ring separation of the atrial 
and ventricular myocardium by the developing annulus fibrosis was already 
observed (Figure 5 A, B, E). The primitive ventricular septum was already 
present at 11.5 dpc and ventricular septation was completed between 13.5-14.5 
dpc. At these stages expression of Cx43 was present in the working myocardium 
of both atria and ventricles (Figure 5 C), whereas Cx43 expression was absent 
in the myocardium of the complete AV canal (Figure 5 C and E). At the dorsal 
side of the heart a broad myocardial continuity between the atria and ventricles 
was observed, the AV conduction axis comprising the AVN and the bundle of His 
(data not shown). 
In all early post-septated hearts (13.5-15.5 dpc; n=29) APs were found 
around both the mitral and tricuspid orifice of the AV canal. Some of the APs 
consisted of a single strand of myocardium whereas others comprised broad 
myocardial continuities. At these stages the APs, similar to the complete AV 
Figure 4. representative electrophysiological recording of a Base-to-Apex activated 
heart. (A) shows a recording of a late post-septated embryonic heart of 16.5dpc with a 
cycle length of 775ms (77bpm). 68ms after activation of the right atrium (RA) the first 
ventricular activation was observed at the left ventriclar base (LVB). Subsequently the 
left ventricular apex (LVA) and right ventricular base (RVB) were activated at 70ms and 
71ms respectively. (B) magnification of the ventricular activation patterns, clearly show-
ing that the point of the steepest negative deflection at the LVB precedes 2ms prior to 
LVA and 3ms prior to RVB activation, thereby creating an base-to-apex activation of the 
ventricles.
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junctional myocardium, were negative for Cx43 (Figure 5 G, H). Expression 
of Cx43 was still clearly present in the working myocardium of the atria and 
ventricles. At early post-septated stages APs were mostly located around the 
mitral orifice (63%; P=0.000), and analyses of the AP-width also showed a larger 
mean total AP-width around the mitral orifice (P=0.000) (Table 2). Interestingly, 
in almost all early post-septated hearts (24/29) a broad Cx43 negative AP was 
present at the anterolateral position of the left AV junction connecting the left 
atrial myocardium with the left ventricular myocardium along its free wall 
(Figure 5 F-H). 
Figure 5. MLC2a and Cx43 expression in the AV junction in pre- and post-septated 
hearts. A. Represents a frontal section of a pre-septated heart of 12.5dpc stained with 
MLC-2a. In the AV junction area. B. Magnification of boxed area in (A), the expression of 
connnexin43 (Cx43) was absent ((C) consecutive section of (A)). Expression of Cx43 was 
clearly present in both the working myocardium of the atria and ventricles (C). D. and E., 
magnifications of boxed areas in (B) and (C) respectively, shows a detail of the myocardium 
of the right AV junction which is positive for MLC-2a (asterisk in (D)) and negative for 
Cx43 (asterisk in (E)). F. Shows a frontal section of a 15.5dpc heart stained with MLC-2a. 
G. magnification of the boxed area in (F) shows the location of the large antero-lateral 
AP which was observed in 37 of the 42 post-septated hearts which were investigated. 
Arrows in (G) indicate the exact location of the myocardial connections between the atria 
and ventricles. The myocardium of the AV junction, which includes these connections is 
negative for Cx43 (arrows in (H)). RA indicates right atrium; RV=right ventricle; LA=left 
atrium; LV=left ventricle. Scalebar A-C and F=300�m; D, E=30 �m; G, H=60�m.
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In all late post-septated hearts (16.5-18.5 dpc; n=13) APs were still observed 
around the mitral and tricuspid orifice. The expressions pattern of Cx43 was 
similar as compared to earlier stages and all APs were still Cx43 negative (data 
not shown). Whereas the mean total AP width at these stages was largest at the 
mitral orifice (P=0.028), no differences were found between the mean number 
of APs at the mitral and tricuspid orifice (P=ns). Compared to earlier stages 
the mean number of APs per heart around the mitral orifice had decreased 
significantly (P=0.000), whereas no significant decrease was observed at the 
tricuspid orifice (P=0.136) (Table 2). Furthermore, the anterolateral AP at the 
left AV junction was present in all hearts (13/13).         
Longitudinal analyses of AP-number and AP-width in all post-septated 
hearts of subsequent developmental stages (13.5-18.5 dpc; n=42) showed a 
significant decrease both in mean number of APs (P=0.003) (Figure 6) and 
mean total AP-width (P=0.035). Furthermore, differences were observed in the 
rate by which APs disappeared around the mitral and tricuspid orifice. Although 
the majority of APs were located around the mitral orifice, a higher rate of AP 
disappearance of these left sided APs was observed (P=0.015). 
Early post-septated
13,5-15,5dpc (n=29)
Late post-septated
16,5-18,5dpc (n=13)
Statistics (early vs late)
Mean number of APs 8,1 5,2 P=0,003
Mean number left sided APs 5,1 3,1 P=0,000
Mean number right sided APs 3,0 2,1 P=ns
Statistics mean AP number (left vs right) P=0,000 P=ns -
Mean width (µm) of APs 347 214 P=0,035
Mean width (µm) left sided APs 238 138 P=0,000
Mean width (µm) right sided APs 109 76 P=ns
Statistics mean AP width (µm; left vs right) P=0,000 P=0,028 -
Table 2. Summary of the morphological analyses of APs in early and late 
post-septated hearts. For statistical analysis an Unianova was used, a P of <0.05 was 
considered to be significant.
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Periostin Expression in Relation to Annulus Fibrosis Development 
and APs
Immunohistochemical analysis showed that cardiac expression of periostin 
was present in all embryonic and fetal stages, which were investigated (11.5-
18.5  dpc). Expression of periostin was limited to specific cardiac structures i.e. 
the epicardium, the endothelial lining of the atrial and ventricular trabeculae, 
the subendocardial region of both outflow and AV cushions and the interstitial 
fibroblasts which were flanked by working myocardium in the atria and ventricles. 
At later stages (>14.5 dpc) strong expression was also observed in the AV cushion 
derived AV valves including their tension apparatus and in the endothelial 
lining of the developing coronary vessels. Remarkable absence of periostin was 
observed in parts of the AV conduction axis, especially in the AVN (data not 
shown). Periostin expression was clearly present in the developing annulus 
fibrosis. Strongest expression was observed at the immediate border between 
the developing annulus fibrosis and myocardium of the AV canal (Figure 7 A-
C, G-I). Furthermore, high expression of periostin seemed to overlie the MLC2a 
positive APs around both the mitral and tricuspid orifice (Figure 7 I). 
Immunofluorescent double stained sections with periostin and Nkx2.5        
were used for detailed studies on periostin expression in the developing annulus          
fibrosis in relation to the AP cardiomyocytes (Figure 7 D-F, J-L). At all stages 
Figure 6. The course of APs in post-septated mouse hearts. The graph schematically 
represents the course of APs around both the developing tricuspid and mitral valve orifice 
in post-septated mouse hearts (n=42). Each heart is represented by a black circle which 
indicates the total number of APs in each heart (Y-axis), at subsequent developmental 
stages (X-axis). The gray line indicates the hypothesized course of persistent APs at the 
developing annulus fibrosus.
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of development periostin was strongly expressed in fibroblasts bordering AP 
cardiomyocytes (11.5-18.5 dpc), however no periostin expression could be 
demonstrated in the Nkx2.5 positive cardiomyocytes themselves  (Figure 7 F, 
L).  It appears that periostin was predominantly expressed in fibroblasts flanking 
cardiomyocytes suggesting an inductive role in the process of isolation by the 
developing annulus fibrosis. 
 At early post-septated stages low expression of periostin was observed in 
almost all hearts at the anterior side of the left AV junction, which corresponds 
to the location of the left anterolateral APs. These broad APs were positive for 
the myocardial markers MLC2a and Nkx2.5 and negative for periostin. (Figure 
7 A-F). At later post-septated stages, expression of periostin increased at these 
specific areas (Figure 7 G-L). 
Figure 7. Nkx2.5 and periostin double expression in the developing annulus fi-
brosus and persistent APs. A. frontal section of an early post-septated heart of 13.5dpc 
stained with MLC-2a. The boxed area in (A) shows a left sided antero-lateral accessory 
myocardial pathway (AP) magnified in (B). Expression of periostin was observed next 
to the MLC-2a positive AP ((C) consecutive of (A)). An immunofluorescent (IF) double 
stained section shows that this AP ((F) consecutive section of (A)) was positive for Nkx2.5 
(D) and negative for periostin (E). G. Frontal section of almost the same area in (A) 
of a late post-septated heart of 16.5dpc stained with MLC-2a. H. Magnification of the 
boxed area in (G), showing an MLC-2a positive AP which also is positive for periostin 
((I) consecutive section of (G)). Compared to early post-septated stages (F), this AP ((L) 
IF consecutive section of (A)) is comprised of an intermingling network of Nkx2.5 posi-
tive cardiomyocytes (J) and periostin positive fibroblasts (L). RA indicates right atrium; 
RV=right ventricle; LA=left atrium; LV=left ventricle. Scalebars A, G=300�m; B-E=30 
�m; H-I=60�m.
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Discussion
AVRT is a relatively common tachyarrhythmia in the fetus and neonate that 
appears to resolve in the majority of cases during the first year of life.1, 2 It has 
been suggested that APs involved in these tachycardias are remnant myocardial 
AV connections that disappear during the ongoing development of the isolating 
annulus fibrosis before and after birth.4, 15 Although the presence of APs has 
been demonstrated during normal cardiac development in human fetuses and 
neonates, their conducting properties as well as their causative role in AVRT 
remains unknown.4, 5, 19, 20 
It has been demonstrated that cardiac development is not finished by 
the time of birth and that cardiac maturation is an ongoing process extending 
into the first year of life.19, 21, 22 Shortly after formation of the primary heart tube 
derived from two cardiogenic primordia, the future atrial and ventricular part 
of the heart develop with complete myocardial continuity at the primitive AV 
canal. Even in this primary heart tube before the formation of the specialized 
AV conduction axis, fast and slow conducting myocardial areas can already be 
discriminated. The primitive AV canal is composed of slow conducting Cx43 
negative myocardium,23 thereby separating the fast Cx43 positive atrial and 
ventricular myocardium, which will cause the heart to contract in a peristaltic 
manner.24 
Eventually the AV conduction axis will develop, which coincides with 
the formation of the isolating annulus fibrosis between atria and ventricles in 
the region of the Cx43 negative AV canal myocardium. The development of this 
isolating structure is regulated through a complex of several developmental 
processes, in which bone morphogenetic protein (BMP) signaling,13, 25 periostin 
an osteoblast specific factor8, 15 and epicardium derived cells entering the 
heart at the AV sulcus play a key role.11, 12, 15, 26, 27 Annulus fibrosis formation 
is not a process strictly limited to the embryonic stages of development, since 
contemporary studies have shown that the formation of the fibrous structures 
of the heart, including the annulus fibrosis and AV valves, extends into early 
postnatal development.21, 22 
In the current study we have shown that the development of the annulus 
fibrosis occurs in the area of the Cx43 negative AV canal myocardium. During 
formation of this isolating structure we demonstrated the presence of antegrade 
conducting APs in normal mouse heart development. These APs significantly 
decreased in number and size at subsequent developmental stages, but remained 
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present even at late post-septated stages of heart development (Figure 6). Modern 
electrophysiological animal studies demonstrated the conducting properties of 
primitive AV canal myocardium17 and the incidental presence of APs, which have 
been related to the etiology of Mahaim tachycardias in early developing mouse 
hearts.18 The presence and course of functional APs as described in the present 
study have not been reported during mammalian heart development before. 
A recent study of normal quail heart development also demonstrated 
antegrade conducting APs decreasing in number and size at subsequent 
developmental stages.15 In quail the majority of APs were located at the 
posteroseptal aspect of the developing tricuspid orifice whereas in mouse hearts 
the APs were mainly located around the anterolateral aspect of the developing 
mitral orifice especially at later developmental stages.  
Several factors may underlie the preferential location of persistent APs 
at the developing annulus fibrosis and the differences observed between mouse 
and avian. As a result of the physiological delay of right ventricular inflow tract 
formation, the isolation of this part of the annulus fibrosis in general is delayed 
as compared to the left side,18 which might explain the high incidence of right 
posteroseptal APs in quail.15 This however may only explain the APs present 
around the tricuspid orifice and not the high frequency of left anterolateral 
APs as observed in developing mouse hearts. Interestingly, recent studies on 
the development of the cardiac conduction system (CCS) by means of CCS-
lacZ expression in mouse hearts, designated bundles of CCS-lacZ expressing 
cardiomyocytes at the same left anterolateral position at the developing AV 
junction. These b-galactosidase positive myocardial bundles, which are not a 
part of the developing CCS, could be traced in some hearts until postnatal stages 
of development and have been related to Wolff-Parkinson-White (WPW) pre-
excitation syndrome.16
AP Location in Relation to Arrhythmias 
The current study showed the presence of APs around the mitral as well as 
the tricuspid valve orifice at early and late post-septated stages of development. 
Like others, a direct one-to-one relation between morphologically observed APs 
and their ability to conduct could not be made.15 However, differences were 
found between APs around the mitral and tricuspid valve orifice. At early post-
septated stages a significant majority of APs were observed around the mitral 
orifice. In late post-septated hearts no significant differences were observed, 
although absolute AP numbers showed that the majority of APs were still 
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located at the left side. In addition, the total AP-width both in early and late 
post-septated hearts was largest around the mitral valve orifice. Interestingly, 
the electrophysiological recordings showed that in the majority of early and late 
post-septated hearts, base-to-apex activation occurred at the LVB. Furthermore, 
in most concurrent apex and base activated hearts activation arose between the 
LVA and LVB. Therefore, it seems most likely that premature base activation 
in post-septated hearts occurs more often via the large and broad APs situated 
around the mitral valve orifice. 
Interestingly, we have recently reported,4 like several others in the past 
on the presence of similar APs in developing human hearts.5, 19, 20 In these hearts 
APs were observed around both the developing mitral and tricuspid valve orifice. 
Even in newborns APs were present with similar characteristics as observed in 
embryos and fetuses.20 Although these APs have been related to clinically observed 
arrhythmias, their true functionality had never been established. In fetuses and 
infants APs involved in AVRT are found around both the tricuspid and more 
frequently around the mitral valve orifice,28 which seems to be equivalent to 
the high frequency of temporary conducting APs at the developing mitral valve 
orifice as observed in the current study. However, we have to notice that we only 
measured antegrade conduction of the APs, which could serve as substrate for 
AVRTs and that neither retrogradely conducting APs nor sustained arrhythmias 
were recorded.
 
Periostin Expression in Relation to Annulus Fibrosis Formation 
and Persistent APs
Periostin is a member of the fasciclin gene family and acts as an adhesion molecule 
through binding of cell surface integrins.29 In mouse heart development periostin 
expression can be detected as from 9.5 dpc in low levels in the developing AV 
cushions and cardiac expression levels slightly decrease along development.8, 30 
Like others we also observed that periostin expression was mainly present in 
those parts of the developing heart, which are known to be subjected to high 
rates of mechanical stress.9 Furthermore we showed that expression of periostin 
was clearly present in the developing annulus fibrosis,4, 15 specifically at locations 
were separation of atrial and ventricular myocardium is needed. At these regions 
periostin might induce formation of the isolating fibrous tissue, since it can 
directly regulate collagen-I fibrillogenesis.9 
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The broad Cx43 negative anterolateral left sided APs which most probably have 
an imperative role in the large group of early LVB and concurrent activated 
hearts were predominantly periostin negative in early post-septated stages of 
development. At later stages periostin expression increased at the location of left 
anterolateral APs, suggesting an active process of isolation at that specific area 
of the AV junction. Therefore we postulate that periostin has an important role 
in the isolation of the AV junction by the stimulation of fibrous tissue formation 
thereby separating the atrial and ventricular myocardium, which subsequently 
will lead to regression of temporary APs for conduction.
The exact signaling pathway by which periostin is regulated remains 
unknown, although it has been shown that periostin is upregulated by several 
growth factors including BMPs.31 Transforming Growth Factor-Beta (TGF-b)7 
and Platelet Derived Growth Factors (PDGFs),32 which are highly expressed in 
the developing AV region. In addition, state of the art studies performed in avian 
showed that Epicardium Derived Cells (EPDCs) play a key role in periostin 
regulation underlying proper annulus fibrosis development. Inhibition of the 
epicardial outgrowth at early embryonic stages of development, resulted in a 
disturbed annulus fibrosis development, which coincided with a high frequency 
of antegrade conducting APs staining negative for periostin.11, 12 
The etiology of APs has not yet been clarified. In the majority of patients with 
WPW syndrome there is no familial involvement. APs are also associated with 
congenital heart disease specifically with abnormal development of the tricuspid 
valve like in Morbus Ebstein.33 A minority of cases is inherited as a single gene 
disorder or occurs as part of a syndrome with a strong genetic basis.34, 35 In 
humans LAMP2, PRKAG2 gene mutations have been identified to be involved 
in familial WPW syndrome associated with cardiac hypertrophy.36, 37 Animal 
studies have shown that mutations in the Alk3 gene result in Cx43 positive 
APs due to disrupted formation of the annulus fibrosis.13 In the present study 
we demonstrate that antegrade conducting APs remain present until late fetal 
stages of normal mouse heart development. These APs are Cx43 negative and 
appear to be remnants of the primitive AV myocardium. The presence of these 
APs may act as transient substrate for AVRT and may explain the spontaneous 
resolution of these arrhythmias in the fetal and neonatal period.
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Study Limitations
All electrophysiological recordings were performed at a basal heart rate of a           
spontaneously beating mouse heart under sub-physiological circumstances, which 
of course influences the heart rate. For all electrophysiological recordings four     
unipolar electrodes were used. The authors are aware of the fact that with this 
small number of electrodes a direct one-to-one relation cannot be made between 
a morphologically discriminated AP and the electrophysiological measurements. 
As a consequence, the positioning of the electrodes together with the relatively 
small size of these embryonic mouse hearts might therefore explain that no 
differences were observed in AV conduction time between apex-to-base, base-to-
apex and concurrent activated hearts.
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Online Data Supplement
Methods
 
Immunohistochemistry
Immunohistochemical experiments were performed using the following 
antibodies against: atrial myosin light chain 2 (MLC2a, gift from S.W. Kubalak), 
periostin (Gift from R.R. Markwald) and Connexin 43 (Cx43, Sigma, C6219). 
After fixation in 4% PFA, the hearts were dehydrated and embedded in paraffin. 
The embedded hearts were 5 µm sectioned and mounted 1 to 5 onto protein/
glycerin coated slides, so 5 different staining procedures could be performed 
on one embryo. After dehydration of the slides, inhibition of the endogenous 
peroxidase was performed for MLC2a with a solution of 0.3% H2O2 in PBS for 
20 min. For periostin and Cx43 antigen retrieval was performed in 0.01M Citric 
buffer of Ph 6.0 at 97oC for 12 minutes, followed by inhibition of the endogenous 
peroxidase in a solution of 0.3% H2O2 in PBS for 20 min. Overnight incubation 
with the primary antibodies was performed: 1/2000 anti-MLC2a, 1/1000 anti-
periostin and 1/200 anti-Cx43. The primary antibodies were dissolved in PBS-
Tween-20 with 1% Bovine Serum Albumin (BSA, Sigma Aldrich, USA). The slides 
were rinsed between subsequent incubation steps: PBS (2x) and PBS-Tween-20 
(1x). A 40 min incubation with secondary antibodies was performed, for MLC2a, 
periostin and Cx43: 1/200 goat-anti-rabbit-biotin (Vector Laboratories, USA, BA-
100) and 1/66 goat serum (Vector Laboratories, USA, S1000) in PBS-Tween-20. 
Thereafter a 40 minute incubation with ABC-reagent (Vector-Laboratories, USA, 
PK 6100) was performed. For visualization, all slides were incubated with 400 
µg/ml 3-3’di-aminobenzidin tetrahydrochloride (DAB, Sigma-Aldrich Chemie, 
USA, D5637) dissolved in Tris-maleate buffer pH7.6 to which 20 µl H2O2 was 
added for 10 min. 0.1% Haematoxilin (Merck, Darmstad, Germany) was used to 
counter stain the slides: MLC2a and Cx43 10 sec and periostin 5 sec, followed by 
rinsing with tap water for 10 minutes. Finally, the slides were dehydrated and 
mounted with Entellan (Merck, Darmstadt, Germany). 
Immunofluoresence
An immunofluorescent double staining was performed with antibodies specifically 
against periostin and NK2 transcription factor related locus 5 (Nkx2.5, Santa 
Cruz Biotechnology, sc-8697). Preparation of sections was executed as described 
above. Overnight incubation with the primary antibodies was performed 1/2000 
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Nkx2.5 in combination with 1/250 periostin. Thereafter, a 60 minute incubation 
with the secondary antibody (1/200 horse-anti-goat-biotin and 1/66 horse serum) 
in combination with 1/50 donkey-anti-rabbit-FITC (Santa Cruz Biotechnology, 
sc-2090) was performed, followed by another 60 minute incubation with 1/200 
Avidine-TRITC (Vector Laboratories, USA, A-2002). A 5 minute incubation with 
4’,6-diamidine-2-phenylidole-dihydrochloride (DAPI, Molecular probes, D3571) 
was executed to counter stain the slides. Finally the slides were mounted with 
Prolong Gold (Molecular probes, P36930).  
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Abstract
Background. Fetal and neonatal atrioventricular reentrant 
tachycardias (AVRTs) can be life threatening but resolve in most 
cases during the first year of life. Transient presence of accessory 
atrioventricular (AV) myocardial connections during annulus 
fibrosis development may explain this phenomenon.
Methods and Results. 45 human embryonic, fetal and neonatal 
sectioned hearts (4 to 36 weeks of development) were studied 
immunohistochemically. Accessory myocardial AV connections were 
quantified and categorized according to their specific location and 
3-D AMIRA reconstructions were made. Between 4 and 6 weeks of 
development: atrial and ventricular myocardium was continuous 
at the primitive AV canal. At 6-10 weeks: numerous accessory 
myocardial AV connections were identified at the left (45%), right 
(35%) and septal (20%) region of the AV junction. Most right sided 
accessory connections comprised distinct myocardial strands, 
left sided connections consisted of larger myocardial continuities. 
At 10-20 weeks: all accessory AV connections comprised discrete 
myocardial strands and gradually decreased in number. The majority 
of accessory connections were located at the right AV junction (67%), 
predominantly at the lateral aspect (45%). At the left AV junction 
17% and at the septal region 16% of the accessory connections were 
observed. 3-D reconstructions of the developing AV nodal area at 
these stages demonstrated multiple AV nodal related accessory 
connections. From 20 weeks until birth and in neonatal hearts no 
more accessory myocardial AV connections were observed.      
Conclusions. Isolation of the AV junction is a gradual and ongoing 
process and particularly right lateral accessory myocardial AV 
connections are commonly found at later stages of normal human 
cardiac development. These transitory accessory connections may 
act as substrate for AVRTs in fetuses or neonates.
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Introduction
Atrioventricular reentrant tachycardia (AVRT) requiring the presence of an 
accessory atrioventricular (AV) myocardial pathway (AP) is the most common 
type of supraventricular tachycardia (SVT) in both the foetus and newborn.1,2 
AVRT is a potentially life threatening problem in this young age group and 
these tachycardias are sometimes difficult to control with antiarrhythmic drug 
therapy.3-5 However, most tachycardias spontaneously resolve within the first 
months of life and more than 60% of patients require no antiarrhythmic drug 
therapy and remain free of symptoms after the age of one year.2, 3 
 This self-limiting character of most perinatal AVRTs suggests that the 
majority of the accessory AV pathways involved eventually disappear after birth, 
furthermore a discontinuation of tachycardia initiating events may also explain 
the disappearance of these type of arrhythmias. It is unknown whether APs 
involved in perinatal AVRT have a different etiology as compared to APs involved 
in AVRT presenting later in life. We hypothesize that self-limiting perinatal 
AVRT can be explained by the transitory presence of accessory myocardial 
connections during the normal process of isolation of the AV junction in cardiac 
development. 
 Shortly after the formation of the primary heart tube, the heart is subjected 
to extensive remodeling processes.6 Previous studies have shown that around 
the seventh week of human development, the separation process of the atrial 
and ventricular myocardium at the primitive AV canal has started. As from the 
twelfth week of development atrial and ventricular myocardium are separated 
by a layer of fibrous tissue, the annulus fibrosis, in which the AV conduction axis 
comprises the only myocardial continuity.7 Recently, electrophysiological studies 
in avian8 and mouse models9, 10 have shown that up to late stages of cardiac 
development multiple accessory AV myocardial connections were present. These 
accessory connections demonstrated retrograde10 and antegrade AV conduction 
and gradually decreased in number at subsequent developmental stages.8 In 
addition, an electrophysiological study in mice demonstrated the onset of AVRT 
at early stages of development.10 
 In this study we investigated the presence and the specific locations of 
accessory AV myocardial pathways in relation to the process of formation of 
the annulus fibrosis during the different stages of normal heart development in 
humans. 
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Methods
Hearts
The human embryonic, fetal and neonatal hearts (n=45) were obtained from the 
collection of the Department of Anatomy and Embryology of the Leiden University 
Medical Center, The Netherlands. The study was approved by the local Medical 
Ethical Committee. Only specimens with a normal karyotype and structural 
normal hearts were included for this study. All hearts were already sectioned 
either in transverse, frontal or sagittal plain and immunohistochemically 
stained with different myocardial (HHF-35, DAKO, Glostrup, Denmark; 
Myosin, a-MHC and b-MHC kindly supplied by A.F.M. Moorman) and fibrous 
tissue (Fibronectin, A245, DAKO, Glostrup, Denmark ; CollagenVI, Southern 
Biotechnology, Birmingham, AL ; Laminin, PU078, BioGenex, San Remon, USA) 
markers. Furthermore, histological stained sections were used: Haematoxylin 
eosin (HE), Resorcin-fuchsin-iron haematoxylin-picric acid-thiazin red (modified 
Verhoeff-Van Gieson stain) and Azan. A detailed description of staining protocols 
can be found in previous publications.11, 12 According to pregnancy duration and 
Crown-Rump-Length (CRL) all embryos, fetuses and neonates were separated 
into 4 groups of subsequent gestational stages of development: Group 1: 4 weeks 
/ CRL5mm - 6 weeks / CRL11mm (n=2); Group 2: 6 weeks / CRL11mm - 10 weeks 
/  CRL 40 mm (n=7); Group 3: 10 weeks / CRL 40mm - 20 weeks / CRL164-170mm 
(n=27); Group 4: 20 weeks / CRL164-170 -birth- neonates (n=9).
The hearts were carefully studied section by section for the presence of 
accessory AV myocardial connections at the left, right and septal area of the 
AV junction using an Olympus BH-2 light microscope. An accessory myocardial 
AV connection was defined as an uninterrupted strand of myocardium, which 
crosses the annulus fibrosis in addition to the AV conduction axis in post-septated 
hearts.
All accessory myocardial AV connections in the embryonic or fetal hearts 
were categorized based on their specific location in the AV junction. The accessory 
myocardial connections related to the developing AV node (AVN) were described 
separately.
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Immunohistochemistry
Additional immunohistochemical experiments were performed using MLC2a 
and periostin specific antibodies as additional myocardial and fibrous tissue 
markers respectively. All embryonic hearts were fixed in 4% paraformaldehyde 
(PFA), after dehydration they were embedded in paraffin. The embedded hearts 
were 5 �m sectioned and mounted 1 to 6 onto protein/glycerin-coated slides,          
so 6 different staining procedures could be performed on one embryo. After 
dehydration of the slides, inhibition of the endogenous peroxidase was performed 
for MLC2a with a solution of 0.3% H2O2 in PBS for 20 min. For periostin antigen 
retrieval was performed in 0.01M Citric buffer of Ph 6.0 at 97oC for 12 minutes, 
followed by inhibition of the endogenous peroxidase in a solution of 0.3% H2O2 in 
PBS for 20 min. Overnight incubation with the primary antibody was performed 
with the following antibodies: 1/2000 anti-atrial myosin light chain 2 (MLC2a, 
gift from S.W. Kubalak) and 1/1000 anti-periostin (gift from R.R. Markwald). 
The primary antibodies were dissolved in PBS-Tween-20 with 1% Bovine 
Serum Albumin (BSA, Sigma Aldrich, USA). The slides were rinsed between 
subsequent incubation steps: PBS (2x) and PBS-Tween-20 (1x). For both MLC2a 
and periostin, a 40 min incubation with the secondary antibodies was performed 
using 1/200 goat-anti-rabbit-biotin (Vector Laboratories, USA, BA-100) and 1/66 
goat serum (Vector Laboratories, USA, S1000) in PBS-Tween-20.  Thereafter a 
40 minute incubation with ABC-reagent (Vector-Laboratories, USA, PK 6100) 
was performed. For visualisation, all slides were incubated with 400 �g/ml 3- 
3’di-aminobenzidin tetrahydrochloride (DAB, Sigma-Aldrich Chemie, USA, 
D5637) dissolved in Tris-maleate buffer pH7.6 to which 20 �l H 2O2 was added for 
10 min. 0.1% Haematoxylin (Merck, Darmstad, Germany) was used to counter 
stain the slides: MLC2a 10 sec and periostin 5 sec, followed by rinsing with tap 
water for 10 minutes. Finally, the slides were dehydrated and mounted with 
Entellan (Merck, Darmstadt, Germany). 
AMIRA reconstruction
Reconstructions were made of the developing AVN region, as described earlier,9 
using the AMIRA software package (Template Graphics Software, San Diego, 
USA).  
The authors had full access to and take responsibility for the integrity of the 
data. All authors have read and agree to the manuscript as written.
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Results
Morphology of the Developing Annulus Fibrosis
4 weeks / CRL 5 mm – 6 weeks / CRL 11 mm (n=2) 
At 4 weeks (CRL 5mm) of development the heart tube had looped and the 
common atrium was completely positioned above the primitive left ventricle. 
Large endocardial cushions were observed in the region of the common outflow 
tract and at the anterosuperior and posteroinferior luminal side of the primitive 
AV canal. At this stage, the atrial and ventricular myocardium was continuous 
at the region of the primitive AV junction. At 5 weeks (CRL 7 mm) the formation 
of the right ventricle had started and the future left and right ventricle were 
clearly discernible. In the AV canal region the myocardium of the primitive atria 
and the ventricles was continuous (data not shown).  
6 weeks / CRL 11 mm – 10 weeks / CRL 40 mm (n=7)
Between 6-7 weeks, the AV cushions had fused and the future tricuspid and 
mitral valve orifice of the AV junction became visible. Almost all atrial and 
ventricular myocardium was still continuous at the AV junction. Around the 
seventh week of development ventricular septation was nearly completed, 
thereby separating the left and right blood streams. The separation of atrial and 
ventricular myocardium had clearly commenced at the right dorsal aspect of the 
embryonic heart and to a lesser extent at the left dorsal side. At 7 to 8 weeks, 
ventricular septation was completed and formation of the partially AV cushion 
derived tricuspid valves at the right and mitral valve at the left AV junction had 
started. At the end of the ninth week AV cushion tissue was no longer observed, 
and well shaped mitral and tricuspid valves were present at the AV junction. 
At this stage, the atrial and ventricular myocardium was almost completely 
separated by the fibrous tissue of the developing annulus fibrosis. At the dorsal 
side of the fetal heart a distinct AV myocardial continuity was observed which 
corresponded to the developing AV conduction axis, comprising the developing 
AVN and the bundle of His. Between 6 and 10 weeks of development, many 
parts of the AV junction showed an incomplete isolation at the annulus fibrosis 
(Figure 1A-C). Accessory AV myocardial connections were found both at the left 
(45%), right (35%) and septal (20%) region of the AV junction (Figure 1D). Most 
of the accessory myocardial connections were identified as broad accessory AV 
myocardial continuities. At the dorsal aspect of the right AV junction accessory 
connections consisted of small single myocardial strands. 
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At the right AV junction, the so-called right AV ring (RAVR) bundle could easily 
be distinguished from the atrial myocardium as a separate structure. The RAVR 
bundle, considered to be part of the embryonic AV conduction system, formed a 
ring of myocardium around the tricuspid annulus at the atrial side (Figure 2 
A-C).13 
Figure 1. Separation of atrial and ventricular myocardium at 6 to 10 weeks of 
development. In early post-septated hearts large myocardial continuities between atrial 
and ventricular myocardium were observed at the right AV junction ((A) magnification of 
boxed area in (B)) and left AV junction ((C) magnification of boxed area in (B)), as shown 
in these frontal sections of an MLC-2a stained embryonic heart of 7 weeks of development 
(B). The region between the arrowheads in (A) and (C) show the myocardial continuity 
at the left and right lateral AV junction. (D) Between 6 and 10 weeks of development 
7 hearts were studied, the red numbers indicate the total number of hearts in which 
accessory myocardial AV continuities were observed at a specific location at the tricuspid 
and mitral orifice of the developing AV junction. The percentages represent the total 
amount of accessory myocardial AV continuities at a specific location, compared to the total 
number of accessory myocardial AV continuities at the entire AV junction. VS indicates 
ventricular septum; LA=left atrium; LV=left ventricle; LAM=left atrial myocardium; 
LVM=left ventricular myocardium; RV=right ventricle; RAM=right atrial myocardium; 
RVM=right ventricular myocardium. Scale bars: A, C=150 �m; B=300 �m.
206
PART I: Development of the Annulus Fibrosis and Accessory Pathway Persistence in Relation to Arrhythmia Etiology
Interestingly, the majority of the right-sided accessory myocardial AV connections 
(65%) were located subendocardially and made contact with the RAVR bundle. 
In all examined hearts the isolating tissue between the RAVR bundle and the 
ventricular myocardium was not as extensive as at other locations at the AV 
junction. Frequently, only a single layer of fibrous tissue was observed between 
the RAVR bundle and the ventricular myocardium.
Figure 2. Separation of atrial and ventricular myocardium at eleven weeks of 
development. The right AV junction ((A) magnification of boxed area in (D)) of an eleven 
week old fetal heart frontally sectioned (D). Atrial and ventricular myocardium is separa-
ted by a layer of periostin positive fibrous annulus fibrosis tissue (asterisk in (A), (B) and 
(C)). HHF-35 positive accessory AV myocardial connections (region between arrowheads 
in (B), magnification of boxed area in (A)), negative for periostin ((C) adjacent section of 
(B)), were present between the right atrioventricular ring (RAVR) bundle and the right 
ventricular myocardium (RVM). E. Magnification of dotted box in (D) shows that the left 
atrial myocardium (LAM) and left ventricular myocardium (LVM) are separated by a 
thick layer of periostin positive ((F) adjacent section of (E)) fibrous annulus fibrosis tissue 
(asterisk in (E) and (F)).  RA indicates right atrium; RV=right ventricle; LA=left atrium; 
LV=left ventricle; VS=ventricular septum. Scale bars: D=1 mm; all others 60 �m.
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10 weeks / CRL 40 mm - 20 weeks / CRL 164-170 mm (n=27)
Between 10 (CRL 40 mm) and 20 weeks (CRL 164-170 mm) of development 
the annulus fibrosis and valve formation had progressed further and cardiac 
development was mainly dominated by growth. At the left AV junction, the 
annulus fibrosis had become a firm structure with a thick layer of fibrous 
tissue isolating the left atrial and ventricular myocardium (Figure 2 D-F). 
The developing AVN was positioned in the right posteroseptal region and 
was continuous with the bundle of His traversing the annulus fibrosis behind 
the aorta. At the right AV junction the annulus fibrosis was more fragile and 
accessory myocardial AV connections were frequently found especially adjacent 
to the RAVR bundle (Figure 2 A-D), which could still be observed in most hearts 
up to 20 weeks. 
Between 10 and 20 weeks broad accessory AV myocardial continuities 
as seen at earlier embryonic stages, could no longer be detected. However, up 
to 20 weeks of development numerous accessory myocardial AV connections 
were identified (Figure 3 A-E). At these stages, all accessory myocardial AV 
connections only consisted of single strands of myocardium crossing the annulus 
fibrosis (Figure 3 C-E). As expected, the majority of accessory myocardial AV 
connections were now located at the right AV junction (67%) and only 17% 
were located at the left AV junction. Furthermore, 16% of accessory myocardial 
AV connections were observed at the midseptal and anteroseptal region of 
the AV junction (Figure 3 F). Right-sided connections (45%) were located 
subendocardially at the lateral aspect of the right AV junction, mostly related to 
the RAVR bundle (Figure 3 C,E). 
20 weeks / CRL 164-170 mm – birth - neonatal stages (n=9)
The annulus fibrosis of 5 fetal and 4 neonatal hearts was examined completely. 
In both fetal and neonatal hearts no accessory myocardial AV connections were 
observed at the left, right and septal area of the AV junction (data not shown). 
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Accessory Connections Related to the Developing AVN
The developing AVN and bundle of His were examined during different stages 
of fetal heart development. The cardiomyocytes of the AVN were large pale and 
rounded cells and could be well distinguished from the adjacent atrial working 
myocardium (data not shown). From 10 weeks onward the developing AVN 
remained positioned anterior to the coronary sinus ostium to the mid-atrial 
septum, immediately adjacent to the tricuspid annulus (Figure 4 A). Shortly 
after completion of ventricular septation, the bundle of His was a prominent 
structure crossing the annulus fibrosis in the midseptal region continuing at the 
ventricular side divided into a left and right bundle branch. Along fetal heart 
development the bundle of His was better isolated and could be easily identified 
from the surrounding structures. During subsequent stages of development until 
birth, numerous small strands of cardiomyocytes originating from the AVN region, 
penetrated the annulus fibrosis. These accessory AV nodal extensions of large 
pale rounded cardiomyocytes connected to the ventricular septal myocardium 
but had no relationship with the penetrating bundle of His (Figure 4 A, B). 
Sections and a three dimensional reconstruction of the AVN region and AV nodal 
accessory connections of a 14,2 week fetal heart are shown in Figure 4.
Figure 3. (left) Separation of atrial and ventricular myocardium at 10 to 20 
weeks of development. Between 10 and 20 weeks of development several accessory 
myocardial AV connections bypassing the AV conduction axis were present. A. Modified 
Verhoeff-Van Gieson stain stained frontal section of a 15,3 week fetal heart in which 
myocardium is stained yellow-brown and fibrous tissue is stained red. B. Represents the 
boxed area in (A) showing a detail of the annulus fibrosis of the right AV junction which 
is in continuity with the base of the tricuspid valve (arrows in A and B). C. Detail of the 
boxed area in (B), showing the right atrioventricular ring (RAVR) bundle which is in 
continuity with the ventricular myocardium, thereby creating an accessory myocardial 
AV connection (arrow in (C)). D. Shows a frontal section of the right AV junction of a fetal 
heart of 19,6 weeks of development. The arrows indicate the tricuspid valve in continuity 
with the fibrous tissue of the annulus fibrosis (red). E. Represents the magnification of 
the boxed area in (D) showing an accessory myocardial AV connection in contact with the 
RAVR bundle (arrow in (E)). Between 10 and 20 weeks of development 27 fetal hearts 
were investigated for the presence of accessory myocardial AV connections at the deve-
loping AV junction (F). The red numbers indicate the total number of hearts in which 
accessory myocardial AV connections were present at a specific location at the AV junc-
tion. The percentages represent the amount of accessory myocardial AV connections at a 
specific location at the AV junction compared to the total number of accessory myocardial 
AV connections at the entire AV junction. RA indicates right atrium; RV=right ventricle; 
AO=aorta. Scale bars: A, D 1mm; B=200 �m; C, E=100 �m.
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Figure 4. Accessory atrioventricular connections related to the developing 
atrioventricular node (AVN). A. Shows a modified Verhoeff-Van Gieson stain stained 
transverse section of a 14,2 week fetal heart. The boxed area in (A) shows the AVN region 
of which a 3-D reconstruction is shown in (B). During subsequent stages of development 
until birth multiple accessory myocardial connections related to the AVN were observed. 
(B) The 3-D reconstruction visualizes a frontal view of these so-called nodoventricular 
connections penetrating the annulus fibrosis (red transparent) and connecting the AVN 
with the ventricular septal (VS) myocardium. For display purpose the nodoventricular 
connections have been elongated, which are indicated by the arrows in (B). RA indicates 
right atrium; LA=left atrium; RV=right ventricle; LV=left ventricle. In the 3-D recon-
struction, red indicates base of mitral valve (MV) and tricuspid valve (TV); blue, myo-
cardium of the atrioventricular conduction axis, including the bundle of His (HIS). Scale 
bar: A=1 mm
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Discussion
SVTs affect about 0.1% of fetuses and newborns. In most cases the substrate 
for arrhythmia is an abnormal electrical conduction through an accessory AV 
myocardial pathway causing a circus movement between atria and ventricles.1 
However, the majority of children presenting with AVRT in the fetal or neonatal 
period has no recurrences after the age of one year and show disappearance 
of ventricular preexcitation and non-inducibility of AVRT by transesophageal 
electrophysiological studies in approximately one third of the patients.14, 15 This 
self-limiting character of most AVRTs in fetuses and newborns is an intriguing 
clinical phenomenon, but the mechanism has not yet been elucidated. AVRT in 
this age group has been speculated to originate from the transient presence of 
conducting APs during the normal process of maturation of the annulus fibrosis.8, 
16 The development of this isolating structure involves several processes in 
which the endocardial cushions lining the luminal side of the primitive AV canal 
together with the inward migration of the epicardially located AV sulcus tissue 
have an important role.17-19 Recently, it has been shown in more detail that a 
combination of bone-morphogenetic-protein (BMP) signalling,20, 21 periostin an 
osteoblast–specific factor22 and epicardial derived cells which enter the heart at 
the AV sulcus play a key role in this process.23, 24 
The etiology of APs has not been elucidated. The majority of APs conduct 
antegradely as seen in patients with Wolff-Parkinson-White (WPW) syndrome 
(OMIM #194200; incidence in general population 1,5 per 1000 persons),25 the 
prevalence of WPW syndrome in children under 13 years of age is lower (0.07%).26 
In adults, twenty-five percent of APs involved in AVRT are concealed indicating 
that they only have retrograde conducting properties.27 In infants, the percentage 
of concealed APs is higher, approximately 60%.28 In the majority of cases of WPW 
syndrome there is no familial involvement. However, significant minority of 
cases are inherited as a single gene disorder or occur as part of a syndrome with 
a strong genetic basis.25, 29, 30 Recently PRKAG2 gene missense mutations have 
been identified to be involved in familial WPW syndrome often associated with 
cardiac hypertrophy.29 Animal studies have shown that mutations in the Alk3 
gene result in a disrupt formation of the annulus fibrosis causing ventricular 
preexcitation via posterior paraseptal bypass tracts.20 The differences in location 
and specific electrophysiological properties of APs as well as their association 
with structural heart disease like hypertrophic cardiomyopathy and congenital 
heart disease indicate that not all APs share the same etiological pathway. 
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Previous studies have demonstrated the presence of accessory myocardial 
AV connections between atrial and ventricular myocardium during normal 
embryological and fetal heart development in humans16, 31, 32 and other 
mammals.9, 10 However, the present study for the first time systematically 
describes the presence and the specific locations of gradually disappearing 
accessory AV myocardial connections crossing the developing annulus fibrosis 
in human embryonic, fetal and neonatal hearts. We demonstrate that atrial 
and ventricular myocardium was continuous at the primitive AV canal at early 
stages of development. First separation of atrial and ventricular myocardium 
by the developing annulus fibrosis was observed at the right dorsal AV junction 
around 7 weeks of development and myocardial continuity persisted longer 
near the left junction. Total separation of atrial and ventricular myocardium 
was completed around ten to eleven weeks, which corresponds to other studies 
regarding the formation of the annulus fibrosis in developing human hearts.7 
However, numerous accessory AV myocardial connections can be identified up 
to the end of the second trimester of pregnancy. Comparable to other studies,16 
these accessory AV myocardial connections were observed at the subendocardial 
aspect of both the right and left lateral AV junction of the heart. In the second 
and third trimester the left AV ring becomes firmly isolated by a thick layer of 
fibrous tissue followed by isolation of the right AV ring. 
Especially the isolation of the right AV ring is weak and frequently 
consists only of very thin layers of fibrous tissue. Up to 20 weeks of gestation 
small AV myocardial strands remain present near the lateral side of the tricuspid 
valve that are mainly located subendocardially. The high frequency of these right 
sided accessory myocardial AV connections and the weak isolation of especially 
this part of the AV junction might be associated with the normal developmental 
process of the right ventricular inflow tract. In early stages of heart development, 
as observed in the current study, the common atrium is completely positioned 
above the left ventricle. Formation of the right ventricular inflow tract starts with 
a groove, which is embedded in the myocardium of the primary fold. As a result 
of the expansion and outgrowth of this myocardial groove the right ventricular 
inflow tract will be formed, which eventually establishes the right part of the AV 
junction.9 Therefore, the formation of the right ventricular inflow tract might 
result in a weaker isolation and a high frequency of accessory myocardial AV 
connections, since this part of the AV junction develops subsequent to the already 
existent left AV junction. The right sided AV myocardial connections frequently 
are located in close relationship with the RAVR bundle.13 This semicircular 
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structure forms part of the temporary embryological specialized AV conduction 
system and is continuous with the AVN posteriorly. In the fetus it can be identified 
as a ring of node-like cells in the right atrium just above the tricuspid valve 
that obliterates later on.13, 33, 34 These accessory myocardial AV connections seem 
to correspond to the presumed multiple AV nodes and pathways as originally 
reported by Kent and reviewed by Anderson (1996).35 The relationship of right 
sided accessory myocardial AV connections with the RAVR bundle could explain 
the decremental properties as seen in some of the right sided APs.36 
Within the developing AVN small myocardial extensions can be 
identified that cross the annulus fibrosis and connect the developing AVN with 
the ventricular septal myocardium. These AV nodal extensions remain present 
until birth. The presence of the so-called nodoventricular connections in fetal 
and neonatal hearts has been reported earlier and this phenomenon has been 
described as fetal dispersion of the AVN.37 In the first months after birth extensive 
remodeling of the fibrous heart skeleton including the AVN area takes place,31, 38 
in which the AVN becomes a more solid structure.39 AV nodal extensions appear 
to be a common finding in neonatal hearts, although it has been associated with 
sudden infant death syndrome in the past.40 In theory, nodoventricular pathways 
could provide the substrate for SVT, but to our knowledge this rare form of 
reentrant tachycardia has not been documented in the perinatal period. 
Recently, the temporary presence of functional accessory myocardial 
AV connections has been demonstrated by electrophysiological studies in avian 
hearts up to late stages of fetal development. These connections appeared to 
have antegrade conducting properties, which was demonstrated by unipolar 
electrogram recordings showing premature left and right ventricular base 
activation in post-septated hearts.8 Furthermore, studies performed in mammals9, 
10 showed that in normal mouse embryos conducting accessory AV pathways 
are present during cardiac development that can actually create the substrate 
for reentrant tachycardias. Some of these pathways even appeared to have 
decremental properties as observed in the Mahaim preexcitation syndrome.9 
In normal human fetuses the conducting properties of transient accessory AV 
connections, depending on factors such as intercellular coupling remain to be 
elucidated as well as their capability to establish a pathway for AVRT. However, 
these accessory myocardial AV connections in human fetuses and their specific 
locations show strong similarities with the conducting accessory myocardial AV 
connections as demonstrated in avians and mice.8-10  
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APs in adult patients with AVRT are mostly found around the mitral valve 
orifice and approximately 60% are located in the left ventricular free wall.27 
In the pediatric age group the incidence of APs around the tricuspid annulus 
appears to be higher.41 APs around the tricuspid valve are usually located at 
the subendocardial aspect of the heart, whereas left sided APs can also have a 
more epicardial course in the AV sulcus. This implicates that the persistence of 
subendocardially located accessory myocardial AV connections as demonstrated 
in normal fetuses could only partly explain the pathogenesis of APs in patients 
with AVRT. However the delayed disappearance of fetal APs as reported in the 
current study offers a good explanation for the onset and disappearance of fetal 
and neonatal AVRT.  One-third of the fetuses and neonates with AVRT have WPW 
syndrome showing ventricular pre-excitation on the postnatal electrocardiogram, 
the others have concealed APs with only retrograde conduction.42 Although late 
recurrences of tachycardia after 8 to 10 years have been reported in neonates with 
WPW syndrome, the majority of these children remains free of symptoms during 
life.43 Recently it has been reported that the group of neonates with concealed 
APs has an even better prognosis and more than 80% remain asymptomatic 
after the first year, without recurrences later in life.42 In the present study we 
have demonstrated that accessory myocardial AV connections remain present 
up to late stages of fetal heart development, which indicates that the process 
of isolation of the AV junction is a continuous process not finished by the time 
of birth. The temporary presence of these accessory myocardial AV connections 
could serve as substrate for perinatal AVRT.  
Study Limitations
The current study demonstrated the presence of accessory AV connections in 
normal heart development. However, none of the hearts investigated were 
from fetuses or neonates with known episodes of SVT. Therefore, it cannot be 
determined whether the accessory connections served as functional substrate 
for AP mediated SVT. 
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Clinical Perspective
Atrioventricular reentrant tachycardias presenting in fetal or neonatal life can be 
life threatening but also tend to resolve in the majority of patients in the first year 
of life. The etiology of accessory pathway mediated tachycardias in the perinatal 
period has not been elucidated. In early embryonic development the atrial and        
ventricular myocardium are continuous in the primitive atrioventricular canal. 
The AV conduction axis will then develop, which coincides with separation of the 
atrial and ventricular myocardium by formation of the annulus fibrosis. Annulus 
fibrosis development involves several processes in which the endocardial AV 
cushions lining the luminal side of the primitive AV canal together with the     
inward migration of the epicardially located AV sulcus tissue have an important 
role. In post-septated human hearts we demonstrated the presence of numerous 
accessory AV myocardial connections around both the mitral and tricuspid 
annulus during normal cardiac development. At the end of the second trimester 
the connections gradually decreased in number and size, and were located mostly 
around the tricuspid annulus. The persistence of fetal AV connections may serve 
as substrate for AV reentrant tachycardia in the fetus and newborn. The self 
limiting character of most of these tachycardias could be explained by loss of the 
substrate due to the ongoing development of the annulus fibrosis, a process not 
completely finished by the time of birth. 
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Abstract
While the ontogenic development of the AV nodal region has, since 
the first detailed report on the specialized AV node (AVN) in the 
monumental monograph of Sunao Tawara in 1906, been studied for 
over a 100 years now, the anatomical boundaries and developmental 
origin of the  AVN still remain a subject of debate. Clinically, the vast 
majority (>90%) of patients with AVNRT are cured by radiofrequency 
(RF) catheter ablation procedures targeting the slow pathway of the 
AVN, while the anatomical boundaries of the electrophysiologically 
distinct slow (a) and fast (b) AV nodal pathways as substrates for 
AVNRT have still remained a conundrum in this confusing field. In 
this review, an overview of historical and contemporary knowledge on 
the anatomy of the AVN and its atrial inputs is given. Furthermore, 
structural AV nodal development and the cellular electrophysiology 
of the developing AV junction in relation to the adult AVN and the 
concept of AV nodal conduction dichotomy are discussed.
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Atrioventricular (AV) Nodal Reentrant Tachycardia (AVNRT) is the most 
common mechanism of supraventricular tachycardia (SVT) in adults (>80%),1 
yet it accounts for a comparatively small number of cases of SVTs in pediatric 
patients (5-16%).2 Although currently the vast majority (>90%) of patients with 
AVNRT are cured by radiofrequency catheter ablation procedures,3 it is still 
unknown whether the areas that appear ‘specialized’ to and are targeted by 
the electrophysiologist indeed show distinctive morphological characteristics, 
neither has the developmental origin of the AV Node (AVN) been clarified. In 
view of the persisting discrepancies in literature and the rekindled interest in the 
developmental morphology of the AVN, the purpose of this article is to review the 
developmental anatomy, physiology and ontogeny of the AV specialized tissues 
in relation to AV nodal arrhythmia etiology. 
 
The Anatomical Location of the Adult AVN
The architecture of the AV conduction axis was first described in 1906 by Sunao 
Tawara, who stated that this axis was the only myocardial structure that crossed 
the insulating plane of the annulus fibrosis at the AV junction.4 In the normal 
mature heart, the atrial components of the AV conduction axis are contained 
within the triangle of Koch.5 The triangular area of Koch occupies the atrial 
component of the muscular AV septum and is delimited by three anatomical 
landmarks: 1) superiorly by the tendon of Todaro (the fibrous commissure of 
the flap guarding the openings of the inferior caval vein and the coronary sinus) 
positioned in the center of the myocardialized spina vestibulum, 2) inferiorly by 
the attachment of the septal leaflet of the tricuspid valve and 3) at the base by 
the mouth of the coronary sinus (CS). The apex of the triangle of Koch overlies 
the membranous component of the AV septum and lies at the center of the short 
axis of the heart.5, 6 Within the triangle of Koch, between the mouth of the CS and 
the hinge of the septal leaflet of the tricuspid valve, the septal isthmus can be 
found, which is thought to carry the histologically undefined slow pathway into 
the AVN.7, 8  The AVN itself lies only a few millimeters anterior to the CS ostium, 
directly adjacent to the central fibrous body (CFB) of the heart and directly 
beneath the right atrial septal endocardium and above the septal attachment of 
the tricuspid valve, where it rests on the CFB, which forms the anchor for the 
septal portion of the mural leaflet of the mitral valve. The atrial margin of the 
AVN is apposed to the myocardialized vestibular spine, containing the tendon of 
Todaro, while the ventricular margin of the AVN is continuous with the bundle 
of His (Figure 1).9, 10 
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Figure 1. Schematic representation of the AVN in the triangle of Koch. The 
triangular area of Koch (white dotted lines) is delimited by three anatomical landmarks: 
1) superiorly by the tendon of Todaro, 2) inferiorly by the attachment of the septal leaflet 
of the tricuspid valve and 3) at the base by the mouth of the coronary sinus (CS). The apex 
of the triangle of Koch overlies the membranous component of the AV septum and lies at 
the center of the short axis of the heart. Within the triangle of Koch, between the mouth 
of the CS and the hinge of the septal leaflet of the tricuspid valve, the septal isthmus can 
be found, which is thought to carry the slow pathway into the AVN. The adult AVN (grey) 
is positioned a few millimeters anterior to the CS ostium, directly adjacent to the central 
fibrous body (CFB) of the heart and directly beneath the right atrial septal endocardium 
and above the septal attachment of the tricuspid valve, where it rests on the central 
fibrous body, which forms the anchor for the septal portion of the mural leaflet of the 
mitral valve. The atrial margin of the AVN is apposed to the myocardialized vestibular 
spine, containing the tendon of Todaro, while the ventricular margin of the AVN is 
continuous with the bundle of His. The slow pathway of the AVN (green) is a myocardial 
inferior extension of the compact part of the AVN running rightwards over the septal 
isthmus towards the tricuspid valve annulus. The fast pathway of the AVN (blue) starts 
anterosuperiorly in the interatrial septum. Both the slow and fast pathway converge onto 
the AVN at sites known as the posterior and anterior nodal inputs, respectively.
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The AVN Relative to its Atrial Inputs in Koch’s Triangle 
The compact AVN itself only occupies a small area of the triangle of Koch and is 
composed of a half-oval of distinctive interweaving cells, while the larger area 
of the triangle of Koch is occupied by transitional cells, which interpose between 
the nodal cells and atrial myocytes.9 Transitional cells are intermediate in 
their morphology between nodal cells and ordinary atrial musculature, are not 
insulated by fibrous tissue and their arrangement varies markedly form heart 
to heart.9, 11, 12 
When traced inferiorly, the compact part of the AVN gives rise to two 
myocardial inferior nodal extensions: a large inferior nodal extension (INE) 
running rightwards towards the tricuspid valve annulus and a smaller INE 
running leftwards towards the mitral valve annulus.11 The myocardial right-
sided INE of the compact AVN runs through the vestibule of the tricuspid valve 
over the septal isthmus to the subthebesian sinus. While morphologically the 
larger right-sided INE has been recognized as the anatomical correlate of the 
electrophysiologically distinct slow pathway of the AVN,7 clinicopathologic studies 
in the human heart targeted for slow pathway ablation only demonstrated lesions 
in the normal working myocardium distant from the INE and compact AVN.8 
The fast pathway of the AVN allegedly starts anterosuperiorly in the interatrial 
septum. Both the slow and fast pathway converge onto the AVN at sites known 
as the posterior and anterior nodal inputs, respectively.13, 14 In addition to the 
fast and slow AVN pathways multiple other anatomic pathways composed of 
atrial myocytes enter the AVN.6
 Classically, the  adult AV junction can be subdivided into three 
anatomically distinct cell types correlating to different cellular electrophysiologic 
features: AN (Atrio-Nodal, transitional cell), N (Nodal, mid-Nodal cell) and 
NH (Nodal-His, lower bundle cells).15-17 Similarly, 3 types of cardiomyocytes 
have recently been visualized by distinct expression levels of Nav1.5 (the most 
prominent sodium a-subunit in the heart generating the INa current initiating the 
action potential of the normal and cardiac conduction system (CCS myocardium) 
in the AV junction of the adult rat heart.18 
The Sino-Atrial-Node (SAN) and the Internodal Pathways
In the adult heart, the SAN is located in the crista terminalis (representing 
the internal fusion-line of the sinus venosus and the primitive atrium) near 
the superior caval entrance into the right atrium.19, 20 During mammalian 
development, the first morphological signs of the developing SAN are present 
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at Carnegie stage 15 (~5 weeks of human development, avians ~HH stage 18, 
mouse ~E 11.5)21 in the anterior wall of the right common cardinal vein, which 
will ultimately give rise to the superior caval vein.22 While all adult heart muscle 
cells retain the capacity to rhythmically beat without an external stimulus, the 
cells of the SAN are those with the most rapid intrinsic rate of excitation (the 
dominant pacemaking rate).23
 Within the right atrium three internodal tracts for preferential 
interatrial conduction have been demonstrated between the SAN and AVN: 
1) the anterior bundle running through the septum spurium (SS),26 which 
connects to Bachmann’s bundle24-25 running in a retroaortic position connecting 
the right atrium to the left atrium, 2) the posterior bundle running through 
the right venous valve (RVV)27 partly corresponding to the posterior bundle 
or Thorel’s bundle27 localized along the crista terminalis and 3) the posterior 
bundle running through the left venous valve (LVV)26 partly corresponding to 
the middle bundle or Wenckebach’s bundle.24-28 Considerable controversy and 
debate has however surrounded the mostly semantic discussion on the existence 
of these internodal tracts in the atrium between the SAN and AVN, which 
were initially postulated to be specialized and insulated.24, 27, 28 Currently, it is 
well established that preferential conduction, through the ultrastructural and 
electrophysiological heterogenic atrial myocardium between the cardiac nodes 
(SAN and AVN), highly depends on the nonuniform anisotropic arrangement 
of the normal working myocardial fibers giving rise to the internodal pathways, 
instead of on the existence of truly specialized and insulated atrial internodal 
tracts.29 These internodal atrial tracts are made up in part of transitional cells, 
which interpose between the working atrial myocardium and the unequivocally 
histologically specialized compact AVN.11While these internodal tracts can 
be differentiated based on histological, immunohistochemical and molecular 
characteristics,24-28, 30-32  the exact functional correlate of these anatomical tracts 
still remains unclear. Interestingly, elegant experimental studies in dogs, in 
which elevated levels of potassium (to depolarize the atrial tissues) were used 
to render the atrial myocardium inexcitable, have revealed that the electrical 
impulse is normally conducted through distinct internodal tracts between the 
SAN and AVN, relatively insensitive to potassium levels.33, 34 Additionally, 
optical mapping studies have demonstrated a non-radial spread of intra-atrial 
conduction in the rat in a pattern corresponding to the anterior and posterior 
internodal pathways,35 while three bundles with unique conduction properties 
were demonstrated to run between the SAN and AVN in the adult dog heart.36 
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Anatomical Recognition of the Adult versus Embryonic CCS 
Tissues
Histologically, in the adult heart the cardiomyocytes of the CCS share some 
characteristics with embryonic normal working cardiomyocytes: they are small 
compared to the cardiomyocytes of the surrounding adult working myocardium 
and have poorly organized actin and myosin filaments and a scantily developed 
sarcoplasmatic reticulum. By applying the criteria established by Monckeberg 
and Aschoff in 1910, using the AV conduction axis as the paradigm, discrete 
specialized conduction tracts in the postnatal heart: 1) are histologically distinct, 
2) can be followed from section to section and 3) are insulated from the adjacent 
working myocardium by fibrous tissue.37 While these criteria permit adequate 
recognition of the components of the CCS in the postnatal human heart, in the 
early embryonic heart the individual cells of the CCS can hardly be distinguished 
from the surrounding myocardium by unique histological features, while their 
separate arrangement and topography can in some cases be helpful.22, 38, 39 A 
multitude of transgenes, such as minK-LacZ,32 and Engrailed2-lacZ/CCS-LacZ31, 
40 has however been consistently proposed to properly reflect the arrangement of 
the developing CCS. 
 Moreover, each subcomponent of the CCS expresses a distinct set of 
discriminating ion channels,41, 42 channel-associated proteins,43 connexins,44-
46 cytoskeletal components47, 48 and transcriptional regulators,49, 50 useful for 
immunohistological recognition. Additionally, important known signaling and 
transcription factors implicated in the induction, maturation and patterning 
of the CCS including endothelin (ET),51-56 neuregulin,57, 58 Notch,57 Wnt,59 Msx,60 
Nkx,61-64 Hop,65 Id-2,66 Tbx, podoplanin67 and GATA gene families68-71 can also be 
of help. State-of-the-art studies focusing on the transcription factors involved in 
cardiogenesis have made evident that myocardial differentiation to CCS cells 
cannot be dependent on a single gene, but should be considered as a multifactorial 
process in which many of different gene families must contribute.
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A Century of Theories on the Developmental Origin of the AVN
In the debate of the 20th century, controversy concerning the ontogenic 
development of the AVN has led to a multitude of proposals for its origin. 
While these competing theories based on observations in different species and 
complicated by the use of variable terminology for identification and non-specific 
staining, failed to provide a definitive resolution on this subject, these studies 
provide essential tools in our further understanding of the structure-function 
correlation in the developing and adult AVN region. Morphological studies in the 
embryonic calf, mouse and human heart suggested that the AVN is solely derived 
as a remnant of the musculature of the AV canal,72-75 further substantiated by 
functional studies in the developing chick heart demonstrating decremental 
impulse conduction across the early embryonic AV junction.76-78 Conversely, 
extensive morphological studies in various animal and human hearts suggested 
that the AVN is an actively growing supraventricular structure budding off at a 
proliferating part of the posterior AV canal myocardium.73, 79-82
 Early morphological studies in the developing chick and human heart, 
furthermore suggested that the AVN develops as a left-sided counterpart of the 
SAN in the left sinus horn and is moved to its adult location by development of 
the body of the left atrium and incorporation of the sinus venosus into the atria.83, 
84 Subsequently, in the human embryo two cellularly distinct collections of tissue 
were identified in the AVN region ultimately becoming more closely related and 
enclosing an intermediate block of specialized tissue and suggested to derive 
from both the left sinus horn myocardium and the AV canal musculature.15
 The concept of  dual AVN primordia was further advocated by identification 
of dual primordia in the posterior wall of the common atrium in the developing 
human and ferret heart.85-87 In the human heart, these two (left and right) 
distinct AVN primordia could be identified from the fourth week of gestation in 
humans in the posterior atrial wall in the region of the posterior mesocardium, 
while postnatally these two components appeared as one fused structure.87 Quite 
similarly, later studies in the developing rat and human heart identified dual 
AVN primordia reported to be positioned anteriorly in the myocardium along 
the upper right portion of the superior endocardial cushion and posteriorly in the 
base of the septum secundum.88, 89 This concept was extended by morphological 
studies in the developing human embryo, demonstrating the presence of a 
prominent medioposterior AVN primordium (continuous with the bundle of His) 
and a smaller medioanterior AVN primordium (continuous with the retroaortic 
ring), minutely apposing during cardiac development.30
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Another concept on AVN development was based on the classical ring theory, 
according to which the CCS is derived from a set of myocardial rings of specialized 
myocardium positioned between the primitive segments of the heart: 1) the 
sinoatrial (SA) ring between the sinus venosus and atrium, 2) the AV ring between 
the atrium and ventricle, 3) the bulboventricular ring  or primary ring or fold 
between the bulbus and ventricle and 4) the truncobulbar or ventriculo-arterial 
ring between the outflow tract and ventricle.10, 15, 28, 90-92 During development, 
parts of these rings loose their specialized character and the remaining parts are 
identified as putative elements of the mature CCS (Figure 2).15, 28, 31, 64
 
Figure 2. Schematic representation of the spatiotemporal relation of the 
myocardial rings of specialized tissue in cardiogenesis. During cardiogenesis the 
tubular heart undergoes dextral looping, which transforms the heart in a C-shape (A) and 
later in a S-shape (B) and finally in a four chambered heart (C). In the embryonic heart, 
the transitional zones or rings dividing the different putative chambers of the heart can 
be recognized, being the sinu-atrial transition (SAR), the atrioventricular ring (AVR), 
the primary ring (PR) and the ventriculo-arterial transition (VAR). The SAR seems to 
contribute to both the sinoatrial node (SAN) and atrioventricular node (AVN), while the 
AVN seems to receive a contribution from both the SAR, AVR and PR. RCV=right cardinal 
vein, LCV=left cardinal vein,CS=coronary sinus, SVC=superior vena cava, IVC=inferior 
vena cava. 
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Initially, the SA ring was thought to contribute to formation of the SAN, the SA 
ring and the AV ring were thought to both contribute to the AVN and the primary 
ring was thought to give rise to the His bundle and bundle branches,28 while a 
single ring origin in the primary ring or fold has also been suggested.93 Later on, 
contemporary marker studies could again confirm the important contribution 
of the SA ring to the developing SAN and AVN by HNK-1 expression patterns 
in the developing human embryo and analysis of CCS-LacZ and MinK-LacZ 
expression in the mouse embryo identified the SA ring, AV ring and primary 
ring as important contributors to CCS development.26,30-32 
Contemporary Views on AVN Development
While currently insight into the molecular and genetic underpinnings of the 
specification and formation of the CCS is still growing, contemporary marker 
studies demonstrating expression patterns of multiple signaling and transcription 
factors implicated in the induction, maturation and patterning of the cardiac 
conduction system (CCS) – e.g. Nkx2.5, Shox-2, podoplanin, Id-2, HNK-1, Leu-
7, PSA-NCAM, CCS-LacZ and minK-LacZ30-32, 64, 66, 67, 94-96 - have re-established 
the hypothesized83, 84 link between the myocardium of the sinus venosus (SV) 
(derived from the second heart field)67 and the developing CCS. 
 Additionally, bone morphogenetic protein (BMP) – a multifunctional 
signaling molecule expressed throughout development in a multitude of tissues 
- has been shown to be required in the myocardium of the AV canal to assure 
proper structural development and function of the annulus fibrosis and the AVN 
itself.97 Interestingly, BMP signaling seems to stimulate expression of periostin,98 
a profibrogenic extracellular matrix protein implicated in the formation of the 
annulus fibrosis and essential in maintaining the integrity of the fibrous heart 
skeleton of the mature heart.99-101 While the T-box transcription factors Tbx2, Tbx3 
and Tbx5 have also been shown to be essential molecular components for proper 
formation of the AV conduction axis as a whole,68 their specific role in formation 
of the AVN itself remains unclear. In the developing heart, Tbx2, Tbx3 and Tbx5 
are variably expressed in the developing SAN, AVN, internodal myocardium, 
His bundle and the bundle branches.70, 71, 102 Studies aimed at identifying targets 
important for molecular specification of the CCS have identified Tbx3 as a critical 
factor in formation of the SAN103 and molecular specification of the AV bundle 
and bundle branches.68 Tbx2 is regulated by Hesr1 and Hesr2 (transcriptional 
repressors of the Hes-related gene family) expression and is required to repress 
chamber differentiation in the AV canal myocardium and seems important for 
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formation of the boundaries between the atrial and ventricular myocardium.104, 
105 Furthermore, dominant mutations in the Tbx5 gene are known to cause 
congenital heart defects and conduction system abnormalities (resembling Holt-
Oram syndrome) in the adult human and mouse heart.69, 106, 107
 The role of Nkx2.5 – one of the earliest markers of cardiac progenitor 
cells108 - in normal differentiation and function of the CCS, has also been 
extensively substantiated in both animal models and humans.62, 63 Since Nkx2.5 
mRNA is transiently upregulated during formation of conduction fibers relative 
to the surrounding myocardium in embryonic chick, mouse and human hearts, a 
role in the development of the CCS seems highly plausible.64 Additionally, in line 
with the demonstrated myocardial heterogeneity in the AV conduction system,109 
Nkx2.5 negative myocardial areas, additionally visualized by podoplanin,67 
Tbx18,110 RhoA and Isl-1 positivity111 and Nav1.5 and Cx43 negativity112 (see 
also Chapter 7, this Thesis) and postulated to contribute to the developing 
CCS, have recently also been identified. While mutations in the human Nkx2.5 
gene mapped to chromosome 5q35113 have been shown to give rise to structural 
heart malformations - including ventricular septal defects, tetralogy of Fallot, 
ventricular hypertrophy, pulmonary atresia and subvalvular aortic stenosis – 
and AV conduction delays localized in the AVN,63 the precise role of Nkx2.5 in 
the AVN remains unclear. Animal studies have however shown that the Nkx2.5 
null mutant embryos completely lack the primordium of the developing AVN, 
while embryos with Nkx2.5 haploinsufficiency demonstrate an AVN with half 
the normal number of cells.61 
 Another recently discovered transcription gene, Id-2, which is a member of 
the Id family of transcriptional repressors, has been shown to have a conduction-
system-specific expression pattern, which is dependent on its cooperatively 
expressed upstream targets Nkx2.5 and Tbx5 in specification of the ventricular 
conduction system.66 Expression of Id-2 is also evident in the developing AV 
sulcus and AV cushions,114 while its potential role in specification of the AVN 
has not been investigated.
Cellular Electrophysiology of the Developing AV Junction in 
Relation to the Function of the Adult AVN
In the early primary heart tube consisting solely of the common ventricle, a 
primitive electrocardiogram (ECG) can already be recorded showing a sinusoidal 
curve dropping below and above the isoelectric line, reflecting the linear, 
caudocephalic and isotropic impulse conduction with constant low velocity 
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of the primitive myocardium.115-119 As the developing heart transforms from a 
tubular to a looped morphology, the pattern and speed of ventricular activation 
also undergo their first changes. The pattern of universally slow propagation 
along the primitive tubular heart develops heterogeneities in conduction 
properties in the different cardiac segments.120, 121 As cardiac looping proceeds, 
a slowly conducting AV canal is forming separating the synchronous activation 
of the atrial and ventricular segments,116, 122, 123 while action potentials in the 
atrial and ventricular working myocardium with a fast rising phase and high 
amplitude characteristic of fast voltage-gated sodium channels are concordantly 
emerging.124, 125
 As a consequence, the emerging atrium and ventricle in the embryonic 
looped heart start displaying fast conduction, while the myocardium of the AV 
junction is now characterized by relatively slow conduction, which is thought to 
result from a lack of fast sodium channels and a relative lack of the gap junctional 
protein connexin-43.76, 78, 118, 126 In the looped embryonic heart, an adult type 
electrocardiogram including a P-wave reflecting atrial activation, an AV delay 
caused by relatively slow conduction in the embryonic AV junctional myocardium 
and a QRS complex reflecting fast ventricular activation, can already be recorded 
in animal models in the absence of a structurally recognizable AVN.117, 127-129 
 Furthermore, the cellular electrophysiology of the embryonic AV 
junctional tissue is also already quite similar to the adult nodal tissue:130 it 
responds to adenosine with a reduction in action potential amplitude and dV/
dtmax.
14 Histologically, like the adult SAN and adult AVN but unlike the working 
myocardium, the developing AV junctional tissue displays a relative lack of 
connexin-43.126 Myocytes at the AV junction preferentially express connexin-
45,131 a low conductance gap junction channel that is also expressed in the SAN 
as well as in the AVN of the mature heart.44
 Besides maintaining an AV conduction delay (decremental conduction) 
essential for efficient hemodynamic functioning,132, 133 the adult AVN is also 
responsible for 1) gathering the incoming signals from the SAN (probably through 
the internodal pathways, as described above), 2) directing the electrical impulse 
to the His bundle, 3) automaticity and generation of an escape rhythm and 4) 
responding to the autonomic nervous system and humoral signals.132, 134, 135 
 While propagation of the electrical impulse from the AVN to the adjacent 
bundle of His seems relatively simple, physical contact between the node and 
bundle is brought about by a complex developmental remodeling process in 
which the muscular interventricular septum (IVS) fuses with the right tubercle 
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of the dorsal endocardial cushion (future right basal portion of the interatrial 
septum) facilitating the continuity between the AV bundle and AVN.129 The 
ontogenic origin of the bundle of His is equally indistinct compared to the origin 
of the AVN. Various studies have provided puzzling proof for simultaneous74, 
75 or independent28, 90-92 AVN and His bundle development, consecutive AVN 
and His bundle development73, 79, 80, 136 and consecutive His bundle and AVN 
development.137-139 
 Traditionally, the leading pacemaker site responsible for automaticity 
in the AV junction was thought to be located in the compact AVN or nodal-
His regions.140 Contemporary studies however demonstrated that automaticity 
in the AVN in case of e.g. SAN dysfunction with ectopic pacemaking, is most 
often initiated in the region of the INE or slow pathway of the rabbit AVN,141-
143 a cellular population which has been postulated to originate from the early 
pacemaking left sinus horn primordial AVN tissues of the developing embryo.111, 
112 (see also Chapter 7, this thesis). Moreover, during RF ablation of the slow 
pathway in case of AVNRT, the emergence of an accelerated junctional rhythm 
(AJR), which has been suggested to result from enhanced automaticity of the 
AV Nodal or perinodal tissues in response to thermal effects,144 is frequently 
observed and used as a guide for successful application.144, 145 Interestingly, in 
animal studies  a heat sensitive area of nodal type cells was observed inferiorly 
to the compact AVN.146 
 The autonomic control of the AV junction and AVN has been the subject 
of numerous studies. In the rat AV junction, the distribution of sympathetic and 
parasympathetic neurons has been elaborately documented.147 Functionally, 
autonomic modulation of AV junctional conduction has also been extensively 
studied.148, 149 The AV junctional pacemaker can be autonomically modulated to 
increase its rate to levels similar to the SAN,142 comparable to the AJR observed 
after slow pathway ablation for treatment of AVNRT.144-146
 
AV Nodal Conduction Dichotomy
Clinically, interest in the structure of the AVN mainly focuses on the anatomical 
basis for the reentry circuit in AVNRT which has still remained poorly defined. 
The agreed-upon substrate for AVNRT, electrophysiologically defined by the 
response to atrial extrastimulation, with a 50-millisecond increase or greater 
in AVN conduction time (A2H2) in response to a 10-millisecond decrease in 
atrial coupling interval (A1A2), implies involvement of functionally separate 
and anatomically discrete dual AVN pathways (dual AV nodal physiology).150, 151 
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Many essential elements of AV nodal reentry were already described in the first 
known functional experiments on the AV connections of the heart of the electric 
ray in 1913 by Mines.152 Important terms in AV nodal reentry were subsequently 
introduced by Scherf and Schookhoff in 1926 (longitudinal dissociation) and by 
Rosenblueth in 1958 (echo), further established by Schuilenburgin 1968.153, 154,155
 The true concept of dual AV nodal conduction was first demonstrated in 
the late 1950s and 1960s by microelelectrode recordings in dog and rabbit hearts 
by Moe and colleagues.156 Evidence linking AV nodal conduction dichotomy and 
AVNRT in humans was subsequently found in the late 1960s and early 1970s157, 
158 and established in 1981 by the demonstration of distinct atrial exits during 
retrograde conduction through the fast (region of the anterior septum) and slow 
(region of the CS) AV nodal pathways.159 Functionally, the two pathways have 
distinct conduction velocities and refractory periods, although their precise 
anatomic boundaries are unknown. The fast pathway conducts rapidly and has 
a relatively long refractory period in the antegrade direction, while the slow 
pathway conducts relatively slowly and has a shorter antegrade refractory period 
than the fast pathway.160
 The polemic in dual AV nodal pathways has however concentrated on 
confinement of the slow and fast pathway to the AVN itself or the presence 
of an upper common pathway in the adjacent atrial tissues to complete the 
reentry circuit. In dual AV nodal physiology, the retrograde atrial exit of the fast 
pathway in the anterior approaches to the AVN is found at the lower septal right 
atrium and the exit of the slow AV nodal pathway in the posterior approaches to 
the AVN is located in or near the coronary sinus ostium,159 while an origin well 
outside the specialized area of the triangle of Koch has also been postulated.6 
 Experimentally, evidence in favor of an intra AV nodal reentry circuit was 
found in vivo in various animal models161, 162 while evidence for the participation 
of adjacent extra-nodal tissues was also provided.163-166 Clinically, the concept 
of intra AV nodal reentry was advocated by its proponents,167 while placement 
of multiple lesions in the slow pathway region around the AVN to cure AVNRT 
without altering AV nodal conduction however eventually eroded support for 
this view.3, 160, 168-171 The currently largely accepted anatomic understanding of the 
AVN, in which the INEs as well as the transitional cells are part of the AVN,172 
largely resolves this debate. Needless to say, precise knowledge of the exact 
anatomical substrates for normal and abnormal conduction would aid refinement 
of the placement of the lesion lines when treating AV nodal arrhythmias.
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The Presence of Dual AVN Pathways as Substrates for AVNRT: 
Physiology versus Pathophysiology ?
AV Nodal Reentrant Tachycardia (AVNRT) demonstrates an age related incidence 
disparity, with increasing incidence with age.2, 173, 174 Although AVNRT is the most 
common mechanism of supraventricular tachycardia (SVT) in adults (>80%),1 
it only accounts for a comparatively small number of SVT cases in pediatric 
patients (5-16%),2 eventually becoming the most common form of SVT around 
adolescence.175 Later on in life, both the incidence of AVNRT and the functional 
presence of dual AV nodal pathways however progressively decreases again.176 
Mechanistically, these apparent age-differences in AVNRT incidence initially 
seem to reflect maturational histological and electrophysiological changes in the 
AVN region, while at the end of life in the setting of coronary artery disease 
or hypertension a natural degeneration of the AV conduction axis seems more 
likely.173, 176 
 Structurally, the compact AVN and its transitional zone have been 
shown to undergo gradual structural and geometric changes until the age of 20 
years, including a widening of the transitional zone, a progressive increase in 
fibrofatty tissue and an increase in the right inferior nodal extension (INE) (slow 
pathway)  of the AVN.177 Electrophysiologically, in comparison to adolescents, 
pediatric AVNRT patients demonstrate a significantly shorter fast pathway 
effective refractory period (ERP), slow pathway ERP and AVNRT cycle length, 
gradually lengthening with increasing age.175 
Interestingly, in the pediatric AVNRT population the prevalence of dual 
AV nodal physiology is reported to be equal in comparison to pediatric controls.178 
The presence of dual AV nodal pathways in patients without AVNRT increases 
with age,173 which was also demonstrated in experimental studies on maturational 
differences of AV nodal physiology in mice.179 Moreover, ventriculoatrial (VA) 
conduction through the AVN is possible in 40% to 90% of normal adults180 and 
61% of normal children.173 
 Although it has been fully established that the ability to generate 
AVNRT implies the presence of dual anatomically distinct AV nodal pathways, 
in some cases the two pathways cannot be demonstrated with typical criteria in 
electrophysiological (EP) studies, as was illustrated in a report of 159 children 
with AVNRT in which in only 62% percent of children a clear dual AV nodal 
physiology could be demonstrated.181 In adult AVNRT patients however, dual AV 
nodal physiology can normally be demonstrated in 82-100% of cases.157, 180 The 
inability to elicit dual AV nodal pathways by programmed electrical stimulation 
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might reflect the relative infrequency of AVNRT in the pediatric age group173 
and has been suggested to be caused by a age-related difference in response to 
autonomic input, while the current concept of dual AV nodal pathways might 
also simply be inadequate to explain this mechanism.151 
 Furthermore, AVNRT displays a striking 2:1 predominance of women.182-
184 Experimental studies have shown direct hormonal effects on the expression 
and function of cardiac ion channels,185 while clinically the frequency and 
duration of tachycardia was found to be positively correlated with progesterone 
levels and inversely correlated with b-estradiol levels.186 Since gender-related 
differences in AV nodal ERP persist after major changes in hormonal status 
after menopause,187 an additional role for the autonomic nervous system seems 
plausible. While large studies concerning gender-related differences in normal 
AVN function do not exist, intrinsic changes in the electrophysiology of the SAN 
and AVN have been reported in long-term physical training.188
 Based on the clinical data at hand, dual AV nodal pathways are probably 
present in all structurally normal hearts with and without reported episodes 
of AVNRT.134, 189 While large studies on the inducibility of echoes or repetitive 
reentry in normal hearts of arrhythmia free patients unfortunately do not exist, 
both historical and contemporary developmental data on AVN development seems 
largely in favor of the suggestion that the presence of functional longitudinal 
dissociation in AV conduction should be considered normal physiology of the 
AVN. The question however still remains, why and when some people develop 
AVNRT and other do not. 
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Conclusions
While the electrophysiological substrates for AVNRT are well known, 
the anatomical correlates forming the reentry circuit have still remained 
incompletely understood. Similarly, the physiology of the adult AVN has also 
still remained puzzling, since the structural boundaries of the AVN itself and its 
developmental origin are largely unknown. Although recent marker studies have 
provided some clues to the origin of the AVN,67, 110-112 further studies examining 
the ontogeny of the individual parts of the AVN are essential in unraveling the 
(patho)physiological structure-function relations of the adult AVN region. In an 
era where increasingly sophisticated strategies to unambiguously identify cells 
of the CCS and determine their pattern of gene expression and function continue 
to evolve,190, 191 progress in our theoretical understanding of the mechanisms 
governing physiological AV nodal functioning will provide a benchmark to 
successfully interpret the electrophysiological observations in AVNRT. 
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Abstract
Background. While the electrophysiological substrate causing 
atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is well 
known, the anatomical boundaries and developmental origin of the 
AV node (AVN) remains a subject of debate. We hypothesized that 
the myocardium surrounding the proximal part of the left cardinal 
vein (LCV) contributes to the developing AVN region.
Methods and Results. Isolated embryonic hearts of the Japanese 
quail (HH19-36, n=28) and white leghorn chick (HH19-36, n=36) 
were stained with Periodic-Acid-Schiff (PAS), anti-MLC2a, anti-
Nkx2.5, anti-Nav1.5 and anti-Cx43. Morphology of the developing 
AVN was correlated to spatiotemporal changes in atrial activation 
sequences (HH20-30, n=96). At HH19, a MLC2a positive and Nkx2.5 
negative region, expressing low levels of glycogen, Cx43 and Nav1.5, 
was distinguished surrounding the proximal part of the left cardinal 
vein (LCV) entering the sinus venosus (SV). An identical Nkx2.5 
negative structure was found around HH22 surrounding the right 
cardinal vein (RCV) (sinoatrial node region). Around HH29-31, the 
LCV was transposed to the right to eventually become the coronary 
sinus (CS), while the myocardium surrounding the proximal LCV 
became positioned around the CS-ostium (AVN region). While in the 
majority of hearts right atrial (RA) activation preceded left atrial 
(LA) activation, dominant pacemaking originating in the LA could 
still be found until late developmental stages (until HH30). 
Conclusions. The LCV tissues provide an important functional 
contribution to the AVN Anlagen. Based on the spatial relation of the 
embryonic LCV tissues and the adult AVN region, we furthermore 
postulate that the LCV myocardium contributes to formation of the 
slow pathway region of the AVN.
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Introduction
Atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is the most common 
(> 80%) supraventricular tachycardia (SVT) in adults,1  yet it accounts for less 
than 5% of SVT cases in infants and toddlers and for only 13-16% of SVTs in 
children and adolescents.2 Although currently the vast majority (>90%) of patients 
with AVNRT are cured by radiofrequency (RF) catheter ablation procedures 
targeting the slow (a) pathway of the AVN,3 the anatomical boundaries of the 
electrophysiologically distinct slow (a) and fast (b) AVN pathways as substrates 
for AVNRT have still remained a conundrum in this confusing field.
 Moreover, the ontogenic development of the AVN region has, since the 
first detailed report on the specialized AVN in the monumental monograph of 
Sunao Tawara in 1906, been studied for over a 100 years now.4 In the earliest 
literature on AVN development, an ontogenic origin in the musculature of the 
AV ring myocardium, either as a remnant5 or as a new supraventricular growth 
structure,6 has most consistently been reported. Furthermore, the myocardium 
of the common atrium7 and of the left sinus horn has also long been suggested to 
provide a candidate precursor population for the adult AVN,8, 9 while an origin in 
the four myocardial rings of specialized tissue has been extensively debated as 
well.10-15 
 Later on, several morphological studies in the embryonic human, calf, 
ferret and rat heart identified two distinct collections of tissue in the developing 
AVN region,7, 15 which were suggested to fuse or oppose at the final stages of 
cardiac septation enclosing an intermediate block of specialized conducting 
tissue.10 In the debate of the 20th century, these competing theories based on 
observations in different species complicated by the use of variable terminology 
for identification and non-specific staining, have still failed to provide a definitive 
resolution on this subject. 
 Contemporary marker studies demonstrating expression patterns 
of multiple signaling and transcription factors implicated in the induction, 
maturation and patterning of the cardiac conduction system (CCS)–e.g. Nkx 
2.5, Shox-2, podoplanin, Id-2, HNK-1, Leu-7, PSA-NCAM, CCS-LacZ and minK-
LacZ13-21-have linked the myocardium of the sinus venosus (SV) (derived from 
the second heart field) to the developing CCS. In this study we aimed to combine 
previously established concepts on AVN development with new experiments to 
obtain more insight into the structure-function relationships of the developing 
AVN region in relation to arrhythmia etiology. We hypothesized that the 
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proximal part of the myocardial LCV tissues (the structural counterpart of the 
sinoatrial nodal primordial tissues surrounding the RCV) provides an important 
contribution to the developing AVN region. By analyzing spatiotemporal changes 
in atrial activation sequences in the embryonic avian heart and by correlating 
the electrophysiological data with morphology, we provide a new concept of AVN 
development in which the (heterogeneous) AVN is derived from both the AV ring 
myocardium, primary ring myocardium and the sinoatrial (SA) ring myocardium 
and receives an additional contribution from a population of cells originating 
from the LCV myocardium. 
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Methods
Experimental Preparations 
All animal experiments were approved by the Committee on Animal Welfare of 
the Leiden University Medical Center (LUMC),Leiden, the Netherlands. Animal 
experiments were conducted in compliance with the Guide for the Care and Use 
of Laboratory Animals (NIH Publication No.85-23, revised 1996). Fertilized eggs 
of the Japanese quail (Coturnix coturnix japonica, Leiden University Medical 
Center, The Netherlands) and white leghorn chick (Gallus domesticus) were 
incubated blunt end up at 37.5°C and 80% humidity and staged according to the 
Hamburger-Hamilton(HH) criteria.22
Ex-Ovo Extracellular Electrogram Recordings 
Extracellular electrograms were recorded at HH20-30 in wildtype embryonic 
chick (n=63) and quail (n=33) hearts (group A, HH20-30, n=37;group B, HH24-
27, n=38;group C, HH28-30, n=21). The experimental preparations were 
positioned in a custom-built, fluid-heated, temperature-controlled tissue bath 
and superfused with carbogenated (95% O2 and 5% CO2) Tyrode’s solution 
(30±0.1°C) with the following composition (mmol/l): NaCl 130, KCl 4, KH2PO4 
1.2, MgSO4 0.6, NaHCO3 20, CaCl2 1.5, glucose 10(pH 7.35). 
 Unipolar extracellular electrograms were subsequently recorded, as 
previously described,23 by positioning 3 tungsten recording electrodes (tip:1-2 
µm; impedance 0.5-1.0MΩ,WPI Inc., Berlin, Germany) on respectively the left 
atrium (LA), right atrium (RA) and left ventricular apex (LVA)(Figure 1). A 
reference electrode was placed in the tissue bath.
 The experimental preparations were allowed to equilibrate for 10 minutes 
before starting the recording protocol. Recordings in embryonic hearts with a 
spontaneous heart rate (HR) of < 60bpm were considered non-physiological and 
excluded from the present study.
Definitions, immunohistochemistry and statistical analysis are described in 
detail in the online-only data supplement. The authors had full access to and 
take responsibility for the integrity of the data. All authors have read and agree 
to the manuscript as written.
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Figure 1. A representative HH21 and HH25 chick heart showing recording elec-
trode placement on the LA, RA, and LVA. OFT=outflow tract,LA=left atrium,RA=right 
atrium,CV=common ventricle.
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Results
Ex-Ovo Electrogram Recordings
In 63 chicken and 33 quail hearts (HH20-30) ex-ovo local electrocardiograms 
were recorded during stable sinus rhythm of 171±52bpm(AV interval 88±17ms) 
and 170±42bpm(AV interval 82±12ms), respectively. Since the mean HR and 
AV intervals were similar in chicken and quail hearts (p=0.339 and p=0.074, 
respectively), these data are used interchangeably. In line with our previous 
data,23 these pre-septated avian hearts all demonstrated a base-to-apex 
ventricular activation pattern. 
Spatiotemporal Changes in Atrial Activation Sequences During 
Cardiogenesis
Extracellular electrogram recordings demonstrated a high level of variability in 
atrial activation sequences at consecutive developmental stages. While in the 
majority (54%; 20/37) of hearts in group A (HH20-23, n=37) RA activation preceded 
LA activation, a relatively large number (35%; 13/37) of hearts demonstrated 
dominant pacemaker potentials originating in the high LA, indicating a left-
sided dominant pacemaker (Figure 2).
 
Figure 2. A. A representative example of local electrograms recorded in a HH24 chicken 
heart, demonstrating pacemaking dominance in the LA. B. Magnification.
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Left atrial activation preceding RA activation, was also still found in 21% (8/38) 
of group B hearts (HH24-27, n=38), while in only 5% (1/21) of the hearts in group 
C (HH28-30, n=21) earliest atrial activation was found in the LA. Additionally, 
concurrent activation (time difference <1ms) of the RA and LA was found in 
11% (4/37) of heart in group A, 19% (7/38) of hearts in group B and 14% (3/21) of 
hearts in group C.  There was no difference (p=0.412) in AV interval in embryonic 
hearts with a left-sided pacemaker (n=22; 84±10 ms) versus hearts with a right-
sided pacemaker (n=60; 82±12ms)(Table 1).   
Developmental
Stage,HH
n HR,bpm,mean±SD(range) AV-interval,ms,
mean±SD (range)
LA RA LA=RA
Group A 37 162±38(77-228) 79±8(68-105) 13(35%) 20(54%) 4(11%)
HH20 6 164±50(77-222) 80±9(69-93) 1 5 0
HH21 11 155±36(105-209) 80±10(68-105) 3 7 1
HH22 11 156±38(110-210) 78±7(68-86) 3 6 2
HH23 9 177±32(135-228) 80±8(68-88) 6 2 1
Group B 38 169±36(84-238) 83±11(60-107) 8(21%) 23(61%) 7(18%)
HH24 10 176±35(106-238) 81±8(69-91) 1 6 3
HH25 7 164±26(115-198) 83±13(69-100) 1 4 2
HH26 12 176±35(99-211) 83±11(64-105) 4 7 1
HH27 9 155±47(84-221) 86±15(60-107) 2 6 1
Group C 21 190±54(128-297) 87±15(66-122) 1(5%) 17(81%) 3(14%)
HH28 4 167±17(146-186) 88±11(72-98) 1 2 1
HH29 8 163±30(128-204) 86±16(67-112) 0 6 2
HH30 9 225±64(144-297) 86±16(66-122) 0 9 0
Total 96 171±42(77-297) 83±11(60-122) 22(23%) 60(62%) 14(15%)
Table 1.Developmental stages of avian hearts form groups A, B and C, with correspon-
ding HRs,AV-intervals and atrial activation sequences.
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Immunohistochemical Analysis of the Developing CCS 
HH19-25 (~3-5 days of incubation)
Structurally, at HH19 the linear heart tube was still in the midst of its looping 
phase and the common atrium and AV ring were positioned above the primitive 
left ventricle (LV), while the outflow tract was situated above the primitive right 
ventricle (RV). The interatrial septum (IAS) was still forming, while formation 
of the primitive interventricular septum (IVS) was just initiated. The S-shaped 
heart tube consisted of several segments: the bilateral sinus horns (the myocardial 
parts of the cardinal veins (CV)) draining caudodorsally into the developing sinus 
venosus (SV), the common atrium and the ventricular inlet and outlet segment. 
These segments were divided by so-called transitional zones (described below), 
which will be brought together in the inner curvature of the heart by the ongoing 
looping process.14, 15 
 At HH19, the common atrium, AV ring and primitive ventricle showed 
expression of MLC2a, nuclear localized Nkx2.5, Nav1.5 and Cx43 and were 
characterized by a high glycogen content (PAS staining). Interestingly, a distinct 
MLC2a positive but Nkx2.5 negative region could be distinguished surrounding 
the proximal myocardial part of the left cardinal vein (LCV)(Figure 3,4). Around 
HH22, an identical structure was found in the anterolateral wall of the proximal 
right cardinal vein (RCV)(the future sinoatrial node (SAN) region)(Figure 3,4).
 These bilateral myocardial CV regions were further characterized by a 
relatively low level of Nav1.5 (Figure 3E,F&K,L) and Cx43 (Figure 4E&J) 
expression and a relatively low level of glycogen (Figure 3D&J, 4D&I) compared 
to the staining pattern in the neighboring common atrial and primitive ventricular 
myocardium. In the RCV region, Nav1.5 expression was primarily located in the 
circular periphery, while the central parts of these tissues demonstrated lower 
expression levels of Nav1.5 (Figure 3E,F&K,L).
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Figure 3. Morphological findings in a representative HH24 quail heart. A.Dorsal 
view of frontal MLC2a section at the LCV level. Bar=600�m. B. Magnification of the 
LCV region. Bar=50�m. C. Nkx2.5 staining in the LCV. Bar=50�m. D. PAS staining 
in the LSH. Bar=50�m. E. Nav1.5. staining in the LCV.Bar=50�m. F. Magnification of 
Nav1.5 staining in the LCV region. Bar=30�m. G.Dorsal view of frontal MLC2a section 
at the SAN level (arrow). Bar=600�m. H. Magnification of the SAN region. Bar=50�m. 
I. Nkx2.5 staining in the SAN. Bar=50�m. J. PAS staining in the SAN. Bar=50�m. K. 
Nav1.5 staining in the SAN.Bar=50�m. L. Magnification of Nav1.5 staining in the SAN 
region.Bar=30�m. LCV=left cardinal vein,RCV=right cardinal vein,A=atrium.
269
C
hapter 7
D
evelopm
ent of the AV
 N
ode from
 H
eterogeneous Prim
ordia
PART II: Development of the Atrioventricular Node in Relation to Arrhythmia Etiology
Figure 4. Morphological findings in a representative HH26 quail heart. A. 
Dorsal view of frontal MLC2a section at the LCV level. Bar=600�m. B. Magnification 
of the LCV. Bar=50�m. C. Nkx2.5 staining in the LCV. Bar=50�m. D. PAS staining in 
the LCV. Bar=50�m. E. Cx43 staining in the LCV.Bar=50�m. F .Dorsal view of frontal 
MLC2a section of the SAN level. Bar=600�m. G. Magnification of the SAN. Bar=50�m.H. 
Nkx2.5 staining in the SAN. Bar=50 �m. I. PAS staining in the SAN. Bar=50�m. J. Cx43 
staining in the SAN.Bar=50�m. LCV=left cardinal vein,RCV=right cardinal vein,LA=left 
atrium, RA=right atrium,LV=left ventricle,RV=right ventricle,SAN=sinoatrial node.
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HH26–30(~5-7 days of incubation)
Around HH26, the now septated RA and LA became positioned above the RV and 
LV, respectively and the external shape of a four chambered heart became visible, 
while the IVS had still not fused. From around HH28 onwards, outgrowth of the 
RA myocardium was initiated and the still mainly left-sided SV and LCV were 
transposed to the right to become submerged in the RA (Figure 5,6), running 
through the dorsal mesocardium and myocardialized spina vestibulum to the 
base of the IAS to become the CS at the crux of the heart (adult AVN region). 
Around HH29 the developing IVS started to approach the AV cushions and 
formation of the compact myocardium became evident (data not shown).
  At this stage, the SAN and the LCV tissues were still Nkx2.5 negative 
and the Cx43, Nav1.5 and glycogen expression levels were still relatively low 
(Figure 5). Connexin43 expression was now primarily present in the atrial and 
ventricular myocardium with a predisposition for the endomyocardial trabecular 
surface, while expression in the AV ring was slightly less intense compared to 
the surrounding myocardium. 
HH31–36 (~7–10  days of incubation)
From HH31 onwards, Nkx2.5 expression became more nonuniformely and nuclear 
localized Nkx2.5 expression was clearly higher in the atrial myocardium versus 
ventricular myocardium, while even more intense Nkx2.5 staining was present 
in the AV ring, the IVS and on the endomyocardial surface of the ventricular 
trabeculae (Figure 7). Around HH32, formation of the isolating annulus fibrosis 
was initiated with incorporation of the Nkx2.5 positive AV ring myocardium in 
the lower atrial rim. By the end of HH33 ventricular septation was completed 
(data not shown). 
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Immunohistochemical Expression Patterns in the Transitional 
Zones (Figure 7, on page 275)
At HH30, a band of intense Nkx2.5 positive staining cells encircling the 
outflow tract (ventriculo-arterial ring) was found (A-C). The atrial myocardium 
demonstrated a heterogeneous expression pattern for Nkx2.5, while distinct 
atrial regions and the IAS (corresponding to the SA-ring tissues) stained 
intensely positive for Nkx2.5 (D-F). From HH30 onwards, the region of the AVN 
was characterized by a heterogeneous population of Nkx2.5 positive and negative 
cells (G-I), while the His bundle and bundle branches could easily be identified 
by low levels of glycogen and a heterogeneous expression of Nkx2.5 compared to 
the surrounding myocardium(J-O). Around HH32, an additional band of Nkx2.5 
positive cells could clearly be identified surrounding the AV ring myocardium 
(I&L).
Immunohistochemical Correlations with Electrophysiological 
Data
Morphological findings largely correlated to electrophysiology. Until HH27 the 
LCV tissues were positioned caudodorsally to the LA and functionally a left-
sided dominant pacemaker was still found in a considerable number of cases 
(21%).  Impulse initiation in the LA could however no longer be found after 
HH28, perfectly correlating to the morphological observation that around HH29-
30 the LCV was already submerged in the RA to become the CS.
Figure 5. (page 271) Ventral view of frontal section of the rightward migrated 
LCV submerged in the RA to become the CS in a HH33 quail heart, in which the 
Nkx2.5 nuclear negative myocardial tissue is stretched from the LCV through the 
dorsal mesocardium and spina vestibulum to the crux of the heart (AVN region). 
A.Dorsal view of  frontal MLC2a section at the level of the SAN.Bar=600�m. B. Magnifica-
tion.Bar= 50�m. C. Adjacent Nkx2.5 section, demonstrating nuclear Nkx2.5 negativity in 
the SAN.Bar= 50�m. D. Adjacent PAS section:relatively low levels of glycogen in the SAN.
Bar= 50�m. E. Adjacent Nav1.5 section:relatively low levels of Nav1.5 in the SAN.Bar= 
50�m.F. Adjacent Cx43 section: relatively low levels in the SAN.Bar= 50�m. G. Ventral 
view of frontal MLC2a section at the level of the LCV and SV entering the RA.Bar=600�m.
H. Magnification.Bar= 50�m. I. Adjacent Nkx2.5 section, demonstrating Nkx2.5 nuclear 
negativity in the LCV tissues.Bar= 50�m. J. Adjacent PAS section:relatively low glyco-
gen levels in the LCV and SV tissues. K. Adjacent Nav1.5 section:relatively low Nav1.5 
levels in the LCV tissues.Bar= 50�m. L. Adjacent Cx43 section:relatively low Cx43 levels 
in the LCV tissues. Bar=50 �m. LCV=left cardinal vein,RCV=right cardinal vein,LA=left 
atrium, RA=right atrium,LV=left ventricle,RV=right ventricle,SAN=sinoatrial node.
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Figure 7. (right, page 275) Expression patterns in the transitional zones of the 
quail heart. A. Dorsal view of frontal section of a HH30 heart, demonstrating part of the 
Nkx2.5 positive truncobulbar ring surrounding the outflow tract.Bar=600�m. B. Mag-
nification of the OFT region.Bar=200 �m. C. Adjacent section demonstrating low lev-
els of PAS staining in the specialized ring tissues. Bar=200�m D. Frontal section of a 
HH26 heart demonstrating Nkx2.5 heterogeneity in the atrial myocardium (asterisks) 
and intense Nkx2.5 staining in the IAS (arrow).Bar=600�m. E. Magnification of the IAS. 
Bar=200�m. F. Magnification at the level of the intensely positive Nkx2.5 AV-ring tissues.
Bar=200�m. G.Frontal MLC2a stained section at the AVN region of a HH30 quail heart.
Bar=600�m. H. Magnification.Bar=50�m. I. Magnification demonstrating heterogeneous 
Nkx2.5 expression in the AVN region.Bar=50�m. J. MLC2a stained frontal section at the 
IVS level of a HH30 quail heart.Bar=600�m. K. Magnification of Nkx2.5 expression in the 
AVJ, His bundle and bundle branches. Bar=200�m. L. Magnification of the Nkx2.5 posi-
tive His bundle and bundle branches. Bar=50�m. M. PAS staining in a frontal section of 
a HH34 heart.Bar=200�m.N. Magnification demonstrating low glycogen levels in the His 
bundle (part of the CCS). Bar=30�m. O. Magnification of adjacent MLC2a stained section.
Bar=30�m. LA=left atrium, RA=right atrium,LV=left ventricle,RV=right ventricle,Pu=p
ulmonalis,Ao=aorta, IAS=interatrial septum,IVS=interventricular septum,MV=mitral 
valve,TV=tricuspid valve,HIS=bundle of His,BBs=bundle branches,LBB=left bundle 
branch.
Figure 6. (above on page 273) Schematic representation of the postulated 
ontogeny of the AVN. A. During cardiogenesis the tubular heart undergoes dextral 
looping, which transforms the heart in a C-shape (A) and later in a S-shape (B) and 
finally in a four chambered heart (C). In the embryonic heart, the transitional zones 
or rings dividing the different putative chambers of the heart can be recognized, being 
the sinu-atrial transition (SAR), the atrioventricular ring (AVR), the primary ring (PR) 
and the ventriculo-arterial transition (VAR). The SAR seems to contribute to both the 
sinoatrial node (SAN) (green) and atrioventricular node (AVN) (green), while the AVN 
additionally receives a contribution from both the AVR and PR. D. Dorsal view of the 
developing avian heart around HH stage 24. A distinct MLC2a positive but Nkx2.5 
negative myocardial region surrounds the proximal left cardinal vein (primordial 
AVN, pAVN) and right cardinal vein (right sinoatrial node, RSAN) (green). E. Dorsal 
view of the developing avian heart around HH stage 30. The distinct myocardial region 
surrounding the left cardinal vein (LCV) is now transposed to the right and submerged 
in the right atrium remaining positioned around the LCV, which is now developing into 
the coronary sinus (CS) at the crux of the heart in the region of the slow pathway of the 
AVN. The distinct myocardial tissue surrounding the right cardinal vein (RCV) remains 
positioned around the proximal part of the RCV (future superior vena cava) and becomes 
the SAN. F. Schematic representation of the triangle of Koch summarizing the different 
postulated contributions to the AVN. In green the distinct LCV tissues are positioned in 
the slow pathway region of the AVN and the SAN derived from the distinct RCV tissues 
is positioned in the upper right atrium surrounding the superior vena cava (SVC), in light 
blue part of the SAR tissues are positioned in the fast pathway region of the AVN, in grey 
the compact part of the AVN derived from the AVR and PR is depicted.
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Discussion
Spatiotemporal changes in atrial activation sequences in the embryonic avian 
heart were correlated to developmental morphology to obtain more insight into 
the structure-function relationships of the developing AVN region in relation to 
the development of potential arrhythmogenic substrates. A key finding of the 
present study is that the proximal myocardial tissues of the left cardinal vein 
(LCV) provide an important contribution to the developing AVN. 
Transitions in Atrial Activation Sequence Correlated to 
Developmental Morphology: Fate of the Cardinal Vein 
Myocardium
While in the early embryonic chick heart each cell inherently possesses pacemaker 
activity, only some time after the beginning of circulation the sinus venosus (SV) 
is added to the caudal end of the heart tube (HH12) and becomes the prevailing 
pacemaker. While the dominant pacemaking impulse initially originates from a 
pacemaking area in the LCV entering the SV,8, 24, 25 it is well established that the 
myocardium surrounding the anterolateral wall of the proximal RCV harbors 
the primordium of the definitive SAN, whereas the vein itself becomes the right 
superior caval vein.26, 27
 In line with early functional reports,8 the temporal presence of bilateral 
pacemakers in the SV of the early developing heart could also be confirmed in the 
present study. Extracellular electrograms demonstrated pacemaker dominance 
in the RA in the vast majority of hearts, while initiation of the electrical impulse 
could still be found in the LA in a substantial number of hearts (21%) until 
late stages of cardiogenesis (HH30). Similarly, persistent LA dominance in 
~10% of HH16-36 chick hearts was recently found in another avian study, while 
comparable atrial activation patterns have also been shown in the embryonic 
mammalian heart.28 Furthermore, simultaneous activation (<1 ms) of the RA 
and LA was demonstrated in 15%(14/96) of HH20-30 hearts in the present study, 
possibly indicating nearly simultaneously firing bilateral pacemakers or rapid 
interatrial conduction through Bachmanns bundle, as was elegantly shown to 
become functionally active in avians between HH17 and 24.28 
 Structural correlation demonstrated that both the myocardial avian 
SAN primordium in the RCV and its left-sided counterpart in the LCV were 
characterized by low levels of glycogen expression, while the surrounding 
myocardium demonstrated a high glycogen content, in line with previous reports 
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in avians.29 In contrast to mammalian glycogen expression, low levels of glycogen 
were reported in the specialized CCS tissues of the avian heart, implicating the 
LCV tissues as an important contributor to the CCS.30, 31 
 Furthermore, both primordia were identified by the expression of low levels 
of Nav1.5 (the most prominent sodium a-subunit in the heart generating the INa 
current initiating the action potential of the normal and CCS myocardium) and 
Cx43 (the principle connexin of the working myocardium), but failed to express 
the homeobox transcription factor Nkx2.5. The latter is perfectly in line with 
previous expression studies describing Nkx2.5 expression in the developing mouse 
SV.17, 19, 26, 27 While the observed expression gradient of Nav1.5 and Cx43 in the 
avian SAN seems comparable to expression patterns described in the developing 
mammalian SAN, 32, 33 the expression pattern of Nav1.5, whose functional 
contribution to the activity of pacemaker cells has profoundly been rekindled in 
recent developmental studies,34 has never been described in avian cardiogenesis 
before. Interestingly however, experimental studies in adult rats identified 3 
types of cardiomyocytes in the AVN region expressing distinct and relatively 
low levels of Nav1.5 as compared to the surrounding atrial myocardium.35It is 
tempting to speculate that the distinct tissues surrounding the proximal LSH 
expressing relatively low levels of Nav1.5, described in the present study, might 
provide one of these cellular populations to the adult AVN.
 
Although based on the present data, a direct structure-function correlation 
cannot be made, the demonstrated bilateral morphologically distinct Nkx2.5 
negative myocardial regions at the terminal portion of the RCV and LCV, 
expressing low levels of Cx43, Nav1.5 and glycogen, could structurally indeed 
represent the areas responsible for the demonstrated impulse initiation in the 
RA or LA, respectively. With ongoing development, the terminal portion of the 
LCV entering the SV becomes the CS attaching the RA to the cardiac venous 
system at the base of the IAS at the crux of the heart, while the remaining 
portion of the LCV is atrophied and recognizable as the oblique vein of Marshall 
in the adult human heart.36 Due to these positional changes, the early Nkx2.5 
negative myocardium surrounding the proximal LCV is transposed through the 
myocardialized spina vestibulum, along the base of the IAS to the crux of the 
heart surrounding the CS (the position of the adult AVN), in line with the recently 
described podoplanin expression pattern at the venous pole of the developing 
mouse heart.19 Interestingly, abundant LacZ expression (indicating the presence 
of CCS tissue) in the myocardium surrounding the CS orifice has previously 
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been demonstrated in the CCS-LacZ mouse,14 perfectly in line with the ultimate 
position of the morphologically distinct primordial AVN tissues derived from 
the LCV myocardium described in the present study. This would implicate that 
both the SAN and AVN (partly) derive from symmetrically distinct myocardial 
tissues with identical expression patterns for Nav1.5, Cx43, Nkx2.5 and MLC2a, 
surrounding the lumina of the developing early RCV and LCV respectively.
 While a SV contribution to the developing AVN was already first suggested 
more than 50 years ago8, 9 and several contemporary marker studies, including 
HNK1 and Leu715, 20 and transgenic reporter studies for CCS-LacZ and MinK,13, 14 
have linked the SV myocardium to the developing CCS, a LCV contribution to the 
developing AVN region has, to our best knowledge, been extensively suggested 
but both structurally and functionally not been studied systematically. 
The Role of the Myocardial Specialized Ring Tissues in AVN 
Development
According to the classical ring theory,11, 14, 15 the CCS is derived from four separate 
rings of specialized myocardium positioned between the primitive segments of 
the heart:1) the SA-ring between the SV and atrium, 2) the AV ring between 
the atrium and ventricle, 3) the bulboventricular ring or primary ring or fold 
between the bulbus and ventricle and 4) the truncobulbar or ventriculo-arterial 
ring between the outflow tract and ventricle. During development, parts of these 
rings loose their specialized character and the remaining parts are identified as 
putative parts of the mature CCS.10, 11, 14, 15 
 The contribution of the AV ring myocardium to the adult AVN has been 
well established.6, 37 In avians, by 42 hours of development (~HH11) as cardiac 
looping proceeds, the AV ring myocardium is characterized by relatively low 
levels of Cx43, as also described in the present study, and starts displaying 
slow conduction responsible for an AV conduction delay, already giving rise to 
an adult type electrocardiogram.38-40 During formation of the isolating annulus 
fibrosis,23 the AV ring myocardium is sequestered as an atrial structure, forming 
the smooth walled atrial vestibules, leaving a small part of the slow conducting 
AV ring myocardium in-situ contributing to the developing AVN.41 Interestingly, 
in the present study from ~HH31 onwards, the myocardium of the AV ring 
was found to express relatively high levels of Nkx2.5 possibly indentifying the 
precursors population of the Nkx2.5 positive cells in the future heterogeneous 
AVN.
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Initially both the AV ring tissues and SA ring were demonstrated to contribute 
to the developing AVN,11 while a single ring origin of the AVN in the primary 
ring or fold has also been suggested.42 Later on, the important contribution of the 
SA ring to the developing AVN could again be established by HNK-1 expression 
patterns in the human embryo and analysis of CCS-LacZ and minK-LacZ 
expression in the mouse embryo.13-15 The SA ring tissues furthermore provide a 
direct connection between the SAN and AVN and give rise to the 3 internodal 
pathways,14, 15, 43 since both the anterior internodal pathway through the septum 
spurium and the two posterior internodal pathways in the region of the left and 
right venous valves are continuous with the AV ring.14, 15 Since these pathways 
do not seem to satisfy the criteria set for adult specialized conduction tissue,44 
controversy has persisted about the existence and definition of these specialized 
fast conducting tissues in the atria.43 In the present study however, from HH30 
onwards distinct Nkx2.5 positive strands of myocardial cells were identified in 
the common atrial myocardial wall and IAS, again establishing parts of the SA-
ring. Additionally, parts of the AV ring, primary ring and ventriculo-arterial 
ring could also be identified by Nkx2.5 staining (Figure 7). While transient 
elevated Nkx2.5 expression levels in the developing His bundle, bundle branches 
and Purkinje fibers were recently shown in chick cardiogenesis,16 the myocardial 
specialized ring tissues have to our best knowledge, never been identified in the 
avian embryo by Nkx2.5 expression before.
Clinical Significance
Spatially, the ultimate location of the distinct LCV tissues described in the present 
study correlates to the location of the slow pathway of the adult human AVN 
located in the septal isthmus45 which corresponds to the extensively described 
inferior nodal extension (INE) of the AVN46 and often seems to follow the proximal 
part of the anterior margin of the CS.45 Similar to the adult rabbit INE of the 
AVN,46 relatively low expression levels of Nav1.5 and Cx43 were demonstrated 
in the AVN primordial LCV tissues running along the slow pathway region of 
the AVN in the present study, which might provide a morphological substrate 
for slow conduction in this region. Furthermore, during ectopic pacemaking in 
the AVN in case of SAN dysfunction, the action potential is first initiated in the 
region of the INE of the AVN.46 While in the present study, the tissues of the 
developing LCV were indeed shown to be functionally capable of pacemaking, 
expression of proteins implicated in generating a pacemaking current was not 
analyzed. The rabbit INE of the adult AVN has however been shown to display 
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abundant expression of hyperpolarization activated cyclic nucleotide-gated 
potassium channel 4 (HCN4)46 – the major isoform responsible for pacemaking If 
current – while the embryonic sinus horn tissues of the developing mouse heart 
were recently also demonstrated to express HCN4.26
  Clinically, the remnant of the LCV in the CS region is known as the 
ligament of Marshall (LOM) and has been recognized as a potential source of 
ectopic activity deflagrating atrial tachyarrhythmias and atrial fibrillation 
amendable for RF ablation.47 Based on the structural and functional data 
demonstrated in the present study, we postulate that rapid firing and slow 
conduction in the LOM region could very well be caused by functional remnants 
of early pacemaking cells of the LCV. 
Proposed Concept of AVN Development 
Based on the present data and previously established concepts,11,14,15,19 we propose 
that the adult AVN is formed from heterogeneous AVN primordia. As previously 
demonstrated and partly re-established in the present study, both the AV ring, 
primary ring and SA ring contribute to the developing AVN forming at their 
junction 11, 13-15 Furthermore, as demonstrated in the present study an additional 
atrial contribution to the slow pathway region of the AVN is provided by the 
early morphologically distinct proximal part of the LCV myocardium, ultimately 
stretched to the crux of the heart surrounding the CS orifice. We furthermore 
speculate that the tissues of the SA ring might contribute to formation of the 
fast-pathway region anterosuperior to the compact AVN, while the remnants of 
the AV ring and primary ring myocardium might contribute to the compact part 
of the AVN (Figure 7). 
 In this concept, we postulate that the Nkx2.5 negative LCV primordial 
AVN tissues surrounding the CS orifice join the AVN primordial Nkx2.5 positive 
tissues (the remnants of the AV ring, primary ring and SA ring tissue) already 
brought together at the crux of the heart, together constructing a heterogeneous 
AVN. It remains to be determined whether ultimate positioning of the early 
proximal LCV myocardium around the CS orifice in the AVN region is simply the 
result of the physiological remodeling process of the RA and SV or might result 
from outgrowth of the left atrium and left mitral valve orifice.
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Study Limitations
The aim of the present study was to correlate changes in atrial activation 
sequences to the morphology of the developing AVN. Due to technical limitations 
we recorded local electrograms in the common atria while the pacemaking tissues 
were morphologically found in the dorsally adjoining CV myocardium. Similarly, 
electrical mapping of the human adult atrium identifies the first activated region 
of the working atrial myocardium rather than the distinct actual pacemaker 
site.48
Conclusions
The tissues of the LCV myocardium provide an important functional contribution 
to the AVN Anlagen. We furthermore propose a new concept of AVN development 
in which the adult AVN is postulated to derive from heterogeneous AVN 
primordia: the remnants of the AV ring myocardium, PR myocardium and the 
SA ring myocardium and the LCV primordium contributing to the slow pathway 
region of the AVN. 
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Online Data Supplement
Experimental Preparations 
All animal experiments were approved by the Committee on Animal Welfare of 
the Leiden University Medical Center (LUMC), Leiden, the Netherlands. Animal 
experiments were conducted in compliance with the Guide for the Care and Use 
of Laboratory Animals (NIH Publication No.85-23, revised 1996). Fertilized eggs 
of the Japanese quail (Coturnix coturnix japonica, Leiden University Medical 
Center, The Netherlands) and white leghorn chick (Gallus domesticus) were 
incubated blunt end up at 37.5°C and 80% humidity. Embryos were staged 
according to the Hamburger-Hamilton (HH) criteria.1
Ex-Ovo Extracellular Electrode Recordings – Technical Features 
& Recording Protocol
In total, extracellular electrode recordings were performed at HH20-30 in 
wildtype embryonic chick (n=34) and quail (n=33) hearts (group A, HH20-30, 
n=37; group B, HH24-27, n=38; group C, HH28-30, n=21). The experimental 
preparations were placed in a custom-built, fluid-heated, temperature-controlled 
tissue bath and superfused with carbogenated (95% O2 and 5% CO2) Tyrode’s 
solution (30 ± 0.1°C) with the following composition (mmol/l): NaCl 130, KCl 4, 
KH2PO4 1.2, MgSO4 0.6, NaHCO3 20, CaCl2 1.5, glucose 10 (pH 7.35). 
 Unipolar extracellular electrogram recording was subsequently 
performed, as previously described,2, 3 by consistently positioning 3 tungsten-
recording electrodes (tip:1-2µm; impedance 0.5-1.0MΩ, WPI Inc., Berlin, 
Germany) on the left atrium (LA), right atrium (RA) and left ventricular apex 
(LVA) (Figure 1). A silver reference electrode was placed in the tissue bath.
 In short, the experimental preparations were allowed to equilibrate 
for 10 minutes before starting the recording protocol. Recordings in embryonic 
hearts with a spontaneous heart rate (HR) of < 60 bpm were considered non-
physiological and excluded from the present study.
Definitions
In extracellular electrogram recording, a mean difference in local depolarization 
time between two recording electrodes of  ≥1 ms was considered significant.2, 3 In 
all experiments, a stable 1:1 relation between atrial and ventricular activation 
was assured to be present. The time difference between LA activation and the 
location of earliest ventricular activation was denominated as the AV interval.
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Immunohistochemistry
After completion of extracellular electrogram recordings, the hearts were removed 
from the Tyrode’s solution and fixated in a 4% paraformaldehyde solution for 
24 hours, dehydrated and embedded in paraffin. Subsequently, 36 chick and 28 
quail (HH19–36) hearts were serially sectioned in the frontal plane at 5 µm, 
transferred to albumin/glycerin-coated objective slides. After deparaffinization 
and rehydration, the sections were prepared for standard Periodic-Acid-Schiff 
(PAS) staining or for immunohistochemical staining by treatment with 0.3% 
H2O2 in phosphate buffered saline (PBS) for 20 minutes to smother endogenous 
peroxidase activity. 
 Routine immunohistochemical staining was subsequently performed by 
overnight incubation with the primary antibody; rabbit primary antibody against 
Myosin-Light-Chain 2 atrium (MLC2a) (Kubalak) diluted 1:5000, goat primary 
antibody against Nkx2.5 (Abcam, ab-266) diluted 1:3000 rabbit primary antibody 
against Cx43 (Abcam, ab-407) diluted 1:200 and goat primary antibody against 
SCN5a (Nav1.5)(Santa Cruz, Sc-23174) diluted 1:200 in PBS with 0.05% Tween-
20 and 1% Bovine Serum Albumin (BSA) (Sigma Aldrich, USA) in a humified 
chamber. 
After rinsing in PBS and PBS-Tween, the sections were incubated with 
Goat-anti-Rabbit IgG labeled with biotin (GAR-Biotin, Vector Laboratories, 
USA, BA-100) or Horse anti-Goat IgG labeled with biotin (HAG-biotin, Vector 
Laboratories, USA) diluted 1:200 and 1:66 Goat-serum (Vector Laboratories, 
USA, PK 6100) or Horse-serum (Vector Laboratories, USA) diluted 1:66 in PSB-
Tween for 40 minutes. Goat/Horse serum was used to block aspecific binding 
of the secondary antibody. After rinsing in PBS and PBS-Tween, the sections 
were incubated with ABC-reagent, which consisted of reagent A diluted 1:100 
and reagent B diluted 1:100 in PBS, in a humified chamber for 40 minutes. 
After rinsing with PBS, PBS-Tween and tris/maleate pH 7.6, the sections were 
incubated with 3,3’-diaminobenzidin (DAB, Sigma-Aldrich Chemie, USA, D5637) 
in a concentration of 400 mg/l with 4 droplets of H2O2 acting as a catalyzer, for 
5 minutes. After incubation with DAB, the sections were rinsed with H2O-demi 
and counterstained with 0.1% Heamatoxylin (Merck, Darmstadt, Germany) for 
10 seconds. Finally, the sections were rinsed with tap water for 10 minutes, 
dehydrated and mounted in Entellan (Merck, Darmstadt, Germany).
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Statistical Analysis
The symmetry of the distribution was determined by determining the Skewness 
value. Heart rates and AV interval were compared between groups using the 
2-tailed Student t test for normally distributed values. For comparison of 
categorical variables (atrial activation sequences), the c2-test was applied. A P 
value <0.05(2-tailed) was considered statistically significant. All analyses were 
performed using the Statistical Package for Social Studies version 12.0 (SPSS 
Inc, Chicago, Ill).  
The authors had full access to the data and take responsibility for its integrity. 
All authors have read and agree to the manuscript as written. 
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Abstract
Objective. Analysis of long-term results with radiofrequency      
catheter ablation (RF ablation) in children.
Design. Retrospective.
Method. Data were analysed from all 118 pediatric patients B 
18 years old who underwent RF ablation at the Leiden University 
Medical Center (LUMC), the Netherlands, during the period 1 
December 1992-31 May 2004.
Results. The group consisted of 60 boys and 58 girls with a 
mean age of 12.7 years (SD: 4.6). They underwent 140 RF ablation 
procedures for 122 disorders. Indications for RF ablation were: 
failure or side effects of antiarrhythmic medication (45%), patient/
parent choice (45%), cardiomyopathy or life-threatening arrhythmia 
(8%), and impending surgery for a congenital heart defect (2%). The 
mean follow-up interval was 4 years (SD: 3.2; range: 1.2 months-
11.3 years). The final total success rate for RF was 93% (n = 110). 
19 patients (16%) underwent a total of 22 repeat procedures. 
Recurrences occurred after a mean period of 2.3 months (SD: 2.5) 
following successful RF ablation. Major complications (2nd degree 
AV block) occurred in 2 patients. During follow-up, no evidence was 
found of new arrhythmias or of coronary artery lesion development 
as the result of RF ablation. There was no difference between the < 
10 years of age group and the C 10 years of age group in terms of 
final success rate (93% vs. 93%; p = 0.914) and complication rate (3% 
vs. 7%,p = 0.680).
Conclusion. The long-term outcome of pediatric patients who 
underwent RF ablation was good. RF ablation in young children (< 10 
years) was found to be safe and effective. These results demonstrate 
that it is also possible to curatively treat this group of patients with 
RF ablation in specialized centers.
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Samenvatting
Doel. Analyse van de langetermijnresultaten van katheterablatie 
met radiofrequente energie (RF ablatie) bij kinderen.
Opzet. Retrospectief.
Methode. Van alle 118 kinderen in de leeftijd van 0-18 jaar die in 
de periode 1 december 1992-31 mei 2004 in het Leids Universitair 
Medisch Centrum (LUMC) een RF ablatie ondergingen, werden de 
gegevens geanalyseerd.
Resultaten. De groep bestond uit 60 jongens en 58 meisjes met een 
gemiddelde leeftijd van 12,7 jaar (SD: 4,6). Zij hadden in totaal 140 
RF ablaties voor 122 aandoeningen ondergaan. De indicaties voor 
RF ablatie waren: falen van of bijwerkingen van antiarrhythmica 
(45%), keuze van patiënt/ouder(s) (45%), cardiomyopathie of 
levensbedreigende hartritmestoornissen (8%), voorgenomen 
chirurgie voor aangeboren hartafwijkingen (2%). De follow-upduur 
was gemiddeld 4 jaar (SD: 3,2; uitersten: 1,2 maand-11,3 jaar). 
Het uiteindelijke totale succespercentage van RF ablatie was 93 
(n = 110). Er ondergingen 19 patiënten (16%) in totaal 22 tweede 
of derde ingrepen. Recidieven traden gemiddeld 2,3 maanden (SD: 
2,5) na een succesvolle RF ablatie op. Belangrijke complicaties 
(tweedegraads AV blok) kwamen voor bij 2 patiënten. Er waren 
geen aanwijzingen voor het optreden van nieuwe aritmieën of voor 
het ontstaan van coronairlaesies na RF ablatie tijdens de follow-
upperiode. Tussen de groep kinderen < 10 jaar (n = 29; 25%) en de 
groep kinderen ≥ 10 jaar (n = 89; 75%) bestond geen verschil in het 
uiteindelijke succespercentage (93 versus 93%; p = 0,914) en in het 
totale complicatierisico (3 versus 7%; p = 0,680).
Conclusie. De langetermijnresultaten van RF ablatie bij kinderen 
waren goed. Ook bij jonge kinderen (< 10 jaar) was RF ablatie veilig 
en effectief, wat ruimte biedt om in gespecialiseerde centra ook deze 
groep curatief met RF ablatie te behandelen.
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Introductie
Supraventriculaire tachycardieën (SVT’s) vormen, met een geschatte prevalentie 
van 0,4-1,0%, de belangrijkste groep hartritmestoornissen bij kinderen.1 In 
ongeveer tweederde van de gevallen treedt de aritmie voor het eerst op vóór 
de geboorte of in de eerste levensmaanden. Bij een groot deel van deze jonge 
kinderen verdwijnen de SVT-episoden spontaan na het eerste levensjaar, maar 
ze kunnen rond de puberteit terugkeren. Indien de eerste presentatie op oudere 
leeftijd optreedt, blijven de SVT-episoden in het algemeen bestaan.2, 3 
 Men spreekt van een SVT wanneer de boezem en/of de atrioventriculaire 
knoop bij het mechanisme van de tachycardie zijn betrokken. Paroxismale 
atrioventriculaire ‘re-entry’-tachycardieën (AVRT’s), ofwel cirkeltachycardieën 
tussen boezem en kamer op basis van een extra myocardverbinding, vormen de 
belangrijkste groep SVT’s bij kinderen (Figuur 1). Rond de puberteit komen ook 
de atrioventriculaire nodale re-entrytachycardieën steeds vaker voor, waarbij 
er cirkeltachycardieën bestaan tussen een snel en langzaam geleidend pad in 
de atrioventriculaire knoop. Chronische vormen van SVT zoals ‘permanent 
junctional reciprocating’ tachycardie en ectopische atriale tachycardie zijn veel 
zeldzamer, maar zijn typisch voor jonge patiënten en kunnen leiden tot een 
ernstige gedilateerde cardiomyopathie.2, 4 
 De belangrijkste therapie voor hartritmestoornissen bestond aanvankelijk 
uit het chronisch gebruik van antiarrhythmica. Begin jaren negentig van de 
vorige eeuw werd echter katheterablatie met radiofrequente energie (RF ablatie) 
geïntroduceerd als nieuwe behandelingsmethode voor hartritmestoornissen, naast 
de bestaande chirurgische behandeling en katheterablatie met hoogenergetische 
gelijkstroomschokken.5 RF ablatie wordt inmiddels bij volwassen patiënten op 
grote schaal succesvol toegepast. Tevens is het indicatiegebied het afgelopen 
decennium sterk uitgebreid.6 
 In 1990 werd de eerste succesvolle RF ablatie bij een kind beschreven7 
en sedertdien zijn verscheidene studies gepubliceerd waarin goede 
kortetermijnresultaten van RF ablatie bij kinderen worden beschreven.8-15 Deze 
gunstige resultaten hebben ertoe geleid dat ook de indicaties voor RF ablatie bij 
kinderen de afgelopen tien jaar veranderd zijn. Op de kinderleeftijd vormde het 
falen van medicamenteuze therapie aanvankelijk de belangrijkste indicatie voor 
RF ablatie. Tegenwoordig wordt RF ablatie beschouwd als een goed alternatief 
voor medicamenteuze therapie bij kinderen vanaf 5-8 jaar. In veel gevallen heeft 
RF ablatie de voorkeur van de patiënt en/of de ouders bij oudere kinderen.2, 16, 17
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Figuur 1. Schematische weergave van het mechanisme van een orthodrome 
atrioventriculaire ‘re-entry’-tachycardie (AVRT). Deze vorm van SVT komt veruit 
het meeste voor bij kinderen. Er ontstaat een cirkeltachycardie tussen de boezems en de 
kamers ten gevolge van een extra atrioventriculaire myocardverbinding rond de tricus-
pidalis-of mitralisklep. Bij een orthodrome AVRT wordt het antegrade pad van de cirkel 
gevormd door de AV-knoop en het retrograde pad door de extra verbinding. Op het ECG is 
een regelmatige smalle QRS-complextachycardie zichtbaar met de P-top achter het QRS-
complex. Door radiofrequente energie af te geven via de tip van een stuurbare katheter 
kan de extra myocardverbinding worden onderbroken.
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Desalniettemin zijn er argumenten om met name bij jonge kinderen terughoudend 
te zijn in het toepassen van RF ablatie. Grote studies hebben aangetoond dat de 
kans op ernstige complicaties als gevolg van RF ablatie, waaronder zelfs sterfte, 
verhoogd is bij jonge kinderen.10, 11, 18
 Uit dierexperimenteel onderzoek is tevens gebleken dat RF laesies in 
immatuur myocard op de lange termijn in afmeting toenemen en aritmogene 
substraten zouden kunnen vormen; ook kan RF stroom laesies in de 
coronairarteriën veroorzaken.19-21 
 Het werkelijke risico op late complicaties na RF ablatie bij kinderen, 
alsmede de effectiviteit op de lange termijn, is tot op heden onvoldoende 
aangetoond. Het is nu meer dan 11 jaar geleden dat in het Leids Universitair 
Medisch Centrum (LUMC) het eerste kind een RF ablatie onderging. In de hier 
beschreven studie analyseerden wij de resultaten en de follow-upgegevens van 
alle kinderen die sindsdien binnen ons centrum een RF ablatie ondergingen.
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Methode
In de periode 1 december 1992-31 mei 2004 ondergingen 118 kinderen (leeftijd: 
0-18 jaar) in het LUMC een RF ablatie. De gegevens van deze kinderen werden 
retrospectief geanalyseerd.
 
RF ablatietechniek 
Elektrofysiologisch onderzoek en RF ablatie vonden bij alle patiënten gedurende 
dezelfde procedure plaats onder heparinisatie (100 E/kg lichaamsgewicht). Bij 
jonge kinderen werden de procedures verricht onder algehele anesthesie en 
bij kinderen vanaf 13-14 jaar werd veelal gekozen voor lokale anesthesie met 
sedatie. Bij een standaardprocedure werden via de V. femoralis rechts of links 3 
tot 4 diagnostische elektrodekatheters (4, 5 of 6 Fr) en een RF ablatiekatheter (7 
Fr) in het hart geplaatst. Bij zuigelingen en jonge kinderen werd gebruikgemaakt 
van een ablatiekatheter met een 5 Fr en 4 mm tip (5 Fr Medtronic RF Marinr; 
Medtronic Inc, Minneapolis, MN, VS) en werd het aantal intracardiale 
katheters beperkt tot 2 of zelfs tot 1 katheter en werd voor atriale stimulatie 
via de slokdarm een elektrodekatheter geplaatst (Figuur 2). Na bepaling van 
het mechanisme van de aritmie en de lokalisatie van het aritmogene substraat 
door middel van geprogrammeerde elektrische stimulatie, mappingtechnieken 
en röntgendoorlichting werd de tip van de stuurbare RF katheter op het 
aritmogene substraat geplaatst. Door temperatuurgecontroleerde (maximale 
tiptemperatuur: 60-70°C) afgifte van RF energie (300-750 kHz) aan de tip van de 
ablatiekatheter vond coagulatie van het aritmogene substraat plaats. Bij kinderen 
met aangeboren hartafwijkingen en postoperatieve atriale tachycardieën werd 
gebruikgemaakt van een driedimensionaal elektro-anatomisch mappingsysteem 
(CARTO; Biosense Webster Inc, Waterloo, België).22
 
Vervolgonderzoek 
Na de RF ablatie werd de patiënt gedurende 12 h gehepariniseerd (15 E/kg 
lichaamsgewicht/h) en onder telemetriebewaking 1 nacht ter observatie gehouden. 
De dag na de ingreep werden een elektrocardiogram en echocardiogram gemaakt, 
waarna ontslag volgde. Poliklinische controles vonden plaats na 2 tot 3 maanden 
en na 1 jaar. Na deze controles werd de patiënt/ouder(s) gevraagd om in het 
geval van klachten direct een nieuwe poliklinische afspraak te maken.
 
302
PART III: Clinical Aspects of Supraventricular Tachycardia in Neonates and Children
Figuur 2. Katheterablatie met radiofrequente energie (‘RF-ablatie’) bij een 
patiënt van 1,5 maand oud met een lichaamsgewicht van 2,1 kg en het Wolff-
Parkinson-White-syndroom. (a) Röntgendoorlichting tijdens de procedure. Een slok-
darmelektrode werd gebruikt voor atriale stimulatie en een 5 Fr RF-ablatiekatheter met 
een 4 mm tip werd via het open foramen ovale in het linker atrium op de linkslateraal 
gelegen extra verbinding geplaatst. (b) Oppervlakte-ECG-afleiding I en elektrodekath-
etersignalen voor en tijdens de behandeling. Mapping en RF-applicatie vonden plaats 
tijdens tachycardie. De RF-ablatiekathetertip (ABL-tip) is precies op de extra verbinding 
geplaatst, hetgeen af te leiden is uit het korte VA-interval in deze afleiding (c). De extra 
verbinding viel na ongeveer 3 s uit. V = ventriculair elektrogram, A = atriaal elektrogram, 
de VA-tijd op de slokdarmelektrode is 80 ms, die op de ABL-tip 37 ms.
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Definities 
Het initiële succespercentage werd gedefinieerd als het percentage RF ablaties 
waarbij het aritmogene substraat met elektrofysiologisch onderzoek niet 
meer aantoonbaar was aan het einde van de behandeling. Het uiteindelijke 
succespercentage werd gedefinieerd als het percentage patiënten dat na één of 
meer RF ablaties zonder antiarrhythmica vrij was van recidieven en bij wie het 
aritmogene substraat met elektrofysiologisch onderzoek na afloop van de laatste 
behandeling niet meer aantoonbaar was.
Statistische analyse 
De gegevens worden gepresenteerd als gemiddelden met standaarddeviatie of 
als medianen met spreiding. De c2-toets en de t-toets voor twee steekproeven 
werden gebruikt om de resultaten te vergelijken. Bij p < 0,05 (tweezijdig) werd 
een verschil als significant beschouwd. Het tijdsinterval van RF ablatie tot het 
optreden van een recidief werd geanalyseerd met de Kaplan-Meier-methode.
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Resultaten
Demografische gegevens en diagnosen 
De groep bestond uit 60 jongens en 58 meisjes, die in totaal 140 RF 
ablatieprocedures ondergingen voor 122 aandoeningen. De demografische 
gegevens en de diagnosen zijn weergegeven in Tabel 1. De gemiddelde duur van 
de follow-up was 4 jaar (SD: 3,2; uitersten: 1,2 maand-11,3 jaar) en de follow-
upgegevens van alle 118 patiënten waren in ons bestand aanwezig.
 
Indicaties
De indicaties voor RF ablatie waren: het falen van/bijwerkingen van 
antiarrhythmica (n = 63; 45%), de keuze van patiënt/ouder(s) (63; 45%), 
cardiomyopathie of levensbedreigende hartritmestoornissen (11; 8%), en 
voorgenomen chirurgie voor aangeboren hartafwijkingen (3; 2%).
 
Röntgendoorlichtings- en behandeltijd 
De röntgendoorlichtingstijd was gemiddeld 38,9 min (SD: 26,0) en de gemiddelde 
tijd die nodig was voor de ingreep was 186 min (SD: 84,2).
Tabel 1. Demografische gegevens van de 118 patiënten die een RF-ablatie had-
den ondergaan in de periode 1 december 1992-31 mei 2004, Leids Universitair 
Medisch Centrum. * het aantal en het percentage patiënten per diagnose van het totaal 
aantal patiënten, ** het aantal en het percentage patiënten met een aangeboren 
hartafwijking per diagnose, *** 4 patiënten hadden 2 verschillende diagnosen en komen 
in meer dan 1 groep voor: 2 patiënten met AV-nodale re-entrytachycardie en ectopische-
atriale tachycardie, 1 patiënt met een verborgen extra verbinding en Wolff-Parkinson-
White-syndroom, 1 patiënt met Wolff-Parkinson-White-syndroom en Mahaim
tachycardie.
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Succespercentage 
De RF ablatie was initieel succesvol bij 106 (90%) van de 118 patiënten (Figuur 
3). Er ondergingen 19 patiënten (16%) een tweede ingreep en 3 van deze 19 
patiënten een derde ingreep wegens het falen van de eerste behandeling, de 
aanwezigheid van een tweede aritmogeen substraat of het optreden van een 
recidief. Van deze 19 hadden 15 een AVRT. Uiteindelijk werd de aritmie bij 110 
van de 118 (93%) patiënten definitief succesvol behandeld met RF ablatie (zie 
Figuur 3). Het initiële en uiteindelijke succespercentage verschilde per diagnose 
(zie Tabel 2).
 Het initiële succespercentage van RF ablatie voor AVRT verschilde 
per lokalisatie van de extra verbinding. In totaal was 90% (101/112) van de 
RF ablaties voor AVRT succesvol. Er was geen statistisch significant verschil 
in succespercentage tussen rechts, septaal en links gelokaliseerde extra 
verbindingen: respectievelijk 86% (24/28) versus 84% (27/32) versus 96% (50/52) 
(p = 0,219).
 
Complicaties 
Met de ingreep samenhangende geringe complicaties kwamen voor bij 5 (4%) 
patiënten: nabloeding in de lies (n = 4) en pericardeffusie (n = 1). Belangrijke 
complicaties kwamen voor bij 2 (2%) patiënten; bij beiden ontstond een 
tweedegraads AV blok. Bij geen van de patiënten traden late complicaties op, met 
name werden geen nieuwe aritmieën of symptomen passend bij coronairlaesies 
gevonden.
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Figuur 3. Schematische weergave van het klinische beloop bij de 118 patiënten 
die een katheterablatie met radiofrequente energie (‘RF-ablatie’) hadden on-
dergaan in de periode 1 december 1992-31 mei 2004, Leids Universitair Medisch 
Centrum.
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Recidieven 
Na 18 van de in totaal 125 initieel succesvolle RF ablaties (14%) deed zich 
een recidief voor. Recidieven traden gemiddeld 2,3 maanden (SD: 2,5) na een 
succesvolle RF ablatie op; 6 maanden na een succesvolle RF ablatie werden geen 
recidieven meer geobserveerd.
 
Recidieven na RF ablatie voor AVRT 
Na 10 van de in totaal 101 initieel succesvolle RF ablaties voor AVRT (10%) deed 
zich een recidief voor. De Kaplan-Meier-analyse voor afwezigheid van recidief na 
een succesvolle RF ablatie voor AVRT is weergegeven in Figuur 4. Recidieven 
traden gemiddeld 1,8 maanden (SD: 1,5) na een succesvolle RF ablatie op.
Tabel 2. Succespercentages van katheterablatie met radiofrequente energie bij 
de 118 kinderen die deze hadden ondergaan in de periode 1 december 1992-31 
mei 2004, Leids Universitair Medisch Centrum *4 patiënten hadden 2 verschillende 
aandoeningen en komen in meer dan 1 groep voor: 2 patiënten met AV-nodale re-entry 
tachycardie en ectopische-atriale tachycardie, 1 patiënt met een verborgen extra verbin-
ding en WPW-syndroom, en 1 patiënt met WPW-syndroom en Mahaim-tachycardie. †Het 
initiële succespercentage werd gedefinieerd als het percentage RFablaties waarbij het 
aritmogene substraat met elektrofysiologisch onderzoek niet meer aantoonbaar was aan 
het einde van de behandeling. ‡Het uiteindelijke succespercentage werd gedefinieerd als 
het percentage patiënten dat na één of meer RF-ablaties zonder antiarrhythmica vrij was 
van recidieven en bij wie het aritmogene substraat met elektrofysiologisch onderzoek na 
afloop van de laatste behandeling niet meer aantoonbaar was.
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Vroeg (december 1992-2000) versus laat tijdperk (2001-mei 2004) 
In het vroege tijdperk (8,1 jaar) werden in totaal 69 RF ablaties uitgevoerd en 
in het late tijdperk (3,4 jaar) 71. Het percentage initieel succesvolle RF ablaties 
in het vroege tijdperk was 86 (59/69) en in het late 93 (66/71) (p = 0,154). De 
gemiddelde doorlichtingstijd in de late periode was significant lager dan in de 
vroege: 32,4 (SD: 22,1) versus 45,4 (SD: 28,2) min (p = 0,003). Ook de gemiddelde 
proceduretijd was in het late tijdperk significant lager dan in het vroege: 156,20 
(SD: 60,9) versus 217,7 (SD: 93,7) min (p < 0,0001). Het percentage complicaties 
was in het vroege tijdperk 6 (4/69) en in het late 4 (3/71) (p = 0,670).
Samenhang van de leeftijd met de resultaten van RF ablatie
Tussen de groep kinderen < 10 jaar (n = 29; 25%) en de groep kinderen ≥ 10 jaar 
(n = 89; 75%) was geen verschil in het uiteindelijke totale succespercentage: 93 
(27/29) en 93 (83/89) (p = 0,914). Hetzelfde gold voor het totale complicatierisico: 
3 (1/29) versus 7 (6/89) (p = 0,680).
Figuur 4. Kaplan-Meier-analyse voor het vrij van recidief zijn na een geslaagde kath-
eterablatie met radiofrequente energie wegens atrioventriculaire ‘re-entry’-tachycardieën 
(n = 101 ablaties bij 97 patiënten) in de periode 1 december 1992-31 mei 2004, Leids
Universitair Medisch Centrum.
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Beschouwing
In deze studie beschrijven wij de resultaten van RF ablatie bij kinderen na een 
gemiddelde follow-upduur van 4 jaar. Het merendeel van ons cohort (n = 97; 80%) 
bestond uit kinderen met een AVRT. Het uiteindelijke succespercentage binnen 
het gehele cohort was 93, waarbij 19 patiënten (16%) een tweede behandeling 
ondergingen en 3 van hen een derde. Het eerste recidief trad gemiddeld na 2,3 
maanden (SD: 2,5) op en 6 maanden na een succesvolle RF ablatie werden geen 
nieuwe recidieven meer geobserveerd. Bij 2 kinderen trad een tweedegraads AV 
blok als belangrijke complicatie van de RF ablatieprocedure op.
 Deze resultaten zijn vergelijkbaar met de kortetermijnresultaten van 
andere pediatrische studies in één centrum.13, 15 In de multicenterstudie van 
de North American Pediatric Radiofrequency Catheter Ablation Registry, tot 
op heden het grootste onderzoek in de literatuur, vond men 3% belangrijke 
complicaties.11 
 Inmiddels neemt het complicatiepercentage met de groeiende ervaring 
verder af. Het complicatierisico van RF ablatie bij kinderen is aanzienlijk lager 
dan het risico op het optreden van levensbedreigende proaritmie bij chronisch 
gebruik van klasse-I- en klasse-III-antiarrhythmica of het potentiële risico 
van de hartritmestoornis zelf.23-25 Zo had in onze studie 8% van de patiënten 
ernstige cardiomyopathie gekregen als gevolg van een chronische tachycardie 
of reanimatie ondergaan wegens atriumfibrillatie met snel kamervolgen bij het 
Wolff-Parkinson-White-syndroom.
 Onlangs werd in een studie naar de langetermijnresultaten van RF ablatie 
bij 24 kinderen met een structureel normaal hart na een mediane follow-upduur 
van 10 jaar een uiteindelijk totaal succespercentage van 100 gerapporteerd. Bijna 
de helft (46%) van de patiënten onderging echter een tweede ingreep. Recidieven 
traden over het algemeen binnen 6 maanden op, terwijl bij 17% van de patiënten 
jaren na de RF ablatie nog recidieven optraden.9 
 Er bestaan belangrijke argumenten om met name bij jonge kinderen 
terughoudend te zijn bij het toepassen van RF ablatie. De kans op ernstige 
complicaties, waaronder ook sterfte, zou met name bij kinderen < 15 kg 
lichaamsgewicht verhoogd zijn,10, 11, 18 hoewel deze bevinding in een recentere 
publicatie niet werd bevestigd.8 In onze studie was geen verschil aantoonbaar 
in het succes- en complicatiepercentage tussen kinderen < 10 jaar en ≥ 10 
jaar en ook bij de relatief beperkte groep jonge kinderen (< 2 jaar of < 15 kg 
lichaamsgewicht) verliepen de behandelingen succesvol en ongecompliceerd.
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Uit een recente studie is gebleken dat de kans op ernstige complicaties na RF 
ablatie bij jonge kinderen samenhangt met de totale dosis RF stroom per kilogram 
lichaamsgewicht.26 Bij deze jongste groep patiënten blijft voorzichtigheid 
derhalve geboden, mede gezien het gunstige spontane natuurlijke beloop van 
de meeste hartritmestoornissen bij kinderen < 1 jaar.2, 4, 27 Door aanpassingen in 
de RF ablatietechniek, zoals het gebruik van slechts 1 of 2 kleine intracardiale 
katheters in combinatie met een slokdarmelektrode voor atriale stimulatie en 
een lagere hoeveelheid RF energie, kunnen de risico’s op complicaties zoveel 
mogelijk verkleind worden.
 Bij proefdieronderzoek met jonge biggen is aangetoond dat als gevolg van 
RF ablatie coronairlaesies kunnen ontstaan, hetgeen ook incidenteel bij jonge 
kinderen is gerapporteerd.19, 20, 28, 29  Bovendien werd bij lammeren aangetoond dat 
RF laesies in immatuur myocard in grootte toe kunnen nemen gedurende de groei 
en aritmogene substraten zouden kunnen vormen.21 Een belangrijke bevinding 
in onze studie is dat er ook op langere termijn geen klinische aanwijzingen zijn 
voor het optreden van nieuwe aritmieën als gevolg van de RF laesies in het 
groeiende hart of voor het ontstaan van vroege of late coronairlaesies na RF 
ablatie.
 Een beperking van onze follow-up is dat er geen routinematige 24-uur-
Holter-registraties vervaardigd zijn en dat de kinderen binnen onze cohort geen 
coronairangiografieën hebben ondergaan, waardoor het optreden van nieuwe 
aritmieën of het bestaan van subklinische coronairlaesies niet geheel uitgesloten 
kan worden. Tevens zou het aantal recidieven mogelijk onderschat kunnen zijn, 
daar de patiënt en/of de ouders, na de poliklinische controle 1 jaar na de RF 
ablatieprocedure, gevraagd werd zelf contact met ons op te nemen in het geval 
van recidiverende klachten.
 Hoewel de gemiddelde röntgendoorlichtingstijd gedurende de 
studieperiode statistisch significant afgenomen is, blijft het risico op het ontstaan 
van maligniteiten zeker bij kinderen een punt van zorg. Het risico op het 
ontstaan van een maligniteit na het ondergaan van 1 uur röntgendoorlichting bij 
volwassenen bedraagt 0,1%.30  De voortschrijdende ontwikkelingen op het gebied 
van non-fluoroscopische mappingtechnieken bieden echter perspectief op een 
verdere reductie van de röntgendoorlichtingstijd tijdens RF ablatieprocedures in 
de toekomst.
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Conclusie
De ervaring die in de afgelopen jaren met RF ablatie bij kinderen is opgedaan, 
heeft in goede langetermijnresultaten geresulteerd. Ook bij jonge kinderen (< 
10 jaar) is RF ablatie op lange termijn veilig en effectief. Dit biedt de ruimte om 
in gespecialiseerde centra ook deze groep patiënten curatief met RF ablatie te 
behandelen.
Belangenconflict
Geen gemeld. 
Financiële ondersteuning
Geen gemeld.
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Abstract
A hydropic premature neonate was born at 32 weeks of gestation 
after successful direct fetal amiodarone therapy via cordocentesis 
for incessant supraventricular tachycardia. After birth the 
tachycardia could not be controlled despite high doses of amiodarone 
and flecainide and the patient developed severe respiratory and 
circulatory failure. After three weeks, weighing 2 kg, he underwent 
successful and uncomplicated radiofrequency catheter ablation of a 
left free-wall accessory pathway using low-energy RF application.
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Introduction
Fetal hydrops associated with tachyarrhythmia results in high prenatal and 
postnatal morbidity and mortality.1, 2 After failure of maternal drug therapy 
with either digoxin, sotalol or flecainide, direct amiodarone fetal therapy can be 
considered.3, 4 After birth, supraventricular tachycardias usually respond well 
to antiarrhythmic drug therapy, although combined therapies are occasionally 
necessary to control the arrhythmia.2, 5 
Accessory pathways form the most common substrate for tachycardia 
in fetuses and newborns and more than two-thirds of cases remain free of 
symptoms by the age of one year.1, 6 Radiofrequency catheter ablation (RFCA) is 
rarely necessary in this age group and considerable concerns exist about RFCA in 
neonates.7 In the present report we describe a successful radiofrequency catheter 
ablation procedure to control drug-refractory tachycardia in a 2 kg premature 
neonate only using low-energy RFCA.  
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Case report
At 24 weeks of gestation fetal tachycardia was diagnosed in a 30-year-old female. 
M-mode echocardiography demonstrated a regular tachycardia of 260 beats/min. 
with 1:1 atrio(A)ventricular(V) association and a short VA-time suggesting an 
atrioventricular reciprocating tachycardia. Despite combined maternal digoxin/
flecainide therapy and later combined digoxin/sotalol therapy, tachycardia of 
220 beats/min. persisted and severe fetal hydrops developed. 
At 28 weeks of gestation, conversion to sinus rhythm was achieved by 
two direct fetal amiodarone injections via cordocentesis (10 mg and 15 mg) 
combined with a maternal amiodarone loading dose of 1.2 g/day for 48 hours. 
Additionally, fetal paracentesis was performed to reduce the amount of ascites. 
The fetus remained in sinus rhythm the following 4 weeks and the maternal 
amiodarone dose was reduced to 200 mg/day.  
Figure 1. The boy with severe hydrops fetalis, weighing 1.7 kg, after delivery by caesar-
ian section at 32 weeks of gestation (printed with parental informed consent).
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Premature rupture of the membranes was the indication for a caesarian section 
at 32 weeks of gestation and a boy was born with severe hydrops (Figure 1). He 
required mechanical ventilation and developed idiopathic respiratory distress 
syndrome (IRDS).  Thyroid suppletion was instituted for mild hypothyroidism, 
most probably due to the fetal amiodarone therapy. The electrocardiogram (ECG) 
at birth revealed normal sinus rhythm without pre-excitation but tachycardia 
recurred within 24 hours. The ECG showed regular small QRS complex 
tachycardia with retrograde negative P-waves in I, II and AVL, suggesting an 
orthodromic atrioventricular reciprocating tachycardia through a left free-wall 
accessory pathway (Figure 2).  
Figure 2. The electrocardiogram (ECG) 24 hours after birth revealing regular small 
complex tachycardia with retrograde negative P-waves in I, II and AVL, suggesting a left 
free-wall accessory pathway.
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Combined therapy with digoxin and propranolol failed and intravenous 
amiodarone therapy (10mg/kg/day) was successfully re-instituted postnatally. 
Hydrops regressed and the boy, weighing 1.7 kg, was successfully weaned from 
the ventilator. However, incessant tachycardia (220 beats/min.) recurred and 
could not be controlled with high dose of amiodarone (20 mg/kg/day) eventually 
combined with flecainide (0.2 mg/kg/uur). The child developed severe congestive 
heart failure and required mechanical ventilation.
 At 36 weeks of gestation radiofrequency catheter ablation was considered 
as ultimate therapy. At the time of the procedure, the child was three weeks of 
age and weighed 2 kg. A single standard 5 Fr, 4mm tip deflectable quadripolar 
catheter (RF Marinr, Medtronic Inc. Minneapolis, MN, USA) was introduced 
through the right femoral vein for mapping, pacing and ablation and a 5 Fr 
quadripolar electrode catheter (Josephson quadripolar catheter, Medtronic Inc.) 
was positioned into the esophagus for left atrial recordings and stimulation. The 
mapping catheter was easily positioned into the left atrium through a patent 
foramen ovale (Figure 3A).
Figure 3. A. Radiograph recorded during the RFCA-procedure. A 5 Fr RFCA-catheter 
(ABL) was placed anterogradely through the patent foramen ovale and a second electrode 
catheter was placed in the esophagus (Eso) for atrial recordings and stimulation.
B. Mapping and radiofrequency catheter ablation during incessant tachycardia. The 
negative retrograde P-wave was visible in lead I of the surface-ECG. The esophagus-
electrode showed both left ventricular (V) and left atrial (A) electrograms. The bipolar 
electrogram of the tip of the ablation catheter (ABL-tip) showed the earliest atrial 
activation and the shortest VA-interval (37 msec.) at the posterolateral part of the mitral 
ring. Radiofrequency energy immediately terminated tachycardia. Total RF-energy 
application time was 33 seconds. V-pacing demonstrated VA-dissociation.
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Mapping was performed during incessant tachycardia (cycle length 310 ms.) 
and confirmed the diagnosis of orthodromic tachycardia through a left free-wall 
accessory pathway. The shortest VA-interval (37 msec.) during tachycardia 
was delineated as the most favorable site for ablation. Only one application of 
radiofrequency energy of 30 seconds with a temperature- and power limit of 
55 ˚C and 25 W respectively, caused immediate termination of the tachycardia 
(Figure 3B) and subsequent ventricular pacing demonstrated VA-dissociation. 
Total procedural time was 35 minutes and fluoroscopy time was 6 minutes. 
Post-procedural echocardiography showed an echodense “RFCA lesion” 
of the left atrium of 2 x 3 mm. just above the posterolateral part of the mitral ring 
(Figure 4). There was no mitral regurgitation or pericardial effusion. He was 
successfully weaned from the ventilator within one week but required oxygen 
therapy because of bronchopulmonary dysplasia for 8 months. 
The echodense lesion in the left atrium could no longer be identified after 
the age of 3 months. Echocardiography (6 monthly) showed good systolic left 
ventricular function (shortening fraction 35%) and normal regional wall motions. 
Color flow Doppler echocardiography showed patency of the circumflex artery and 
no clinical symptoms nor electrocardiographic (ECG) findings of ischemia were 
found during follow-up. Thyroid suppletion was successfully discontinued at the 
age of 9 months and latest follow-up at 18 months showed normal psychomotor 
development.
 
Figure 4. Post-procedural echocardiogram showing a echodense “RFCA-lesion” of the 
left atrium (LA) of 2 x 3 mm. just above the posterolateral part of the mitral ring. (LV = 
left ventricle, MV = mitral valve).
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Discussion
The natural course of supraventricular tachycardia in fetuses or neonates is 
usually benign.5 The most common tachyarrhythmias are those that involve 
accessory pathways that appear to resolve in more than sixty percent of cases by 
the time the child is 1 year of age.1, 5, 6 RFCA is rarely indicated in this age group 
and should be restricted to cases in which Class Ic as well as Class III drugs are 
ineffective and the tachycardia causes hemodynamic compromise.7 
There are significant concerns to perform RFCA in neonates and infants. 
Several studies have shown a greater complication-rate for RFCA in children 
weighing <15 kg,8, 9 although this increased risks could not be confirmed in the 
most recent large series of the Pediatric RFCA Registry.10 
However, the registry of a very small number of procedure-related late 
deaths after the ablation procedure suggests caution in the use of RFCA in young 
children.8, 9, 11 Furthermore, both right and left coronary lesions have been reported 
during RFCA procedures in infants and young children.12, 13 Experimental animal 
data have shown that RF lesions in the developing myocardium may have the 
potential to expand with time and effect coronary perfusion.14-16 
The previously described RFCA procedures in neonates and infants in 
literature, were usually performed with 5 Fr or 7 Fr, 4 mm tip RF catheters 
and standard RFCA applications of 25 to 50 W power-limit in a temperature-
controlled mode of 60 to 70 °C of 15 to 30 seconds.12, 17-19 
We describe a premature hydropic neonate with respiratory and 
circulatory failure as a result of a drug-refractory tachycardia, involving a left 
free-wall accessory pathway. This patient was converted to sinus rhythm in 
utero by direct fetal amiodarone therapy via cordocentesis. Incessant tachycardia 
recurred shortly after birth despite combined amiodarone and flecainide therapy 
and RFCA was indicated as the last remaining option. 
This case is one of the youngest premature neonates in whom RFCA 
has been performed. RFCA was successful with a 5 Fr, 4 mm tip RF catheter 
using one single RF  application of 30 seconds with a power limit of 30 W in 
a temperature-controlled mode of 55 ˚C. Despite the single low-energy RF 
application post-procedural echocardiography demonstrated a clear 2 x 3 mm. 
echodens lesion of the left atrium. Follow-up echocardiography showed normal 
left ventricular function and no regional wall motion abnormalities.  
At our institution the current practice is to use this low-energy RFCA 
approach in newborns and young infants < 10 kg as initial attempt to minimize 
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the risk of valvulair damage and coronary artery lesions. A recent study by 
Blaufox et al. showed that complications of RFCA in small infants appear to 
be related to the RF dose indexed for body size and this study also emphasises 
the importance to reduce the RF dose in this very young age group.20 A further 
reason to minimize the RF lesion in small neonatal hearts comes from animal 
experiments showing an increase of RF lesion size in the immature heart of 
lambs during growth.16 
In neonates and young infants RFCA is rarely indicated and should 
only be performed with extreme caution. In addition to the use of small 5 Fr 
RF catheters and a limited number of intracardiac catheters, low-energy RF 
application could further reduce the risk of major complications. 
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Summary, Conclusions & Future Perspectives
Summary
The General Introduction in Chapter 1 of this thesis provides an overview of 
structural cardiogenesis and the development of the cardiac conduction system 
(CCS) in avians (with references to equivalent mouse and human developmental 
timelines). Next, developmental transitions in impulse propagation and the        
construction of the individual components of the specialized CCS and the 
atrioventricular node (AVN) in particular, are shortly outlined. Current concepts 
on the transitions in ventricular activation sequences during cardiogenesis 
are subsequently discussed, preceded by a description of the changes in 
electrocardiograms (ECGs) during embryogenesis. Thereafter, contemporary 
knowledge on the development of the isolating annulus fibrosis, the key 
structure involved in accessory pathway (AP) persistence, in relation to general 
CCS development is reviewed. Subsequently, relevant general characteristics 
of the different animal models and the immunohistochemical markers used in 
this thesis are briefly outlined. Following the description of the structural basics 
of cardiogenesis, attention is focused on current knowledge of clinical SVTs in 
neonates and children and the treatment of these arrhythmias.
After the General Introduction, this thesis is divided in 3 main parts. 
In PART I of this thesis, both the (patho) physiological development of the 
isolating annulus fibrosus cordis and the etiological origin of clinical AP 
mediated atrioventricular (AV) reentrant tachycardia (AVRT) in children and 
adults is analyzed in experimental animal (quail and mouse) models and human 
histological sections. Subsequently, PART II of this thesis describes historical and 
contemporary concepts on the ontogeny of the AVN, followed by an experimental 
(quail/chick) study postulating a new concept on the developmental origin of the 
AVN and in particular the slow pathway of the AVN in relation to the etiology 
of AV nodal reentrant tachycardia (AVNRT). Finally, in PART III of this thesis 
therapeutical clinical issues in pediatric supraventricular tachycardia (SVT) will 
be outlined.
PART I
In Chapter 2, the physiological development of the isolating annulus fibrosus 
cordis was studied in the Japanese quail (Coturnix coturnix japonica) model. 
Ventricular activation patterns were deducted from ex-ovo extracellular 
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electrogram recordings in both the embryonic (n=80; HH stage 30-44) and 
adult (n=6; 5-6 months old) quail heart and correlated to the developmental 
morphology of the insulating AV annulus. Functionally, premature activation 
of the ventricular base indicating impulse propagation through persistent APs 
bypassing the AVN was found to remain possible at near-hatching stages of 
quail development. Morphological data in 16 embryonic and 1 adult quail heart 
confirmed this functional analysis by demonstrating persistent muscular AV 
connections coursing through the fibrous annulus in the embryonic heart until 
the last stages of development, while the adult heart demonstrated complete 
fibrous annular isolation. Longitudinal analysis revealed that these persistent 
APs decreased both in number (p=0.004) and width (p=0.179) at increasing 
developmental stages and were mainly found in the posteroseptal region of the 
heart. Furthermore, the region of these persistent APs was found to stain positive 
for periostin, a non-myocardial marker used to visualize cells with a fibrous 
identity, suggesting that these pathways eventually loose their myocardial 
phenotype, indicating an extended physiological process of perinatal completion 
of AV ring isolation. Results from this study support the hypothesis that 
persistent APs bypassing the AVN remain present and functional at late post-
septated stages of embryonic development, possibly providing a physiological 
substrate for transient AVRTs in postnatal life, which is suggested to provide 
an etiological explanation for the clinical observation that AVRTs in human 
neonates are known to spontaneously disappear before the age of one year in the 
vast majority of cases.
In Chapter 3, the pathological development of the isolating annulus fibrosus 
cordis was studied in a Japanese quail (Coturnix coturnix japonica) model in which 
the migration of Epicardium-Derived-Cells (EPDCs) was mechanically inhibited 
by inserting a small piece of eggshell membrane between the dorsal wall of the 
embryonic HH stage 15-18 heart and the pericardial villi by in-ovo microsurgery. 
After reincubation, in-ovo electrocardiograms (ECGs) were subsequently 
recorded in normal (n=12) and EPDC-inhibited (n=12) HH stage 38-42 quail 
eggs. Additionally, ventricular activation patterns were deducted from ex-ovo 
extracellular electrogram recordings in both normal (n=45) and EPDC-inhibited 
(n=12) quail hearts at HH stages 38-42 and correlated to the developmental 
morphology of the insulating atrioventricular (AV) annulus. Functionally, in 
a subgroup of EPDC-inhibited embryos in-ovo ECGs demonstrated the 3 main 
electrocardiographic features of ventricular preexcitation syndromes: 1) a short 
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PR-interval, 2) a delta wave and 3) a prolonged QRS-complex. Furthermore, ex-
ovo electrograms demonstrated premature activation of the ventricular base in all 
EPDC-inhibited hearts. Morphologically, the presence of posteroseptal APs was 
reconfirmed in normal quail hearts and was also confirmed in the EPDC-inhibited 
hearts. The EPDC-inhibited hearts however additionally demonstrated relatively 
broad APs in the right and left lateral free wall regions. Periostin staining was 
found in the regions where EPDCs are known to be present, for example in the 
epicardium, the endocardial AV cushions, the epicardial AV sulcus, the atrial 
and ventricular subendocardium, the interstitial fibroblasts and around the AV 
junction. While the posteroseptal APs stained positive for periostin, the broad 
lateral APs in EPDC-inhibited hearts were periostin negative. EPDCs thus seem 
essential for proper formation of the isolating annulus fibrosis, since inhibition of 
EPDC-migration during cardiogenesis results in marked defects in the annulus 
fibrosis with persistence of broad APs, functionally giving rise to ventricular 
preexcitation. While under physiological conditions small septal APs in the 
wildtype heart temporarily remain functionally active, broad lateral APs in the 
EPDC-inhibited heart might provide a pathological substrate for postnatally 
persistent APs and AVRTs into childhood or adult life.
Following this experimental study, an editorial in response to the experimental 
data described in this chapter written by Siew Yen Ho from the Department of 
Cardiac Morphology and the National Heart & Lung Institute of the Imperial 
College London and the Royal Brompton Hospital in the United Kingdom, is 
presented to provide additional background of state-of-the art knowledge on APs 
from a developmental point of view.
In Chapter 4, the physiological development of the isolating annulus fibrosus 
cordis was studied in the wildtype mouse (strain: C57B16/Jico and CD1) model 
to extrapolate avian data to mammalian development. Ventricular activation 
patterns were deducted from ex-ovo extracellular electrogram recordings in the 
11.5-18.5 dpc embryonic (n=48) mouse heart and correlated to the morphology 
of the developing AV annulus in all hearts (n=48). In this study, the annulus 
fibrosis was shown to develop in the AV junctional myocardium, which was devoid 
of connexin-43 (Cx43). Similarly to the embryonic avian heart, persistent APs 
giving rise to premature activation of the ventricular base could also be found 
during mouse heart development. These persistent APs were devoid of Cx43, 
indicating an AV junctional myocardial origin, and were at early post-septated 
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stages mainly found around both the mitral and tricuspid orifice, while at late 
post-septated stages AP number had significantly (p<0.001) decreased around 
the mitral valve annulus. Similar to avians, periostin expression was found in the 
epicardium, the endothelial lining of the ventricular and atrial trabeculae, the 
subendocardial cushions, the interstitial fibroblast and around the AV junction. 
In contrast to the avian heart, in the mouse heart periostin expression could not 
be found in the Cx43 negative cardiomyocytes of the AP itself, while high levels 
of periostin were found in the fibroblasts adjacent to or in the APs. While these 
persistent APs significantly decreased in number (p=0.003) and size (p=0.035) at 
consecutive developmental stages, APs could still be found at late post-septated 
stages of mammalian heart development. Similarly to avian cardiogenesis, the 
physiological perinatal presence of APs in the mammalian heart, may provide 
transient substrates for neonatal AVRT.
In Chapter 5, the presence and specific locations of accessory pathways (APs) 
were systematically investigated in relation to the physiological developmental 
morphology of the isolating annulus fibrosis in human cardiogenesis. 
Immunohistochemical sections of 45 human embryonic, fetal and neonatal 
hearts from 4 to 36 weeks of development (avians ~HH 14-46, mouse ~E 10-
19) were analyzed for AP number and location. While the annulus fibrosis was 
already laid down around 10 to 11 weeks of human gestation (avians ~ HH 21-
27, mouse ~ E 12.5-13.5), numerous APs crossing the isolating AV ring could 
still be found mainly at both the left and right lateral AV junction up to the 
end of the second trimester of pregnancy. In the second and third trimester, the 
left AV annulus became firmly isolated by a thick layer of fibrous tissue, while 
the right AV annulus only demonstrated weak isolation frequently consisting 
only of very thin layers of fibrous tissue. As a consequence, up to 20 weeks of 
human gestation (avians ~HH 40, mouse ~E 17) APs near the lateral side of the 
tricuspid valve remained present. These right-sided APs frequently seemed to 
be located in close proximity to the right AV ring bundle, which is part of the 
temporary embryological specialized AV conduction axis. Furthermore, small 
myocardial extensions crossing the isolating annulus fibrosis connecting the 
developing AVN with the ventricular septal myocardium were found, remaining 
present until birth corresponding to previously described phenomenon of foetal 
dispersion of the AVN. In this study we confirmed our data from previous avian 
and mammalian studies and concluded that in human embryos isolation of the 
annulus fibrosis is normally completed postnatally, leaving mostly right-sided 
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persistent APs in the foetal heart which may act as substrates for transient 
AVRT in foetuses or neonates. 
PART II
In Chapter 6, a review of historical and contemporary knowledge on the 
anatomy, physiology and ontogeny of the AVN and its atrial inputs is provided. 
Furthermore, structural AV nodal development and the cellular electrophysiology 
of the developing AV junction in relation to the adult AVN and the concept of 
AV nodal conduction dichotomy are discussed. While the electrophysiological 
substrates for AVNRT are well known, the anatomical correlates forming the 
reentry circuit have still remained incompletely understood. Although recent 
marker studies have provided some clues to the developmental origin of the 
AVN, its physiology, structural boundaries and ontogeny still remain puzzling. 
This review is followed by Chapter 7, describing an experimental avian (quail 
and chick) study, in which a new concept on the developmental origin of the 
AVN is postulated. In this study, spatiotemporal changes in atrial activation 
sequences in the embryonic avian (Japanese quail and white leghorn chick) heart 
(HH stages 19-36, n=96) were correlated to developmental morphology (n=64). 
Around HH stage 19-22, bilateral morphologically distinct myocardial regions 
could be identified surrounding the proximal myocardial part of the left cardinal 
vein (LCV) and the proximal myocardial part of the right cardinal vein (RCV). 
These bilateral regions were both characterized by MLC2a positivity, Nkx2.5 
negativity and relatively low levels of Cx43, Nav1.5 and glycogen compared to 
the surrounding myocardium. Although the proximal myocardial part of the right 
cardinal vein (RCV) corresponds to the primordium of the sinoatrial node (SAN), 
the proximal myocardial part of the left cardinal vein (LCV) was hypothesized 
to contribute to the developing AV nodal tissues. Until HH stage 27, the distinct 
LCV tissues were positioned caudodorsally to the left atrium and functionally a 
left-sided dominant pacemaker could still be found in a considerable number of 
cases (21%), while unilateral impulse initiation was already expected in the SAN 
region in the right atrium. After HH stage 28, impulse initiation in the left atrium 
could however no longer be found, perfectly correlating to the morphological 
observation that around HH stage 29-30 the LCV was already transposed to 
the right and submerged in the right atrium to become the coronary sinus (CS), 
while the myocardium surrounding the proximal LCV became positioned around 
the CS ostium in the slow pathway region of the adult AVN. In this study, we 
C
hapter 0
Sum
m
ary, C
onclusions &
 Future Perspectives
337
demonstrated that the LCV tissues provide an important functional contribution 
to the AVN Anlagen in the slow pathway region.
PART III
In Chapter 8, the long-term results of radiofrequency catheter ablation 
(RF ablation) in 118 paediatric patients, who underwent 140 RF ablation      
procedures for 122 substrates of supraventricular arrhythmias, were analyzed   
retrospectively. Indications for RF ablation were: failure or side effects of           
antiarrhythmic medication (45%), patient/parent choice (45%), cardiomyopathy 
or life-threatening arrhythmia (8%), and impending surgery for congenital 
heart defects (2%). In this study, we concluded that the long-term outcome of 
pediatric patients who underwent RF ablation was favorable in terms of success, 
recurrence and complication rates. Additionally, RF ablation in young children 
(< 10 years) was found to be as safe and effective as RF ablation procedures in 
older children and adolescents (10-18 years). These results demonstrate that it is 
also possible to curatively and safely treat this young group of pediatric patients 
with RF ablation in specialized centers.
Finally, in Chapter 9, an illustrative case report of incessant accessory pathway 
(AP) mediated SVT in a premature neonate with hydrops foetalis, is presented. 
While RF ablation in neonates and young infants is rarely indicated and 
only should be performed with extreme caution, in this case RF ablation was 
indicated as the last remaining option. A hydropic premature neonate was born 
at 32 weeks of gestation after successful direct fetal amiodarone therapy via 
cordocentesis for incessant supraventricular tachycardia. After birth tachycardia 
could not be controlled despite high doses of amiodarone and flecainide and the 
patient developed severe respiratory and circulatory failure. After three weeks, 
weighing 2 kg, he underwent successful and uncomplicated RF ablation of a left 
free-wall accessory pathway using low-energy RF application.
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Conclusions
•	 Accessory pathways (APs) bypassing the isolating annulus fibrosis and 
atrioventricular node (AVN) are structural remnants of the embryonic AV 
junctional myocardium and remain morphologically present and functional 
in avian and mammalian hearts at late post-septated stages of embryonic 
development and might provide a transient physiological substrate for AV 
reentrant tachycardia (AVRT) in perinatal life. 
•	 Epicardium-Derived-Cells (EPDCs) are essential for proper formation of the 
isolating annulus fibrosis.
•	 Inhibition of EPDC-migration during cardiogenesis results in marked defects 
in the isolating annulus fibrosis with persistence of broad APs, functionally 
resulting in ventricular preexcitation, possibly providing a pathological 
mechanism for postnatally persistent APs and AVRTs into childhood or 
adult life.
•	 Periostin is a profibrogenic extracellular matrix protein strongly expressed 
in collagen-rich fibrous connective tissues. Expression of periostin in the 
annulus fibrosis in the region around myocardial APs in the avian and 
mammalian developing heart, seems to indicate their ultimate perinatal 
fate.
•	 In humans, up to 20 weeks of gestation, APs remain present and are mainly 
found around the tricuspid valve annulus and are frequently located in 
close proximity to the right AV ring bundle, which is part of the temporary 
embryological specialized AV conduction axis.
•	 In the developing avian heart bilateral functional pacemakers are temporarily 
present in the right and left cardinal vein myocardium, while ultimately 
the right sinoatrial nodal (SAN) primordium becomes the prevailing 
pacemaker.
•	 The myocardium surrounding the proximal part of the left cardinal vein 
(LCV) in the embryonic avian heart provides an important contribution to 
the slow pathway region of the developing heterogeneous AVN.  
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•	 The long-term outcome of pediatric patients who underwent RF ablation is 
favorable in terms of success, recurrence and complication rate. 
•	 While RF ablation in neonates and young infants (<10 years of age) is rarely 
indicated and only should be performed with extreme caution, RF ablation 
can safely be indicated as a last remaining option in experienced centers.
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Future Perspectives
By studying avian, mammalian and human cardiogenesis we have been able 
to unravel some clues on the physiological and pathological development of 
the isolating annulus fibrosis and the atrioventricular node (AVN). From these 
studies it is clear that with respect to the developing annulus fibrosis and cardiac 
conduction system (CCS), physiology and pathology are divided by a very thin 
line. While we demonstrated that normally isolation of the annulus fibrosis is 
completed postnatally, established an essential role for EPDCs in normal annulus 
fibrosis development, postulated a new concept on AV nodal development and 
identified (immuno)histochemical markers such as PAS-staining, the antibodies 
MLC2a, Nkx2.5, periostin, Cx43 and Nav1.5, suited to study these processes, 
several aspects of normal and abnormal annulus fibrosis formation and AV nodal 
development remain unanswered. Although we analyzed the developmental 
process of annulus fibrosis formation in both avian and mammalian models and 
extrapolated these data to human sections, it remains to be determined how the 
postulated functional implications can be translated to clinically relevant issues. 
Furthermore, the conundrum of whether accessory pathways (APs) presenting 
later in life also represent postnatally persistent APs temporarily remaining 
functionally quiescent or represent de novo occurring APs growing through 
newly developed holes in the annulus fibrosis, still remains. 
To tackle these and other questions, future research in this field will be 
aimed at more elaborate studies of atrial and ventricular activation patterns in 
the developing and adult heart by using Multi-Electrode-Array (MEA) recordings 
and optical mapping with voltage sensitive dyes. Knowledge of the cellular 
electrophysiology of the persistent APs and postulated AV nodal primordial 
tissues, described in this thesis, by analyzing intracellular electrophysiology 
with patch clamping would further aid in our understanding of the functional 
implications of current and future experimental findings. Future research 
will furthermore be aimed at the application of (new) genetically engineered 
animal models (such as the podoplanin-KO and Shox2-KO mouse model) and 
identification and exploration of the expression of (new) myocardial (such as 
Nkx2.5) and CCS markers (such as Islet-1 and Id-2) and their interaction. 
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The studies described in this thesis have illustrated that in future research the 
analysis of structure-function relations is key to unraveling the developmental 
mechanisms underlying annulus fibrosis formation, AP persistence and AV 
nodal development and will provide a translational benchmark to successfully 
interpret clinically relevant aspects in cardiac arrhythmias. 
With respect to the clinical research on pediatric supraventricular tachycardias 
and therapeutic options described in this thesis, currently ongoing large 
prospective pediatric studies will provide the next step and more insight in 
evaluation of the clinical presentation of pediatric SVTs and treatment strategies 
in this specific age group. 
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Samenvatting
De algemene inleiding in Hoofdstuk 1 van dit proefschrift geeft een overzicht van 
de structurele cardiogenese en de ontwikkeling van het cardiale geleidingssysteem 
in het vogelmodel (met referenties naar equivalente ontwikkelingsstadia in 
het muismodel en de mens). Vervolgens worden de ontwikkelingsbiologische 
transities in de voortgeleiding van de elektrische impuls en de aanleg van 
de verschillende elementen van het gespecialiseerde geleidingssysteem en 
met name de atrioventriculaire knoop (AV knoop) uiteengezet. Aansluitend 
worden de veranderingen in het embryonale elektrocardiogram tijdens de 
embryogenese en de huidige ideeën betreffende de transities in ventriculaire 
activatiesequenties tijdens de cardiogenese besproken. Daarna wordt de huidige 
kennis van de ontwikkeling van de isolerende annulus fibrosis, een structuur 
die belangrijk is bij het persisteren van accessoire verbindingen, in relatie tot 
de ontwikkeling van het gespecialiseerde geleidingssysteem, bediscussieerd. 
Vervolgens worden relevante algemene karakteristieken van de verschillende 
diermodellen en de (immuno)histochemische markers (antilichamen), die zijn 
gebruikt in de experimentele studies beschreven in dit proefschrift, uiteengezet. 
Na deze beschrijving van de structurele basis van de cardiogenese, volgt er een 
uiteenzetting over de huidige klinische kennis betreffende supraventriculaire 
tachycardieën (SVTs) bij neonaten en kinderen en de behandeling van deze 
ritmestoornissen.
 Na de algemene inleiding, is dit proefschrift verdeeld in 3 delen. In DEEL 
I van dit proefschrift, wordt zowel de fysiologische als de pathofysiologische 
ontwikkeling van de isolerende annulus fibrosus cordis en de etiologie van klinische 
door accessoire verbindingen gemedieerde atrioventriculaire (AV) reentry 
tachycardieën (AVRTs) bij kinderen en volwassenen structureel en functioneel 
geanalyseerd in verschillende experimentele diermodellen (kwartels, kippen en 
muizen) en in humane histologische en immunohistochemische coupes. Daarna 
worden in DEEL II van dit proefschrift allereerst de historische en huidige 
opvattingen betreffende de ontogenese van de AV knoop besproken. Aansluitend 
wordt een experimentele studie (in het kwartel en kipmodel) gepresenteerd, 
waarin een nieuw concept betreffende de ontwikkelingsbiologische oorsprong 
van de AV knoop en het slow pathway gebied van de AV knoop in relatie tot de 
etiologie van AV nodale reentry tachycardieën (AVNRTs) wordt gepostuleerd. 
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Afsluitend, worden in DEEL III van dit proefschrift therapeutische en andere 
klinische aspecten van SVTs bij kinderen besproken.
DEEL I
In Hoofdstuk 2, werd de fysiologische ontwikkeling van de isolerende annulus 
fibrosus cordis bestudeerd in de Japanse kwartel (Coturnix coturnix japonica). 
Ventriculaire activatiesequenties werden afgeleid van ex-ovo extracellulair 
opgenomen electrogrammen in zowel het embryonale (n=80; HH stadium 
30-44) als volwassen (n=6; 5-6 maanden) kwartelhart en gecorreleerd aan 
de ontwikkelingsbiologische morfologie van de isolerende annulus fibrosis. 
Functioneel bleek premature activatie van de ventriculaire basis als uiting 
van impuls voortgeleiding door persisterende accessoire verbindingen, op te 
kunnen treden tot de laatste stadia van de embryonale kwartel ontwikkeling. 
Morfologische data verkregen uit 16 embryonale en 1 volwassen kwartelhart 
bevestigde de functionele data en liet persisterende musculaire AV verbindingen 
door gaten in de isolerende annulus zien, terwijl in het volwassen hart complete 
continuïteit in de fibreuze annulus geobserveerd werd. Longitudinale analyse 
toonde aan dat deze persisterende accessoire verbindingen zowel in aantal 
(p=0.004) als in volume (p=0.179) afnamen met toenemend ontwikkelingsstadium 
en voornamelijk in de posteroseptale regio van het embryonale hart gelokaliseerd 
waren. Deze persisterende accessoire verbindingen bleken positief te kleuren voor 
het proteïne periostin, een non-myocardiale marker die gebruikt werd om cellen 
met een fibreuze identiteit te visualiseren, wat suggereert dat deze verbindingen 
uiteindelijk hun fibreuze identiteit zullen verliezen en daarmee aangeeft dat het 
proces van AV ring isolatie onder fysiologische omstandigheden pas postnataal 
gecompleteerd wordt. De resultaten van deze studie ondersteunen de hypothese 
dat persisterende accessoire verbindingen die de AV knoop zowel morfologisch 
als elektrofysiologisch passeren, structureel en functioneel aanwezig kunnen 
blijven tot op late post-gesepteerde stadia van de embryonale hartontwikkeling 
en op deze manier een fysiologisch substraat voor voorbijgaande AVRTs in 
het postnatale leven zouden kunnen vormen, wat mogelijk een etiologische 
verklaring zou kunnen geven voor de klinische observatie dat AVRTs in humane 
neonaten in de meerderheid van de gevallen spontaan lijken te verdwijnen voor 
de leeftijd van 1 jaar.
In Hoofdstuk 3, werd de pathofysiologische ontwikkeling van de isolerende 
annulus fibrosus cordis bestudeerd in een experimenteel model in de Japanse 
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kwartel (Coturnix coturnix japonica), waarin de migratie van ‘Epicardium-
Derived-Cells’ (EPDCs) mechanisch geïnhibeerd werd door de positionering 
van een klein stukje eierschaalmembraan tussen de dorsale wand van het 
embryonale kwartelhart en de pericardiale villi van het Pro-Epicardiale-
Orgaan (PEO) op ontwikkelingsstadium HH 15-18, met behulp van in-ovo 
microchirurgie. Na reïncubatie, werden in-ovo electrocardiogrammen (ECGs) 
opgenomen in normale (n=12) en EPDC-geïnhibeerde (n=12) HH stadium 38-
42 kwarteleieren. Aanvullend werden ventriculaire activatiesequenties afgeleid 
van ex-ovo extracellulaire electrogram opnamen in zowel het normale (n=45) als 
het EPDC-geïnhibeerde (n=12) kwartelhart op HH stadia 38-42 en gecorreleerd 
aan de ontwikkelingsbiologische morfologie van de isolerende annulus fibrosis. 
In een subgroep van EPDC-geïnhibeerde embryonen lieten de in-ovo ECGs 
de 3 belangrijkste electrocardiografische karakteristieken van ventriculaire 
pre-excitatie syndromen zien: 1) een verkort PR-interval, 2) een delta golf en 
3) een verlengd QRS-complex. Ex-ovo electrogrammen brachten aan het licht 
dat premature activatie van de ventriculaire basis in alle EPDC-geïnhibeerde 
embryonen voorkwam. Morfologisch kon ook in deze studie bevestigd worden 
dat er in het normale kwartelhart met name posteroseptaal gelokaliseerde 
accessoire verbindingen aanwezig zijn, welke ook in de EPDC-geïnhibeerde 
harten terug gevonden kunnen worden. In de EPDC-geïnhibeerde harten bleken 
echter additionele en relatief brede accessoire verbindingen in de rechter en 
linker laterale vrije myocardwand aanwezig te zijn. Periostin positiviteit werd 
gevonden in alle regionen van het hart waar ook EPDCs aanwezig zijn, zoals 
in het epicard, de endocardiale AV kussens, de epicardiale AV sulcus, het 
atriale en ventriculaire subendocard, de interstitiële fibroblasten en rondom de 
AV overgang. Hoewel de posteroseptale accessoire verbindingen positief voor 
periostin kleurden, bleek er rondom de brede laterale accessoire verbindingen 
in het EPDC-geïnhibeerde hart geen periostin expressie te zijn. Aan de hand 
van deze studie kunnen we concluderen dat EPDCs essentieel zijn voor een 
adequate formatie van de isolerende annulus fibrosis, daar inhibitie van de 
migratie van EPDCs tijdens de cardiogenese resulteert in grote defecten in 
de annulus fibrosis en het persisteren van brede accessoire verbindingen, die 
functioneel verantwoordelijk lijken te zijn voor het optreden van ventriculaire 
pre-excitatie. 
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Hoewel onder fysiologische omstandigheden smalle posteroseptale accessoire 
verbindingen tijdelijk functioneel actief blijven, zouden bredere lateraal 
gelokaliseerde accessoire verbindingen in het EPDC-geïnhibeerde hart mogelijk 
een pathologisch substraat voor postnataal persisterende accessoire verbindingen 
en AVRTs tot op de kinderleeftijd of volwassenheid kunnen vormen.
Na de beschrijving van deze experimentele studie, volgt een editorial dat 
geschreven is in antwoord op de resultaten van deze studie door Siew Yen Ho 
van de ‘Department of Cardiac Morphology and the National Heart & Lung 
Institute of the Imperial College London and the Royal Brompton Hospital ‘ uit 
het Verenigd Koninkrijk, waarin additionele ‘state-of-the-art’ kennis betreffende 
accessoire verbindingen vanuit een ontwikkelingsbiologisch oogpunt wordt 
beschreven.
In Hoofdstuk 4, werd de fysiologische ontwikkeling van de isolerende annulus 
fibrosus cordis bestudeerd in het wildtype muismodel (stam C57B16/Jico en CD1) 
om de data uit het vogelmodel te kunnen extrapoleren naar een zoogdiermodel. 
Met behulp van ex-ovo electrogrammen werden ventriculaire activatiesequenties 
afgeleid in het embryonale muizenhart (n=48) op de ontwikkelingsstadia  E 11.5 
– 18.5 dpc en gecorreleerd aan de morfologie van de zich ontwikkelende annulus 
fibrosis in alle elektrofysiologisch geanalyseerde harten (n=48). In deze studie 
hebben we laten zien dat de annulus fibrosis zich ontwikkelt in het embryonale 
AV junctionele myocard, waar geen connexine 43 (Cx43) tot expressie wordt 
gebracht. Net als in het kwartelhart, bleken persisterende accessoire verbindingen 
en functionele premature activatie van de ventriculaire basis ook tijdens de 
cardiogenese in de muis te bestaan. De persisterende accessoire verbindingen 
in het embryonale muizenhart bleken overblijfselen van het AV junctionele 
myocard te zijn, omdat deze verbindingen net als het AV junctionele myocard 
ook geen Cx43 tot expressie brachten. Op vroege post-gesepteerde stadia van 
de hartontwikkeling in de muis bleken de accessoire verbindingen voornamelijk 
rondom zowel de mitralis als tricuspidalis klep annulus gelokaliseerd te zijn, 
terwijl de hoeveelheid accessoire verbindingen rondom de mitraalklep annulus 
significant (p<0.001) afnam in het laat post-gesepteerde muizenhart. Net als in 
het kwartelmodel, werd expressie van periostin in het muizenmodel gevonden 
in het epicardium, de endotheliale bekleding van het atriale en ventriculaire 
myocard, de interstitiële fibroblasten, de endocardiale AV kussens, de epicardiale 
AV sulcus en de AV overgang. In de muis bleken de myocardiale Cx43 negatieve 
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cardiomyocyten van de accessoire verbindingen in tegenstelling tot de kwartel 
zelf geen periostin tot expressie te brengen, terwijl hoge concentraties periostin 
wel in de fibroblasten aangrenzend aan en in de accessoire verbindingen gevonden 
werd. Hoewel de accessoire verbindingen ook in de muis significant afnamen in 
zowel aantal (p=0.003) als volume (p=0.035) op toenemende ontwikkelingsstadia, 
bleken persisterende accessoire verbindingen aanwezig te zijn tot op late gepost-
speteerde stadia van de zoogdierontwikkeling. Vergelijkbaar met het vogelmodel, 
zou de fysiologische perinatale aanwezigheid van accessoire verbindingen in het 
muizenhart een tijdelijk substraat voor AVRTs in het perinatale leven kunnen 
vormen.
In Hoofdstuk 5, werd de aanwezigheid en specifieke lokalisatie van 
accessoire verbindingen tijdens de humane cardiogenese in relatie tot de 
fysiologische ontwikkeling van de isolerende annulus fibrosis bestudeerd. 
Immunohistochemische coupes van 45 humane embryonale, foetale en neonatale 
harten van 4 tot 6 weken gestatie (vogels ~HH stadium 14-46, muis ~E 10-19) 
werden geanalyseerd op het aantal en de locatie van accessoire verbindingen. 
Hoewel de annulus fibrosis in beginsel reeds aanwezig was rond 10 à 11 weken 
humane gestatie (vogels ~HH 21-27, muis ~E12.5-13.5), bleken multipele 
accessoire verbindingen de isolerende AV ring van zowel de linker als rechter 
annulus fibrosis te passeren tot aan het einde van het tweede trimester van 
de zwangerschap. Tijdens het tweede en derde trimester van de zwangerschap, 
was de linker annulus fibrosis reeds goed geïsoleerd door een dikke laag fibreus 
weefsel, terwijl de rechter AV annulus op dit ontwikkelingsstadium nog slechts 
zwak geïsoleerd was door een zeer dunne laag fibreus weefsel. Als gevolg 
hiervan, bleken er tot 20 weken humane gestatie (vogels ~HH 40, muis ~E17) 
accessoire verbindingen rond de laterale zijde van de tricuspidaalklep annulus 
aanwezig te zijn. Deze rechts gelokaliseerd accessoire verbindingen waren vaak 
in nabijheid van de rechter AV ring bundel, welke onderdeel uitmaakt van het 
tijdelijke embryonale gespecialiseerde AV geleidingssysteem, gelokaliseerd. 
Naast deze klassieke accessoire verbindingen bleken er in het zich ontwikkelende 
humane hart tot aan de geboorte ook myocardiale extensies te zijn die de zich 
ontwikkelende AV knoop met het myocard van het ventrikelseptum verbonden 
via gaten in de annulus fibrosis, corresponderend met het eerder beschreven 
fenomeen van foetale dispersie van de AV knoop. In deze studie hebben we 
onze morfologische data van eerdere dierexperimentele studies in het vogel 
en muismodel kunnen bevestigen en laten zien dat zoals gepostuleerd ook 
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in het humane hart de completering van de annulus fibrosis pas postnataal 
geschied, waarbij voornamelijk rechts gelokaliseerde persisterende accessoire 
verbindingen aanwezig blijven in het embryonale hart tot op late stadia van de 
ontwikkeling en zo mogelijk als substraat voor tijdelijke AVRTs bij foetussen of 
neonaten zouden kunnen functioneren.
DEEL II
In Hoofdstuk 6, werd een review betreffende de historische en huidige kennis 
omtrent de anatomie, fysiologie en ontogenese van de AV knoop en zijn atriale 
inputs gepresenteerd. Ook de structurele ontwikkeling van de AV knoop en de 
cellulaire elektrofysiologie van de embryonale AV overgang in relatie tot de 
volwassen AV knoop en het concept van AV nodale conductie dichotomie werden 
in dit hoofdstuk besproken. Hoewel het elektrofysiologisch substraat voor 
AVNRT uitgebreid bekend is, zijn de anatomische equivalenten die het reentry 
circuit vormen, grotendeels onbekend gebleven. Alhoewel recente markerstudies 
enige aanwijzingen betreffende de ontwikkelingsbiologische oorsprong van de 
AV knoop hebben gegeven, blijft de fysiologie, de structurele begrenzing en de 
ontogenese van de AV knoop grotendeels een raadsel.
Dit review wordt gevolgd door een experimentele studie in het kippen en 
kwartelmodel in Hoofdstuk 7, waarin een nieuw concept betreffende de 
ontwikkelingsbiologische oorsprong van de AV knoop werd gepostuleerd. In deze 
studie, werden spatiotemporele veranderingen in atriale activatiesequenties 
in het embryonale vogelhart (Japanse kwartel en witte Leghorn kip, HH stadia 
19-36, n=96) gecorreleerd aan de morfologie van het zich ontwikkelende hart 
(n=64). Rond HH stadium 19-22, werden bilaterale morfologisch onderscheidbare 
gebieden van myocardweefsel geïdentificeerd rondom het proximale myocardiale 
deel van de linker en rechter cardinaalvenen. Deze bilaterale gebieden werden 
beiden gekarakteriseerd door MLC2a positiviteit, Nkx2.5 negativiteit en 
relatief lage concentraties connexine 43, Nav1.5 en glycogeen vergeleken met 
het aangrenzende atriale myocard. Hoewel het proximale myocardiale deel van 
de rechter cardinaalvene (RCV) correspondeert met het primordium van de 
sinusknoop (SAN), werd gehypothetiseerd dat het proximale deel van de linker 
cardinaalvene (LCV) een contributie levert aan de formatie van de AV knoop. Tot 
op HH stadium 27, bleven de LCV weefsels caudodorsaal aan het linker atrium 
gepositioneerd en bleek er functioneel een duidelijke links-zijdige dominante 
pacemaker te zijn in 21% van de functioneel geanalyseerde harten, terwijl op 
348
deze stadia unilaterale impuls initiatie verwacht werd in de SAN in het rechter 
atrium. Na HH stadium 28, werd impuls initiatie in het linker atrium echter niet 
langer gevonden, wat perfect bleek te correleren aan de morfologische observatie 
dat rond HH stadium 28-30 de LCV reeds naar rechts getranspositioneerd was 
om in de basis van het rechter atrium de sinus coronarius (CS) te vormen, terwijl 
het myocard rondom het proximale deel van de LCV hierdoor gepositioneerd werd 
rondom het CS ostium in het slow pathway gebied van de toekomstig volwassen 
AV knoop. In deze studie hebben we laten zien dat de weefsels van de LCV een 
belangrijke functionele contributie aan de aanleg van de AV knoop in het slow 
pathway gebied lijken te leveren.
DEEL III
In Hoofdstuk 8, werden de langetermijnresultaten van radiofrequente 
katheterablatie (RF ablatie) in 118 pediatrische patiënten, die 140 RF 
ablatie procedures ondergingen voor 122 substraten voor supraventriculaire 
tachycardieën (SVTs), retrospectief geanalyseerd. De indicaties voor deze 
procedures waren: het falen of bijwerkingen van anti-arrhythmica (45%), keuze 
van patiënt/ouders (45%), cardiomyopathie of levensbedreigende aritmieën 
(8%) of naderende chirurgie voor congenitale hartdefecten (2%). In deze studie 
werd geconcludeerd dat de langetermijn uitkomst van pediatrische patiënten 
die RF ablatie hadden ondergaan wat betreft succespercentage, recidieven en 
complicatierisico gunstig is. Tevens bleek RF ablatie bij jongere kinderen (< 
10 jaar) net zo veilig en effectief te zijn als RF ablatie bij oudere kinderen en 
adolescenten (10-18 jaar). Deze resultaten laten zien dat het in gespecialiseerde 
centra ook goed mogelijk is om de jongste pediatrische SVT patiënten curatief en 
veilig te behandelen met RF ablatie.
In Hoofdstuk 9, werd een illustratief case report beschreven over het optreden 
van ‘incessant SVTs’  gemedieerd door een persisterende accessoire verbinding 
in een premature neonaat met hydrops foetalis. Hoewel RF ablatie bij neonaten 
en jonge kinderen zelden geïndiceerd is en enkel uitgevoerd dient te worden 
met inachtneming van maximale veiligheidsmaatregelen, werd in deze casus 
gekozen voor RF ablatie als laatste therapeutische optie. De hydropische neonaat 
werd geboren op 32 weken gestatie na een tijdelijke succesvolle directe foetale 
amiodarone-therapie via de navelstreng. Na de geboorte bleek de tachycardie 
echter oncontroleerbaar ondanks hoge doseringen amiodarone en flecaïnide, 
waarna de patiënt ernstig respiratoir en circulatoir falen ontwikkelde. 
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Drie weken na de geboorte, met een lichaamsgewicht van  2 kg, onderging deze 
patiënt een succesvolle en ongecompliceerde RF ablatieprocedure waarbij een 
accessoire verbinding in de linker vrije wand als substraat voor de SVTs werd 
gevonden en behandeld met low-energy RF applicatie.
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Conclusies
•	 Accessoire verbindingen die de isolerende annulus fibrosis en atrioventriculaire 
knoop (AV knoop) passeren zijn structurele overblijfselen van het embryonale 
AV junctionele myocard en blijven morfologisch aanwezig en functioneel 
in het kwartel en muizen hart tot op late post-gesepteerde stadia van de 
embryonale ontwikkeling en zouden een tijdelijk fysiologisch substraat voor 
AV reentry tachycardieën (AVRTs) in het perinatale leven kunnen vormen.
•	 Epicardium-Derived-Cells (EPDCs) zijn essentieel voor een adequate 
formatie van de isolerende annulus fibrosis.
•	 Inhibitie van EPDC-migratie tijdens de cardiogenese resulteert in grote 
defecten in de annulus fibrosis met het persisteren van brede accessoire 
verbindingen tot gevolg, die functioneel kunnen zorgen voor ventriculaire pre-
excitatie en mogelijk een pathologisch mechanisme vormen voor postnataal 
persisterende accessoire verbindingen en AVRTs op de kinderleeftijd of 
volwassen leeftijd.
•	 Periostin is een profibrogeen extracellulair matrix proteïne dat sterk tot 
expressie komt in collageenrijk fibreus weefsel. Expressie van periostin 
in de annulus fibrosis rondom myocardiale accessoire verbindingen in 
het embryonale kwartel en muizen hart, lijkt het postnatale lot van deze 
verbindingen aan te geven.
•	 Tijdens de humane ontwikkeling, tot op 20 weken gestatie, blijken accessoire 
verbindingen met name rondom de tricuspidaalklep annulus aanwezig 
te blijven en zijn vaak in nabijheid van de rechter AV ring bundel, die 
onderdeel uitmaakt van het tijdelijke embryonale gespecialiseerde AV 
geleidingssysteem, gelokaliseerd.
•	 In het zich ontwikkelende vogelhart zijn er initieel tijdelijk bilateraal 
functionele pacemakers aanwezig in het rechter en linker cardinaalvene 
myocard, waarna het rechter sinoatriale knoop myocard in de rechter 
cardinaalvene de dominante pacemaker zal worden.
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•	 Het myocard rondom het proximale deel van de linker cardinaalvene (LCV) 
in het embryonale vogelhart levert een belangrijke bijdrage aan het slow 
pathway gebied van de zich ontwikkelende heterogene AV knoop.
•	 De langetermijnuitkomst van pediatrische patiënten die een RF ablatie 
hebben ondergaan is wat betreft successpercentage, recidieven en 
complicatierisico gunstig. 
•	 Hoewel RF ablatie bij neonaten en jonge kinderen (<10 jaar) zelden geïndiceerd 
is en enkel uitgevoerd dient te worden met maximale voorzichtigheid, kan 
RF ablatie als veilig laatste alternatief geïndiceerd zijn in gespecialiseerde 
centra.
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Toekomstperspectieven
Door bestudering van de cardiogenese in het vogel, muizen en humane hart 
hebben we enkele aanwijzingen betreffende de fysiologische en pathologische 
ontwikkeling van de isolerende annulus fibrosis en de AV knoop aan het licht 
kunnen brengen. Uit deze studies is gebleken dat fysiologie en pathologie bij 
de ontwikkeling van de annulus fibrosis en het centrale geleidingssysteem 
nauw aan elkaar verbonden. Hoewel we hebben laten zien dat isolatie van 
de annulus fibrosis normaal gesproken pas postnataal gecompleteerd wordt, 
een essentiële rol voor EPDCs in de formatie van de annulus fibrosis hebben 
aangetoond, een nieuw concept betreffende de ontwikkeling van de AV knoop 
hebben gepostuleerd en bruikbare (immuno)histochemische markers zoals PAS-
staining en de antilichamen MLC2a, Nkx2.5, periostin, Cx43 en Nav1.5,  hebben 
geïdentificeerd voor de analyse van deze processen, blijven verscheidene aspecten 
van normale en abnormale annulus fibrosis formatie en AV knoop ontwikkeling 
onbeantwoord. Alhoewel we het ontwikkelingsbiologische proces van annulus 
fibrosis formatie zowel in het vogel en als in het muizenmodel hebben onderzocht 
en deze data hebben geëxtrapoleerd naar onderzoek in humane coupes, blijft de 
vraag bestaan hoe de gepostuleerde functionele implicaties getransleerd kunnen 
worden naar klinisch relevante problemen. Ook het conundrum betreffende de 
vraag of accessoire verbindingen die zich pas later in het leven presenteren tevens 
verbindingen zijn die postnataal zijn blijven bestaan maar tijdelijk functioneel 
verborgen zijn gebleven of dat deze verbindingen de novo zijn ontstaan en door 
nieuw ontwikkelde gaten in de annulus fibrosis zijn gegroeid, blijft bestaan.  
 Om deze en andere onderzoeksvragen verder te kunnen analyseren, zal 
toekomstig onderzoek op dit terrein met name gericht zijn op additionele  analyse 
van atriale en ventriculaire activatiesequenties in het zich ontwikkelende en 
volwassen hart met behulp van nieuwere technieken zoals Multi-Electrode-
Array (MEA) opnamen en optical mapping door toepassing van voltage 
sensitieve kleurstoffen. Ook kennis betreffende de cellulaire elektrofysiologie 
van de persisterende accessoire verbindingen en de gepostuleerde AV nodale 
primordiale weefsels, zoals beschreven in dit proefschrift, door analyse van de 
intracellulaire elektrofysiologie met behulp van patch clamp opnames, zal meer 
licht schijnen op de functionele implicaties van onze huidige en toekomstige 
experimentele bevindingen. Toekomstig onderzoek zal ook gericht zijn op de 
toepassing van (nieuwe) genetisch gemodificeerde diermodellen (zoals bv. de 
podoplanine-KO muis of Shox2-KO muis) en de identificatie en exploratie van 
353
C
hapter 0
Sam
envatting, C
onclusies &
 Toekom
stperspectieven
de expressie van (nieuwe) myocardiale markers (zoals Nkx2.5) en markers 
voor het cardiale geleidingssysteem (zoals Islet-1 en Id-2) en hun onderlinge 
interacties. De studies in dit proefschrift hebben in ieder geval laten zien dat 
een systematische analyse van de anatomie in relatie tot de functionaliteit ook 
fundamenteel zal zijn in toekomstig onderzoek naar de ontwikkelingsbiologische 
mechanismen die ten grondslag liggen aan de formatie van de annulus fibrosis 
en AV knoop ontwikkeling en uiteindelijk een translationele basis zal vormen 
om klinisch relevante aspecten van cardiale arritmieën succesvol te kunnen 
interpreteren. 
Wat betreft het klinisch onderzoek naar pediatrische SVTs en de therapeutische 
opties beschreven in dit proefschrift, is de verwachting dat huidige lopende 
grote prospectieve pediatrische studies een volgende stap in de evaluatie van 
de klinische presentatie en het bepalen van behandelingsstrategieën zullen 
vormen.
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